
<html lang="en"     class="pb-page"  data-request-id="2f82b70f-809c-4a3f-bdb4-02fe0e67947b"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;article:article:10.1021/acs.jmedchem.6b00879;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2016.59.issue-16;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Design and Synthesis of Orally Bioavailable 4-Methyl Heteroaryldihydropyrimidine Based Hepatitis B Virus (HBV) Capsid Inhibitors" /></meta><meta name="dc.Creator" content="Zongxing  Qiu" /></meta><meta name="dc.Creator" content="Xianfeng  Lin" /></meta><meta name="dc.Creator" content="Mingwei  Zhou" /></meta><meta name="dc.Creator" content="Yongfu  Liu" /></meta><meta name="dc.Creator" content="Wei  Zhu" /></meta><meta name="dc.Creator" content="Wenming  Chen" /></meta><meta name="dc.Creator" content="Weixing  Zhang" /></meta><meta name="dc.Creator" content="Lei  Guo" /></meta><meta name="dc.Creator" content="Haixia  Liu" /></meta><meta name="dc.Creator" content="Guolong  Wu" /></meta><meta name="dc.Creator" content="Mengwei  Huang" /></meta><meta name="dc.Creator" content="Min  Jiang" /></meta><meta name="dc.Creator" content="Zhiheng  Xu" /></meta><meta name="dc.Creator" content="Zheng  Zhou" /></meta><meta name="dc.Creator" content="Ning  Qin" /></meta><meta name="dc.Creator" content="Shuang  Ren" /></meta><meta name="dc.Creator" content="Hongxia  Qiu" /></meta><meta name="dc.Creator" content="Sheng  Zhong" /></meta><meta name="dc.Creator" content="Yuxia  Zhang" /></meta><meta name="dc.Creator" content="Yi  Zhang" /></meta><meta name="dc.Creator" content="Xiaoyue  Wu" /></meta><meta name="dc.Creator" content="Liping  Shi" /></meta><meta name="dc.Creator" content="Fang  Shen" /></meta><meta name="dc.Creator" content="Yi  Mao" /></meta><meta name="dc.Creator" content="Xue  Zhou" /></meta><meta name="dc.Creator" content="Wengang  Yang" /></meta><meta name="dc.Creator" content="Jim Z.  Wu" /></meta><meta name="dc.Creator" content="Guang  Yang" /></meta><meta name="dc.Creator" content="Alexander V.  Mayweg" /></meta><meta name="dc.Creator" content="Hong C.  Shen" /></meta><meta name="dc.Creator" content="Guozhi  Tang" /></meta><meta name="dc.Description" content="Targeting the capsid protein of hepatitis B virus (HBV) and thus interrupting normal capsid formation have been an attractive approach to block the replication of HBV viruses. We carried out multid..." /></meta><meta name="Description" content="Targeting the capsid protein of hepatitis B virus (HBV) and thus interrupting normal capsid formation have been an attractive approach to block the replication of HBV viruses. We carried out multid..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="August 10, 2016" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.6b00879" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2016 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b00879" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.6b00879" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b00879" /></link>
        
    
    

<title>Design and Synthesis of Orally Bioavailable 4-Methyl Heteroaryldihydropyrimidine Based Hepatitis B Virus (HBV) Capsid Inhibitors | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.6b00879" /></meta><meta property="og:title" content="Design and Synthesis of Orally Bioavailable 4-Methyl Heteroaryldihydropyrimidine Based Hepatitis B Virus (HBV) Capsid Inhibitors" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00879/20160819/images/large/jm-2016-008799_0021.jpeg" /></meta><meta property="og:description" content="Targeting the capsid protein of hepatitis B virus (HBV) and thus interrupting normal capsid formation have been an attractive approach to block the replication of HBV viruses. We carried out multidimensional structural optimizations based on the heteroaryldihydropyrimidine (HAP) analogue Bay41-4109 (1) and identified a novel series of HBV capsid inhibitors that demonstrated promising cellular selectivity indexes, metabolic stabilities, and in vitro safety profiles. Herein we disclose the design, synthesis, structure–activity relationship (SAR), cocrystal structure in complex with HBV capsid proteins and in vivo pharmacological study of the 4-methyl HAP analogues. In particular, the (2S,4S)-4,4-difluoroproline substituted analogue 34a demonstrated high oral bioavailability and liver exposure and achieved over 2 log viral load reduction in a hydrodynamic injected (HDI) HBV mouse model." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.6b00879"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.6b00879">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.6b00879&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.6b00879&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.6b00879&amp;href=/doi/10.1021/acs.jmedchem.6b00879" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2016</span><span class="cit-fg-volume">, 59</span><span class="cit-fg-issue">, 16</span><span class="cit-fg-pageRange">, 7651-7666</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/59/16" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.6b00860" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.6b00906" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Design and Synthesis of Orally Bioavailable 4-Methyl Heteroaryldihydropyrimidine Based Hepatitis B Virus (HBV) Capsid Inhibitors</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zongxing++Qiu">Zongxing Qiu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xianfeng++Lin">Xianfeng Lin</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mingwei++Zhou">Mingwei Zhou</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yongfu++Liu">Yongfu Liu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Wei++Zhu">Wei Zhu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Wenming++Chen">Wenming Chen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Weixing++Zhang">Weixing Zhang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lei++Guo">Lei Guo</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Haixia++Liu">Haixia Liu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Guolong++Wu">Guolong Wu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mengwei++Huang">Mengwei Huang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Min++Jiang">Min Jiang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zhiheng++Xu">Zhiheng Xu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zheng++Zhou">Zheng Zhou</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ning++Qin">Ning Qin</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Shuang++Ren">Shuang Ren</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hongxia++Qiu">Hongxia Qiu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sheng++Zhong">Sheng Zhong</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yuxia++Zhang">Yuxia Zhang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yi++Zhang">Yi Zhang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xiaoyue++Wu">Xiaoyue Wu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Liping++Shi">Liping Shi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Fang++Shen">Fang Shen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yi++Mao">Yi Mao</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xue++Zhou">Xue Zhou</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Wengang++Yang">Wengang Yang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jim+Z.++Wu">Jim Z. Wu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Guang++Yang">Guang Yang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alexander+V.++Mayweg">Alexander V. Mayweg</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hong+C.++Shen">Hong C. Shen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Guozhi++Tang">Guozhi Tang</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text"><sup>†</sup>Roche Innovation Center Shanghai, <sup>‡</sup>Medicinal Chemistry, <sup>§</sup>Chemical Biology, <sup>∥</sup>Pharmaceutical Sciences, and <sup>⊥</sup>Discovery Virology, Roche Pharma Research and Early Development, 720 Cailun Road, Shanghai, 201203 China</span></div><div class="corresp-info"><strong>*</strong>Phone: +86 21 28946723. E-mail: <a href="/cdn-cgi/l/email-protection#dfb8aab0a5b7b6abbeb1b8ee9fb7b0abb2beb6b3f1bcb0b2"><span class="__cf_email__" data-cfemail="d9beacb6a3b1b0adb8b7bee899b1b6adb4b8b0b5f7bab6b4">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b00879&amp;href=/doi/10.1021%2Facs.jmedchem.6b00879" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2016</span></span><span class="cit-volume">, 59</span><span class="cit-issue">, 16</span><span class="cit-pageRange">, 7651–7666</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">July 26, 2016</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>12 June 2016</li><li><span class="item_label"><b>Published</b> online</span>10 August 2016</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 25 August 2016</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.6b00879" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00879</a></div><div class="article_header-article-copyright"><strong>Copyright © 2016 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D7651%26pageCount%3D16%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DZongxing%2BQiu%252C%2BXianfeng%2BLin%252C%2BMingwei%2BZhou%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D59%26issueNum%3D16%26contentID%3Dacs.jmedchem.6b00879%26title%3DDesign%2Band%2BSynthesis%2Bof%2BOrally%2BBioavailable%2B4-Methyl%2BHeteroaryldihydropyrimidine%2BBased%2BHepatitis%2BB%2BVirus%2B%2528HBV%2529%2BCapsid%2BInhibitors%26numPages%3D16%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D7666%26publicationDate%3DAugust%2B2016">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.6b00879"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2917</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">42</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.6b00879" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Design and Synthesis of Orally Bioavailable 4-Methyl Heteroaryldihydropyrimidine Based Hepatitis B Virus (HBV) Capsid Inhibitors&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Zongxing&quot;,&quot;last_name&quot;:&quot;Qiu&quot;},{&quot;first_name&quot;:&quot;Xianfeng&quot;,&quot;last_name&quot;:&quot;Lin&quot;},{&quot;first_name&quot;:&quot;Mingwei&quot;,&quot;last_name&quot;:&quot;Zhou&quot;},{&quot;first_name&quot;:&quot;Yongfu&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Wei&quot;,&quot;last_name&quot;:&quot;Zhu&quot;},{&quot;first_name&quot;:&quot;Wenming&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Weixing&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Lei&quot;,&quot;last_name&quot;:&quot;Guo&quot;},{&quot;first_name&quot;:&quot;Haixia&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Guolong&quot;,&quot;last_name&quot;:&quot;Wu&quot;},{&quot;first_name&quot;:&quot;Mengwei&quot;,&quot;last_name&quot;:&quot;Huang&quot;},{&quot;first_name&quot;:&quot;Min&quot;,&quot;last_name&quot;:&quot;Jiang&quot;},{&quot;first_name&quot;:&quot;Zhiheng&quot;,&quot;last_name&quot;:&quot;Xu&quot;},{&quot;first_name&quot;:&quot;Zheng&quot;,&quot;last_name&quot;:&quot;Zhou&quot;},{&quot;first_name&quot;:&quot;Ning&quot;,&quot;last_name&quot;:&quot;Qin&quot;},{&quot;first_name&quot;:&quot;Shuang&quot;,&quot;last_name&quot;:&quot;Ren&quot;},{&quot;first_name&quot;:&quot;Hongxia&quot;,&quot;last_name&quot;:&quot;Qiu&quot;},{&quot;first_name&quot;:&quot;Sheng&quot;,&quot;last_name&quot;:&quot;Zhong&quot;},{&quot;first_name&quot;:&quot;Yuxia&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Yi&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Xiaoyue&quot;,&quot;last_name&quot;:&quot;Wu&quot;},{&quot;first_name&quot;:&quot;Liping&quot;,&quot;last_name&quot;:&quot;Shi&quot;},{&quot;first_name&quot;:&quot;Fang&quot;,&quot;last_name&quot;:&quot;Shen&quot;},{&quot;first_name&quot;:&quot;Yi&quot;,&quot;last_name&quot;:&quot;Mao&quot;},{&quot;first_name&quot;:&quot;Xue&quot;,&quot;last_name&quot;:&quot;Zhou&quot;},{&quot;first_name&quot;:&quot;Wengang&quot;,&quot;last_name&quot;:&quot;Yang&quot;},{&quot;first_name&quot;:&quot;Jim&quot;,&quot;last_name&quot;:&quot;Z. Wu&quot;},{&quot;first_name&quot;:&quot;Guang&quot;,&quot;last_name&quot;:&quot;Yang&quot;},{&quot;first_name&quot;:&quot;Alexander&quot;,&quot;last_name&quot;:&quot;V. Mayweg&quot;},{&quot;first_name&quot;:&quot;Hong&quot;,&quot;last_name&quot;:&quot;C. Shen&quot;},{&quot;first_name&quot;:&quot;Guozhi&quot;,&quot;last_name&quot;:&quot;Tang&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2016&quot;,&quot;month&quot;:&quot;08&quot;,&quot;day&quot;:&quot;10&quot;,&quot;issue&quot;:&quot;16&quot;,&quot;volume&quot;:&quot;59&quot;,&quot;pages&quot;:&quot;7651-7666&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.6b00879&quot;},&quot;abstract&quot;:&quot;Targeting the capsid protein of hepatitis B virus (HBV) and thus interrupting normal capsid formation have been an attractive approach to block the replication of HBV viruses. We carried out multidimensional structural optimizations based on the heteroaryldihydropyrimidine (HAP) analogue Bay41-4109 (1) and identified a novel series of HBV capsid inhibitors that demonstrated promising cellular selectivity indexes, metabolic stabilities, and in vitro safety profiles. Herein we disclose the design, synthesis, structure–activity relationship (SAR), cocrystal structure in complex with HBV capsid proteins and in vivo pharmacological study of the 4-methyl HAP analogues. In particular, the (2S,4S)-4,4-difluoroproline substituted analogue 34a demonstrated high oral bioavailability and liver exposure and achieved over 2 log viral load reduction in a hydrodynamic injected (HDI) HBV mouse model.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00879&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00879" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00879&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00879" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00879&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00879" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b00879&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00879&amp;href=/doi/10.1021/acs.jmedchem.6b00879" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.6b00879" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.6b00879" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00879&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.6b00879%26sid%3Dliteratum%253Aachs%26pmid%3D27458651%26genre%3Darticle%26aulast%3DQiu%26date%3D2016%26atitle%3DDesign%2Band%2BSynthesis%2Bof%2BOrally%2BBioavailable%2B4-Methyl%2BHeteroaryldihydropyrimidine%2BBased%2BHepatitis%2BB%2BVirus%2B%2528HBV%2529%2BCapsid%2BInhibitors%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D59%26issue%3D16%26spage%3D7651%26epage%3D7666%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291316" title="Mixtures">Mixtures</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=290723" title="Solutions">Solutions</a>,</li><li><a href="/action/doSearch?ConceptID=292349" title="Alkyls">Alkyls</a>,</li><li><a href="/action/doSearch?ConceptID=291439" title="Genetics">Genetics</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/59/16" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/jmcmar.2016.59.issue-16/20160825/jmcmar.2016.59.issue-16.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00879/20160819/images/medium/jm-2016-008799_0021.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00879/20160819/images/large/jm-2016-008799_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00879&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Targeting the capsid protein of hepatitis B virus (HBV) and thus interrupting normal capsid formation have been an attractive approach to block the replication of HBV viruses. We carried out multidimensional structural optimizations based on the heteroaryldihydropyrimidine (HAP) analogue Bay41-4109 (<b>1</b>) and identified a novel series of HBV capsid inhibitors that demonstrated promising cellular selectivity indexes, metabolic stabilities, and in vitro safety profiles. Herein we disclose the design, synthesis, structure–activity relationship (SAR), cocrystal structure in complex with HBV capsid proteins and in vivo pharmacological study of the 4-methyl HAP analogues. In particular, the (2<i>S</i>,4<i>S</i>)-4,4-difluoroproline substituted analogue <b>34a</b> demonstrated high oral bioavailability and liver exposure and achieved over 2 log viral load reduction in a hydrodynamic injected (HDI) HBV mouse model.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31621" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31621" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Chronic hepatitis B virus (HBV) infection remains a major threat to public health despite the fact that HBV vaccination programs have been extensively implemented in the past. There are about 350 million chronic HBV carriers in the world and disease progression among many of them often leads to cirrhosis and hepatocellular carcinoma.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> It has been estimated that HBV infection directly or indirectly accounts for an annual death of 600 000 patients. Nevertheless, current treatment options are limited to interferons (IFNs) and nucleos(t)ides-based reverse transcriptase inhibitors that do not offer a satisfactory clinical cure rate for chronic HBV carriers.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> For example, the response rate in HBeAg-positive patients following 4–5 years of treatment with nucleos(t)ides is about 0–10%, and 8–15% with pegylated IFN-α or pegylated IFN-α plus lamivudine, whereas the response rate in HBeAg-negative patients is even lower. Of note, nucleos(t)ide therapies typically require lifetime treatment to prevent viral rebound while IFNs require parenteral administration and are associated with adverse effects such as “flu-like” symptoms. To achieve a higher HBV cure rate than current standard of care, a multipronged approach with new molecular entities is very likely required.<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3, 4)</a> As such, there is a tremendous unmet medical need to identify and develop novel, efficacious, and safe anti-HBV agents with diverse mechanisms of action.</div><div class="NLM_p">As a structural component of the viral nucleocapsid, the HBV capsid protein plays multiple roles in the HBV lifecycle including reverse transcription of pregenomic RNA (pgRNA), formation and intracellular trafficking of relaxed circular DNA, and subviral particle formation.<a onclick="showRef(event, 'ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref5 ref6">(5, 6)</a> To date, a number of reported capsid inhibitors (or effectors) are able to interrupt normal capsid assembly and thus inhibit HBV DNA synthesis (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>). Among them, Bay 41-4109 (<b>1</b>), a heteroaryldihydropyrimidine (HAP) compound, is a seminal HBV capsid inhibitor that has been well studied in the past.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Mechanistic and biostructural studies indicate that <b>1</b> can fit into a hydrophobic pocket located at the interface of capsid dimers and trigger aberrant capsid assembly and aggregation.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Treatment of virus-producing HepG2.2.15 cells with <b>1</b> leads to reduction of HBV DNA as well as dose-dependent depletion of core proteins and nucleocapsids.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> However, further development of <b>1</b> has been hindered by several factors including in vitro and in vivo toxicity and limited efficacy in animal models.<a onclick="showRef(event, 'ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref9 ref10">(9, 10)</a> GLS-4 (<b>2</b>) and <b>3</b> are a new generation of HAP analogues featuring 6-morpholine substituents and 2-thioazolyl groups attached to the core scaffold.<a onclick="showRef(event, 'ref11 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref11 ref12 ref13">(11-13)</a> Although reported to be more potent and less cytotoxic in in vitro tests, <b>2</b> demonstrated similar in vivo effects as <b>1</b> in a mouse model.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Acrylamide <b>4</b> (previously reported as AT-61 but with the wrong <i>E</i>-configuration),<a onclick="showRef(event, 'ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref14 ref15">(14, 15)</a> sulfamoylbenzamide DVR23 (<b>5</b>),<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> and isothiafludine (<b>6</b>)<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> are the other class of capsid inhibitors that have distinct effects on the HBV capsid assembly process from that of HAPs. Mechanistically, compounds <b>4</b>–<b>6</b> also bind to capsid proteins and accelerate the capsid assembly process, but they usually result in normal-sized and pgRNA-free empty capsids. Sometimes referred to as pgRNA encapsidation blockers, <b>4</b>–<b>6</b> inhibit HBV DNA synthesis without the capsid depletion effects of HAPs.<a onclick="showRef(event, 'ref16 ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref16 ref17 ref18">(16-18)</a> Whether the in-cell capsid depletion induced by HAPs provides an extra benefit to treat HBV infection or not remains to be investigated in relevant animal models and eventually in a clinical setting.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00879/20160819/images/medium/jm-2016-008799_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00879/20160819/images/large/jm-2016-008799_0002.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Chemical structures of reported HBV capsid inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00879/20160819/images/large/jm-2016-008799_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00879&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">To develop novel, orally bioavailable, and in vivo efficacious anti-HBV agents, we attempted to explore the chemistry space of HAPs from benchmark analogue <b>1</b> with goals to enhance anti-HBV activity, reduce cytotoxicity, and improve metabolic stability and in vitro safety profiles.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78336" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78336" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Section 1. Design and Synthesis of 4-Methyl HAPs</h3><div class="NLM_p">Because of the lack of high resolution cocrystal structures of capsid protein and HAPs at the time,<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> an information-driven approach was carried out to optimize the HAP series represented by <b>1</b>. First, metabolite identification studies of <b>1</b> upon incubation with human and mouse liver microsomes (HLM and MLM) indicated that aromatization of the dihydropyrimidine core (M-2H) is a major metabolic pathway. When evaluated in HepDE19 cells that support high levels of HBV DNA replication,<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a><b>1</b> demonstrates anti-HBV activity with an EC<sub>50</sub> of 0.14 μM. The corresponding CC<sub>50</sub> value of <b>1</b> is 13.4 μM in the same cell line. Further structure–activity relationship (SAR) study of 4-H HAPs revealed that 2-Cl on the 4-phenyl head group is indispensable to their anti-HBV activities and that the 3,5-difluoropyridinyl moiety is chemically susceptible to nucleophilic S<sub>N</sub>Ar displacements (unpublished results). Taken together, it was anticipated that 4-methyl-substituted HAPs would not be susceptible to aromatization and that the methyl group could also take a position close to the 2-Cl substituent of <b>1</b> and recapitulate its role in capsid binding (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>). Indeed, predicted lowest energy conformations of 4-methyl HAP <b>7a</b> (4-<i>S</i> enantiomer as shown) and 4-H HAPs like <b>1</b> overlay well with one another and the 4-methyl group of <b>7a</b> points in the same direction as the 2-Cl substituent of <b>1</b>. Further conformation analysis also suggested that the 4-phenyl group of <b>7a</b> remains orthogonal to the HAP core and that the 2-thiazolyl moiety is essentially coplanar with the HAP core due to the formation of an intramolecular hydrogen bond and 1,4-N–S interaction.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Thus, a series of 4-methyl-substituted HAP analogues including <b>7a</b>–<b>c</b> were synthesized and evaluated in HepDE19 cells.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00879/20160819/images/medium/jm-2016-008799_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00879/20160819/images/large/jm-2016-008799_0003.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Predicted lowest energy conformations of <b>1</b> (A) and (<i>S</i>)-enantiomer of <b>7a</b> (B) in vacuum. Force field MMFF94x<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> was applied in Molecular Operating Environment (MOE), CCG. An intramolecular hydrogen-bonding (HB) interaction between 1-NH and 2-heteroaryl group is indicated. Molecules are presented as ball and stick with electrostatic surface included. Carbon, oxygen, nitrogen, fluorine, and chlorine atoms are shown in gray, red, blue, green, and dark green colors, respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00879/20160819/images/large/jm-2016-008799_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00879&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Generally, 4-methyl HAP analogues can be prepared from β-ketoester <b>8</b> and a variety of benzaldehydes <b>9</b> according to the procedures shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. Briefly, an aldol condensation of <b>8</b> and <b>9</b> was carried out and the resulting products were treated with CH<sub>3</sub>CuLi to give 1,4-Michael addition products <b>10</b>. Ketoesters <b>10</b> were then treated by a two-step phenylselenation and oxidation to give α, β-unsaturated esters <b>11</b>, which were separated and used in the subsequent step as a mixture of <i>E</i>/<i>Z</i>-isomers. The condensation and ring cyclization reactions of <b>11</b> and amidines <b>12</b> turned out to be quite sluggish and complicated, in part because of high steric hindrance and decomposition of <b>11</b> at high temperature. To minimize the decomposition issue, olefins <b>11</b> were dissolved in NMP and added dropwise into a stirring mixture of <b>12</b> and NaHCO<sub>3</sub> in NMP that was prewarmed to 120 °C. By this method, the methyl-substituted HAP scaffold with a quaternary carbon was successfully built up from <b>11</b> and <b>12</b> in moderate to high yields.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00879/20160819/images/medium/jm-2016-008799_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00879/20160819/images/large/jm-2016-008799_0006.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of 4-Alkyl-Substituted HAP Analogues <b>7a</b>–<b>j</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00879/20160819/images/large/jm-2016-008799_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00879&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) piperidine, HOAc, EtOH; (b) CH<sub>3</sub>CuLi, THF, – 78 °C; (c) PhSeCl, NaH, THF; (d) H<sub>2</sub>O<sub>2</sub>/H<sub>2</sub>O, DCM; (e) NaHCO<sub>3</sub>, NMP, 120 °C, 2 h, 30–70%; (f) NaBH<sub>4</sub>, EtOH; (g) SOCl<sub>2</sub>, DCM, 90% for 2 steps; (h) <b>8</b>, NaH, THF, 60%; (i) thiazole-2-carboxamidine, AcOK, <i>i</i>-PrOH, 120 °C, 15%.</p></p></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Section 2. SAR at the 4-Phenyl Head Group of 4-Methyl HAPs</h3><div class="NLM_p">Analogues <b>7a</b> and <b>7b</b> moderately reduced HBV DNA in cellular activity tests with EC<sub>50</sub> values of 11.6 μM and 7.1 μM, respectively (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). On the other hand, they were also much less cytotoxic to HepDE19 cells with CC<sub>50</sub> values above 100 μM and had good aqueous solubility in lyophilized solubility assays (LYSA). To confirm the anti-HBV activity of this new HAP scaffold, we conducted chiral separation of <b>7a</b> by supercritical fluid chromatography (SFC) and determined that enantiomer (<i>S</i>)-<b>7a</b> is active in HepDE19 cells with an EC<sub>50</sub> of 6.8 μM. The absolute configuration of (<i>S</i>)-<b>7a</b> was confirmed by single crystal X-ray studies, and it is clear that the core structures and 4-phenyl head groups of (<i>S</i>)-<b>7a</b> and <b>1</b> are well aligned to each other (see the <a href="/doi/suppl/10.1021/acs.jmedchem.6b00879/suppl_file/jm6b00879_si_001.pdf" class="ext-link">Supporting Information</a>). Notably, analogue <b>7c</b> with the same 2-Cl, 4-F phenyl group of <b>1</b> was less active than <b>7a</b> and <b>7b</b> and was more cytotoxic to HepDE19 cells with a CC<sub>50</sub> of 82.5 μM. The 2-Cl substituent of <b>7c</b> may occupy a position opposite the 4-methyl group, an orientation that may not favor target binding. Furthermore, 4-methyl HAPs may generally have different SAR and chemistry space relative to <b>1</b>, especially at the 4-phenyl head group. Thus, additional structural explorations of the 4-methyl HAPs were carried out in an attempt to rescue their in vitro anti-HBV activities.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Effects on HBV DNA Reduction and Physicochemical Properties of <b>7a</b>–<b>j</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00879/20160819/images/medium/jm-2016-008799_0011.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00879/20160819/images/medium/jm-2016-008799_0012.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">EC<sub>50</sub> values [μM] for the reduction of HBV DNA in HepDE19 cells. The levels of HBV DNA in supernatant were determined by dot-blot experiments in duplicate runs, with variation of <15%.</p></div><div class="footnote" id="t1fn2"><sup>Table b</sup><p class="last">CC<sub>50</sub> values [μM] measured by CCK-8 in HepDE19 cells. Experiments were in duplicate runs with variation of <15%.</p></div><div class="footnote" id="t1fn3"><sup>Table c</sup><p class="last">Selectivity index (SI) of CC<sub>50</sub>/EC<sub>50</sub> in HepDE19 cells.</p></div><div class="footnote" id="t1fn4"><sup>Table d</sup><p class="last">Predicted partition coefficient between octanol phase and water phase (K<sub>ow</sub>logP).</p></div><div class="footnote" id="t1fn5"><sup>Table e</sup><p class="last">Lyophilized solubility assay (LYSA) from duplicate runs, mean values reported in μg/mL with variation of <10%.</p></div></div><div></div></div><div class="NLM_p">A number of analogues with structure variations at the 4-phenyl head group (substitution at the C4 of the HAP core) were prepared and evaluated for their anti-HBV activities (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). SAR analysis indicated that the <i>p</i>-F substituent on the 4-phenyl group is critical for anti-HBV activity and that replacements like −H, −SO<sub>2</sub>Me, −OMe, and −CN reduce potency in HepDE19 cells (analogues including <b>7d</b> and <b>7f</b>–<b>h</b>). Just like <b>7c</b>, analogue <b>7e</b> had inferior cytotoxicity and metabolic stability profiles with MLM of 85 mL min<sup>–1</sup> kg<sup>–1</sup>, presumably due to their high lipophilicity (K<sub>ow</sub>logP ≥ 4.6). On the other hand, polar and electron-withdrawing substituents such as −SO<sub>2</sub>Me, −CN, −CO<sub>2</sub>H and amide groups improved the metabolic stability and solubility profiles of 4-methyl HAPs. For example, analogues <b>7f</b> and <b>7h</b> showed lower intrinsic clearance with MLM of 57 and 75 mL min<sup>–1</sup> kg<sup>–1</sup>, respectively. Introducing a second fluorine substitution at the <i>m</i>-position improved the potency of analogue <b>7i</b> relative to <b>7a,</b> with an EC<sub>50</sub> of 4.1 μM. However, <b>7i</b> was also highly lipophilic (K<sub>ow</sub>logP = 4.4) with MLM of 83 mL min<sup>–1</sup> kg<sup>–1</sup>. We speculated that the head groups sit in a hydrophobic pocket making close molecular contacts with HBV capsid proteins such that minor structural modifications can have profound effects on anti-HBV activity.</div><div class="NLM_p last">Considering the SAR findings discussed above, we explored the tolerability of larger alkyl groups including ethyl at the 4-position of HAPs. To synthesize the 4-ethyl-substituted HAP analogue <b>7j</b>, ketone <b>13</b> was reduced with NaBH<sub>4</sub> and the resulting alcohol was converted to substituted benzyl chloride <b>14</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). Chloride <b>14</b> was then treated with <b>8</b> and NaH to afford β-ketoester <b>15</b>. By use of the same methods as described previously, tetrasubstituted olefin <b>16</b> was obtained, and it was added into a mixture of thiazole-2-carboxamidine and KOAc in isopropanol at 120 °C to give analogue <b>7j</b>. Unforutnately, <b>7j</b> was inactive in HepDE19 cells (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). Thus, the 4-methyl HAP core was fixed in subsequent explorations of structure–property relationships focused on the 2-heteroaryl and 5- and 6-positions of the HAP core.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Section 3. SAR of 2-Heteroaryls in 6-Morpholine-Substituted 4-Methyl HAPs</h3><div class="NLM_p">As in the case of 4-H HAPs like <b>2</b> and <b>3</b>,<a onclick="showRef(event, 'ref11 ref22'); return false;" href="javascript:void(0);" class="ref ref11 ref22">(11, 22)</a> a solubilizing 6-morpholine substituent may help improve in vitro anti-HBV potency, yet its impact on the 4-methyl HAPs remained to be investigated. Accordingly, 6-morpholine substituted analogues <b>18a</b>–<b>k</b> were prepared from racemic or optically pure intermediates <b>7</b> (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). As an efficient method, 4-methyl HAPs were treated with (Boc)<sub>2</sub>O anhydride and <i>N</i>,<i>N</i>′-dimethylaminopyridine (DMAP) and the <i>N</i>-Boc protected products were treated with NBS and azobisisobutyronitrile (AIBN) at 50 °C to give bromides <b>17</b>. Without purification, bromides <b>17</b> were substituted with morpholine and the products were treated with trifluoroacetic acid (TFA) to give analogues <b>18a</b>–<b>k</b> in over 40% yields.</div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00879/20160819/images/medium/jm-2016-008799_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00879/20160819/images/large/jm-2016-008799_0007.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of 4-Methyl HAP Analogues <b>18a</b>–<b>k</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00879/20160819/images/large/jm-2016-008799_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00879&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (Boc)<sub>2</sub>O, DMAP, DCM, rt, overnight; (b) NBS, AIBN, CCl<sub>4</sub>, 50 °C, 2 h; (c) morpholine, DCM, 50 °C, 1 h; (d) TFA, DCM, rt.</p></p></figure><div class="NLM_p">Generally, the 6-morpholine substituted 4-methyl HAPs demonstrated better cellular activities than their parent compounds in HepDE19 cells. For example, enantiomer (<i>S</i>)-<b>18a</b> was 40 times more active than (<i>S</i>)-<b>7a</b> with an EC<sub>50</sub> of 0.17 μM (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). 3,4-Difluoro-substituted analogue (<i>S</i>)-<b>18b</b> significantly reduced HBV DNA with an EC<sub>50</sub> of 70 nM in HepDE19 cells. However, 3-Cl, 4-F-substituted analogue <b>18c</b> was over 100 times less active than (<i>S</i>)-<b>18b</b> with an EC<sub>50</sub> of 8.1 μM and a CC<sub>50</sub> of 67.7 μM. In agreement with previous SAR observations, enantiomers (<i>R</i>)-<b>18a</b> and (<i>R</i>)-<b>18b</b> had moderate to weak anti-HBV activities with EC<sub>50</sub> values of 26.8 μM and 65.8 μM, respectively.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Effects on HBV DNA Reduction and Physicochemical Properties of <b>18a</b>–<b>k</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00879/20160819/images/medium/jm-2016-008799_0013.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00879/20160819/images/medium/jm-2016-008799_0014.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">Definitions are the same as those described in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>.</p></div></div><div></div></div><div class="NLM_p">(<i>S</i>)-<b>18a</b> and (<i>S</i>)-<b>18b</b> are highly potent anti-HBV inhibitors with selectivity margins in HepDE19 cells that meet our primary goals for in vitro potency. However, they have poor metabolic stability and limited oral availability. For example, the mouse liver microsome (MLM) clearance of (<i>S</i>)-<b>18a</b> and (<i>S</i>)-<b>18b</b> was 81 and 89 mL min<sup>–1</sup> kg<sup>–1</sup>, respectively. The oral bioavailability (<i>F</i>) of (<i>S</i>)-<b>18a</b> was about 1.5% in a mouse single dose pharmacokinetics (SDPK) study. We therefore set out to improve the metabolic stability of HAPs and to identify orally bioavailable analogues with sufficient target organ exposure for in vivo efficacy studies.</div><div class="NLM_p last">In an attempt to improve microsomal stability and physiochemical properties, the 2-thiazolyl group was replaced with polar heteroaryls to reduce lipophilicity, and analogues such as <b>18d</b>–<b>j</b> were prepared accordingly. A number of these analogues had increased microsomal stability relative to (<i>S</i>)-<b>18a</b> and also were expected to have good aqueous solubility based on LYSA results of >300 μg/mL (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). Both <i>N</i>-methylimidazolyl and 5-F pyridinyl groups were tolerated with EC<sub>50</sub> values of <1 μM (analogues <b>18d</b> and <b>18f</b>), whereas oxazolyl (<b>18e</b>), pyrimidinyl (<b>18i</b>), and pyridazinyl (<b>18j</b>) resulted in lower potencies than (<i>S</i>)-<b>18a</b>. Our results also suggested that polar substituents cannot be tolerated on the heteroaryls; for example, 5-methoxypyridinyl analogue <b>8g</b> was 25 times less active than <b>18f</b>. In addition, aliphatic groups were not tolerated at the 2-position of HAPs, leading to a total loss of activity (analogue <b>18k</b>).</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Section 4. SAR at 5-Position of 4-Methyl HAPs</h3><div class="NLM_p">The 5-ester group appeared to have unclear roles in target binding. In our SAR studies of the 5-ester group, we found that direct chemistry conversions of the ester moiety were problematic. Neither hydrolysis nor reduction of analogues like <b>7</b> gave desired products even under harsh conditions, probably due to conjugation effects with the HAP core and high steric hindrance of the ester moiety. To address these issues, <i>tert</i>-butyl β-ketoester <b>19</b> was used as the starting material and <i>tert</i>-butyl ester <b>20</b> was prepared by means of the same method as shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. Treatment of <b>20</b> with TFA smoothly afforded acid <b>21</b>, and further functionalization was in turn carried out (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>). In one case, <b>21</b> was treated with 2-(7-aza-1<i>H</i>-benzotriazole-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate (HATU) and ammonia to give primary amide <b>22</b>, which was then converted to 5-CN analogue <b>23</b> upon treatment with trifluoroacetic acid anhydride (TFAA). On the other hand, amide analogues such as <b>24</b> and <b>25</b> were prepared by treating <b>21</b> with <i>N</i>,<i>N</i>′-carbonyldiimidazole (CDI) and then specified amines at elevated temperature. Amide <b>25</b> was treated with polyphosphoric acid (PPA) at 120 °C to give 5-oxazole-substituted analogue <b>26</b>. Finally, analogues <b>27a</b>–<b>e</b> were prepared by converting their respective precursors to bromide intermediates and then subsequently treating with morpholine. Besides exploring the polarity and heteroaryl vectors like oxazole, we also looked into steric factors via isopropyl ester <b>27f</b>, which was synthesized with isopropyl β-ketoester as the initial starting material.</div><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00879/20160819/images/medium/jm-2016-008799_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00879/20160819/images/large/jm-2016-008799_0008.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of HAP Analogue <b>27a</b>–<b>e</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00879/20160819/images/large/jm-2016-008799_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00879&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) TFA, DCM, 3 h, 100%; (b) HATU, NH<sub>3</sub>, NEt<sub>3</sub>, DCM, 40%; (c) TFAA, DCM, 3 h, 87%; (d) CDI, THF; (e) CH<sub>3</sub>NH<sub>2</sub>·HCl, NEt<sub>3</sub>, CH<sub>3</sub>CN, 90 °C, 80%; (f) 2,2-dimethoxyethanamine, CH<sub>3</sub>CN, 0.5 h, 120 °C, microwave, 90%; (g) PPA, 2 h, 120 °C, 30%; (h) NBS, AIBN, CCl<sub>4</sub>, 50 °C, 2 h, then morpholine, DCM, 50 °C, 1 h, >20% over 2 steps.</p></p></figure><div class="NLM_p">The cellular activities, physicochemical properties, and microsome stabilities of analogues <b>27a</b>–<b>f</b> are shown in <a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>. Polar groups such as −CO<sub>2</sub>H and amides improved microsome stability as well as solubility but were not tolerated with EC<sub>50</sub> values of >100 μM in HepDE19 cells (analogues <b>27a</b>,<b>b</b>,<b>d</b>). Heteroaryls and bulky groups like isopropyl ester were also detrimental to both cellular potency and metabolic stability. For example, analogues <b>27e</b> and <b>27f</b> showed moderate anti-HBV activities and narrow selectivity margins, with reduced metabolic stabilities in liver microsomes. In contrast, the less lipophilic 5-CN analogue <b>27c</b> had a better selectivity margin and microsome stability than <b>27e</b> and <b>27f</b>, with an EC<sub>50</sub> of 2.7 μM in HepDE19 cells.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Effects on HBV DNA Reduction and Physicochemical Properties of <b>27a</b>–<b>f</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00879/20160819/images/medium/jm-2016-008799_0015.gif" alt="" id="fx5" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00879/20160819/images/medium/jm-2016-008799_0016.gif" alt="" id="fx6" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>Table a</sup><p class="last">Definitions are the same as those described in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>.</p></div><div class="footnote" id="t3fn2"><sup>Table b</sup><p class="last">Scaled intrinsic clearance [mL min<sup>–1</sup> kg<sup>–1</sup>] in mouse liver microsome (MLM). Experiments were run in duplicate, with variation of <10%.</p></div></div><div></div></div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Section 5. SAR at the 6-Position of 4-Methyl HAPs</h3><div class="NLM_p">As part of our effort to optimize the 4-methyl HAP series, we sought to address the potential metabolic liability of the 6-morpholine moiety that is often associated with N–C and O–C cleavage. Thus, we developed a highly efficient and easily scalable synthesis of <b>7a</b>. First, tetrasubstituted olefin <b>29</b> was obtained by one-step indium(III)-catalyzed condensation of β-ketoester <b>8</b> and alkyne <b>28</b> in 40% yield (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>).<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Second, the condensation of <b>29</b> and thiazole-2-carboxamidine was carried out as described before and the product <b>7a</b> was converted to bromide intermediate <b>30</b> for chemical diversification. Finally, in the case of N-linked analogues, <b>30</b> was treated with selected amines or (sulfon)amides (<b>32</b>) and complementary bases such as K<sub>2</sub>CO<sub>3</sub> and <i>t</i>-BuOK in DMF. The resulting products were then treated with TFA to give <b>31a</b>–<b>r</b> (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>). For the synthesis of 6-amino acid substituted analogues <b>31s</b>,<b>t</b>, amino esters were alkylated with bromide <b>30</b>, followed by LiOH-mediated hydrolysis and finally removal of the <i>N</i>-Boc protecting group. These analogues were then tested in HepDE19 cells.</div><figure id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00879/20160819/images/medium/jm-2016-008799_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00879/20160819/images/large/jm-2016-008799_0009.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of N-Linked and O-Linked Analogues <b>31a</b>–<b>w</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00879/20160819/images/large/jm-2016-008799_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00879&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) In(OTf)<sub>3</sub>, <i>o</i>-xylene, 120 °C, 1 h, 40%; (b) thiazole-2-carboxamidine, NaHCO<sub>3</sub>, NMP, 120 °C, 2 h, 60%; (c) (Boc)<sub>2</sub>O, DMAP, DCM, rt, overnight; (d) NBS, CCl<sub>4</sub>, 50 °C, 2 h, 82% for 2 steps; (e) amine <b>32</b>, K<sub>2</sub>CO<sub>3</sub> or <i>t</i>-BuOK [for (sulfon)amides], DMF, 40 °C, 3 h; (f) LiOH, MeOH/H<sub>2</sub>O, rt, 2 h for hydrolysis of the amino ester group; (g) TFA, DCM, rt, 2 h; (h) alcohol <b>33</b>, NaH, THF, rt, overnight.</p></p></figure><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Effects on HBV DNA Reduction and Physicochemical Properties of <b>31a</b>–<b>w</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00879/20160819/images/medium/jm-2016-008799_0017.gif" alt="" id="fx7" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00879/20160819/images/medium/jm-2016-008799_0018.gif" alt="" id="fx8" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>Table a</sup><p class="last">Definitions are the same as those described in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>.</p></div></div><div></div></div><div class="NLM_p">Substitution of the morpholine group with piperidine and piperazine, common “bioisosteres” of morpholine, led to a complete loss of activity (analogues <b>31a</b>,<b>b</b>). <i>Gem</i>-dimethyl morpholine was well tolerated (<b>31c</b>), suggesting that some steric bulk could be accommodated. However, a conformationally constrained bridged morpholine led to a significant potency drop (<b>31d</b>). Finally, lactams were clearly detrimental and both <b>31e</b> and <b>31f</b> had weak cellular activities.</div><div class="NLM_p">Without knowing the molecular interactions that the morpholine group plays in capsid binding, we attempted to identify fragments that may resemble the role of the morpholine oxygen atom. The 4-hydroxylpiperidine analogue <b>31g</b> was weakly active with an EC<sub>50</sub> of 65.2 μM, while analogues with thiomorpholine dioxide and 4,4-difluoropiperidine substitutions (<b>31h</b> and <b>31i</b>) were about 10 times more potent than <b>31g</b>. With a shifting of the <i>gem</i>-difluoro substituents to the 3-position of the piperidine ring, the anti-HBV potency was further improved, as analogue <b>31j</b> had an EC<sub>50</sub> of 2.1 μM. Next, 3,3-difluoropyrrolidine-substituted analogue <b>31m</b> was prepared and showed a 15-fold improvement over <b>31j</b> with an EC<sub>50</sub> value of 0.14 μM. In contrast, 3-CF<sub>3</sub>-substituted pyrrolidine analogue <b>31n</b> had moderate potency with an EC<sub>50</sub> of 8.1 μM and 3-hydroxylpyrrolidine analogue <b>31k</b> was only weakly active. Notably, sulfonamide analogue <b>31p</b> had better activities than lactams <b>31e</b> and <b>31f</b>, and groups like imidazole and azetidine were not tolerated (analogues <b>31q</b>–<b>r</b>).</div><div class="NLM_p last">In addition, structural explorations with noncyclic amines were carried out. Among those modifications, the α-aminocyclopropanecarboxylic acid substituted analogue <b>31t</b> demonstrated moderate cellular potency with an EC<sub>50</sub> of 21.3 μM. In particular, <b>31t</b> had significantly improved solubility and metabolic stability compared to other analogues with LYSA of >510 μg/mL and MLM of 42 mL min<sup>–1</sup> kg<sup>–1</sup>, respectively. It seems that the <i>c</i>-Pr moiety is important for cellular activity, as sarcosine substituted analogue <b>31s</b> was inactive. Subsequently, we applied the SAR learning from the N-linked series and prepared O-linked analogues by treating bromide <b>30</b> with alcohols <b>33</b> and NaH, followed by the removal of the <i>N</i>-Boc protecting group by TFA (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>). <b>31u</b>–<b>w</b> had moderate anti-HBV activities, and carboxylic acid analogue <b>31w</b> had highly attractive physicochemical properties with LYSA > 649 μg/mL and MLM of 24 mL min<sup>–1</sup> kg<sup>–1</sup> (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>).</div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Section 6. Design of 6-Cyclic Amino Acid Substituted 4-Methyl HAPs</h3><div class="NLM_p">Analogues <b>31c</b> and <b>31m</b> were highly potent in vitro but lacked sufficient systemic exposure for in vivo efficacy studies, because of their lipophilic characteristics. A logical next step was to combine their 6-substituents with that of carboxylic acid based analogues <b>31t</b> and <b>31w</b>, which had moderate activities but nevertheless promising physicochemical properties. Thus, the 6-cyclic amino acid substituted analogues <b>34a</b>–<b>e</b> were synthesized from optically pure intermediate (<i>S</i>)-<b>7a</b> according to the procedures shown in <a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>. Esters <b>36</b> were obtained in medium to high yields after <i>N</i>-Boc protection of (<i>S</i>)-<b>7a</b>, bromination, and subsequent S<sub>N</sub>2 reaction with chiral amino esters <b>35</b>. Esters <b>36</b> were then hydrolyzed with LiOH, and the resulting acid intermediates were treated with TFA to give desired products.</div><figure id="sch5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00879/20160819/images/medium/jm-2016-008799_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00879/20160819/images/large/jm-2016-008799_0010.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Design and Synthesis of Amino Acid Substituted HAPs <b>34a</b>–<b>f</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00879/20160819/images/large/jm-2016-008799_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00879&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (Boc)<sub>2</sub>O, DMAP, DCM, rt, overnight; (b) NBS, CCl<sub>4</sub>, 50 °C, 2 h, 82% for 2 steps; (c) amino ester, K<sub>2</sub>CO<sub>3</sub>, DMF, 40 °C, 3 h; (d) LiOH, MeOH, rt, 2 h; (e) TFA, DCM, rt, 2 h.</p></p></figure><div class="NLM_p">Among them, the (2<i>S</i>,4<i>S</i>)-4,4-difluoroproline substituted analogue <b>34a</b> demonstrated significantly improved potency and solubility profiles with an EC<sub>50</sub> of 0.084 μM and LYSA > 645 μg/mL (<a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>). Importantly, <b>34a</b> had a selectivity index (SI) of 1905-fold in HepDE19 cells, a significant improvement over <b>1</b>. The (2<i>R</i>,4<i>S</i>)-4,4-difluoroproline substituted analogue <b>34c</b> was significantly less active than its diastereoisomer <b>34a</b> with an EC<sub>50</sub> of 6.6 μM, as was the (2<i>R</i>,4<i>S</i>)-morpholine acid analogue <b>34d</b> in comparison to diastereoisomer <b>34b</b>. Interestingly, the (2<i>R</i>,4<i>S</i>)-isomers had better stability profiles than the corresponding (2<i>S</i>,4<i>S</i>)-isomers in both human and mouse liver microsome stability tests (analogues <b>34a</b>–<b>d</b>). The <i>gem</i>-difluoro substituents and the carboxylic acid moiety appear to be important for anti-HBV activity, since the (2<i>S</i>,4<i>S</i>)-proline analogue <b>34e</b> lost activity and the ester analogue <b>34f</b> was a few times less active than <b>34a</b>.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Effects on HBV DNA Reduction and Physicochemical Properties of 6-Amino Acid Derivatives <b>34a</b>–<b>f</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00879/20160819/images/medium/jm-2016-008799_0019.gif" alt="" id="fx9" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00879/20160819/images/medium/jm-2016-008799_0020.gif" alt="" id="fx10" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>Table a</sup><p class="last">Definitions are the same as those described before. HLM, human liver microsomal test.</p></div></div><div></div></div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Section 7. Cocrystal Structure of <b>34a</b> in Complex with HBV Capsid Protein</h3><div class="NLM_p">To gain additional SAR understanding and elucidate the molecular interaction network of 4-methyl HAPs with the HBV capsid protein, we carried out crystallization studies with those amino acid based analogues. A high resolution cocrystal structure of <b>34a</b> in complex with Y132A mutant capsid protein was obtained with diffraction up to 1.7 Å (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5GMZ">5GMZ</a>). The 4-methyl HAP scaffold of <b>34a</b> fits into the hydrophobic pocket of the capsid protein dimer–dimer interface consistent with the 5 Å complex structure of HAP1, a close analogue of <b>1</b>.<a onclick="showRef(event, 'ref8 ref22'); return false;" href="javascript:void(0);" class="ref ref8 ref22">(8, 22)</a> It is clear that the 2-thiazolyl group of <b>34a</b> is coplanar with the dihydropyrimidine core as anticipated and is buried in a well-defined hydrophobic cavity formed by residues Phe23, Pro25, Tyr118, Trp102, Thr128′, and Ala132′ (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>). In addition, 4-methyl substitution on the core and the <i>p</i>-fluorophenyl group of <b>34a</b> occupy an adjacent and larger hydrophobic pocket and make van der Waals (VDW) contacts with residues including Pro25, Leu30, Thr33, Trp102, Ile105, Ser106, Val124′, Arg127′, and Thr128′. Given the limited space around the <i>p</i>-fluorophenyl group, large and polar substituents are generally not well tolerated and they typically result in loss of activity for analogues such as <b>7f</b>–<b>h</b>. While an <i>o</i>-substituent on the 4-phenyl group is expected to take an opposite position to the 4-methyl group on the core, it will elicit steric clash with the side chain of Thr128 and make analogues such as <b>7c</b> much less active. Importantly, the methyl group of the 5-ester contacts the outer rim of a pocket formed by Leu37 and Thr109 so that polar and large groups may not be favored at this position (examples <b>27a</b>–<b>f</b>).</div><figure id="fig3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00879/20160819/images/medium/jm-2016-008799_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00879/20160819/images/large/jm-2016-008799_0004.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Binding site of <b>34a</b> with HBV capsid protein Y132A. The compound binding pocket at B–C interface is shown as an exemplary site. Chain B and chain C of Y132A-<b>34a</b> structure are colored in cyan and magenta, respectively. Compound <b>34a</b> is highlighted in green stick. Residues within 4 Å radius are shown as lines. Red spheres represent water molecules in the pocket. Black dash lines indicate hydrogen bonds between <b>34a</b> and core protein.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00879/20160819/images/large/jm-2016-008799_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00879&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">The 4,4-difluoroproline group is partially solvent-exposed; however, the <i>gem</i>-fluoro substituents interact with Trp125′, Thr128′, Arg133′, and Pro134′, and the carboxylic acid moiety makes bidentate HB interactions with Ser141. Those interactions could contribute to the high binding affinity of <b>34a</b> to capsid proteins and its increased anti-HBV activity. In contrast, amino ester analogue <b>34f</b> and 2<i>R</i>-diastereoisomer <b>34c</b> cannot make bidentate HB interactions with Ser141 in the binding site, and both of them had reduced activities relative to <b>34a</b>. Moreover, a water-bridged HB network exists between the 2-thiazole and carboxyl groups of <b>34a</b> (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>). This well-defined water molecule and the HB formed between the dihydropyrimidine core and Trp102 are also noted in the recent cocrystal structure of the N-terminal assembly domain of the HBV capsid protein in complex with 4-H HAP analogue <b>3</b> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5E0I">5E0I</a>).<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Interestingly, besides the molecule of <b>34a</b> binding to the dimer–dimer interface, an additional molecule was identified at the A–B spike probably due to the excess of ligand during the crystallization setup (<a href="/doi/suppl/10.1021/acs.jmedchem.6b00879/suppl_file/jm6b00879_si_001.pdf" class="ext-link">Figure S3 in Supporting Information</a>).</div></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Section 8. DMPK and in Vivo Efficacy of <b>34a</b></h3><div class="NLM_p">Amino acid analogue <b>34a</b> had desirable in vitro potency and physicochemical properties with a polar surface area (PSA) of 85 Å<sup>2</sup> and a measured log <i>D</i> of 0.25. Since the “zwitterionic” structural features of <b>34a</b> are often associated with permeability issues, we carried out mechanistic and SDPK studies of <b>34a</b>. Compound <b>34a</b> had a <i>P</i><sub>app</sub>(A→B) of 1.9 × 10<sup>–6</sup> cm s<sup>–1</sup> and <i>P</i><sub>app</sub> ratio of 3.6 in the Caco-2 assay. The unbound fraction of <b>34a</b> was determined to be 1.9% and 8.1% in human and mouse plasma, respectively. The SDPK profile of <b>34a</b> was evaluated in CD-1 mice following intravenous (iv) and oral (po) administration. <b>34a</b> had moderate plasma clearance (Cl) (55.3 mL min<sup>–1</sup> kg<sup>–1</sup>) with an oral bioavailability (<i>F</i>) of 36% in mice (<a class="ref internalNav" href="#tbl6" aria-label="Table 6">Table 6</a>). In particular, <b>34a</b> had a high exposure in the liver with an area under the curve (AUC<sub>(0–<i>t</i>)</sub>) of 107 000 μg L<sup>–1</sup> h<sup>–1</sup> and very limited tissue distribution to lung, heart, and brain. The liver exposure of <b>34a</b> was about 20 times higher than that in plasma by oral administration. In contrast, <b>1</b> is not stable in liver homogenate so its liver exposure could not be determined (data not included). The preferential liver distribution of <b>34a</b> could be a useful characteristic in treating chronic HBV infections, where the disease organ is the liver.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. ADME Parameters of 4-Methyl HAP <b>34a</b> in CD-1 Mice<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char=".">dose (mg/kg)</th><th class="colsep0 rowsep0" align="center" char=".">CL (mL min<sup>–1</sup> kg<sup>–1</sup>)</th><th class="colsep0 rowsep0" align="center" char="."><i>V</i><sub>ss</sub> (L/kg)</th><th class="colsep0 rowsep0" align="center" char="."><i>t</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="center" char=".">plasma <i>C</i><sub>max</sub> (μg/L)</th><th class="colsep0 rowsep0" align="center" char=".">plasma AUC<sub>(0–<i>t</i>)</sub> (μg L<sup>–1</sup> h<sup>–1</sup>)</th><th class="colsep0 rowsep0" align="center" char=".">liver <i>C</i><sub>max</sub> (μg/L)</th><th class="colsep0 rowsep0" align="center" char=".">liver AUC<sub>(0–<i>t</i>)</sub> (μg L<sup>–1</sup> h<sup>–1</sup>)</th><th class="colsep0 rowsep0" align="center" char="."><i>F</i> (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">iv</td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="char" char=".">55.3</td><td class="colsep0 rowsep0" align="char" char=".">0.22</td><td class="colsep0 rowsep0" align="char" char=".">0.18</td><td class="colsep0 rowsep0" align="char" char=".">12400</td><td class="colsep0 rowsep0" align="char" char=".">1500</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">po</td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">0.8</td><td class="colsep0 rowsep0" align="char" char=".">2470</td><td class="colsep0 rowsep0" align="char" char=".">5420</td><td class="colsep0 rowsep0" align="char" char=".">41200</td><td class="colsep0 rowsep0" align="char" char=".">107000</td><td class="colsep0 rowsep0" align="char" char=".">36</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>a</sup><p class="last">The single-dose pharmacokinetics (SDPK) study of <b>34a</b> was carried out in CD-1 mice according to standard procedures. Major parameters, including plasma clearance (Cl), volume of distribution at steady state (<i>V</i><sub>ss</sub>), <i>t</i><sub>1/2</sub> (iv), maximal concentration (<i>C</i><sub>max</sub>), area under the curve (AUC), and oral bioavailability (<i>F</i>) are reported.</p></div></div></div><div class="NLM_p">In addition, <b>34a</b> exhibits low CYP inhibition with IC<sub>50</sub> > 30 μM against five major CYP enzymes (3A4, 2D6, 2C9, 2C19, 1A2) and was also not a time dependent CYP inhibitor. Moreover, <b>34a</b> did not significantly inhibit the hERG ion channel with IC<sub>20</sub> > 10 μM and was negative in preliminary in vitro safety evaluations such as glutathione (GSH) adduct, Ames, as well as micronucleus test (MNT) assays. In contrast, compound <b>1</b> and non carboxylic acid 4-methyl HAP analogues (<i>S</i>)-<b>18a</b> and <b>31m</b> were tested positive in GSH adduct assays. Our mechanistic studies indicated that <b>34a</b> induces capsid assembly (or aggregation) of the N-terminal capsid assembly domain (Cp149) in a concentration dependent manner, in agreement with previous reports on the 4-H HAP-based capsid inhibitors (see the <a href="/doi/suppl/10.1021/acs.jmedchem.6b00879/suppl_file/jm6b00879_si_001.pdf" class="ext-link">Supporting Information</a>).<a onclick="showRef(event, 'ref7 ref13'); return false;" href="javascript:void(0);" class="ref ref7 ref13">(7, 13)</a></div><div class="NLM_p">Finally, the in vivo efficacy of <b>34a</b> was evaluated in BALB/c mice that underwent hydrodynamic injection (HDI) with replication-competent HBV DNA plasmid.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Entecavir (ETV, 0.1 mg/kg) was used as the positive control in the HDI experiment. HBV replication was quickly built up in the liver of HDI mice after injection of the HBV plasmid, and the levels of HBV DNA were determined by real-time PCR. As shown in <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>A, <b>34a</b> demonstrated dose-dependent reduction of HBV DNA in the plasma of infected mice when the compound was orally administered twice a day (b.i.d.) at 12.5 mg/kg (mpk), 25 mpk, and 50 mpk, respectively. In comparison to the vehicle control group, treatment with 50 mpk of <b>34a</b> b.i.d. achieved over 2 log viral load reduction in the plasma of HDI mice on day 5.</div><figure id="fig4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00879/20160819/images/medium/jm-2016-008799_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00879/20160819/images/large/jm-2016-008799_0005.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Levels of HBV DNA in the plasma (A) and liver (B) of infected mice. Treatments with the vehicle control, <b>34a</b>, and ETV are included. The HBV DNA was quantified by real-time PCR. Error bars represent standard error. Statistical analysis was done by Student’s <i>t</i> test: (∗) <i>P</i> < 0.001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00879/20160819/images/large/jm-2016-008799_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00879&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">The levels of HBV DNA in mouse liver were determined 5 days after hydrodynamic injection of the HBV DNA plasmid (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>B). The liver DNA was isolated and subjected to real-time PCR for quantification of HBV DNA. Consistent with the results in mouse plasma, <b>34a</b> dose-dependently reduced HBV DNA levels in the mouse liver, achieving levels comparable to the positive control on day 5 with oral dosing at 50 mpk b.i.d.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_55772" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_55772" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In summary, we have identified a novel class of 4-methyl HAP-based HBV capsid inhibitors by an information-driven strategy. A highly efficient synthetic method was developed for SAR and structure–property relationship (SPR) studies with the aim to improve the in vitro anti-HBV activity and cytotoxicity profile and to optimize physicochemical properties. Structural optimization resulted in the identification of (2<i>S</i>,4<i>S</i>)-4,4-difluoroproline substituted analogue <b>34a</b>, which exhibited an EC<sub>50</sub> value of 84 nM and an over 1900-fold selectivity margin in HepDE19 cells. In particular, this kind of zwitterionic compound had good plasma stability and oral bioavailability with high liver exposure in mice. In in vivo studies, <b>34a</b> dose-dependently reduced HBV DNA in both the plasma and liver of HBV-infected HDI mice, achieving over 2 log viral load reduction on day 5 with 50 mpk b.i.d. dosing. Future optimizations of <b>34a</b> include core modifications and peripheral substituent changes with the specific aim to reduce efficacious doses.</div><div class="NLM_p last">In the course of SAR exploration, it was noted that minor changes in HAP structure can have profound effects on the capsid assembly or aggregation process and thus inhibition of HBV DNA synthesis. A cocrystal structure of <b>34a</b> and Y132A mutant capsid protein was obtained with 1.7 Å resolution, clearly elucidating the binding mode of <b>34a</b> and importantly the role that the (2<i>S</i>)-4,4-difluoroproline group plays in protein–ligand interactions. Specifically, the fluorine atoms make important VDW contacts with Trp125′, Thr128′, Arg133′, and Pro134′ of the capsid protein and the carboxylic acid moiety forms bidentate HB interactions with Ser141. The SAR, biostructure, SPR, DMPK, and in vivo efficacy studies of 4-methyl HAP analogues like <b>34a</b> provide valuable information for further structural optimizations of the HAP scaffold in our endeavor to identify and develop highly efficacious and safe HBV capsid inhibitors, the results of which will be published in due course.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i23">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08005" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08005" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Synthetic Chemistry General Comments</h3><div class="NLM_p last">All of the intermediates were purified by silica gel chromatography using either a Biotage SP1 system or an ISCO CombiFlash chromatography instrument. All of the final compounds were purified by preparative HPLC (prep-HPLC) on a reversed-phase column using a Waters XBridge OBD Phenyl (30 mm × 100 mm, 5 μm) or OBD RP18 (30 mm × 100 mm, 5 μm) column under acidic conditions (A, 0.1% formic acid in H<sub>2</sub>O; B, 0.1% formic acid in acetonitrile) or basic conditions (A, 0.01% ammonia in H<sub>2</sub>O; B, acetonitrile). For SFC chiral separation, the intermediates were separated using a chiral column (Daicel Chiralpak IC, 30 mm × 250 mm, 5 μm) on a Mettler Teledo SFC-Multigram system (solvent system of 95% CO<sub>2</sub> and 5% IPA (0.5% TEA in IPA), backpressure of 100 bar, UV detection at 254 nm). Optical rotation was measured using a Rudolph Autopol V automatic polarimeter at a wavelength of 589 nm. LC–MS spectra were obtained using a MicroMass Platform LC (Waters Alliance 2795-ZQ2000). NMR spectra were obtained using a Bruker Avance 400 MHz NMR spectrometer. All of the starting materials were obtained commercially, and amidines <b>12</b> were prepared in house according to literature reported methods (see the <a href="/doi/suppl/10.1021/acs.jmedchem.6b00879/suppl_file/jm6b00879_si_001.pdf" class="ext-link">Supporting Information</a>). All of the final compounds have purities greater than 95% based upon LC–MS and <sup>1</sup>H NMR analyses. All of the reported yields are for isolated products and are not optimized.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> General Synthetic Procedures for 4-Methyl HAP Analogues <b>7a</b>–<b>i</b></h3><div class="NLM_p">A mixture of methyl 3-oxobutanoate (compound <b>8</b>, 10 mmol) and a benzaldehyde derivative <b>9</b> (10 mmol), piperidine (0.5 mmol), and AcOH (0.5 mmol) in anhydrous EtOH (100 mL) was stirred at rt for 12 h. After removal of the solvent, the residue was purified by flash chromatography to afford the aldol condensation product, which was then dissolved in 50 mL of anhydrous THF and added dropwise to a fresh prepared THF solution of CH<sub>3</sub>CuLi (2 equiv) at −78 °C. The reaction mixture was stirred for 1 h and quenched with saturated NH<sub>4</sub>Cl solution. The aqueous solution was extracted with EtOAc, and the combined organic phase was concentrated. The residue was purified by flash column chromatography to give β-ketoester <b>10</b>.</div><div class="NLM_p">To a solution of NaH (60%, 15 mmol) and <b>10</b> (10 mmol) in anhydrous THF (100 mL) was added a solution of phenylselenyl chloride (15 mmol) in THF (20 mL), and the reaction mixture was stirred at rt for 1 h. A mixture of pentene/ether (v/v = 1/1, 60 mL) and 30 mL of saturated NaHCO<sub>3</sub> solution was added to the flask. The organic layer was separated and then treated with H<sub>2</sub>O<sub>2</sub> (30%, 2 mL) in 30 mL of DCM. The mixture was stirred at rt for 1 h and diluted with DCM before workup. Tetrasubstituted olefin <b>11</b> was obtained as yellowish oil after purification by flash chromatography.</div><div class="NLM_p">A mixture of amidine <b>12</b> (10 mmol) and NaHCO<sub>3</sub> (20 mmol) in 15 mL of NMP was preheated to 120 °C, and to this stirring mixture was added dropwise a solution of <b>11</b> (10 mmol) in NMP (5 mL). The reaction mixture was stirred at 120 °C for 2 h before it was cooled to rt and diluted with water. The aqueous phase was extracted with EtOAc, and the combined organic phase was washed with brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and concentrated. The residue was purified by flash column chromatography to afford <b>7a</b>–<b>i</b> as powder.</div><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> Methyl (4<i>S</i>)-(4-Fluorophenyl)-4,6-dimethyl-2-(2-methylthiazol-4-yl)-1<i>H</i>-pyrimidine-5-carboxylate [(<i>S</i>)-<b>7a</b>]</h4><div class="NLM_p last">(<i>S</i>)-<b>7a</b> was obtained by chiral SFC separation. Optical rotation: [α]<sub>D</sub><sup>20</sup> 75.6 (1.0 mg/mL, MeOH). MS: calcd (MH<sup>+</sup>) 346.1, exp (MH<sup>+</sup>) 346.1. HRMS: calcd (MH<sup>+</sup>) 346.1020, exp (MH<sup>+</sup>) 346.1020. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>) δ 7.93 (d, <i>J</i> = 3.3 Hz, 1H), 7.72 (d, <i>J</i> = 3.3 Hz, 1H), 7.52–7.46 (m, 2H), 7.07–7.00 (m, 2H), 3.45 (s, 3H), 2.28 (s, 3H), 1.90 (s, 3H).</div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> Methyl 2-(3,5-Difluoro-2-pyridyl)-4-(4-fluorophenyl)-4,6-dimethyl-1<i>H</i>-pyrimidine-5-carboxylate (<b>7b</b>)</h4><div class="NLM_p last">MS: calcd (MH<sup>+</sup>) 376.1, exp (MH<sup>+</sup>) 376.1. HRMS: calcd (MH<sup>+</sup>) 376.1267, exp (MH<sup>+</sup>) 376.1269. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>) δ 8.46 (d, <i>J</i> = 2.5 Hz, 1 H), 7.71 (ddd, <i>J</i> = 9.8, 8.6, 2.3 Hz, 1 H), 7.53 (dd, <i>J</i> = 9.1, 5.3 Hz, 2 H), 7.04 (t, <i>J</i> = 8.8 Hz, 2 H), 3.45 (s, 3 H), 2.24 (s, 3 H), 1.92 (s, 3 H).</div></div><div id="sec4_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> Methyl 4-(2-Chloro-4-fluorophenyl)-4,6-dimethyl-2-thiazol-2-yl-1<i>H</i>-pyrimidine-5-carboxylate (<b>7c</b>)</h4><div class="NLM_p last">MS: calcd (MH<sup>+</sup>) 380.1, exp (MH<sup>+</sup>) 380.1. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>) δ 7.95 (d, <i>J</i> = 3.2 Hz, 1H), 7.72 (d, <i>J</i> = 3.2 Hz, 1H), 7.70–7.67 (m, 1H), 7.15–7.08 (m, 2H), 3.51 (s, 3H), 2.3 (s, 3H), 1.95 (s, 3H).</div></div><div id="sec4_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> Methyl 4,6-Dimethyl-4-phenyl-2-thiazol-2-yl-1<i>H</i>-pyrimidine-5-carboxylate (<b>7d</b>)</h4><div class="NLM_p last">MS: calcd (MH<sup>+</sup>) 328.1, exp (MH<sup>+</sup>) 328.1. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>) δ 7.93 (d, <i>J</i> = 3.3 Hz, 1H), 7.73 (d, <i>J</i> = 3.3 Hz, 1H), 7.49 (dd, <i>J</i> = 8.5, 1.1 Hz, 2H), 7.32 (t, <i>J</i> = 7.7 Hz, 2H), 7.24–7.17 (m, 1H), 3.42 (s, 3H), 2.28 (s, 3H), 1.92 (s, 3H).</div></div><div id="sec4_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> Methyl 4-(4-Chlorophenyl)-4,6-dimethyl-2-thiazol-2-yl-1<i>H</i>-pyrimidine-5-carboxylate (<b>7e</b>)</h4><div class="NLM_p last">MS: calcd (MH<sup>+</sup>) 362.1, exp (MH<sup>+</sup>) 362.1. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>) δ 7.93 (d, <i>J</i> = 3.0 Hz, 1H), 7.71 (d, J = 3.0 Hz, 1H), 7.44 (d, J = 8.6 Hz, 2H), 7.31 (d, J = 8.6 Hz, 2H), 3.45 (s, 3H), 2.29 (s, 3 H), 1.88 (s, 3H).</div></div><div id="sec4_2_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> Methyl 4,6-Dimethyl-4-(4-methylsulfonylphenyl)-2-thiazol-2-yl-1<i>H</i>-pyrimidine-5-carboxylate (<b>7f</b>)</h4><div class="NLM_p last">MS: calcd (MH<sup>+</sup>) 436.1, exp (MH<sup>+</sup>) 436.1. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>) δ 7.94 (d, <i>J</i> = 3.3 Hz, 1H), 7.91 (d, <i>J</i> = 8.3 Hz, 2H), 7.75 (d, <i>J</i> = 8.6 Hz, 2H), 7.71 (d, <i>J</i> = 3.3 Hz, 1H), 3.45 (s, 3H), 3.12 (s, 3H), 2.34 (s, 3H), 1.93 (s, 3H).</div></div><div id="sec4_2_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> Methyl 4-(4-Methoxyphenyl)-4,6-dimethyl-2-thiazol-2-yl-1<i>H</i>-pyrimidine-5-carboxylate (<b>7g</b>)</h4><div class="NLM_p last">MS: calcd (MH<sup>+</sup>) 358.1, exp (MH<sup>+</sup>) 358.1. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>) δ 7.93 (d, <i>J</i> = 3.0 Hz, 1H), 7.72 (m, 1H), 7.39 (m, 2H), 6.88 (d, <i>J</i> = 8.6 Hz, 2H), 3.79 (s, 3H), 3.44 (s, 3H), 2.26 (s, 3H), 1.89 (s., 3H).</div></div><div id="sec4_2_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> Methyl 4-(4-Cyanophenyl)-4,6-dimethyl-2-thiazol-2-yl-1<i>H</i>-pyrimidine-5-carboxylate (<b>7h</b>)</h4><div class="NLM_p last">MS: calcd (MH<sup>+</sup>) 353.1, exp (MH<sup>+</sup>) 353.1. HRMS: calcd (MH<sup>+</sup>) 353.1067, exp (MH<sup>+</sup>) 353.1068. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>) δ 7.93 (d, <i>J</i> = 3.3 Hz, 1H), 7.73–7.62 (m, 5H), 3.44 (s, 3H), 2.33 (s, 3H), 1.90 (s, 3H).</div></div><div id="sec4_2_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> Methyl 4-(3,4-Difluorophenyl)-4,6-dimethyl-2-thiazol-2-yl-1<i>H</i>-pyrimidine-5-carboxylate (<b>7i</b>)</h4><div class="NLM_p last">MS: calcd (MH<sup>+</sup>) 364.1, exp (MH<sup>+</sup>) 364.1. HRMS: calcd (MH<sup>+</sup>) 364.0926, exp (MH<sup>+</sup>) 364.0925. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>) δ 7.94 (d, <i>J</i> = 3.0 Hz, 1H), 7.72 (d, <i>J</i> = 3.3 Hz, 1H), 7.36–7.14 (m, 3H), 3.48 (s, 3H), 2.30 (s, 3H), 1.86 (s, 3H).</div></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> Synthesis of 4-Ethyl HAP Analogue <b>7j</b></h3><div class="NLM_p">To a mixture of 1-(4-fluorophenyl)propan-1-one (compound <b>13</b>, 0.1 mol) in 100 mL of EtOH was added NaBH<sub>4</sub> (0.2 mol), and the mixture was stirred at rt for 2 h. After removal of the solvent, the residue was treated with saturated Na<sub>2</sub>CO<sub>3</sub> solution and extracted with EtOAc. The organic phase was washed with brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and concentrated. The crude product was dissolved in 200 mL of DCM, and to this solution was added thionyl chloride (0.2 mol) at 0 °C. After 3 h of stirring at rt, the mixture was concentrated and benzyl chloride <b>14</b> was obtained as yellowish oil.</div><div class="NLM_p">To a mixture of <b>8</b> (2.9 mmol) in THF (20 mL) was added NaH (60%, 3.5 mmol), and the reaction mixture was stirred at 0 °C for 20 min. Chloride <b>14</b> (2.9 mmol) was added into the flask, and the resulting mixture was stirred at rt for 12 h before it was quenched with 5 mL of brine. The organic layer was separated and concentrated. The residue was purified by flash chromatography to afford methyl 2-acetyl-3-(4-fluorophenyl)pentanoate (<b>15</b>) in 60% yield. MS: exp (MH<sup>+</sup>) 253.3.</div><div class="NLM_p">Methyl 2-acetyl-3-(4-fluorophenyl)pent-2-enoate (<b>16</b>) was obtained as a mixture of <i>E</i>/<i>Z</i> isomers from <b>15</b> by the two-step phenylselenation and oxidation reactions as described previously. To a mixture of thiazole-2-carboxamidine hydrochloride (0.4 mmol) and AcOK (0.4 mmol) in 5 mL of isopropanol was added a solution of <b>16</b> (0.4 mmol) in 2 mL of isopropanol at 120 °C. The reaction mixture was stirred at 120 °C for 3 h before it was concentrated in vacuum. The residue was purified by prep-HPLC to afford <b>7j</b> as yellowish solid in 15% yield.</div><div id="sec4_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> Methyl 4-Ethyl-4-(4-fluorophenyl)-6-methyl-2-thiazol-2-yl-1<i>H</i>-pyrimidine-5-carboxylate (<b>7j</b>)</h4><div class="NLM_p last">MS: calcd (MH<sup>+</sup>) 360.1, exp (MH<sup>+</sup>) 360.1. HRMS: calcd (MH<sup>+</sup>) 360.1182, exp (MH<sup>+</sup>) 360.1191. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>) δ 7.97 (d, <i>J</i> = 8.0 Hz, 1H), 7.72 (d, <i>J</i> = 8.0 Hz, 1H), 7.49–7.45 (m, 2H), 7.04–7.00 (m, 2H), 3.51 (s, 3H), 2.65 (m, 1H), 2.30(s, 3H), 2.04 (m, 1H), 1.00 (m, 3H)</div></div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> General Procedures for the Synthesis of 6-Morpholine Substituted Analogues <b>18a</b>–<b>k</b></h3><div class="NLM_p">To a solution of intermediates <b>7</b> (3 mmol) and DMAP (1.5 mmol) in 20 mL of DCM was added Boc<sub>2</sub>O (4.5 mmol), and the mixture was stirred at rt overnight. The organic phase was washed with water and brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and concentrated. The residue was purified by flash chromatography to afford the <i>N</i>-Boc protected intermediate in quantitative yield. The product was dissolved in 30 mL of CCl<sub>4</sub>. To this solution was added NBS (3 mmol), and the mixture was brought to 50 °C. AIBN (30 mg) was added to the flask, and the mixture was stirred at 50 °C for 2 h. The mixture was filtered through silica gel and washed with EtOAc. The filtrate was concentrated to afford <b>17</b> as yellowish powder, and it was used for the next reaction directly.</div><div class="NLM_p">To a solution of <b>17</b> (1 mmol) in 20 mL of DCM was added morpholine (0.5 mL), and the mixture was stirred at 50 °C for 1 h. After concentration, the residue was dissolved in EtOAc and washed with 1 N HCl and brine. The organic phase was concentrated, and the residue was dissolved in 20 mL of DCM. To this solution was added TFA (1 mL), and the mixture was stirred at rt for 2 h. After removal of the solvent, the residue was purified by prep-HPLC to afford <b>18a</b>–<b>k</b>.</div><div id="sec4_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> (<i>S</i>)-4-(4-Fluorophenyl)-4-methyl-6-morpholin-4-ylmethyl-2-thiazol-2-yl-1,4-dihydropyrimidine-5-carboxylic Acid Methyl Ester [(<i>S</i>)-<b>18a</b>]</h4><div class="NLM_p last">(<i>S</i>)<i>-</i><b>18a</b> was obtained together with (<i>R</i>)<i>-</i><b>18a</b> by the SFC chiral separation of racemic <b>18a</b>. Optical rotation: [α]<sub>D</sub><sup>20</sup> 70.5 (1.0 mg/mL, MeOH). MS: calcd (MH<sup>+</sup>) 431.1, exp (MH<sup>+</sup>) 431.1. HRMS: calcd (MH<sup>+</sup>) 431.1548, exp (MH<sup>+</sup>) 431.1550. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>) δ 7.96 (d, <i>J</i> = 3.0 Hz, 1H), 7.74 (d, <i>J</i> = 3.3 Hz, 1H), 7.52–7.43 (m, 2H), 7.03 (t, <i>J</i> = 8.8 Hz, 2H), 3.78 (t, <i>J</i> = 4.4 Hz, 4H), 3.64 (d, <i>J</i> = 17.1 Hz, 1H), 3.60 (d, <i>J</i> = 16.2 Hz, 1H), 3.46 (s, 3H), 2.55–2.60 (m, 4H), 1.90 (s, 3H).</div></div><div id="sec4_4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> (<i>R</i>)-4-(4-Fluorophenyl)-4-methyl-6-morpholin-4-ylmethyl-2-thiazol-2-yl-1,4-dihydropyrimidine-5-carboxylic Acid Methyl Ester [(<i>R</i>)-<b>18a</b>]</h4><div class="NLM_p last">[α]<sub>D</sub><sup>20</sup> −68.0 (0.95 mg/mL, MeOH). (<i>R</i>)<b>-18a</b> had identical <sup>1</sup>H NMR spectra as (<i>S</i>)<i>-</i><b>18a</b>.</div></div><div id="sec4_4_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> Methyl (4<i>S</i>)-4-(3,4-Difluorophenyl)-4-methyl-6-(morpholinomethyl)-2-thiazol-2-yl-1<i>H</i>-pyrimidine-5-carboxylate [(<i>S</i>)-<b>18b</b>]</h4><div class="NLM_p last">(<i>S</i>)<i>-</i><b>18b</b> and (<i>R</i>)<i>-</i><b>18b</b> were obtained by the SFC chiral separation of racemic <b>18b</b>. They had identical <sup>1</sup>H NMR spectra. MS: calcd (MH<sup>+</sup>) 449.1, exp (MH<sup>+</sup>) 449.1. HRMS: calcd (MH<sup>+</sup>) 449.1453, exp (MH<sup>+</sup>) 449.1452. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>) δ 7.97 (d, <i>J</i> = 3.3 Hz, 1H), 7.75 (d, <i>J</i> = 3.3 Hz, 1H), 7.33 (ddd, <i>J</i> = 12.4, 7.8, 2.3 Hz, 1H), 7.14–7.28 (m, 2H), 3.79 (t, <i>J</i> = 4.6 Hz, 4H), 3.59–3.74 (m, 2H), 3.50 (s, 3H), 2.52–2.67 (m, 4H), 1.88 (s, 3H).</div></div><div id="sec4_4_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> Methyl 4-(3-Chloro-4-fluorophenyl)-4-methyl-6-(morpholinomethyl)-2-thiazol-2-yl-1<i>H</i>-pyrimidine-5-carboxylate (<b>18c</b>)</h4><div class="NLM_p last">MS: calcd (MH<sup>+</sup>) 465.1, exp (MH<sup>+</sup>) 465.1. HRMS: calcd (MH<sup>+</sup>) 465.1158, exp (MH<sup>+</sup>) 465.1155. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>) δ 7.97 (d, <i>J</i> = 3.3 Hz, 1H), 7.76 (d, <i>J</i> = 3.0 Hz, 1H), 7.52 (dd, <i>J</i> = 7.2, 2.4 Hz, 1H), 7.41 (ddd, <i>J</i> = 8.7, 4.6, 2.4 Hz, 1H), 7.18 (t, <i>J</i> = 8.8 Hz, 1H), 3.79 (t, <i>J</i> = 4.5 Hz, 4H), 3.75–3.60 (m, 2H), 3.50 (s, 3H), 2.63–2.54 (m, 4H), 1.88 (s, 3H).</div></div><div id="sec4_4_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> Methyl 4-(4-Fluorophenyl)-4-methyl-2-(1-methylimidazol-2-yl)-6-(morpholinomethyl)-1<i>H</i>-pyrimidine-5-carboxylate (<b>18d</b>)</h4><div class="NLM_p last">MS: calcd (MH<sup>+</sup>) 428.2, exp (MH<sup>+</sup>) 428.2. HRMS: calcd (MH<sup>+</sup>) 428.2098, exp (MH<sup>+</sup>) 428.2099. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>) δ 7.49 (m, 2H), 7.19 (m, 1H), 7.04 (m, 3H), 3.91 (s, 3H), 3.76 (m, 4H), 3.60 (m, 2H), 3.48 (s, 3H), 2.55 (m, 4H), 1.89 (s, 3H).</div></div><div id="sec4_4_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> Methyl 4-(4-Fluorophenyl)-4-methyl-2-(5-methyloxazol-2-yl)-6-(morpholinomethyl)-1<i>H</i>-pyrimidine-5-carboxylate (<b>18e</b>)</h4><div class="NLM_p last">MS: calcd (MH<sup>+</sup>) 429.2, exp (MH<sup>+</sup>) 429.2. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>) δ 7.47 (m, 2H), 7.04 (m, 3H), 3.79 (m, 4H), 3.65 (m, 2H), 3.46 (s, 3H), 2.57 (m, 4H), 2.41 (s, 3H), 1.91 (s, 3H).</div></div><div id="sec4_4_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> Methyl 4-(4-Fluorophenyl)-2-(5-fluoro-2-pyridyl)-4-methyl-6-(morpholinomethyl)-1<i>H</i>-pyrimidine-5-carboxylate (<b>18f</b>)</h4><div class="NLM_p last">MS: calcd (MH<sup>+</sup>) 443.2, exp (MH<sup>+</sup>) 443.2. HRMS: calcd (MH<sup>+</sup>) 443.1894, exp (MH<sup>+</sup>) 443.1889. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>) δ 8.58 (m, 1H), 8.22 (m, 1H), 7.70 (m, 1H), 7.47 (m, 2H), 7.03 (m, 2H), 3.79 (m, 4H), 3.65 (m, 2H), 3.46 (s, 3H), 2.59 (m, 4H), 1.90 (s, 3H).</div></div><div id="sec4_4_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> Methyl 4-(4-Fluorophenyl)-4-methyl-2-(3-methyl-2-pyridyl)-6-(morpholinomethyl)-1<i>H</i>-pyrimidine-5-carboxylate (<b>18g</b>)</h4><div class="NLM_p last">MS: calcd (MH<sup>+</sup>) 439.2, calcd (MH<sup>+</sup>) 439.2. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>) δ 8.50 (m, 1H), 7.76 (m, 1H), 7.57 (m, 2H), 7.45 (m, 1H), 7.08 (m, 2H), 3.78 (m, 4H), 3.52 (m, 5H), 2.52 (m, 7H), 1.98 (s, 3H).</div></div><div id="sec4_4_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> Methyl 4-(4-Fluorophenyl)-2-(5-methoxy-2-pyridyl)-4-methyl-6-(morpholinomethyl)-1<i>H</i>-pyrimidine-5-carboxylate (<b>18h</b>)</h4><div class="NLM_p last">MS: calcd (MH<sup>+</sup>) 455.2, exp (MH<sup>+</sup>) 455.2. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>) δ 8.36 (m, 1H), 8.11 (m, 1H), 7.47 (m, 3H), 7.03 (m, 2H), 3.95 (s, 3H), 3.80 (m, 4H), 3.64 (m, 2H), 3.45 (s, 3H), 2.58 (m, 4H), 1.89 (s, 3H).</div></div><div id="sec4_4_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> Methyl 4-(4-Fluorophenyl)-4-methyl-6-(morpholinomethyl)-2-pyrimidin-2-yl-1<i>H</i>-pyrimidine-5-carboxylate (<b>18i</b>)</h4><div class="NLM_p last">MS: calcd (MH<sup>+</sup>) 426.2, calcd (MH<sup>+</sup>) 426.2. HRMS: calcd (MH<sup>+</sup>) 426.1936, exp (MH<sup>+</sup>) 426.1934. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>) δ 8.94 (m, 2H), 7.60 (m, 1H), 7.49 (m, 2H), 7.02 (m, 2H), 3.79 (m, 4H), 3.66 (m, 2H), 3.48 (s, 3H), 2.61 (m, 4H), 1.94 (s, 3H).</div></div><div id="sec4_4_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> Methyl 4-(4-Fluorophenyl)-4-methyl-2-(6-methylpyridazin-3-yl)-6-(morpholinomethyl)-1<i>H</i>-pyrimidine-5-carboxylate (<b>18j</b>)</h4><div class="NLM_p last">MS: calcd (MH<sup>+</sup>) 440.4, exp (MH<sup>+</sup>) 440.2. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>) δ 8.30–8.22 (m, 1H), 7.73–7.68 (m, 1H), 7.53–7.44 (m, 2H), 7.04 (s, 2H), 3.81 (br t, <i>J</i> = 4.6 Hz, 4H), 3.78–3.61 (m, 2H), 3.47 (s, 3H), 2.77 (s, 3H), 2.68–2.54 (m, 4H), 1.93 (s, 3H).</div></div><div id="sec4_4_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> Methyl 2-Cyclopropyl-4-(4-fluorophenyl)-4-methyl-6-(morpholinomethyl)-1<i>H</i>-pyrimidine-5-carboxylate (<b>18k</b>)</h4><div class="NLM_p last">MS: calcd (MH<sup>+</sup>) 388.2, exp (MH<sup>+</sup>) 388.2. HRMS: calcd (MH<sup>+</sup>) 388.2036, exp (MH<sup>+</sup>) 388.2044. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>) δ 7.42 (m, 2H), 7.02 (t, <i>J</i> = 8.7 Hz, 2H), 3.72 (m, 4H), 3.42 (s, 3H), 2.55–2.47 (m, 4H), 1.74 (s, 3H), 1.62 (m, 1H), 0.95–0.83 (m, 4H).</div></div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> Synthesis of Intermediates <b>21</b>–<b>26</b></h3><div class="NLM_p"><i>tert</i>-Butyl ester <b>20</b> was prepared in analogy to <b>7</b> by using <i>tert</i>-butyl 3-oxobutanoate (<b>19</b>) as the starting material. A mixture of <b>20</b> (1 mmol) and TFA (1 mL) in 5 mL of DCM was stirred at rt for 3 h. After removal of the solvent, acid <b>21</b> was obtained and it was used in the next reaction directly.</div><div id="sec4_5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> 4-(4-Fluorophenyl)-4,6-dimethyl-2-thiazol-2-yl-1<i>H</i>-pyrimidine-5-carboxylic Acid (<b>21</b>)</h4><div class="NLM_p">MS: calcd (MH<sup>+</sup>) 332.1, exp (MH<sup>+</sup>) 332.1. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>) δ 8.24 (m, 2H), 7.69–7.66 (m, 2H), 7.18 (t, <i>J</i> = 8.0 Hz, 2H), 2.43 (s, 3H), 2.21 (s, 3H).</div><div class="NLM_p last">To a solution of <b>21</b> (0.45 mmol), HATU (0.9 mmol), and NEt<sub>3</sub> (0.9 mmol) in 15 mL of DCM was added an NH<sub>3</sub> solution (0.5 M in 1,4-dioxane, 1.8 mmol), and the mixture was stirred at rt overnight. The mixture was washed with aqueous NaHCO<sub>3</sub> and brine. The organic layer was separated, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and concentrated. The residue was purified by flash chromatography to afford <b>22</b> in 40% yield.</div></div><div id="sec4_5_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> 4-(4-Fluorophenyl)-4,6-dimethyl-2-thiazol-2-yl-1<i>H</i>-pyrimidine-5-carboxamide (<b>22</b>)</h4><div class="NLM_p">MS: calcd (MH<sup>+</sup>) 331.1, exp (MH<sup>+</sup>) 331.1. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>) δ 7.94 (m, 1H), 7.73–7.57 (m, 3H), 7.03 (m, 2H), 2.10 (s, 3H), 1.84 (s, 3H).</div><div class="NLM_p last">To a solution of <b>22</b> (3 mmol) in 10 mL of THF was added TFAA (3 mL), and the mixture was stirred at rt for 3 h. After removal of THF and excess TFAA, the residue was dissolved in MeOH (20 mL). To this solution was added K<sub>2</sub>CO<sub>3</sub> (14.5 mmol), and the mixture was stirred at rt for 3 h. The reaction mixture was filtered and washed with EtOAc. The filtrate was concentrated and the residue was purified by flash chromatography to afford <b>23</b> as yellowish solid in 87% yield.</div></div><div id="sec4_5_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> 4-(4-Fluorophenyl)-4,6-dimethyl-2-thiazol-2-yl-1<i>H</i>-pyrimidine-5-carbonitrile (<b>23</b>)</h4><div class="NLM_p">MS: calcd (MH<sup>+</sup>) 313.1, exp (MH<sup>+</sup>) 313.1. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>) δ 7.96 (m, 1H), 7.76 (m, 1H), 7.51 (m, 2H), 7.11 (m, 2H), 2.23 (s, 3H), 1.83 (s, 3H).</div><div class="NLM_p last">To a solution of <b>21</b> (0.5 mmol) in 5 mL of THF was added CDI (0.6 mmol), and the mixture was stirred at rt for 1 h. After removal of the solvent, the residue was treated with water and the aqueous solution was extracted with EtOAc. The organic layer was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub> and concentrated. A mixture of the imidazole amide intermediate (0.4 mmol), methylamine HCl salt (0.8 mmol), and NEt<sub>3</sub> (0.2 mL) in 5 mL of CH<sub>3</sub>CN was stirred at 90 °C for 30 min in a microwave reactor. After removal of the solvent, the residue was purified by flash chromatography to afford <b>24</b> in 80% yield.</div></div><div id="sec4_5_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> 4-(4-Fluorophenyl)-<i>N</i>,4,6-trimethyl-2-thiazol-2-yl-1<i>H</i>-pyrimidine-5-carboxamide (<b>24</b>)</h4><div class="NLM_p">MS: calcd (MH<sup>+</sup>) 345.1, exp (MH<sup>+</sup>) 345.1. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>) δ 7.94 (m, 1H), 7.72–7.54 (m, 3H), 7.02 (m, 2H), 2.59 (s, 3H), 2.00 (s, 3H), 1.80 (s, 3H).</div><div class="NLM_p last">A mixture of the oxazole amide intermediate (0.5 mmol), 2,2-dimethoxyethylamine (1.0 mmol) in 5 mL of CH<sub>3</sub>CN was stirred at 120 °C for 30 min in a microwave reactor. After removal of the solvent, the residue was partitioned between water and DCM and the aqueous phase was extracted with DCM. The organic layer was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub> and concentrated to give <b>25</b> as oil in 90% yield. A mixture of <b>25</b> (0.45 mmol) and PPA (5 mL) was stirred at 120 °C for 2 h. After cooling down, the mixture was poured onto ice–water, treated with concentrated NH<sub>3</sub> solution, and the aqueous phase was extracted with EtOAc. The organic layer was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub> and concentrated. The residue was purified by flash chromatography to give <b>26</b> as powder in 30% yield.</div></div><div id="sec4_5_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> 2-[4-(4-Fluorophenyl)-4,6-dimethyl-2-thiazol-2-yl-1<i>H</i>-pyrimidin-5-yl]oxazole (<b>26</b>)</h4><div class="NLM_p last">MS: calcd (MH<sup>+</sup>) 355.1, exp (MH<sup>+</sup>) 355.1. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>) δ 7.95–7.94 (m, 1H), 7.79–7.70 (m, 2H), 7.58–7.46 (m, 2H), 7.11–6.95 (m, 3H), 2.13 (s, 3H), 1.86 (s, 3H).</div></div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> General Procedures for the Synthesis of Analogues <b>27a</b>–<b>f</b></h3><div class="NLM_p">The morpholine-substituted analogues <b>27a</b>–<b>e</b> were synthesized by two-step bromination and morpholine substitution of 4-methyl HAP intermediates <b>21</b>–<b>26</b>. To a solution of this intermediate (<b>21</b>–<b>26</b>, 5 mmol) in 30 mL of CCl<sub>4</sub> were added NBS (5.5 mmol) and AIBN (50 mg), and the mixture was stirred at 50 °C for 2 h. After that, morpholine (1.0 mL) was added to the flask and the reaction mixture was stirred at 50 °C for 1 h. After removal of the solvent, the residue was partitioned between EtOAc and water. The organic phase was washed with brine and concentrated. The residue was purified by prep-HPLC to afford <b>27a</b>–<b>e</b>.</div><div id="sec4_6_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> 4-(4-Fluorophenyl)-4-methyl-6-(morpholinomethyl)-2-thiazol-2-yl-1<i>H</i>-pyrimidine-5-carboxylic Acid (<b>27a</b>)</h4><div class="NLM_p last">MS: calcd (MH<sup>+</sup>) 417.2, exp (MH<sup>+</sup>) 417.2. HRMS: calcd (MH<sup>+</sup>) 417.1396, exp (MH<sup>+</sup>) 417.1402. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>) δ 8.00–7.99 (d, <i>J</i> = 4.0 Hz, 1H), 7.89–7.88 (d, <i>J</i> = 4.0 Hz, 1H), 7.65–7.61 (m, 2H), 7.13–7.09 (t, <i>J</i> = 8.0 Hz, 2H), 4.46 (m, 2H), 4.04–4.02 (m, 4H), 3.52 (m, 4H), 2.12 (s, 3H).</div></div><div id="sec4_6_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> 4-(4-Fluorophenyl)-4-methyl-6-(morpholinomethyl)-2-thiazol-2-yl-1<i>H</i>-pyrimidine-5-carboxamide (<b>27b</b>)</h4><div class="NLM_p last">MS: calcd (MH<sup>+</sup>) 416.2, exp (MH<sup>+</sup>) 416.2. HRMS: calcd (MH<sup>+</sup>) 416.1556, exp (MH<sup>+</sup>) 416.1558. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>) δ 7.99–7.98 (d, <i>J</i> = 4.0 Hz, 1H), 7.83–7.82 (d, <i>J</i> = 4.0 Hz, 1H), 7.66–7.62 (m, 2H), 7.12–7.08 (m, 2H), 3.89 (m, 6H), 3.16–3.11 (m, 4H), 1.97 (s, 3H).</div></div><div id="sec4_6_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> 4-(4-Fluorophenyl)-4-methyl-6-(morpholinomethyl)-2-thiazol-2-yl-1<i>H</i>-pyrimidine-5-carbonitrile (<b>27c</b>)</h4><div class="NLM_p last">MS: calcd (MH<sup>+</sup>) 398.2, exp (MH<sup>+</sup>) 398.2. HRMS: calcd (MH<sup>+</sup>) 398.1445, exp (MH<sup>+</sup>) 398.1448. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>) δ 7.99–7.98 (m, 1H), 7.80 (m, 1H), 7.53–7.49 (m, 2H), 7.14–7.09 (m, 2H), 3.76(m, 4H), 3.50 (m, 2H), 2.56 (m, 4H), 1.85 (s, 3H).</div></div><div id="sec4_6_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> 4-(4-Fluorophenyl)-<i>N</i>,4-dimethyl-6-(morpholinomethyl)-2-thiazol-2-yl-1<i>H</i>-pyrimidine-5-carboxamide (<b>27d</b>)</h4><div class="NLM_p last">MS: calcd (MH<sup>+</sup>) 430.2, exp (MH<sup>+</sup>) 430.2. HRMS: calcd (MH<sup>+</sup>) 430.1712, exp (MH<sup>+</sup>) 430.1711. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>) δ 7.98–7.97 (d, <i>J</i> = 4.0 Hz, 1H), 7.80–7.79 (d, <i>J</i> = 4.0 Hz, 1H), 7.60–7.57 (m, 2H), 7.09–7.04 (m, 2H), 3.82 (m, 4H), 3.52–3.48 (m, 2H), 2.93–2.80 (m, 4H), 2.63 (s, 3H), 1.88 (s, 3H).</div></div><div id="sec4_6_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> 4-[[4-(4-Fluorophenyl)-4-methyl-5-oxazol-2-yl-2-thiazol-2-yl-1<i>H</i>-pyrimidin-6-yl]methyl]morpholine (<b>27e</b>)</h4><div class="NLM_p">MS: calcd (MH<sup>+</sup>) 440.1, exp (MH<sup>+</sup>) 440.1. HRMS: calcd (MH<sup>+</sup>) 440.1556, exp (MH<sup>+</sup>) 440.1559. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>) δ 7.98–7.97 (m, 1H), 7.78–7.74 (m, 2H), 7.49 (m, 2H), 7.10 (s, 1H), 6.99 (m, 2H), 3.74 (m, 4H), 3.44 (m, 2H), 2.51 (m, 4H), 1.88 (s, 3H).</div><div class="NLM_p last">Analogue <b>27f</b> was synthesized in analogy to <b>18a</b> by using isopropyl 3-oxobutanoate as the starting material.</div></div><div id="sec4_6_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> Isopropyl 4-(4-Fluorophenyl)-4-methyl-6-(morpholinomethyl)-2-thiazol-2-yl-1<i>H</i>-pyrimidine-5-carboxylate (<b>27f</b>)</h4><div class="NLM_p last">MS: calcd (MH<sup>+</sup>) 459.2, exp (MH<sup>+</sup>) 459.2. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>) δ 7.95 (d, <i>J</i> = 3.0 Hz, 1H), 7.73 (d, <i>J</i> = 3.3 Hz, 1H), 7.47 (dd, <i>J</i> = 8.2, 5.4 Hz, 2H), 7.04 (t, <i>J</i> = 8.8 Hz, 2H), 4.86 (m, 2H), 4.78 (dt, <i>J</i> = 12.4, 6.3 Hz, 1H), 3.79 (t, <i>J</i> = 4.6 Hz, 4H), 2.59 (m, 4H), 1.90 (s, 3H), 1.10 (d, <i>J</i> = 6.3 Hz, 3H), 0.82 (d, <i>J</i> = 6.3 Hz, 3H).</div></div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> General Procedures for the Synthesis of N-Linked Analogues <b>31a</b>–<b>t</b></h3><div class="NLM_p">To a mixture of methyl 3-oxobutanoate (compound <b>8</b>, 5.0 g, 43.1 mmol), 1-ethynyl-4-fluorobenzene (compound <b>28</b>, 5.0 g, 41.7 mmol) in 20 mL of <i>o</i>-xylene was added In(OTf)<sub>3</sub> (400 mg, 0.71 mmol), and the mixture was stirred at 120 °C for 1–2 h. After removal of the solvent, the residue was purified by flash chromatography (EtOAc/petroleum ether: 1/10) to afford olefin <b>29</b> as light yellowish oil in 40% yield. As described previously, <b>29</b> was treated with thiazole-2-carboxamidine and NaHCO<sub>3</sub> in NMP at 120 °C to give <b>7a</b> in 60% yield. The <i>N</i>-Boc protected bromide intermediate <b>30</b> was prepared in analogy to <b>17</b> by using <b>7a</b> as the starting material.</div><div class="NLM_p">To a mixture of <b>30</b> (2 mmol) and K<sub>2</sub>CO<sub>3</sub> [10 mmol, or <i>t</i>-BuOK for less reactive (sulfon)amides] in 10 mL of DMF was added amine <b>32</b> (2.00 mmol), and the mixture was stirred at 40 °C for 3 h before being partitioned between water and EtOAc. The organic phase was washed with brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and concentrated. The crude product was treated with TFA in DCM at rt to remove the <i>N</i>-Boc protecting group, and analogues <b>31a</b>–<b>r</b> were purified by prep-HPLC. For the synthesis of analogues <b>31s</b>–<b>t</b>, the crude product was treated with LiOH in MeOH at rt for 2 h before treatment with TFA.</div><div id="sec4_7_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> Methyl 4-(4-Fluorophenyl)-4-methyl-6-(1-piperidylmethyl)-2-thiazol-2-yl-1<i>H</i>-pyrimidine-5-carboxylate (<b>31a</b>)</h4><div class="NLM_p last">MS: calcd (MH<sup>+</sup>) 429.2, exp (MH<sup>+</sup>) 429.2. HRMS: calcd (MH<sup>+</sup>) 429.1760, exp (MH<sup>+</sup>) 429.1766. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>) δ 7.84 (d, <i>J</i> = 3.0 Hz, 1H), 7.71 (m, 1H), 7.35 (m, 2H), 6.93 (m, 2H), 3.55–3.36 (m, 2H), 3.34 (s, 3H), 2.41 (m, 2H), 1.93–1.36 (m, 9H), 1.20 (m, 2H).</div></div><div id="sec4_7_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> Methyl 4-(4-Fluorophenyl)-4-methyl-6-(piperazin-1-ylmethyl)-2-thiazol-2-yl-1<i>H</i>-pyrimidine-5-carboxylate (<b>31b</b>)</h4><div class="NLM_p last">MS: calcd (MH<sup>+</sup>) 430.2, exp (MH<sup>+</sup>) 430.2. HRMS: calcd (MH<sup>+</sup>) 430.1713, exp (MH<sup>+</sup>) 430.1723. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>) δ 7.95 (d, <i>J</i> = 3.0 Hz, 1H), 7.77 (d, <i>J</i> = 2.8 Hz, 1H), 7.47 (m, 2H), 7.04 (t, <i>J</i> = 8.8 Hz, 2H), 3.54 (m, 2H), 3.46 (s, 3H), 3.12 (t, <i>J</i> = 5.0 Hz, 4H), 2.69 (m, 4H), 1.90 (s, 3H).</div></div><div id="sec4_7_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> Methyl 6-[(3,3-Dimethylmorpholin-4-yl)methyl]-4-(4-fluorophenyl)-4-methyl-2-thiazol-2-yl-1<i>H</i>-pyrimidine-5-carboxylate (<b>31c</b>)</h4><div class="NLM_p last">MS: calcd (MH<sup>+</sup>) 459.2, exp (MH<sup>+</sup>) 459.2. HRMS: calcd (MH<sup>+</sup>) 459.1866, exp (MH<sup>+</sup>) 459.1868. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>) δ 7.98 (d, <i>J</i> = 3.3 Hz, 1H), 7.75 (d, <i>J</i> = 3.0 Hz, 1H), 7.45 (dd, <i>J</i> = 5.6, 8.8 Hz, 2H), 7.03 (t, <i>J</i> = 9.0 Hz, 2H), 3.90–3.66 (m, 4H), 3.50 (m, 2H), 3.46 (s, 3H), 2.64 (m, 2H), 1.90 (s, 3H), 1.14 (s, 6H).</div></div><div id="sec4_7_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> Methyl 4-(4-Fluorophenyl)-4-methyl-6-(2-oxa-5-azabicyclo[2.2.1]heptan-5-ylmethyl)-2-thiazol-2-yl-1<i>H</i>-pyrimidine-5-carboxylate (<b>31d</b>)</h4><div class="NLM_p last">MS: calcd (MH<sup>+</sup>) 443.1, exp (MH<sup>+</sup>) 443.1. HRMS: calcd (MH<sup>+</sup>) 443.1553, exp (MH<sup>+</sup>) 443.1555. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>) δ 7.94 (d, <i>J</i> = 3.0 Hz, 1H), 7.74 (d, <i>J</i> = 3.0 Hz, 1H), 7.47 (t, <i>J</i> = 5.8 Hz, 2H), 7.08–7.00 (m, 2H), 4.51 (m, 1H), 4.10–3.71 (m, 4H), 3.58 (m, 1H), 3.46 (m, 3H), 3.00–2.73 (m, 2H), 2.00 (d, <i>J</i> = 9.9 Hz, 1H), 1.91 (s, 1.5H), 1.90 (s, 1.5H), 1.82 (d, <i>J</i> = 9.9 Hz, 1H).</div></div><div id="sec4_7_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> Methyl 4-(4-Fluorophenyl)-4-methyl-6-[(3-oxomorpholin-4-yl)methyl]-2-thiazol-2-yl-1<i>H</i>-pyrimidine-5-carboxylate (<b>31e</b>)</h4><div class="NLM_p last">MS: calcd (MH<sup>+</sup>) 445.1, exp (MH<sup>+</sup>) 445.1. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.30 (m, 1H), 8.0–7.92 (m, 2H), 7.52–7.42 (m, 2H), 7.17–7.10 (m, 2H), 4.53–4.36 (m, 2H), 4.15–4.10 (m, 2H), 3.90–3.85 (m, 2H), 3.48–3.43 (m, 5H), 1.94 (s, 3H).</div></div><div id="sec4_7_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> Methyl 4-(4-Fluorophenyl)-4-methyl-6-[(3-oxopiperazin-1-yl)methyl]-2-thiazol-2-yl-1<i>H</i>-pyrimidine-5-carboxylate (<b>31f</b>)</h4><div class="NLM_p last">MS: calcd (MH<sup>+</sup>) 444.1, exp (MH<sup>+</sup>) 444.1. HRMS: calcd (MH<sup>+</sup>) 444.1505, exp (MH<sup>+</sup>) 444.1512. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>) δ 7.94 (d, <i>J</i> = 3.0 Hz, 1H), 7.75 (d, <i>J</i> = 2.8 Hz, 1H), 7.48 (dd, <i>J</i> = 8.3, 5.6 Hz, 2H), 7.04 (t, <i>J</i> = 8.7 Hz, 2H), 3.85–3.65 (m, 2H), 3.47 (s, 3H), 3.42 (t, <i>J</i> = 5.2 Hz, 2H), 3.28 (m, 2H), 2.80 (d, <i>J</i> = 2.3 Hz, 2H), 1.91 (s, 3H).</div></div><div id="sec4_7_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> Methyl 4-(4-Fluorophenyl)-6-[(4-hydroxy-1-piperidyl)methyl]-4-methyl-2-thiazol-2-yl-1<i>H</i>-pyrimidine-5-carboxylate (<b>31g</b>)</h4><div class="NLM_p last">MS: calcd (MH<sup>+</sup>) 445.1, exp (MH<sup>+</sup>) 445. HRMS: calcd (MH<sup>+</sup>) 445.1709, exp (MH<sup>+</sup>) 445.1716. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>) δ 7.95 (d, <i>J</i> = 3.3 Hz, 1H), 7.74 (d, <i>J</i> = 3.3 Hz, 1H), 7.46 (dd, <i>J</i> = 5.3, 8.6 Hz, 2H), 7.03 (t, <i>J</i> = 8.8 Hz, 2H), 3.79–3.54 (m, 3H), 3.45 (s, 3H), 2.84 (d, <i>J</i> = 11.9 Hz, 2H), 2.35 (q, <i>J</i> = 11.5 Hz, 2H), 2.03–1.87 (m, 5H), 1.76–1.60 (m, 2H).</div></div><div id="sec4_7_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> Methyl 6-[(1,1-Dioxo-1,4-thiazinan-4-yl)methyl]-4-(4-fluorophenyl)-4-methyl-2-thiazol-2-yl-1<i>H</i>-pyrimidine-5-carboxylate (<b>31h</b>)</h4><div class="NLM_p last">MS: calcd (MH<sup>+</sup>) 479.1, exp (MH<sup>+</sup>) 479. HRMS: calcd (MH<sup>+</sup>) 479.1222, exp (MH<sup>+</sup>) 479.1228. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>) δ 7.98 (d, <i>J</i> = 3.3 Hz, 1H), 7.77 (d, <i>J</i> = 3.0 Hz, 1H), 7.49 (m, 2H), 7.04 (t, <i>J</i> = 8.6 Hz, 2H), 3.95–3.71 (m, 2H), 3.48 (s, 3H), 3.22 (m, 4H), 3.13 (d, <i>J</i> = 5.8 Hz, 4H), 1.90 (s, 3H).</div></div><div id="sec4_7_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72"> Methyl 6-[(4,4-Difluoro-1-piperidyl)methyl]-4-(4-fluorophenyl)-4-methyl-2-thiazol-2-yl-1<i>H</i>-pyrimidine-5-carboxylate (<b>31i</b>)</h4><div class="NLM_p last">MS: calcd (MH<sup>+</sup>) 465.1, exp (MH<sup>+</sup>) 465.1. HRMS: calcd (MH<sup>+</sup>) 465.1567, exp (MH<sup>+</sup>) 465.1568. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>) δ 7.96 (d, <i>J</i> = 3.3 Hz, 1H), 7.75 (d, <i>J</i> = 3.0 Hz, 1H), 7.47 (dd, <i>J</i> = 8.8, 5.56 Hz, 2H), 7.03 (t, <i>J</i> = 8.7 Hz, 2H), 3.80–3.62 (m, 2H), 3.46 (s, 3H), 2.70 (d, <i>J</i> = 5.0 Hz, 4H), 2.16–2.03 (m, 4H), 1.90 (s, 3H).</div></div><div id="sec4_7_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73"> Methyl 6-[(3,3-Difluoro-1-piperidyl)methyl]-4-(4-fluorophenyl)-4-methyl-2-thiazol-2-yl-1<i>H</i>-pyrimidine-5-carboxylate (<b>31j</b>)</h4><div class="NLM_p last">MS: calcd (MH<sup>+</sup>) 465.1, exp (MH<sup>+</sup>) 465.1. HRMS: calcd (MH<sup>+</sup>) 465.1567, exp (MH<sup>+</sup>) 465.1577. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>) δ 8.03 (d, <i>J</i> = 3.3 Hz, 1H), 7.95 (d, <i>J</i> = 3.3 Hz, 1H), 7.68–7.59 (m, 2H), 7.17–7.09 (m, 2H), 4.52–4.40 (m, 2H), 3.85–3.69 (m, 2H), 3.50 (s, 3H), 3.45 (t, <i>J</i> = 5.3 Hz, 2H), 2.30–2.14 (m, 4H), 2.11 (s, 3H).</div></div><div id="sec4_7_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> Methyl 4-(4-Fluorophenyl)-6-[(3-hydroxypyrrolidin-1-yl)methyl]-4-methyl-2-thiazol-2-yl-1<i>H</i>-pyrimidine-5-carboxylate (<b>31k</b>)</h4><div class="NLM_p last">MS: calcd (MH<sup>+</sup>) 431.1, exp (MH<sup>+</sup>) 431.1. HRMS: calcd (MH<sup>+</sup>) 431.1553, exp (MH<sup>+</sup>) 431.1556. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>) δ 7.94 (d, <i>J</i> = 3.3 Hz, 1H), 7.75 (d, <i>J</i> = 2.8 Hz, 1H), 7.48 (m, 2H), 7.04 (t, <i>J</i> = 8.7 Hz, 2H), 4.45–4.36 (m, 1H), 3.87–3.69 (m, 2H), 3.46 (d, <i>J</i> = 1.5 Hz, 3H), 2.91 (m, 2H), 2.64 (m, 2H), 2.22 (qd, <i>J</i> = 13.9, 7.1 Hz, 1H), 1.90 (s, 3H), 1.81 (m, 1H).</div></div><div id="sec4_7_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75"> Methyl 6-[(3,3-Difluoropyrrolidin-1-yl)methyl]-4-(4-fluorophenyl)-4-methyl-2-thiazol-2-yl-1<i>H</i>-pyrimidine-5-carboxylate (<b>31m</b>)</h4><div class="NLM_p last">MS: calcd (MH<sup>+</sup>) 451.1, exp (MH<sup>+</sup>) 451.1. HRMS: calcd (MH<sup>+</sup>) 451.1415, exp (MH<sup>+</sup>) 451.1416. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>) δ 7.94 (d, <i>J</i> = 3.0 Hz, 1H), 7.74 (d, <i>J</i> = 3.0 Hz, 1H), 7.51–7.44 (m, 2H), 7.04 (t, <i>J</i> = 8.8 Hz, 2H), 3.87–3.70 (m, 2H), 3.46 (s, 3H), 3.15–3.00 (m, 2H), 2.92 (dt, <i>J</i> = 4.5, 6.8 Hz, 2H), 2.37 (tt, <i>J</i> = 7.2, 14.7 Hz, 2H), 1.90 (s, 3H).</div></div><div id="sec4_7_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76"> Methyl 4-(4-Fluorophenyl)-4-methyl-2-thiazol-2-yl-6-{[3-(trifluoromethyl)pyrrolidin-1-yl]methyl}-1<i>H</i>-pyrimidine-5-carboxylate (<b>31n</b>)</h4><div class="NLM_p last">MS: calcd (MH<sup>+</sup>) 483.1, exp (MH<sup>+</sup>) 483.1. HRMS: calcd (MH<sup>+</sup>) 483.1478, exp (MH<sup>+</sup>) 483.1482. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 8.09 (d, <i>J</i> = 3.0 Hz, 1H), 8.03 (d, <i>J</i> = 3.0 Hz, 1H), 7.51 (m, 2H), 7.16 (t, <i>J</i> = 8.8 Hz, 2H), 4.41–4.51 (m, 2H), 3.85–3.77 (m, 2H), 3.68–3.59 (m, 3H), 3.43 (m, 3H), 2.30–2.38 (m, 1H), 2.09 (m, 1H), 1.97 (m, 3H).</div></div><div id="sec4_7_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77"> Methyl 6-[(1,1-Dioxo-1,2-thiazolidin-2-yl)methyl]-4-(4-fluorophenyl)-4-methyl-2-thiazol-2-yl-1<i>H</i>-pyrimidine-5-carboxylate (<b>31p</b>)</h4><div class="NLM_p last">MS: calcd (MH<sup>+</sup>) 465.1, exp (MH<sup>+</sup>) 465.1. HRMS: calcd (MH<sup>+</sup>) 465.1061, exp (MH<sup>+</sup>) 465.1056. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>) δ 7.93 (m, 1H), 7.83–7.70 (m, 1H), 7.67–7.41 (m, 2H), 7.06 (d, <i>J</i> = 7.6 Hz, 2H), 4.41–4.22 (m, 1H), 4.12 (m, 1H), 3.64–3.37 (m, 6H), 3.21 (m, 1H), 2.43 (d, <i>J</i> = 6.3 Hz, 2H), 2.02–1.84 (m, 3H).</div></div><div id="sec4_7_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i78" class="anchor-spacer"></div><h4 class="article-section__title" id="_i78"> Methyl 4-(4-Fluorophenyl)-6-(imidazol-1-ylmethyl)-4-methyl-2-thiazol-2-yl-1<i>H</i>-pyrimidine-5-carboxylate (<b>31q</b>)</h4><div class="NLM_p last">MS: calcd (MH<sup>+</sup>) 412.1, exp (MH<sup>+</sup>) 412.1. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>) δ 9.08 (t, <i>J</i> = 1.4 Hz, 1H), 7.93 (d, <i>J</i> = 3.3 Hz, 1H), 7.79 (d, <i>J</i> = 3.0 Hz, 1H), 7.75 (t, <i>J</i> = 1.8 Hz, 1H), 7.63–7.55 (m, 3H), 7.11 (t, <i>J</i> = 8.8 Hz, 2H), 5.42 (m, 2H), 3.53 (s, 3H), 2.05 (s, 3H).</div></div><div id="sec4_7_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79"> Methyl 4-(4-Fluorophenyl)-6-[(3-methoxyazetidin-1-yl)methyl]-4-methyl-2-thiazol-2-yl-1<i>H</i>-pyrimidine-5-carboxylate (<b>31r</b>)</h4><div class="NLM_p last">MS: calcd (MH<sup>+</sup>) 431.1, exp (MH<sup>+</sup>) 431.1. HRMS: calcd (MH<sup>+</sup>) 431.1553, exp (MH<sup>+</sup>) 431.1558. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>) δ 7.98 (d, <i>J</i> = 3.3 Hz, 1H), 7.88 (d, <i>J</i> = 3.3 Hz, 1H), 7.60 (dd, <i>J</i> = 8.8, 5.3 Hz, 2H), 7.11 (t, <i>J</i> = 8.7 Hz, 2H), 4.57 (m, 4H), 4.39 (m, 1H), 4.33–4.13 (m, 2H), 3.49 (s, 3H), 3.40 (s, 3H), 2.07 (s, 3H).</div></div><div id="sec4_7_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i80" class="anchor-spacer"></div><h4 class="article-section__title" id="_i80"> 2-{[4-(4-Fluorophenyl)-5-methoxycarbonyl-4-methyl-2-thiazol-2-yl-1<i>H</i>-pyrimidin-6-yl]methylmethylamino}acetic Acid (<b>31s</b>)</h4><div class="NLM_p last">MS: calcd (MH<sup>+</sup>) 433.1, exp (MH<sup>+</sup>) 433.1. HRMS: calcd (MH<sup>+</sup>) 433.1340, exp (MH<sup>+</sup>) 433.1341. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>) δ 7.96 (d, <i>J</i> = 3.0 Hz, 1H), 7.86 (d, <i>J</i> = 3.0 Hz, 1H), 7.64–7.58 (m, 2H), 7.12 (t, <i>J</i> = 8.8 Hz, 2H), 4.51–4.37 (m, 2H), 3.84 (m, 2H), 3.50 (s, 3H), 3.07 (s, 3H), 2.08 (s, 3H).</div></div><div id="sec4_7_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i81" class="anchor-spacer"></div><h4 class="article-section__title" id="_i81"> 1-{[4-(4-Fluorophenyl)-5-methoxycarbonyl-4-methyl-2-thiazol-2-yl-1<i>H</i>-pyrimidin-6-yl]methylmethylamino}cyclopropanecarboxylic Acid (<b>31t</b>)</h4><div class="NLM_p last">MS: calcd (MH<sup>+</sup>) 459.1, exp (MH<sup>+</sup>) 459.1. HRMS: calcd (MH<sup>+</sup>) 459.1502, exp (MH<sup>+</sup>) 459.1508. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>) δ 8.13 (d, <i>J</i> = 3.0 Hz, 1H), 8.07 (d, <i>J</i> = 3.0 Hz, 1H), 7.65–7.57 (m, 2H), 7.15 (t, <i>J</i> = 8.8 Hz, 2H), 4.30 (m, 2H), 3.51 (s, 3H), 2.79 (m, 3H), 2.10 (s, 3H), 1.55–1.48 (m, 2H), 1.41–1.35 (m, 2H).</div></div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i82" class="anchor-spacer"></div><h3 class="article-section__title" id="_i82"> General Procedures for the Synthesis of O-Linked Analogues <b>31u</b>–<b>w</b></h3><div class="NLM_p">To a stirring mixture of NaH (60%, 0.6 mmol) and alcohol <b>33</b> (0.5 mmol) in 20 mL of THF was added <b>30</b>, and the reaction mixture was stirred at rt overnight. The mixture was partitioned between water and EtOAc. The organic phase was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, concentrated, and used in the next step without further purification. The crude product was treated with TFA at rt to remove the <i>N</i>-Boc protecting group, and the residue was purified by prep-HPLC to afford analogues <b>31u</b>–<b>v</b>. For analogue <b>31w</b>, the crude product was treated with LiOH in MeOH at rt overnight before treatment with TFA.</div><div id="sec4_8_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i83" class="anchor-spacer"></div><h4 class="article-section__title" id="_i83"> Methyl 4-(4-Fluorophenyl)-4-methyl-6-(tetrahydrofuran-3-yloxymethyl)-2-thiazol-2-yl-1<i>H</i>-pyrimidine-5-carboxylate (<b>31u</b>)</h4><div class="NLM_p last">MS: calcd (MH<sup>+</sup>) 432.1, exp (MH<sup>+</sup>) 432.1. HRMS: calcd (MH<sup>+</sup>) 432.1393, exp (MH<sup>+</sup>) 432.1396. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>) δ 7.94 (d, <i>J</i> = 3.0 Hz, 1H), 7.74 (d, <i>J</i> = 3.3 Hz, 1H), 7.47 (dd, <i>J</i> = 8.5, 5.4 Hz, 2H), 7.04 (t, <i>J</i> = 8.7 Hz, 2H), 4.76–4.66 (m, 2H), 4.38 (m, 1H), 3.98 (dd, <i>J</i> = 15.3, 8.2 Hz, 2H), 3.91–3.80 (m, 2H), 3.45 (d, <i>J</i> = 1.8 Hz, 3H), 2.18–2.10 (m, 2H), 1.93 (s, 3H).</div></div><div id="sec4_8_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i84" class="anchor-spacer"></div><h4 class="article-section__title" id="_i84"> Methyl 4-(4-Fluorophenyl)-4-methyl-2-thiazol-2-yl-6-(2,2,2-trifluoroethoxymethyl)-1<i>H</i>-pyrimidine-5-carboxylate (<b>31v</b>)</h4><div class="NLM_p last">MS: calcd (MH<sup>+</sup>) 444.1, exp (MH<sup>+</sup>) 444.1. HRMS: calcd (MH<sup>+</sup>) 444.1005, exp (MH<sup>+</sup>) 444.1006. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>) δ 7.94 (d, <i>J</i> = 3.0 Hz, 1H), 7.74 (d, <i>J</i> = 3.0 Hz, 1H), 7.53–7.44 (m, 2H), 7.06 (q, <i>J</i> = 8.9 Hz, 2H), 4.85–4.79 (m, 1H), 4.62–4.49 (m, 1H), 4.21–4.02 (m, 2H), 3.55–3.42 (m, 3H), 2.01–1.89 (m, 3H).</div></div><div id="sec4_8_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i85" class="anchor-spacer"></div><h4 class="article-section__title" id="_i85"> 3,3,3-Trifluoro-2-{[4-(4-fluorophenyl)-5-methoxycarbonyl-4-methyl-2-thiazol-2-yl-1<i>H</i>-pyrimidin-6-yl]methoxy}propanoic Acid (<b>31w</b>)</h4><div class="NLM_p last">MS: calcd (MH<sup>+</sup>) 488.1, exp (MH<sup>+</sup>) 488.1. HRMS: calcd (MH<sup>+</sup>) 488.0898, exp (MH<sup>+</sup>) 488.0897. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>) δ 7.93 (d, <i>J</i> = 3.0 Hz, 1H), 7.73 (d, <i>J</i> = 3.3 Hz, 1H), 7.55–7.47 (m, 2H), 7.05 (t, <i>J</i> = 8.8 Hz, 2H), 4.85–4.74 (m, 2H), 4.39 (q, <i>J</i> = 7.8 Hz, 1H), 3.45 (s, 3H), 1.94 (s, 3H).</div></div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i86" class="anchor-spacer"></div><h3 class="article-section__title" id="_i86"> General Procedures for the Synthesis of Amino Acid-Substituted Analogues <b>34a</b>–<b>f</b></h3><div class="NLM_p">Analogues <b>34a</b>–<b>f</b> was synthesized in analogy to <b>31a</b>–<b>t</b> by using enantiomer (<i>S</i>)-<b>7a</b> and chiral amino esters as starting materials. (<i>S</i>)-<b>7a</b> was obtained by chiral SFC separation of <b>7a</b> in 48% yield. To a solution of (<i>S</i>)-<b>7a</b> (6.91 g, 20 mmol) and DMAP (3.66 g, 30 mmol) in 200 mL of DCM was added Boc<sub>2</sub>O (5.46 g, 25 mmol), and the mixture was stirred overnight. The organic phase was washed with water and brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and concentrated. The residue was purified by flash chromatography to afford the <i>N</i>-Boc protected intermediate, which was then dissolved in 300 mL of CCl<sub>4</sub>. To this solution was added NBS (3.56 g, 20 mmol) and AIBN (100 mg), and the mixture was stirred at 50 °C for 2 h. The reaction mixture was washed with water, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and concentrated. The residue was purified by flash chromatography to give bromide intermediate in 82% yield over two steps.</div><div class="NLM_p">To a mixture of this bromide (1.05 g, 2.0 mmol) and K<sub>2</sub>CO<sub>3</sub> (0.7 g) in 10 mL of DMF was added amino ester <b>35</b> (2.0 mmol), and the mixture was stirred at 40 °C for 3 h before it was partitioned between water and EtOAc. The organic phase was washed with brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and concentrated. The residue was purified by flash chromatography to give <b>36</b> in >80% yield. A mixture of <b>36</b> (1.0 mmol) and LiOH (10.0 mmol) in 10 mL of MeOH/H<sub>2</sub>O was stirred at rt for 2 h. When the hydrolysis was complete, the mixture was extracted with EtOAc and the organic phase was washed with brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and concentrated. The residue was dissolved in 10 mL of DCM, and to this solution was added 1 mL of TFA. The reaction mixture was stirred at rt for 2 h before being partitioned between DCM and water. The organic phase was washed with brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and concentrated. Analogues <b>34a</b>–<b>e</b> were purified and obtained as powder in >70% yields.</div><div id="sec4_9_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i87" class="anchor-spacer"></div><h4 class="article-section__title" id="_i87"> (2<i>S</i>)-4,4-Difluoro-1-[[(4<i>S</i>)-4-(4-fluorophenyl)-5-methoxycarbonyl-4-methyl-2-thiazol-2-yl-1<i>H</i>-pyrimidin-6-yl]methyl]pyrrolidine-2-carboxylic Acid (<b>34a</b>)</h4><div class="NLM_p last">[α]<sub>D</sub><sup>20</sup> 56.0 (1.05 mg/mL, MeOH). MS: calcd (MH<sup>+</sup>) 495.1, exp (MH<sup>+</sup>) 495.1. HRMS: calcd (MH<sup>+</sup>) 495.1308, exp (MH<sup>+</sup>) 495.1315. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>) δ 8.22 (m, 2H), 7.68–7.65 (m, 2H), 7.21–7.17 (m, 2H), 4.16 (d, <i>J</i> = 15.6 Hz, 1H), 4.02 (t, <i>J</i> = 8.0 Hz, 1H), 3.93 (d, <i>J</i> = 15.6 Hz, 1H), 3.72–3.61 (m, 1H), 3.53 (s, 3H), 3.29–3.19 (m, 1H), 2.91–2.78 (m, 1H), 2.59–2.55 (m, 1H), 2.17 (s, 3H).</div></div><div id="sec4_9_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i88" class="anchor-spacer"></div><h4 class="article-section__title" id="_i88"> (<i>S</i>)-4-[(<i>S</i>)-6-(4-Fluorophenyl)-5-methoxycarbonyl-6-methyl-2-thiazol-2-yl-3,6-dihydropyrimidin-4-ylmethyl]morpholine-3-carboxylic Acid (<b>34b</b>)</h4><div class="NLM_p last">[α]<sub>D</sub><sup>20</sup> 8.4 (1.0 mg/mL, MeOH). MS: calcd (MH<sup>+</sup>) 475.1, exp (MH<sup>+</sup>) 475.1. HRMS: calcd (MH<sup>+</sup>) 475.1446, exp (MH<sup>+</sup>) 475.1449. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>) δ 8.07 (d, <i>J</i> = 3.0 Hz, 1H), 7.97 (d, <i>J</i> = 3.2 Hz, 1H), 7.64–7.58 (m, 2H), 7.12 (t, <i>J</i> = 8.8 Hz, 2H), 4.33–4.25 (m, 2H), 4.13 (dd, <i>J</i> = 4.4, 2.7 Hz, 2H), 3.98–3.86 (m, 3H), 3.59–3.52 (m, 1H), 3.51–3.48 (m, 3H), 3.01 (ddd, <i>J</i> = 12.4, 5.7, 3.3 Hz, 1H), 2.10–2.06 (m, 3H).</div></div><div id="sec4_9_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i89" class="anchor-spacer"></div><h4 class="article-section__title" id="_i89"> (2<i>R</i>)-4,4-Difluoro-1-{[(4<i>S</i>)-4-(4-fluorophenyl)-5-methoxycarbonyl-4-methyl-2-thiazol-2-yl-1<i>H</i>-pyrimidin-6-yl]methyl}pyrrolidine-2-carboxylic Acid (<b>34c</b>)</h4><div class="NLM_p last">[α]<sub>D</sub><sup>20</sup> 20.0 (0.95 mg/mL, MeOH). MS: calcd (MH<sup>+</sup>) 495.1, exp (MH<sup>+</sup>) 495.1. HRMS: calcd (MH<sup>+</sup>) 495.1308, exp (MH<sup>+</sup>) 495.1310. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>) δ 8.00 (d, <i>J</i> = 3.0 Hz, 1H), 7.87 (d, <i>J</i> = 2.8 Hz, 1H), 7.56 (dd, <i>J</i> = 8.8, 5.3 Hz, 2H), 7.10 (t, <i>J</i> = 8.9 Hz, 2H), 4.10 (d, <i>J</i> = 15.3 Hz, 1H), 4.00–3.92 (m, 2H), 3.66–3.57 (m, 2H), 3.48 (s, 3H), 2.85–2.77 (m, 1H), 2.58–2.50 (m, 1H), 1.99 (s, 3H).</div></div><div id="sec4_9_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i90" class="anchor-spacer"></div><h4 class="article-section__title" id="_i90"> (<i>R</i>)-4-[(<i>S</i>)-6-(4-Fluorophenyl)-5-methoxycarbonyl-6-methyl-2-thiazol-2-yl-3,6-dihydropyrimidin-4-ylmethyl]morpholine-3-carboxylic Acid (<b>34d</b>)</h4><div class="NLM_p last">[α]<sub>D</sub><sup>20</sup> 25.3 (0.9 mg/mL, MeOH). MS: calcd (MH<sup>+</sup>) 475.1, exp (MH<sup>+</sup>) 475.1. HRMS: calcd (MH<sup>+</sup>) 475.1446, exp (MH<sup>+</sup>) 475.1455. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>) δ 8.07 (d, <i>J</i> = 3.0 Hz, 1H), 7.98 (d, <i>J</i> = 3.3 Hz, 1H), 7.65–7.57 (m, 2H), 7.12 (t, <i>J</i> = 8.8 Hz, 2H), 4.29 (q, <i>J</i> = 16.2 Hz, 2H), 4.19–4.06 (m, 2H), 3.99–3.84 (m, 3H), 3.57–3.51 (m, 1H), 3.49 (s, 3H), 3.02 (ddd, <i>J</i> = 12.4, 6.1, 3.2 Hz, 1H), 2.09 (s, 3H).</div></div><div id="sec4_9_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i91" class="anchor-spacer"></div><h4 class="article-section__title" id="_i91"> (2<i>S</i>)-1-[[(4<i>S</i>)-4-(4-Fluorophenyl)-5-methoxycarbonyl-4-methyl-2-thiazol-2-yl-1<i>H</i>-pyrimidin-6-yl]methyl]pyrrolidine-2-carboxylic Acid (<b>34e</b>)</h4><div class="NLM_p last">MS: calcd (MH<sup>+</sup>) 459.3, exp (MH<sup>+</sup>) 459.1. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>) δ 7.96 (dd, <i>J</i> = 3.1, 1.6 Hz, 1H), 7.86 (dd, <i>J</i> = 3.0, 1.8 Hz, 1H), 7.71–7.51 (m, 2H), 7.18–7.03 (m, 2H), 4.61–4.46 (m, 1H), 4.41–4.30 (m, 1H), 4.27–4.15 (m, 1H), 3.93 (m, 2H), 3.49 (m, 2H), 3.15 (m, 1H), 2.64–2.45 (m, 2H), 2.36–2.15 (m, 1H), 2.12–1.92 (m, 4H).</div></div><div id="sec4_9_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i92" class="anchor-spacer"></div><h4 class="article-section__title" id="_i92"> Methyl (4<i>S</i>)-6-[[(2<i>S</i>)-4,4-Difluoro-2-methoxycarbonylpyrrolidin-1-yl]methyl]-4-(4-fluorophenyl)-4-methyl-2-thiazol-2-yl-1<i>H</i>-pyrimidine-5-carboxylate (<b>34f</b>)</h4><div class="NLM_p last">To a solution of <b>36</b> (W = -CF<sub>2</sub>-, 0.5 mmol) in 5 mL of DCM was added 0.5 mL of TFA, and the reaction mixture was stirred at rt for 2 h before being partitioned between water and DCM. The aqueous phase was extracted with DCM, and the combined organic phase was washed with water and brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and concentrated. The residue was purified by prep-HPLC to afford analogue <b>34f</b> as powder in 85% yield. MS: calcd (MH<sup>+</sup>) 509.1, exp (MH<sup>+</sup>) 509. HRMS: calcd (MH<sup>+</sup>) 509.1465, exp (MH<sup>+</sup>) 509.1466. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>) δ 8.26–8.21 (m, 2H), 7.69–7.62 (m, 2H), 7.23–7.13 (m, 2H), 4.15–4.07 (m, 1H), 4.02 (dd, <i>J</i> = 7.3, 8.8 Hz, 1H), 3.96–3.90 (m, 1H), 3.82 (s, 3H), 3.65–3.54 (m, 1H), 3.53 (s, 3H), 3.28–3.13 (m, 1H), 2.89–2.74 (m, 1H), 2.61–2.44 (m, 1H), 2.22–2.14 (m, 3H).</div></div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i93" class="anchor-spacer"></div><h3 class="article-section__title" id="_i93"> Microsomal Stability Assay</h3><div class="NLM_p last">Each incubated mixture contained 0.5 mg/mL liver microsome (human or mouse), 100 mM potassium phosphate buffer (pH 7.4), 10 mM NADPH, and 1 μM test compound in a total volume of 400 μL. After prewarming at 37 °C for 10 min, the NADPH was added to initiate the reaction. The reaction was terminated after 0, 3, 6, 9, 15, or 30 min by adding 150 μL of 100 ng/mL tolbutamide (internal standard) in ice-cold methanol into 300 μL of incubation mixture. The sample was then centrifuged at 4000 rpm for 10 min at 4 °C. The supernatant was then analyzed by LC–MS/MS.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i94" class="anchor-spacer"></div><h3 class="article-section__title" id="_i94"> LYSA Solubility Assay</h3><div class="NLM_p last">A 150 μL aliquot of 10 mM DMSO stock solution of the compound was prepared and divided into two portions. For one portion, the DMSO solution was evaporated to dryness at 35 °C in a centrifugal vacuum evaporator from Genevac Technologies, and the residue was redissolved in 50 mM phosphate buffer (pH 6.5). The mixture was stirred and shaken for 1–2 h. The solution was allowed to stand overnight and then filtered before HPLC analysis. The other portion was used to prepare a calibration curve by dilution of the DMSO stock solution using the same PBS buffer mentioned above to obtain a series of solutions with concentrations in the range of 50–500 μM.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i95" class="anchor-spacer"></div><h3 class="article-section__title" id="_i95"> Biology General Comments</h3><div class="NLM_p last">Brief descriptions of the biological protocols used to generate data in this study can be found below. Cells and culture conditions were as follows. HepDE19 cells were derived from HepG2 cells (ATCC) through transfection with pTet-off plasmid (Clontech) that expresses the Tet-responsive transcriptional activator and pTREHBVDE plasmid in which HBV pgRNA expression is controlled by a tetracycline-responsive CMV promoter.<a onclick="showRef(event, 'ref19 ref25'); return false;" href="javascript:void(0);" class="ref ref19 ref25">(19, 25)</a> The transfected cells were selected with G418 (Invitrogen). In tetracycline-free medium, cells support high levels of HBV DNA replication and HBV virus secretion. Caco-2 cells were obtained from ATCC, and the measurement of compound permeability was carried out according to reported procedures. pcDNA3.1HBV1.1mer plasmid was prepared by Qiagen EndoFree Plasmid Giga Kit. All of the animal studies including DMPK evaluations and the HDI mouse model were approved and regularly reviewed by the Institutional Animal Care and Use Committee (IACUC) of Roche Pharma Research and Early Development (pRED) China.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i96" class="anchor-spacer"></div><h3 class="article-section__title" id="_i96"> Anti-HBV Activity and Cytotoxicity</h3><div class="NLM_p last">HepDE19 cells were seeded into 96-well plates (3 × 10<sup>4</sup> cells/well) with tetracycline-free medium and incubated overnight at 37 °C. The test or control compounds were half-log diluted serially with medium and added into the plates with 0.5% of final DMSO concentration. After a 5 d incubation, cells were washed with PBS and lysed with 50 mM Tris–1 mM EDTA–0.2% CA-630 (pH 8.0) at 37 °C for 20 min. After centrifugation to remove nuclei and other debris, the supernatant was transferred into a new plate and incubated with 2 M NaOH/20 × SSC (3 M NaCl, 0.3 M sodium citrate, pH 7.0) at rt for 30 min. Then the samples were transferred to nylon membrane and neutralized with 1 M Tris (pH 7.4)/2 M NaCl. The presence of HBV DNA was detected by dot-blot with DIG-labeled HBV specific DNA probes and quantified by dot density. To determine the cytotoxicity of test compounds, HepDE19 cells (5 × 10<sup>3</sup> cells/well) were seeded into 96-well plates and incubated with compounds as described above. Five days after treatment, cell viability was measured by addition of 20 μL of CCK-8 reagent. After a 4 h incubation at 37 °C, the absorbance at wavelengths of 450 and 630 nm (OD<sub>450</sub> and OD<sub>630</sub>) was recorded by a plate reader.</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i97" class="anchor-spacer"></div><h3 class="article-section__title" id="_i97"> Protein Expression and Purification</h3><div class="NLM_p last">HBc1–149 Y132A construct was cloned as described previously.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> The recombinant protein was expressed in <i>Escherichia coli</i> strain BL21(DE3) and purified by Ni affinity column followed by anion-exchange chromatography. The His6 tag was removed by using tobacco etch virus (TEV) protease. Then the tagless HBc1–149 Y132A protein with additional C-terminal ENLYFQ was dialyzed into 25 mM Tris buffer (pH 9.0) containing 2 mM DTT and 10 mM EDTA. Finally the product was concentrated and stored at −80 °C.</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i98" class="anchor-spacer"></div><h3 class="article-section__title" id="_i98"> Crystallization and Structure Determination</h3><div class="NLM_p last">Sitting drop was set up using equal volumes of HBc1–149 Y132A (17 mg/mL) in 20 mM Tris buffer (pH 9.0), 2 mM DTT, and crystallization buffer containing 100 mM citrate (pH 5.6), 21% (v/v) isopropanol, 1% (wt/vol) PEG 10 000 at 20 °C. Apo crystal was soaked in the crystallization buffer plus 25% glycerol and 2 mM <b>34a</b> for 2 h before it was flash frozen in liquid nitrogen. The data set was collected on single crystal for Y132A-<b>34a</b> complex structure at BL17U beamline, Shanghai Synchrotron Radiation Facility. Data were processed by using HKL2000.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> The structure was solved by PHASER<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> molecular replacement using 4BMG as the search model. The model was manually built and refined several rounds by using PHENIX package<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> and COOT.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> The final model quality was evaluated by MolProblity<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> (<a href="/doi/suppl/10.1021/acs.jmedchem.6b00879/suppl_file/jm6b00879_si_001.pdf" class="ext-link">Table S1</a>).</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i99" class="anchor-spacer"></div><h3 class="article-section__title" id="_i99"> Pharmacokinetic (PK) Analysis</h3><div class="NLM_p last">All of the compounds were evaluated in CD-1 mice (18–25 g; three mice in each group were used for blood collection at each time point). Compounds were dissolved in 6% Solutol solution (Solutol/ethanol, 1:1, v/v) and 94% 0.9% saline for iv dose and 1% RC591 for oral dose. In each species, blood samples (150 μL) were collected at eight time points (po) or nine time points (iv) into sodium heparin centrifuge tubes, and plasma samples were then isolated by centrifugation and stored at −20 °C prior to analysis. Plasma concentrations were determined by LC–MS/MS, and the data were analyzed by noncompartmental methods using WinNonlin Pro (Pharsight Corp., Mountain View, CA).</div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i100" class="anchor-spacer"></div><h3 class="article-section__title" id="_i100"> In Vivo Efficacy in HDI Mouse Model</h3><div class="NLM_p last">Female BALB/c mice (6–8 weeks old) were injected through tail vein with 20 μg of plasmid pcDNA3.1HBV encoding a 1.1-mer HBV genome (genotype D) in a volume of normal saline equivalent to 8% of the mouse body weight. The total volume was delivered within a few seconds. At 7 h after injection, mice were orally dosed by blank vehicle, 0.1 mg/kg of entecavir, or 12.5 mpk, 25 mpk, and 50 mpk of <b>34a</b> at indicated frequency for 5 days, respectively. Plasma and liver samples were collected at the indicated time points for HBV DNA quantification by real-time PCR.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i101"><a href="/doi/suppl/10.1021/acs.jmedchem.6b00879">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34601" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34601" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.6b00879" class="ext-link">10.1021/acs.jmedchem.6b00879</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Detailed experimental procedures for the synthesis of key intermediates including amidines <b>12</b>, 4,4-difluoroproline methyl ester, and <i>tert</i>-butyl ester <b>20</b>; X-ray structure of (<i>S</i>)-<b>7a</b>; data collection and refinement statistics of Y132A-<b>34a</b> cocrystal structure; CYP inhibition, plasma protein binding assay, and mechanistic studies of <b>34a</b> to the capsid assembly by size-exclusion chromatography (SEC) and transmission electron microscopy (TEM) (<a href="/doi/suppl/10.1021/acs.jmedchem.6b00879/suppl_file/jm6b00879_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and some data (<a href="/doi/suppl/10.1021/acs.jmedchem.6b00879/suppl_file/jm6b00879_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00879/suppl_file/jm6b00879_si_001.pdf">jm6b00879_si_001.pdf (1.07 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00879/suppl_file/jm6b00879_si_002.csv">jm6b00879_si_002.csv (4.8 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">PDB code for <b>34a</b> is <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5GMZ">5GMZ</a>. Authors will release the atomic coordinates and experimental data upon article publication.</p><div class="testing" data-doi="10.1021/acs.jmedchem.6b00879" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34518" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34518" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Guozhi Tang</span> - <span class="hlFld-Affiliation affiliation">†Roche
Innovation Center Shanghai, ‡Medicinal Chemistry, §Chemical Biology, ∥Pharmaceutical Sciences, and ⊥Discovery Virology, Roche Pharma Research and Early Development, 720 Cailun Road, Shanghai, 201203 China</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#761103190c1e1f0217181147361e19021b171f1a5815191b"><span class="__cf_email__" data-cfemail="294e5c465341405d48474e186941465d44484045074a4644">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zongxing Qiu</span> - <span class="hlFld-Affiliation affiliation">†Roche
Innovation Center Shanghai, ‡Medicinal Chemistry, §Chemical Biology, ∥Pharmaceutical Sciences, and ⊥Discovery Virology, Roche Pharma Research and Early Development, 720 Cailun Road, Shanghai, 201203 China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xianfeng Lin</span> - <span class="hlFld-Affiliation affiliation">†Roche
Innovation Center Shanghai, ‡Medicinal Chemistry, §Chemical Biology, ∥Pharmaceutical Sciences, and ⊥Discovery Virology, Roche Pharma Research and Early Development, 720 Cailun Road, Shanghai, 201203 China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mingwei Zhou</span> - <span class="hlFld-Affiliation affiliation">†Roche
Innovation Center Shanghai, ‡Medicinal Chemistry, §Chemical Biology, ∥Pharmaceutical Sciences, and ⊥Discovery Virology, Roche Pharma Research and Early Development, 720 Cailun Road, Shanghai, 201203 China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yongfu Liu</span> - <span class="hlFld-Affiliation affiliation">†Roche
Innovation Center Shanghai, ‡Medicinal Chemistry, §Chemical Biology, ∥Pharmaceutical Sciences, and ⊥Discovery Virology, Roche Pharma Research and Early Development, 720 Cailun Road, Shanghai, 201203 China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wei Zhu</span> - <span class="hlFld-Affiliation affiliation">†Roche
Innovation Center Shanghai, ‡Medicinal Chemistry, §Chemical Biology, ∥Pharmaceutical Sciences, and ⊥Discovery Virology, Roche Pharma Research and Early Development, 720 Cailun Road, Shanghai, 201203 China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wenming Chen</span> - <span class="hlFld-Affiliation affiliation">†Roche
Innovation Center Shanghai, ‡Medicinal Chemistry, §Chemical Biology, ∥Pharmaceutical Sciences, and ⊥Discovery Virology, Roche Pharma Research and Early Development, 720 Cailun Road, Shanghai, 201203 China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Weixing Zhang</span> - <span class="hlFld-Affiliation affiliation">†Roche
Innovation Center Shanghai, ‡Medicinal Chemistry, §Chemical Biology, ∥Pharmaceutical Sciences, and ⊥Discovery Virology, Roche Pharma Research and Early Development, 720 Cailun Road, Shanghai, 201203 China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lei Guo</span> - <span class="hlFld-Affiliation affiliation">†Roche
Innovation Center Shanghai, ‡Medicinal Chemistry, §Chemical Biology, ∥Pharmaceutical Sciences, and ⊥Discovery Virology, Roche Pharma Research and Early Development, 720 Cailun Road, Shanghai, 201203 China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Haixia Liu</span> - <span class="hlFld-Affiliation affiliation">†Roche
Innovation Center Shanghai, ‡Medicinal Chemistry, §Chemical Biology, ∥Pharmaceutical Sciences, and ⊥Discovery Virology, Roche Pharma Research and Early Development, 720 Cailun Road, Shanghai, 201203 China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Guolong Wu</span> - <span class="hlFld-Affiliation affiliation">†Roche
Innovation Center Shanghai, ‡Medicinal Chemistry, §Chemical Biology, ∥Pharmaceutical Sciences, and ⊥Discovery Virology, Roche Pharma Research and Early Development, 720 Cailun Road, Shanghai, 201203 China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mengwei Huang</span> - <span class="hlFld-Affiliation affiliation">†Roche
Innovation Center Shanghai, ‡Medicinal Chemistry, §Chemical Biology, ∥Pharmaceutical Sciences, and ⊥Discovery Virology, Roche Pharma Research and Early Development, 720 Cailun Road, Shanghai, 201203 China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Min Jiang</span> - <span class="hlFld-Affiliation affiliation">†Roche
Innovation Center Shanghai, ‡Medicinal Chemistry, §Chemical Biology, ∥Pharmaceutical Sciences, and ⊥Discovery Virology, Roche Pharma Research and Early Development, 720 Cailun Road, Shanghai, 201203 China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhiheng Xu</span> - <span class="hlFld-Affiliation affiliation">†Roche
Innovation Center Shanghai, ‡Medicinal Chemistry, §Chemical Biology, ∥Pharmaceutical Sciences, and ⊥Discovery Virology, Roche Pharma Research and Early Development, 720 Cailun Road, Shanghai, 201203 China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zheng Zhou</span> - <span class="hlFld-Affiliation affiliation">†Roche
Innovation Center Shanghai, ‡Medicinal Chemistry, §Chemical Biology, ∥Pharmaceutical Sciences, and ⊥Discovery Virology, Roche Pharma Research and Early Development, 720 Cailun Road, Shanghai, 201203 China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ning Qin</span> - <span class="hlFld-Affiliation affiliation">†Roche
Innovation Center Shanghai, ‡Medicinal Chemistry, §Chemical Biology, ∥Pharmaceutical Sciences, and ⊥Discovery Virology, Roche Pharma Research and Early Development, 720 Cailun Road, Shanghai, 201203 China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shuang Ren</span> - <span class="hlFld-Affiliation affiliation">†Roche
Innovation Center Shanghai, ‡Medicinal Chemistry, §Chemical Biology, ∥Pharmaceutical Sciences, and ⊥Discovery Virology, Roche Pharma Research and Early Development, 720 Cailun Road, Shanghai, 201203 China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hongxia Qiu</span> - <span class="hlFld-Affiliation affiliation">†Roche
Innovation Center Shanghai, ‡Medicinal Chemistry, §Chemical Biology, ∥Pharmaceutical Sciences, and ⊥Discovery Virology, Roche Pharma Research and Early Development, 720 Cailun Road, Shanghai, 201203 China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sheng Zhong</span> - <span class="hlFld-Affiliation affiliation">†Roche
Innovation Center Shanghai, ‡Medicinal Chemistry, §Chemical Biology, ∥Pharmaceutical Sciences, and ⊥Discovery Virology, Roche Pharma Research and Early Development, 720 Cailun Road, Shanghai, 201203 China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yuxia Zhang</span> - <span class="hlFld-Affiliation affiliation">†Roche
Innovation Center Shanghai, ‡Medicinal Chemistry, §Chemical Biology, ∥Pharmaceutical Sciences, and ⊥Discovery Virology, Roche Pharma Research and Early Development, 720 Cailun Road, Shanghai, 201203 China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yi Zhang</span> - <span class="hlFld-Affiliation affiliation">†Roche
Innovation Center Shanghai, ‡Medicinal Chemistry, §Chemical Biology, ∥Pharmaceutical Sciences, and ⊥Discovery Virology, Roche Pharma Research and Early Development, 720 Cailun Road, Shanghai, 201203 China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xiaoyue Wu</span> - <span class="hlFld-Affiliation affiliation">†Roche
Innovation Center Shanghai, ‡Medicinal Chemistry, §Chemical Biology, ∥Pharmaceutical Sciences, and ⊥Discovery Virology, Roche Pharma Research and Early Development, 720 Cailun Road, Shanghai, 201203 China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Liping Shi</span> - <span class="hlFld-Affiliation affiliation">†Roche
Innovation Center Shanghai, ‡Medicinal Chemistry, §Chemical Biology, ∥Pharmaceutical Sciences, and ⊥Discovery Virology, Roche Pharma Research and Early Development, 720 Cailun Road, Shanghai, 201203 China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fang Shen</span> - <span class="hlFld-Affiliation affiliation">†Roche
Innovation Center Shanghai, ‡Medicinal Chemistry, §Chemical Biology, ∥Pharmaceutical Sciences, and ⊥Discovery Virology, Roche Pharma Research and Early Development, 720 Cailun Road, Shanghai, 201203 China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yi Mao</span> - <span class="hlFld-Affiliation affiliation">†Roche
Innovation Center Shanghai, ‡Medicinal Chemistry, §Chemical Biology, ∥Pharmaceutical Sciences, and ⊥Discovery Virology, Roche Pharma Research and Early Development, 720 Cailun Road, Shanghai, 201203 China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xue Zhou</span> - <span class="hlFld-Affiliation affiliation">†Roche
Innovation Center Shanghai, ‡Medicinal Chemistry, §Chemical Biology, ∥Pharmaceutical Sciences, and ⊥Discovery Virology, Roche Pharma Research and Early Development, 720 Cailun Road, Shanghai, 201203 China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wengang Yang</span> - <span class="hlFld-Affiliation affiliation">†Roche
Innovation Center Shanghai, ‡Medicinal Chemistry, §Chemical Biology, ∥Pharmaceutical Sciences, and ⊥Discovery Virology, Roche Pharma Research and Early Development, 720 Cailun Road, Shanghai, 201203 China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jim Z. Wu</span> - <span class="hlFld-Affiliation affiliation">†Roche
Innovation Center Shanghai, ‡Medicinal Chemistry, §Chemical Biology, ∥Pharmaceutical Sciences, and ⊥Discovery Virology, Roche Pharma Research and Early Development, 720 Cailun Road, Shanghai, 201203 China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Guang Yang</span> - <span class="hlFld-Affiliation affiliation">†Roche
Innovation Center Shanghai, ‡Medicinal Chemistry, §Chemical Biology, ∥Pharmaceutical Sciences, and ⊥Discovery Virology, Roche Pharma Research and Early Development, 720 Cailun Road, Shanghai, 201203 China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alexander V. Mayweg</span> - <span class="hlFld-Affiliation affiliation">†Roche
Innovation Center Shanghai, ‡Medicinal Chemistry, §Chemical Biology, ∥Pharmaceutical Sciences, and ⊥Discovery Virology, Roche Pharma Research and Early Development, 720 Cailun Road, Shanghai, 201203 China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hong C. Shen</span> - <span class="hlFld-Affiliation affiliation">†Roche
Innovation Center Shanghai, ‡Medicinal Chemistry, §Chemical Biology, ∥Pharmaceutical Sciences, and ⊥Discovery Virology, Roche Pharma Research and Early Development, 720 Cailun Road, Shanghai, 201203 China</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d121e5608-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i103">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_07347" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_07347" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We are grateful to Qinshan Gao, Wenzhi Cheng, and Liqin Chen for purification of final compounds and analytical assistance, Jason C. Wong for scientific discussions, and Feng Yu and Jianhua He at the Shanghai Synchrotron Radiation Facility for assistance on X-ray data collection.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i104" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i104"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i105" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i105"> Abbreviations Used</h2><tr><td class="NLM_term">AIBN</td><td class="NLM_def"><p class="first last">azobisisobutyronitrile</p></td></tr><tr><td class="NLM_term">CDI</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>′-carbonyldiimidazole</p></td></tr><tr><td class="NLM_term">DMAP</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>′-dimethylaminopyridine</p></td></tr><tr><td class="NLM_term">GSH</td><td class="NLM_def"><p class="first last">glutathione</p></td></tr><tr><td class="NLM_term">HAP</td><td class="NLM_def"><p class="first last">heteroaryldihydropyrimidine</p></td></tr><tr><td class="NLM_term">HATU</td><td class="NLM_def"><p class="first last">2-(7-aza-1<i>H</i>-benzotriazole-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate</p></td></tr><tr><td class="NLM_term">HB</td><td class="NLM_def"><p class="first last">hydrogen-bonding</p></td></tr><tr><td class="NLM_term">HBeAg</td><td class="NLM_def"><p class="first last">hepatitis B e-antigen</p></td></tr><tr><td class="NLM_term">HBV</td><td class="NLM_def"><p class="first last">hepatitis B virus</p></td></tr><tr><td class="NLM_term">HDI</td><td class="NLM_def"><p class="first last">hydrodynamic injected</p></td></tr><tr><td class="NLM_term">hERG</td><td class="NLM_def"><p class="first last">human ether-a-go-go related gene</p></td></tr><tr><td class="NLM_term">HLM</td><td class="NLM_def"><p class="first last">human liver microsome</p></td></tr><tr><td class="NLM_term">IFN</td><td class="NLM_def"><p class="first last">interferon</p></td></tr><tr><td class="NLM_term">LYSA</td><td class="NLM_def"><p class="first last">lyophilized solubility assay</p></td></tr><tr><td class="NLM_term">MLM</td><td class="NLM_def"><p class="first last">mouse liver microsome</p></td></tr><tr><td class="NLM_term">MNT</td><td class="NLM_def"><p class="first last">micronucleus test</p></td></tr><tr><td class="NLM_term">mpk</td><td class="NLM_def"><p class="first last">mg/kg or milligram per kilogram</p></td></tr><tr><td class="NLM_term">NBS</td><td class="NLM_def"><p class="first last"><i>N</i>-bromosuccinimide</p></td></tr><tr><td class="NLM_term">NMP</td><td class="NLM_def"><p class="first last"><i>N</i>-methyl-2-pyrrolidone</p></td></tr><tr><td class="NLM_term">pgRNA</td><td class="NLM_def"><p class="first last">pregenomic RNA</p></td></tr><tr><td class="NLM_term">PPA</td><td class="NLM_def"><p class="first last">polyphosphoric acid</p></td></tr><tr><td class="NLM_term">PSA</td><td class="NLM_def"><p class="first last">polar surface area</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">SFC</td><td class="NLM_def"><p class="first last">supercritical fluid chromatography</p></td></tr><tr><td class="NLM_term">SDPK</td><td class="NLM_def"><p class="first last">single dose pharmacokinetics</p></td></tr><tr><td class="NLM_term">SPR</td><td class="NLM_def"><p class="first last">structure–property relationship</p></td></tr><tr><td class="NLM_term">PCR</td><td class="NLM_def"><p class="first last">polymerase chain reaction</p></td></tr><tr><td class="NLM_term">TFA</td><td class="NLM_def"><p class="first last">trifluoroacetic acid</p></td></tr><tr><td class="NLM_term">TFAA</td><td class="NLM_def"><p class="first last">trifluoroacetic acid anhydride</p></td></tr><tr><td class="NLM_term">VDW</td><td class="NLM_def"><p class="first last">van der Waals</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i106">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15486" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15486" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 31 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">You, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jang, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoon, S. K.</span><span> </span><span class="NLM_article-title">Update on hepatitis B virus infection</span> <span class="citation_source-journal">World J. of Gastroenterol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">13293</span><span class="NLM_x">–</span> <span class="NLM_lpage">13305</span><span class="refDoi"> DOI: 10.3748/wjg.v20.i37.13293</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=10.3748%2Fwjg.v20.i37.13293" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=25309066" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFKntrbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2014&pages=13293-13305&author=C.+R.+Youauthor=S.+W.+Leeauthor=J.+W.+Jangauthor=S.+K.+Yoon&title=Update+on+hepatitis+B+virus+infection&doi=10.3748%2Fwjg.v20.i37.13293"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Update on hepatitis B virus infection</span></div><div class="casAuthors">You, Chan Ran; Lee, Sung Won; Jang, Jeong Won; Yoon, Seung Kew</div><div class="citationInfo"><span class="NLM_cas:title">World Journal of Gastroenterology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">13293-13305</span>CODEN:
                <span class="NLM_cas:coden">WJGAF2</span>;
        ISSN:<span class="NLM_cas:issn">1007-9327</span>.
    
            (<span class="NLM_cas:orgname">Baishideng Publishing Group Inc.</span>)
        </div><div class="casAbstract">A review.  Chronic infection with hepatitis B virus (HBV) leads to the development of hepatocellular carcinoma and/or chronic liver failure.  Despite extensive research, the immunopathogenesis is not completely understood.  Viral persistence and clin. outcomes following HBV infection depend on viral factors and host factors; including genetic factors that det. a host's immune mechanisms.  The primary goal of chronic hepatitis B (CHB) treatment is to eradicate HBV or to at least maintain suppression of HBV replication.  Despite recent advances in anti-viral agents for chronic HBV infection, complete eradication of the virus has been difficult to achieve.  Agents for the treatment of CHB are divided mainly into two groups: immunomodulating agents and antiviral nucleos(t)ide analogs (NAs).  Although NAs are safe, effective and easily administered orally, their long-term use poses the risk of drug resistance.  Currently, international evidence-based guidelines have been developed to support physicians in managing CHB patients.  However, treatment of patients with drug resistance is still challenging, as only a few classes of anti-HBV drugs are available and cross-resistance between drugs can occur.  In addn., as the currently available genotypic test for detection of drug resistance still has limitations in identifying the different substitutions present in the same viral genome, the development of a new virol. test to overcome this limitation is necessary.  Among the predictive factors assocd. with response to pegylated interferon (PEG-IFN) therapy, hepatitis B surface antigen quantification is considered to be a surrogate marker for monitoring response to PEG-IFN.  Current practice guidelines stress the importance of profound and durable HBV viral suppression in the treatment of CHB patients.  To this end, it is essential to choose a potent antiviral drug with a low risk of resistance for initial treatment of CHB to achieve sustained virol. response.  This review highlights recent advances in the understanding of the immunopathogenesis of HBV and currently available and developing treatment strategies against HBV infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrb4R2NC4R1obVg90H21EOLACvtfcHk0lj7_ZVQsWs2SA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFKntrbE&md5=bae4ee7caaed772318f0389455a409b2</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.3748%2Fwjg.v20.i37.13293&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3748%252Fwjg.v20.i37.13293%26sid%3Dliteratum%253Aachs%26aulast%3DYou%26aufirst%3DC.%2BR.%26aulast%3DLee%26aufirst%3DS.%2BW.%26aulast%3DJang%26aufirst%3DJ.%2BW.%26aulast%3DYoon%26aufirst%3DS.%2BK.%26atitle%3DUpdate%2520on%2520hepatitis%2520B%2520virus%2520infection%26jtitle%3DWorld%2520J.%2520of%2520Gastroenterol.%26date%3D2014%26volume%3D20%26spage%3D13293%26epage%3D13305%26doi%3D10.3748%2Fwjg.v20.i37.13293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Hadziyannis, S. J.</span><span> </span><span class="NLM_article-title">Update on hepatitis B virus infection: focus on treatment</span> <span class="citation_source-journal">J. Clin. Transl. Hepatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">285</span><span class="NLM_x">–</span> <span class="NLM_lpage">291</span><span class="refDoi"> DOI: 10.14218/JCTH.2014.00026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=10.14218%2FJCTH.2014.00026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=26355326" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=1%3ACAS%3A280%3ADC%252BC283ht1Cktw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2014&pages=285-291&author=S.+J.+Hadziyannis&title=Update+on+hepatitis+B+virus+infection%3A+focus+on+treatment&doi=10.14218%2FJCTH.2014.00026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Update on Hepatitis B Virus Infection: Focus on Treatment</span></div><div class="casAuthors">Hadziyannis Stephanos J</div><div class="citationInfo"><span class="NLM_cas:title">Journal of clinical and translational hepatology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">285-91</span>
        ISSN:<span class="NLM_cas:issn">2225-0719</span>.
    </div><div class="casAbstract">This review article is an update of the current treatment strategies available for chronic hepatitis B.  In addition to achieving on-therapy clinical remission and suppression of HBV replication without resistance, the ultimate goal of therapy is the development of sustained remission and HBsAg loss after discontinuation of treatment.  This is the closest possible to cure outcome for hepatitis B virus (HBV) infection.  These goals can be achieved by response-guided courses of pegylated interferon (peg-IFN)-alpha at rates higher than 30%, both in hepatitis B e antigen (HBeAg)-positive and HBeAg-negative patients.  Review of the data regarding discontinuation of long term NA treatment in HBeAg-negative patients revealed that stopping such therapy is safe with high rates of sustained off treatment responses that appear to be immunologically induced.  Decreasing hepatitis B surface antigen (HBsAg) titers under therapy to <500, particularly <100 IU/mL, and adding a course of peg-IFN to ongoing long term nucleos(t)ide analogue (NA) therapy increase the percentage of sustained responses following discontinuation of NA treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQWNwPk-7Mg3vSAs_PE1QvifW6udTcc2ebhX_7kkJphcrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC283ht1Cktw%253D%253D&md5=48e53aa28d6c1f6b80f24caac84d5e0d</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.14218%2FJCTH.2014.00026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.14218%252FJCTH.2014.00026%26sid%3Dliteratum%253Aachs%26aulast%3DHadziyannis%26aufirst%3DS.%2BJ.%26atitle%3DUpdate%2520on%2520hepatitis%2520B%2520virus%2520infection%253A%2520focus%2520on%2520treatment%26jtitle%3DJ.%2520Clin.%2520Transl.%2520Hepatol.%26date%3D2014%26volume%3D2%26spage%3D285%26epage%3D291%26doi%3D10.14218%2FJCTH.2014.00026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Baltayiannis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karayiannis, P.</span><span> </span><span class="NLM_article-title">Treatment options beyond IFNalpha and NUCs for chronic HBV infection: expectations for tomorrow</span> <span class="citation_source-journal">J. Viral Hepat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">753</span><span class="NLM_x">–</span> <span class="NLM_lpage">761</span><span class="refDoi"> DOI: 10.1111/jvh.12307</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=10.1111%2Fjvh.12307" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=25271858" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVegsrvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2014&pages=753-761&author=G.+Baltayiannisauthor=P.+Karayiannis&title=Treatment+options+beyond+IFNalpha+and+NUCs+for+chronic+HBV+infection%3A+expectations+for+tomorrow&doi=10.1111%2Fjvh.12307"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment options beyond IFNα and NUCs for chronic HBV infection: expectations for tomorrow</span></div><div class="casAuthors">Baltayiannis, G.; Karayiannis, P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Viral Hepatitis</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">753-761</span>CODEN:
                <span class="NLM_cas:coden">JVHEER</span>;
        ISSN:<span class="NLM_cas:issn">1365-2893</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A review.  Summary : Chronic hepatitis B virus (HBV) infection may progress to cirrhosis, hepatocellular carcinoma (HCC) and end-stage liver failure with time.  Interruption of this process can only be achieved through effective antiviral treatment.  This approach has so far involved the use of immunomodulators such as pegylated interferon alpha (Peg-IFNα) for a finite period of up to a year and nucleos-(t)ide analogs (NUCs) for treatment over much longer periods of time.  The latter act by suppressing HBV replication at the level of DNA synthesis by inhibiting the viral reverse transcriptase/DNA polymerase and causing premature termination of DNA synthesis.  The ideal treatment end point is loss of HBsAg in both HBeAg+ve and HBeAg-ve patients following monotherapy.  This, however, is only achievable in a minority of patients.  Secondary outcomes are durable HBeAg loss and seroconversion to anti-HBe, which occur in about 18-30% of HBeAg+ve patients depending on the antiviral used, and sustained suppression of HBV-DNA accompanied by biochem. normalization and histol. improvement in non-HBeAg+ve seroconverting and HBeAg-ve patients.  There is therefore a need for addnl. direct-acting antivirals (DAAs) targeting different stages of the life cycle of the virus, as well as immunotherapeutic approaches.  Such developments may pave the way for their use either alone or more likely in combination in the fight against chronic HBV infection.  Such drugs or approaches, which are currently undergoing preclin. or clin. testing, are the subject of this review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrR0tPQan3UuLVg90H21EOLACvtfcHk0ljdToCM2i4BMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVegsrvK&md5=b786ee6b16533d778883cadc3bf543a4</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1111%2Fjvh.12307&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjvh.12307%26sid%3Dliteratum%253Aachs%26aulast%3DBaltayiannis%26aufirst%3DG.%26aulast%3DKarayiannis%26aufirst%3DP.%26atitle%3DTreatment%2520options%2520beyond%2520IFNalpha%2520and%2520NUCs%2520for%2520chronic%2520HBV%2520infection%253A%2520expectations%2520for%2520tomorrow%26jtitle%3DJ.%2520Viral%2520Hepat.%26date%3D2014%26volume%3D21%26spage%3D753%26epage%3D761%26doi%3D10.1111%2Fjvh.12307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Orlando, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foggia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maraolo, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mascolo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmiero, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tambaro, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tosone, G.</span><span> </span><span class="NLM_article-title">Prevention of hepatitis B virus infection: from the past to the future</span> <span class="citation_source-journal">Eur. J. Clin. Microbiol. Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">1059</span><span class="NLM_x">–</span> <span class="NLM_lpage">1070</span><span class="refDoi"> DOI: 10.1007/s10096-015-2341-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=10.1007%2Fs10096-015-2341-x" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2015&pages=1059-1070&author=R.+Orlandoauthor=M.+Foggiaauthor=A.+E.+Maraoloauthor=S.+Mascoloauthor=G.+Palmieroauthor=O.+Tambaroauthor=G.+Tosone&title=Prevention+of+hepatitis+B+virus+infection%3A+from+the+past+to+the+future&doi=10.1007%2Fs10096-015-2341-x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1007%2Fs10096-015-2341-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10096-015-2341-x%26sid%3Dliteratum%253Aachs%26aulast%3DOrlando%26aufirst%3DR.%26aulast%3DFoggia%26aufirst%3DM.%26aulast%3DMaraolo%26aufirst%3DA.%2BE.%26aulast%3DMascolo%26aufirst%3DS.%26aulast%3DPalmiero%26aufirst%3DG.%26aulast%3DTambaro%26aufirst%3DO.%26aulast%3DTosone%26aufirst%3DG.%26atitle%3DPrevention%2520of%2520hepatitis%2520B%2520virus%2520infection%253A%2520from%2520the%2520past%2520to%2520the%2520future%26jtitle%3DEur.%2520J.%2520Clin.%2520Microbiol.%2520Infect.%2520Dis.%26date%3D2015%26volume%3D34%26spage%3D1059%26epage%3D1070%26doi%3D10.1007%2Fs10096-015-2341-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Packianathan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katen, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dann, C. E.,  3rd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zlotnick, A.</span><span> </span><span class="NLM_article-title">Conformational changes in the hepatitis B virus core protein are consistent with a role for allostery in virus assembly</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">1607</span><span class="NLM_x">–</span> <span class="NLM_lpage">1615</span><span class="refDoi"> DOI: 10.1128/JVI.02033-09</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=10.1128%2FJVI.02033-09" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=19939922" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=1%3ACAS%3A280%3ADC%252BC3c%252Fhslemtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2010&pages=1607-1615&author=C.+Packianathanauthor=S.+P.+Katenauthor=C.+E.+Dannauthor=A.+Zlotnick&title=Conformational+changes+in+the+hepatitis+B+virus+core+protein+are+consistent+with+a+role+for+allostery+in+virus+assembly&doi=10.1128%2FJVI.02033-09"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Conformational changes in the hepatitis B virus core protein are consistent with a role for allostery in virus assembly</span></div><div class="casAuthors">Packianathan Charles; Katen Sarah P; Dann Charles E 3rd; Zlotnick Adam</div><div class="citationInfo"><span class="NLM_cas:title">Journal of virology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1607-15</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">In infected cells, virus components must be organized at the right place and time to ensure assembly of infectious virions.  From a different perspective, assembly must be prevented until all components are available.  Hypothetically, this can be achieved by allosterically controlling assembly.  Consistent with this hypothesis, here we show that the structure of the hepatitis B virus (HBV) core protein dimer, which can spontaneously self-assemble, is incompatible with capsid assembly.  Systematic differences between core protein dimer and capsid conformations demonstrate linkage between the intradimer interface and interdimer contact surface.  These structures also provide explanations for the capsid-dimer selectivity of some antibodies and the activities of assembly effectors.  Solution studies suggest that the assembly-inactive state is more accurately an ensemble of conformations.  Simulations show that allostery supports controlled assembly and results in capsids that are resistant to dissociation.  We propose that allostery, as demonstrated in HBV, is common to most self-assembling viruses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQzWid3-Vdf7nwOGIfWJ7-GfW6udTcc2ebGcMxzmrtd9Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3c%252Fhslemtw%253D%253D&md5=4ce07c34c733c1cb72c9c521ce0b8302</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1128%2FJVI.02033-09&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.02033-09%26sid%3Dliteratum%253Aachs%26aulast%3DPackianathan%26aufirst%3DC.%26aulast%3DKaten%26aufirst%3DS.%2BP.%26aulast%3DDann%26aufirst%3DC.%2BE.%26aulast%3DZlotnick%26aufirst%3DA.%26atitle%3DConformational%2520changes%2520in%2520the%2520hepatitis%2520B%2520virus%2520core%2520protein%2520are%2520consistent%2520with%2520a%2520role%2520for%2520allostery%2520in%2520virus%2520assembly%26jtitle%3DJ.%2520Virol.%26date%3D2010%26volume%3D84%26spage%3D1607%26epage%3D1615%26doi%3D10.1128%2FJVI.02033-09" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Zlotnick, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkatakrishnan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewellyn, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francis, S.</span><span> </span><span class="NLM_article-title">Core protein: A pleiotropic keystone in the HBV lifecycle</span> <span class="citation_source-journal">Antiviral Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">121</span><span class="NLM_x">, </span> <span class="NLM_fpage">82</span><span class="NLM_x">–</span> <span class="NLM_lpage">93</span><span class="refDoi"> DOI: 10.1016/j.antiviral.2015.06.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=10.1016%2Fj.antiviral.2015.06.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=26129969" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtV2ltLvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=2015&pages=82-93&author=A.+Zlotnickauthor=B.+Venkatakrishnanauthor=Z.+Tanauthor=E.+Lewellynauthor=W.+Turnerauthor=S.+Francis&title=Core+protein%3A+A+pleiotropic+keystone+in+the+HBV+lifecycle&doi=10.1016%2Fj.antiviral.2015.06.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Core protein: A pleiotropic keystone in the HBV lifecycle</span></div><div class="casAuthors">Zlotnick, Adam; Venkatakrishnan, Balasubramanian; Tan, Zhenning; Lewellyn, Eric; Turner, William; Francis, Samson</div><div class="citationInfo"><span class="NLM_cas:title">Antiviral Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">121</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">82-93</span>CODEN:
                <span class="NLM_cas:coden">ARSRDR</span>;
        ISSN:<span class="NLM_cas:issn">0166-3542</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Hepatitis B Virus (HBV) is a small virus whose genome has only four open reading frames.  We argue that the simplicity of the virion correlates with a complexity of functions for viral proteins.  We focus on the HBV core protein (Cp), a small (183 residue) protein that self-assembles to form the viral capsid.  However, its functions are a little more complicated than that.  In an infected cell Cp modulates almost every step of the viral lifecycle.  Cp is bound to nuclear viral DNA and affects its epigenetics.  Cp correlates with RNA specificity.  Cp assembles specifically on a reverse transcriptase-viral RNA complex or, apparently, nothing at all.  Indeed Cp has been one of the model systems for investigation of virus self-assembly.  Cp participates in regulation of reverse transcription.  Cp signals completion of reverse transcription to support virus secretion.  Cp carries both nuclear localization signals and HBV surface antigen (HBsAg) binding sites; both of these functions appear to be regulated by contents of the capsid.  Cp can be targeted by antivirals - while self-assembly is the most accessible of Cp activities, we argue that it makes sense to engage the broader spectrum of Cp function.  This article forms part of a symposium in Antiviral Research on "From the discovery of the Australia antigen to the development of new curative therapies for hepatitis B: an unfinished story.".</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyafN5HJZSQLVg90H21EOLACvtfcHk0lgI8zu4EvTJ7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtV2ltLvM&md5=e1bd58b97219cb54136dbb2db2fadb70</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.antiviral.2015.06.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.antiviral.2015.06.020%26sid%3Dliteratum%253Aachs%26aulast%3DZlotnick%26aufirst%3DA.%26aulast%3DVenkatakrishnan%26aufirst%3DB.%26aulast%3DTan%26aufirst%3DZ.%26aulast%3DLewellyn%26aufirst%3DE.%26aulast%3DTurner%26aufirst%3DW.%26aulast%3DFrancis%26aufirst%3DS.%26atitle%3DCore%2520protein%253A%2520A%2520pleiotropic%2520keystone%2520in%2520the%2520HBV%2520lifecycle%26jtitle%3DAntiviral%2520Res.%26date%3D2015%26volume%3D121%26spage%3D82%26epage%3D93%26doi%3D10.1016%2Fj.antiviral.2015.06.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Deres, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schroder, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paessens, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldmann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hacker, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kramer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niewohner, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pleiss, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoltefuss, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graef, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koletzki, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masantschek, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reimann, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaeger, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beckermann, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlemmer, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haebich, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubsamen-Waigmann, H.</span><span> </span><span class="NLM_article-title">Inhibition of hepatitis B virus replication by drug-induced depletion of nucleocapsids</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">299</span><span class="NLM_x">, </span> <span class="NLM_fpage">893</span><span class="NLM_x">–</span> <span class="NLM_lpage">896</span><span class="refDoi"> DOI: 10.1126/science.1077215</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=10.1126%2Fscience.1077215" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=12574631" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpt1Sgsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=299&publication_year=2003&pages=893-896&author=K.+Deresauthor=C.+H.+Schroderauthor=A.+Paessensauthor=S.+Goldmannauthor=H.+J.+Hackerauthor=O.+Weberauthor=T.+Kramerauthor=U.+Niewohnerauthor=U.+Pleissauthor=J.+Stoltefussauthor=E.+Graefauthor=D.+Koletzkiauthor=R.+N.+Masantschekauthor=A.+Reimannauthor=R.+Jaegerauthor=R.+Grossauthor=B.+Beckermannauthor=K.+H.+Schlemmerauthor=D.+Haebichauthor=H.+Rubsamen-Waigmann&title=Inhibition+of+hepatitis+B+virus+replication+by+drug-induced+depletion+of+nucleocapsids&doi=10.1126%2Fscience.1077215"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of Hepatitis B Virus Replication by Drug-Induced Depletion of Nucleocapsids</span></div><div class="casAuthors">Deres, Karl; Schroeder, Claus H.; Paessens, Arnold; Goldmann, Siegfried; Hacker, Hans Joerg; Weber, Olaf; Kraemer, Thomas; Niewoehner, Ulrich; Pleiss, Ulrich; Stoltefuss, Juergen; Graef, Erwin; Koletzki, Diana; Masantschek, Ralf N. A.; Reimann, Anja; Jaeger, Rainer; Gro, Rainer; Beckermann, Bernhard; Schlemmer, Karl-Heinz; Haebich, Dieter; Ruebsamen-Waigmann, Helga</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">299</span>
        (<span class="NLM_cas:issue">5608</span>),
    <span class="NLM_cas:pages">893-896</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Chronic hepatitis B virus (HBV) infection is a major cause of liver disease.  Only interferon-α and the nucleosidic inhibitors of the viral polymerase, 3TC and adefovir, are approved for therapy.  However, these therapies are limited by the side effects of interferon and the substantial resistance of the virus to nucleosidic inhibitors.  Potent new antiviral compds. suitable for monotherapy or combination therapy are highly desired.  We describe non-nucleosidic inhibitors of HBV nucleocapsid maturation that possess in vitro and in vivo antiviral activity.  These inhibitors have potential for future therapeutic regimens to combat chronic HBV infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAlJUFASSEhLVg90H21EOLACvtfcHk0ljad_p21H95MA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpt1Sgsg%253D%253D&md5=a5e74b45d335f74ba17ec9fe4d31e24b</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1126%2Fscience.1077215&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1077215%26sid%3Dliteratum%253Aachs%26aulast%3DDeres%26aufirst%3DK.%26aulast%3DSchroder%26aufirst%3DC.%2BH.%26aulast%3DPaessens%26aufirst%3DA.%26aulast%3DGoldmann%26aufirst%3DS.%26aulast%3DHacker%26aufirst%3DH.%2BJ.%26aulast%3DWeber%26aufirst%3DO.%26aulast%3DKramer%26aufirst%3DT.%26aulast%3DNiewohner%26aufirst%3DU.%26aulast%3DPleiss%26aufirst%3DU.%26aulast%3DStoltefuss%26aufirst%3DJ.%26aulast%3DGraef%26aufirst%3DE.%26aulast%3DKoletzki%26aufirst%3DD.%26aulast%3DMasantschek%26aufirst%3DR.%2BN.%26aulast%3DReimann%26aufirst%3DA.%26aulast%3DJaeger%26aufirst%3DR.%26aulast%3DGross%26aufirst%3DR.%26aulast%3DBeckermann%26aufirst%3DB.%26aulast%3DSchlemmer%26aufirst%3DK.%2BH.%26aulast%3DHaebich%26aufirst%3DD.%26aulast%3DRubsamen-Waigmann%26aufirst%3DH.%26atitle%3DInhibition%2520of%2520hepatitis%2520B%2520virus%2520replication%2520by%2520drug-induced%2520depletion%2520of%2520nucleocapsids%26jtitle%3DScience%26date%3D2003%26volume%3D299%26spage%3D893%26epage%3D896%26doi%3D10.1126%2Fscience.1077215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Bourne, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finn, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zlotnick, A.</span><span> </span><span class="NLM_article-title">Global structural changes in hepatitis B virus capsids induced by the assembly effector HAP1</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">80</span><span class="NLM_x">, </span> <span class="NLM_fpage">11055</span><span class="NLM_x">–</span> <span class="NLM_lpage">11061</span><span class="refDoi"> DOI: 10.1128/JVI.00933-06</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=10.1128%2FJVI.00933-06" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=16943288" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1KhurrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2006&pages=11055-11061&author=C.+R.+Bourneauthor=M.+G.+Finnauthor=A.+Zlotnick&title=Global+structural+changes+in+hepatitis+B+virus+capsids+induced+by+the+assembly+effector+HAP1&doi=10.1128%2FJVI.00933-06"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Global structural changes in hepatitis B virus capsids induced by the assembly effector HAP1</span></div><div class="casAuthors">Bourne, Christina R.; Finn, M. G.; Zlotnick, Adam</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">11055-11061</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Hepatitis B virus (HBV) is a leading cause of liver disease and hepatocellular carcinoma; over 400 million people are chronically infected with HBV.  Specific anti-HBV treatments, like most antivirals, target enzymes that are similar to host proteins.  Virus capsid protein has no human homolog, making its assembly a promising but undeveloped therapeutic target.  HAP1 [methyl 4-(2-chloro-4-fluorophenyl)-6-methyl-2-(pyridin-2-yl)-1,4-dihydropyrimidine-5-carboxylate], a heteroaryldihydropyrimidine, is a potent HBV capsid assembly activator and misdirector.  Knowledge of the structural basis for this activity would directly benefit the development of capsid-targeting therapeutic strategies.  This report details the crystal structures of icosahedral HBV capsids with and without HAP1.  We show that HAP1 leads to global structural changes by movements of subunits as connected rigid bodies.  The obsd. movements cause the fivefold vertices to protrude from the liganded capsid, the threefold vertices to open, and the quasi-sixfold vertices to flatten, explaining the effects of HAP1 on assembled capsids and on the assembly process.  We have identified a likely HAP1-binding site that bridges elements of secondary structure within a capsid-bound monomer, offering explanation for assembly activation.  This site also interferes with interactions between capsid proteins, leading to quaternary changes and presumably assembly misdirection.  These results demonstrate the plasticity of HBV capsids and the mol. basis for a tenable antiviral strategy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpdf0rkzY6lbVg90H21EOLACvtfcHk0ljad_p21H95MA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1KhurrJ&md5=9d176d66a1d3c2e323203877c225be6e</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1128%2FJVI.00933-06&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.00933-06%26sid%3Dliteratum%253Aachs%26aulast%3DBourne%26aufirst%3DC.%2BR.%26aulast%3DFinn%26aufirst%3DM.%2BG.%26aulast%3DZlotnick%26aufirst%3DA.%26atitle%3DGlobal%2520structural%2520changes%2520in%2520hepatitis%2520B%2520virus%2520capsids%2520induced%2520by%2520the%2520assembly%2520effector%2520HAP1%26jtitle%3DJ.%2520Virol.%26date%3D2006%26volume%3D80%26spage%3D11055%26epage%3D11061%26doi%3D10.1128%2FJVI.00933-06" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Brezillon, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brunelle, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massinet, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giang, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamant, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DaSilva, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berissi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belghiti, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hannoun, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puerstinger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wimmer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neyts, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hantz, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soussan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morosan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kremsdorf, D.</span><span> </span><span class="NLM_article-title">Antiviral activity of Bay 41-4109 on hepatitis B virus in humanized Alb-uPA/SCID mice</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">e25096</span><span class="refDoi"> DOI: 10.1371/journal.pone.0025096</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=10.1371%2Fjournal.pone.0025096" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=e25096&author=N.+Brezillonauthor=M.+N.+Brunelleauthor=H.+Massinetauthor=E.+Giangauthor=C.+Lamantauthor=L.+DaSilvaauthor=S.+Berissiauthor=J.+Belghitiauthor=L.+Hannounauthor=G.+Puerstingerauthor=E.+Wimmerauthor=J.+Neytsauthor=O.+Hantzauthor=P.+Soussanauthor=S.+Morosanauthor=D.+Kremsdorf&title=Antiviral+activity+of+Bay+41-4109+on+hepatitis+B+virus+in+humanized+Alb-uPA%2FSCID+mice&doi=10.1371%2Fjournal.pone.0025096"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0025096&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0025096%26sid%3Dliteratum%253Aachs%26aulast%3DBrezillon%26aufirst%3DN.%26aulast%3DBrunelle%26aufirst%3DM.%2BN.%26aulast%3DMassinet%26aufirst%3DH.%26aulast%3DGiang%26aufirst%3DE.%26aulast%3DLamant%26aufirst%3DC.%26aulast%3DDaSilva%26aufirst%3DL.%26aulast%3DBerissi%26aufirst%3DS.%26aulast%3DBelghiti%26aufirst%3DJ.%26aulast%3DHannoun%26aufirst%3DL.%26aulast%3DPuerstinger%26aufirst%3DG.%26aulast%3DWimmer%26aufirst%3DE.%26aulast%3DNeyts%26aufirst%3DJ.%26aulast%3DHantz%26aufirst%3DO.%26aulast%3DSoussan%26aufirst%3DP.%26aulast%3DMorosan%26aufirst%3DS.%26aulast%3DKremsdorf%26aufirst%3DD.%26atitle%3DAntiviral%2520activity%2520of%2520Bay%252041-4109%2520on%2520hepatitis%2520B%2520virus%2520in%2520humanized%2520Alb-uPA%252FSCID%2520mice%26jtitle%3DPLoS%2520One%26date%3D2011%26volume%3D6%26spage%3De25096%26doi%3D10.1371%2Fjournal.pone.0025096" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Shi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, C. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheng, H. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, X. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, M. Y.</span><span> </span><span class="NLM_article-title">NMR-spectroscopy-based metabonomic approach to the analysis of Bay41-4109, a novel anti-HBV compound, induced hepatotoxicity in rats</span> <span class="citation_source-journal">Toxicol. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">173</span><span class="NLM_x">, </span> <span class="NLM_fpage">161</span><span class="NLM_x">–</span> <span class="NLM_lpage">167</span><span class="refDoi"> DOI: 10.1016/j.toxlet.2007.07.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=10.1016%2Fj.toxlet.2007.07.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=17826925" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVeqsrrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=173&publication_year=2007&pages=161-167&author=C.+Shiauthor=C.+Q.+Wuauthor=A.+M.+Caoauthor=H.+Z.+Shengauthor=X.+Z.+Yanauthor=M.+Y.+Liao&title=NMR-spectroscopy-based+metabonomic+approach+to+the+analysis+of+Bay41-4109%2C+a+novel+anti-HBV+compound%2C+induced+hepatotoxicity+in+rats&doi=10.1016%2Fj.toxlet.2007.07.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">NMR-spectroscopy-based metabonomic approach to the analysis of Bay41-4109, a novel anti-HBV compound, induced hepatotoxicity in rats</span></div><div class="casAuthors">Shi, Chang; Wu, Chun-qi; Cao, An-min; Sheng, He-Zhang; Yan, Xian-zhong; Liao, Ming-yang</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">173</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">161-167</span>CODEN:
                <span class="NLM_cas:coden">TOLED5</span>;
        ISSN:<span class="NLM_cas:issn">0378-4274</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">An integrated metabonomics study using high-resoln. 1H NMR spectroscopy has been applied to investigate the biochem. compn. of urine, serum, liver tissue aq. exts. (acetonitrile/water) and liver tissue lipidic exts. (chloroform/methanol) obtained from control and Bay41-4109 treated rats (10, 50, 400 mg kg-1 d-1 for 5 days, i.g.).  Principal components anal. was used to visualize similarities and differences in biochem. profiles.  The results showed the effects induced by Bay41-4109 at 400 mg kg-1 d-1 are different from those induced at 10, 50 mg kg-1 d-1.  The biochem. profiles of 400 mg kg-1 d-1 group might reflect the hepatotoxicity of Bay41-4109 more exactly.  The elevation in the level of 3-HB, lactate, 2-hydroxy-acetol and D-glucose was found in the urine, and the levels of VLDL/LDL(CH2)n, VLDL/LDL-CH3, 2-oxo-3-methyl-n-valerate, 3-HB, lactate, acetate, taurine, 2-hydroxy-isovalerate in serum were increased significantly in 400 mg kg-1 d-1 group.  The predominant changes identified in liver tissue aq. exts. included an increase in the signal intensities of lactate, 3-amino-isovalerate, pyruvate, choline, trimethylamine-N-oxide (TMAO) and a redn. in the intensities of taurine, hippurate and D-glucose.  In liver tissue chloroform/methanol exts., there was a remarkably increase in many of the lipid signals including the triglyceride terminal Me, methylene groups, and CH2CO, N+(CH3)3, CH2OPO2, CH2OCOR.  These observations all provide evidence that fatty acid metab. disorder and mitochondrial inability might contribute to the hepatotoxicity of Bay41-4109.  The application of 1H NMR spectroscopy to an array of biol. samples comprising urine, serum and liver tissue exts. yields new insight into the hepatotoxicity of xenobiotics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEdIWT-FpgZLVg90H21EOLACvtfcHk0lgLh1jvDP84CA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVeqsrrP&md5=89bd5589fb93920c51723e5b75c99673</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.toxlet.2007.07.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.toxlet.2007.07.010%26sid%3Dliteratum%253Aachs%26aulast%3DShi%26aufirst%3DC.%26aulast%3DWu%26aufirst%3DC.%2BQ.%26aulast%3DCao%26aufirst%3DA.%2BM.%26aulast%3DSheng%26aufirst%3DH.%2BZ.%26aulast%3DYan%26aufirst%3DX.%2BZ.%26aulast%3DLiao%26aufirst%3DM.%2BY.%26atitle%3DNMR-spectroscopy-based%2520metabonomic%2520approach%2520to%2520the%2520analysis%2520of%2520Bay41-4109%252C%2520a%2520novel%2520anti-HBV%2520compound%252C%2520induced%2520hepatotoxicity%2520in%2520rats%26jtitle%3DToxicol.%2520Lett.%26date%3D2007%26volume%3D173%26spage%3D161%26epage%3D167%26doi%3D10.1016%2Fj.toxlet.2007.07.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Wu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arzumanyan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clayton, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schinazi, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldmann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feitelson, M. A.</span><span> </span><span class="NLM_article-title">Preclinical characterization of GLS4, an inhibitor of hepatitis B virus core particle assembly</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">5344</span><span class="NLM_x">–</span> <span class="NLM_lpage">5354</span><span class="refDoi"> DOI: 10.1128/AAC.01091-13</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=10.1128%2FAAC.01091-13" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2013&pages=5344-5354&author=G.+Wuauthor=B.+Liuauthor=Y.+Zhangauthor=J.+Liauthor=A.+Arzumanyanauthor=M.+M.+Claytonauthor=R.+F.+Schinaziauthor=Z.+Wangauthor=S.+Goldmannauthor=Q.+Renauthor=F.+Zhangauthor=M.+A.+Feitelson&title=Preclinical+characterization+of+GLS4%2C+an+inhibitor+of+hepatitis+B+virus+core+particle+assembly&doi=10.1128%2FAAC.01091-13"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1128%2FAAC.01091-13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.01091-13%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DG.%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DArzumanyan%26aufirst%3DA.%26aulast%3DClayton%26aufirst%3DM.%2BM.%26aulast%3DSchinazi%26aufirst%3DR.%2BF.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DGoldmann%26aufirst%3DS.%26aulast%3DRen%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DF.%26aulast%3DFeitelson%26aufirst%3DM.%2BA.%26atitle%3DPreclinical%2520characterization%2520of%2520GLS4%252C%2520an%2520inhibitor%2520of%2520hepatitis%2520B%2520virus%2520core%2520particle%2520assembly%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2013%26volume%3D57%26spage%3D5344%26epage%3D5354%26doi%3D10.1128%2FAAC.01091-13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Klumpp, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukacs, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Espiritu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baydo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atkins, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abendroth, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Efimov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flores, O. A.</span><span> </span><span class="NLM_article-title">High-resolution crystal structure of a hepatitis B virus replication inhibitor bound to the viral core protein</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x">, </span> <span class="NLM_fpage">15196</span><span class="NLM_x">–</span> <span class="NLM_lpage">15201</span><span class="refDoi"> DOI: 10.1073/pnas.1513803112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=10.1073%2Fpnas.1513803112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=26598693" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFWqsrbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2015&pages=15196-15201&author=K.+Klumppauthor=A.+M.+Lamauthor=C.+Lukacsauthor=R.+Vogelauthor=S.+Renauthor=C.+Espirituauthor=R.+Baydoauthor=K.+Atkinsauthor=J.+Abendrothauthor=G.+Liaoauthor=A.+Efimovauthor=G.+Hartmanauthor=O.+A.+Flores&title=High-resolution+crystal+structure+of+a+hepatitis+B+virus+replication+inhibitor+bound+to+the+viral+core+protein&doi=10.1073%2Fpnas.1513803112"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">High-resolution crystal structure of a hepatitis B virus replication inhibitor bound to the viral core protein</span></div><div class="casAuthors">Klumpp, Klaus; Lam, Angela M.; Lukacs, Christine; Vogel, Robert; Ren, Suping; Espiritu, Christine; Baydo, Ruth; Atkins, Kateri; Abendroth, Jan; Liao, Guochun; Efimov, Andrey; Hartman, George; Flores, Osvaldo A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">49</span>),
    <span class="NLM_cas:pages">15196-15201</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The hepatitis B virus (HBV) core protein is essential for HBV replication and an important target for antiviral drug discovery.  We report the first, to our knowledge, high-resoln. crystal structure of an antiviral compd. bound to the HBV core protein.  The compd. NVR-010-001-E2 can induce assembly of the HBV core wild-type and Y132A mutant proteins and thermostabilize the proteins with a Tm increase of more than 10 °C.  NVR-010-001-E2 binds at the dimer-dimer interface of the core proteins, forms a new interaction surface promoting protein-protein interaction, induces protein assembly, and increases stability.  The impact of naturally occurring core protein mutations on antiviral activity correlates with NVR-010-001-E2 binding interactions detd. by crystallog.  The crystal structure provides understanding of a drug efficacy mechanism related to the induction and stabilization of protein-protein interactions and enables structure-guided design to improve antiviral potency and drug-like properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYxV-odPonGbVg90H21EOLACvtfcHk0lhqbpHa5NAL6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFWqsrbK&md5=bf487dda7165d1637fad0ebab8f46142</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1513803112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1513803112%26sid%3Dliteratum%253Aachs%26aulast%3DKlumpp%26aufirst%3DK.%26aulast%3DLam%26aufirst%3DA.%2BM.%26aulast%3DLukacs%26aufirst%3DC.%26aulast%3DVogel%26aufirst%3DR.%26aulast%3DRen%26aufirst%3DS.%26aulast%3DEspiritu%26aufirst%3DC.%26aulast%3DBaydo%26aufirst%3DR.%26aulast%3DAtkins%26aufirst%3DK.%26aulast%3DAbendroth%26aufirst%3DJ.%26aulast%3DLiao%26aufirst%3DG.%26aulast%3DEfimov%26aufirst%3DA.%26aulast%3DHartman%26aufirst%3DG.%26aulast%3DFlores%26aufirst%3DO.%2BA.%26atitle%3DHigh-resolution%2520crystal%2520structure%2520of%2520a%2520hepatitis%2520B%2520virus%2520replication%2520inhibitor%2520bound%2520to%2520the%2520viral%2520core%2520protein%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2015%26volume%3D112%26spage%3D15196%26epage%3D15201%26doi%3D10.1073%2Fpnas.1513803112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Wang, X. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, Z. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, G. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, X. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H. S.</span><span> </span><span class="NLM_article-title">In vitro inhibition of HBV replication by a novel compound, GLS4, and its efficacy against adefovir-dipivoxil-resistant HBV mutations</span> <span class="citation_source-journal">Antiviral Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">793</span><span class="NLM_x">–</span> <span class="NLM_lpage">803</span><span class="refDoi"> DOI: 10.3851/IMP2152</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=10.3851%2FIMP2152" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2012&pages=793-803&author=X.+Y.+Wangauthor=Z.+M.+Weiauthor=G.+Y.+Wuauthor=J.+H.+Wangauthor=Y.+J.+Zhangauthor=J.+Liauthor=H.+H.+Zhangauthor=X.+W.+Xieauthor=X.+Wangauthor=Z.+H.+Wangauthor=L.+Weiauthor=Y.+Wangauthor=H.+S.+Chen&title=In+vitro+inhibition+of+HBV+replication+by+a+novel+compound%2C+GLS4%2C+and+its+efficacy+against+adefovir-dipivoxil-resistant+HBV+mutations&doi=10.3851%2FIMP2152"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.3851%2FIMP2152&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3851%252FIMP2152%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%2BY.%26aulast%3DWei%26aufirst%3DZ.%2BM.%26aulast%3DWu%26aufirst%3DG.%2BY.%26aulast%3DWang%26aufirst%3DJ.%2BH.%26aulast%3DZhang%26aufirst%3DY.%2BJ.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DH.%2BH.%26aulast%3DXie%26aufirst%3DX.%2BW.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DZ.%2BH.%26aulast%3DWei%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DH.%2BS.%26atitle%3DIn%2520vitro%2520inhibition%2520of%2520HBV%2520replication%2520by%2520a%2520novel%2520compound%252C%2520GLS4%252C%2520and%2520its%2520efficacy%2520against%2520adefovir-dipivoxil-resistant%2520HBV%2520mutations%26jtitle%3DAntiviral%2520Ther.%26date%3D2012%26volume%3D17%26spage%3D793%26epage%3D803%26doi%3D10.3851%2FIMP2152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Delaney, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colledge, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Painter, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Locarnini, S.</span><span> </span><span class="NLM_article-title">Phenylpropenamide derivatives AT-61 and AT-130 inhibit replication of wild-type and lamivudine-resistant strains of hepatitis B virus in vitro</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">3057</span><span class="NLM_x">–</span> <span class="NLM_lpage">3060</span><span class="refDoi"> DOI: 10.1128/AAC.46.9.3057-3060.2002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=10.1128%2FAAC.46.9.3057-3060.2002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=12183271" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=1%3ACAS%3A528%3ADC%252BD38Xmtl2kurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2002&pages=3057-3060&author=W.+E.+Delaneyauthor=R.+Edwardsauthor=D.+Colledgeauthor=T.+Shawauthor=P.+Furmanauthor=G.+Painterauthor=S.+Locarnini&title=Phenylpropenamide+derivatives+AT-61+and+AT-130+inhibit+replication+of+wild-type+and+lamivudine-resistant+strains+of+hepatitis+B+virus+in+vitro&doi=10.1128%2FAAC.46.9.3057-3060.2002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Phenylpropenamide derivatives AT-61 and AT-130 inhibit replication of wild-type and lamivudine-resistant strains of hepatitis B virus in vitro</span></div><div class="casAuthors">Delaney, William E., IV; Edwards, Ros; Colledge, Danni; Shaw, Tim; Furman, Phil; Painter, George; Locarnini, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3057-3060</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The phenylpropenamide derivs. AT-61 and AT-130 are nonnucleoside analog inhibitors of hepatitis B virus (HBV) replication.  They inhibited the replication of wild-type HBV with 50% inhibitory concns. of 21.2±9.5 and 2.40±0.92 μM, resp., compared to 0.064±0.020 μM lamivudine.  There were no significant differences in sensitivity between wild-type and nucleoside analog-resistant (rtL180M, rtM204I, and rtL180M + rtM204V) HBV.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4UNW_6bFxUrVg90H21EOLACvtfcHk0lj3clNK7hdt4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xmtl2kurw%253D&md5=ffb8ff070fda879480d93597468cbd9b</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1128%2FAAC.46.9.3057-3060.2002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.46.9.3057-3060.2002%26sid%3Dliteratum%253Aachs%26aulast%3DDelaney%26aufirst%3DW.%2BE.%26aulast%3DEdwards%26aufirst%3DR.%26aulast%3DColledge%26aufirst%3DD.%26aulast%3DShaw%26aufirst%3DT.%26aulast%3DFurman%26aufirst%3DP.%26aulast%3DPainter%26aufirst%3DG.%26aulast%3DLocarnini%26aufirst%3DS.%26atitle%3DPhenylpropenamide%2520derivatives%2520AT-61%2520and%2520AT-130%2520inhibit%2520replication%2520of%2520wild-type%2520and%2520lamivudine-resistant%2520strains%2520of%2520hepatitis%2520B%2520virus%2520in%2520vitro%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2002%26volume%3D46%26spage%3D3057%26epage%3D3060%26doi%3D10.1128%2FAAC.46.9.3057-3060.2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Wang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naduthambi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosley, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furman, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otto, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sofia, M. J.</span><span> </span><span class="NLM_article-title">Phenylpropenamide derivatives: anti-hepatitis B virus activity of the Z isomer, SAR and the search for novel analogs</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">4642</span><span class="NLM_x">–</span> <span class="NLM_lpage">4647</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2011.05.077</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=10.1016%2Fj.bmcl.2011.05.077" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=4642-4647&author=P.+Wangauthor=D.+Naduthambiauthor=R.+T.+Mosleyauthor=C.+Niuauthor=P.+A.+Furmanauthor=M.+J.+Ottoauthor=M.+J.+Sofia&title=Phenylpropenamide+derivatives%3A+anti-hepatitis+B+virus+activity+of+the+Z+isomer%2C+SAR+and+the+search+for+novel+analogs&doi=10.1016%2Fj.bmcl.2011.05.077"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.05.077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.05.077%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DP.%26aulast%3DNaduthambi%26aufirst%3DD.%26aulast%3DMosley%26aufirst%3DR.%2BT.%26aulast%3DNiu%26aufirst%3DC.%26aulast%3DFurman%26aufirst%3DP.%2BA.%26aulast%3DOtto%26aufirst%3DM.%2BJ.%26aulast%3DSofia%26aufirst%3DM.%2BJ.%26atitle%3DPhenylpropenamide%2520derivatives%253A%2520anti-hepatitis%2520B%2520virus%2520activity%2520of%2520the%2520Z%2520isomer%252C%2520SAR%2520and%2520the%2520search%2520for%2520novel%2520analogs%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D4642%26epage%3D4647%26doi%3D10.1016%2Fj.bmcl.2011.05.077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Campagna, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuconati, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Block, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, J. T.</span><span> </span><span class="NLM_article-title">Sulfamoylbenzamide derivatives inhibit the assembly of hepatitis B virus nucleocapsids</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">87</span><span class="NLM_x">, </span> <span class="NLM_fpage">6931</span><span class="NLM_x">–</span> <span class="NLM_lpage">6942</span><span class="refDoi"> DOI: 10.1128/JVI.00582-13</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=10.1128%2FJVI.00582-13" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=23576513" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=1%3ACAS%3A528%3ADC%252BC3sXptlKrsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2013&pages=6931-6942&author=M.+R.+Campagnaauthor=F.+Liuauthor=R.+Maoauthor=C.+Millsauthor=D.+Caiauthor=F.+Guoauthor=X.+Zhaoauthor=H.+Yeauthor=A.+Cuconatiauthor=H.+Guoauthor=J.+Changauthor=X.+Xuauthor=T.+M.+Blockauthor=J.+T.+Guo&title=Sulfamoylbenzamide+derivatives+inhibit+the+assembly+of+hepatitis+B+virus+nucleocapsids&doi=10.1128%2FJVI.00582-13"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Sulfamoylbenzamide derivatives inhibit the assembly of hepatitis B virus nucleocapsids</span></div><div class="casAuthors">Campagna, Matthew R.; Liu, Fei; Mao, Richeng; Mills, Courtney; Cai, Dawei; Guo, Fang; Zhao, Xuesen; Ye, Hong; Cuconati, Andrea; Guo, Haitao; Chang, Jinhong; Xu, Xiaodong; Block, Timothy M.; Guo, Ju-Tao</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">6931-6942</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Chronic hepatitis B virus (HBV) infection, a serious public health problem leading to cirrhosis and hepatocellular carcinoma, is currently treated with either pegylated alpha interferon (pegIFN-α) or one of the five nucleos(t)ide analog viral DNA polymerase inhibitors.  However, neither pegIFN-α nor nucleos(t)ide analogs are capable of reliably curing the viral infection.  In order to develop novel antiviral drugs against HBV, we established a cell-based screening assay by using an immortalized mouse hepatocyte-derived stable cell line supporting a high level of HBV replication in a tetracycline-inducible manner.  Screening of a library consisting of 26,900 small mols. led to the discovery of a series of sulfamoylbenzamide (SBA) derivs. that significantly reduced the amt. of cytoplasmic HBV DNA.  Structure-activity relationship studies have thus far identified a group of fluorine-substituted SBAs with submicromolar antiviral activity against HBV in human hepatoma cells.  Mechanistic analyses reveal that the compds. dose dependently inhibit the formation of pregenomic RNA (pgRNA)-contg. nucleocapsids of HBV but not other animal hepadnaviruses, such as woodchuck hepatitis virus (WHV) and duck hepatitis B virus (DHBV).  Moreover, heterologous genetic complementation studies of capsid protein, DNA polymerase, and pgRNA between HBV and WHV suggest that HBV capsid protein confers sensitivity to the SBAs.  In summary, SBAs represent a novel chem. entity with superior activity and a unique antiviral mechanism and are thus warranted for further development as novel antiviral therapeutics for the treatment of chronic hepatitis B.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNUsTkQKVBQbVg90H21EOLACvtfcHk0lgLoUsx16WBEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXptlKrsr0%253D&md5=80cd9d05d889ecf1bd2f6c28f7946bcf</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1128%2FJVI.00582-13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.00582-13%26sid%3Dliteratum%253Aachs%26aulast%3DCampagna%26aufirst%3DM.%2BR.%26aulast%3DLiu%26aufirst%3DF.%26aulast%3DMao%26aufirst%3DR.%26aulast%3DMills%26aufirst%3DC.%26aulast%3DCai%26aufirst%3DD.%26aulast%3DGuo%26aufirst%3DF.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DYe%26aufirst%3DH.%26aulast%3DCuconati%26aufirst%3DA.%26aulast%3DGuo%26aufirst%3DH.%26aulast%3DChang%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DBlock%26aufirst%3DT.%2BM.%26aulast%3DGuo%26aufirst%3DJ.%2BT.%26atitle%3DSulfamoylbenzamide%2520derivatives%2520inhibit%2520the%2520assembly%2520of%2520hepatitis%2520B%2520virus%2520nucleocapsids%26jtitle%3DJ.%2520Virol.%26date%3D2013%26volume%3D87%26spage%3D6931%26epage%3D6942%26doi%3D10.1128%2FJVI.00582-13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Yang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, X. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, F. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hao, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nan, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuo, J. P.</span><span> </span><span class="NLM_article-title">Isothiafludine, a novel non-nucleoside compound, inhibits hepatitis B virus replication through blocking pregenomic RNA encapsidation</span> <span class="citation_source-journal">Acta Pharmacol. Sin.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">410</span><span class="NLM_x">–</span> <span class="NLM_lpage">418</span><span class="refDoi"> DOI: 10.1038/aps.2013.175</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=10.1038%2Faps.2013.175" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=24487969" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjtl2itrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2014&pages=410-418&author=L.+Yangauthor=L.+P.+Shiauthor=H.+J.+Chenauthor=X.+K.+Tongauthor=G.+F.+Wangauthor=Y.+M.+Zhangauthor=W.+L.+Wangauthor=C.+L.+Fengauthor=P.+L.+Heauthor=F.+H.+Zhuauthor=Y.+H.+Haoauthor=B.+J.+Wangauthor=D.+L.+Yangauthor=W.+Tangauthor=F.+J.+Nanauthor=J.+P.+Zuo&title=Isothiafludine%2C+a+novel+non-nucleoside+compound%2C+inhibits+hepatitis+B+virus+replication+through+blocking+pregenomic+RNA+encapsidation&doi=10.1038%2Faps.2013.175"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Isothiafludine, a novel non-nucleoside compound, inhibits hepatitis B virus replication through blocking pregenomic RNA encapsidation</span></div><div class="casAuthors">Yang, Li; Shi, Li-ping; Chen, Hai-jun; Tong, Xian-Kun; Wang, Gui-feng; Zhang, Yang-ming; Wang, Wen-long; Feng, Chun-lan; He, Pei-lan; Zhu, Feng-hua; Hao, You-hua; Wang, Bao-ju; Yang, Dong-liang; Tang, Wei; Nan, Fa-jun; Zuo, Jian-ping</div><div class="citationInfo"><span class="NLM_cas:title">Acta Pharmacologica Sinica</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">410-418</span>CODEN:
                <span class="NLM_cas:coden">APSCG5</span>;
        ISSN:<span class="NLM_cas:issn">1671-4083</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Aim: To investigate the action of isothiafludine (NZ-4), a deriv. of bis-heterocycle tandem pairs from the natural product leucamide A, on the replication cycle of hepatitis B virus (HBV) in vitro and in vivo.  Methods: HBV replication cycle was monitored in HepG2.2.15 cells using qPCR, qRT-PCR, and Southern and Northern blotting.  HBV protein expression and capsid assembly were detected using Western blotting and native agarose gel electrophoresis anal.  The interaction of pregenomic RNA (pgRNA) and the core protein was investigated by RNA immunopptn.  To evaluate the anti-HBV effect of NZ-4 in vivo, DHBV-infected ducks were orally administered NZ-4 (25, 50 or 100 mg·kg-1·d-1) for 15 d.  Results: NZ-4 suppressed intracellular HBV replication in HepG2.2.15 cells with an IC50 value of 1.33 μmol/L, whereas the compd. inhibited the cell viability with an IC50 value of 50.4 μmol/L.  Furthermore, NZ-4 was active against the replication of various drug-resistant HBV mutants, including 3TC/ETV-dual-resistant and ADV-resistant HBV mutants.  NZ-4 (5, 10, 20 μmol/L) concn.-dependently reduced the encapsidated HBV pgRNA, resulting in the assembly of replication-deficient capsids in HepG2.2.15 cells.  Oral administration of NZ-4 dose-dependently inhibited DHBV DNA replication in the DHBV-infected ducks.  Conclusion: NZ-4 inhibits HBV replication by interfering with the interaction between pgRNA and HBcAg in the capsid assembly process, thus increasing the replication-deficient HBV capsids.  Such mechanism of action might provide a new therapeutic strategy to combat HBV infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfXI1ksk5-erVg90H21EOLACvtfcHk0lgLoUsx16WBEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjtl2itrs%253D&md5=7a046b35ab2f26aa43cf52fa76f85dea</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Faps.2013.175&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Faps.2013.175%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DL.%26aulast%3DShi%26aufirst%3DL.%2BP.%26aulast%3DChen%26aufirst%3DH.%2BJ.%26aulast%3DTong%26aufirst%3DX.%2BK.%26aulast%3DWang%26aufirst%3DG.%2BF.%26aulast%3DZhang%26aufirst%3DY.%2BM.%26aulast%3DWang%26aufirst%3DW.%2BL.%26aulast%3DFeng%26aufirst%3DC.%2BL.%26aulast%3DHe%26aufirst%3DP.%2BL.%26aulast%3DZhu%26aufirst%3DF.%2BH.%26aulast%3DHao%26aufirst%3DY.%2BH.%26aulast%3DWang%26aufirst%3DB.%2BJ.%26aulast%3DYang%26aufirst%3DD.%2BL.%26aulast%3DTang%26aufirst%3DW.%26aulast%3DNan%26aufirst%3DF.%2BJ.%26aulast%3DZuo%26aufirst%3DJ.%2BP.%26atitle%3DIsothiafludine%252C%2520a%2520novel%2520non-nucleoside%2520compound%252C%2520inhibits%2520hepatitis%2520B%2520virus%2520replication%2520through%2520blocking%2520pregenomic%2520RNA%2520encapsidation%26jtitle%3DActa%2520Pharmacol.%2520Sin.%26date%3D2014%26volume%3D35%26spage%3D410%26epage%3D418%26doi%3D10.1038%2Faps.2013.175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Katen, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chirapu, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finn, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zlotnick, A.</span><span> </span><span class="NLM_article-title">Trapping of hepatitis B virus capsid assembly intermediates by phenylpropenamide assembly accelerators</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1125</span><span class="NLM_x">–</span> <span class="NLM_lpage">1136</span><span class="refDoi"> DOI: 10.1021/cb100275b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb100275b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1eku7jL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=1125-1136&author=S.+P.+Katenauthor=S.+R.+Chirapuauthor=M.+G.+Finnauthor=A.+Zlotnick&title=Trapping+of+hepatitis+B+virus+capsid+assembly+intermediates+by+phenylpropenamide+assembly+accelerators&doi=10.1021%2Fcb100275b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Trapping of Hepatitis B Virus Capsid Assembly Intermediates by Phenylpropenamide Assembly Accelerators</span></div><div class="casAuthors">Katen, Sarah P.; Chirapu, Srinivas Reddy; Finn, M. G.; Zlotnick, Adam</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1125-1136</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Understanding the biol. self-assembly process of virus capsids is key to understanding the viral life cycle, as well as serving as a platform for the design of assembly-based antiviral drugs.  Here we identify and characterize the phenylpropenamide family of small mols., known to have antiviral activity in vivo, as assembly effectors of the hepatitis B virus (HBV) capsid.  We have found two representative phenylpropenamides to be assembly accelerators, increasing the rate of assembly with only modest increases in the stability of the HBV capsids; these data provide a phys.-chem. basis for their antiviral activity.  Unlike previously described HBV assembly effectors, the phenylpropenamides do not misdirect assembly; rather, the accelerated reactions proceed on-path to produce morphol. normal capsids.  However, capsid assembly in the presence of phenylpropenamides is characterized by kinetic trapping of assembly intermediates.  These traps resolve under conditions close to physiol., but we found that trapped intermediates persist under conditions that favor phenylpropenamide binding and strong core protein-protein interactions.  The phenylpropenamides serve as chem. probes of the HBV capsid assembly pathway by trapping on-path assembly intermediates, illustrating the governing influence of reaction kinetics on capsid assembly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0sU96uRbhi7Vg90H21EOLACvtfcHk0lghW2LQaY7t7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1eku7jL&md5=90a8728ca9cc6bb2ff3acf47694e0d50</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fcb100275b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb100275b%26sid%3Dliteratum%253Aachs%26aulast%3DKaten%26aufirst%3DS.%2BP.%26aulast%3DChirapu%26aufirst%3DS.%2BR.%26aulast%3DFinn%26aufirst%3DM.%2BG.%26aulast%3DZlotnick%26aufirst%3DA.%26atitle%3DTrapping%2520of%2520hepatitis%2520B%2520virus%2520capsid%2520assembly%2520intermediates%2520by%2520phenylpropenamide%2520assembly%2520accelerators%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2010%26volume%3D5%26spage%3D1125%26epage%3D1136%26doi%3D10.1021%2Fcb100275b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Mao, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levy, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuconati, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Block, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, H.</span><span> </span><span class="NLM_article-title">Indoleamine 2,3-dioxygenase mediates the antiviral effect of gamma interferon against hepatitis B virus in human hepatocyte-derived cells</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">1048</span><span class="NLM_x">–</span> <span class="NLM_lpage">1057</span><span class="refDoi"> DOI: 10.1128/JVI.01998-10</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=10.1128%2FJVI.01998-10" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=21084489" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=1%3ACAS%3A528%3ADC%252BC3MXisVOkurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2011&pages=1048-1057&author=R.+Maoauthor=J.+Zhangauthor=D.+Jiangauthor=D.+Caiauthor=J.+M.+Levyauthor=A.+Cuconatiauthor=T.+M.+Blockauthor=J.+T.+Guoauthor=H.+Guo&title=Indoleamine+2%2C3-dioxygenase+mediates+the+antiviral+effect+of+gamma+interferon+against+hepatitis+B+virus+in+human+hepatocyte-derived+cells&doi=10.1128%2FJVI.01998-10"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Indoleamine 2,3-dioxygenase mediates the antiviral effect of gamma interferon against hepatitis B virus in human hepatocyte-derived cells</span></div><div class="casAuthors">Mao, Richeng; Zhang, Jiming; Jiang, Dong; Cai, Dawei; Levy, Jessica M.; Cuconati, Andrea; Block, Timothy M.; Guo, Ju-Tao; Guo, Haitao</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">1048-1057</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Alpha interferon (IFN-α) is an approved medication for chronic hepatitis B. Gamma interferon (IFN-γ) is a key mediator of host innate and adaptive antiviral immunity against hepatitis B virus (HBV) infection in vivo.  In an effort to elucidate the antiviral mechanism of these cytokines, 37 IFN-stimulated genes (ISGs), which are highly inducible in hepatocytes, were tested for their ability to inhibit HBV replication upon overexpression in human hepatoma cells.  One ISG candidate, indoleamine 2,3-dioxygenase (IDO), an IFN-γ-induced enzyme catalyzing tryptophan degrdn., efficiently reduced the level of intracellular HBV DNA without altering the steady-state level of viral RNA.  Furthermore, expression of an enzymically inactive IDO mutant did not inhibit HBV replication, and tryptophan supplementation in culture completely restored HBV replication in IDO-expressing cells, indicating that the antiviral effect elicited by IDO is mediated by tryptophan deprivation.  Interestingly, IDO-mediated tryptophan deprivation preferentially inhibited viral protein translation and genome replication but did not significantly alter global cellular protein synthesis.  Finally, trytophan supplementation was able to completely restore HBV replication in IFN-γ- but not IFN-α-treated cells, which strongly argues that IDO is the primary mediator of IFN-γ-elicited antiviral response against HBV in human hepatocyte-derived cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrm0Y8NjSSFC7Vg90H21EOLACvtfcHk0lidc74NEatcLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXisVOkurw%253D&md5=dc26e73ed5799bd0a41d2f34cda1f075</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1128%2FJVI.01998-10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.01998-10%26sid%3Dliteratum%253Aachs%26aulast%3DMao%26aufirst%3DR.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DJiang%26aufirst%3DD.%26aulast%3DCai%26aufirst%3DD.%26aulast%3DLevy%26aufirst%3DJ.%2BM.%26aulast%3DCuconati%26aufirst%3DA.%26aulast%3DBlock%26aufirst%3DT.%2BM.%26aulast%3DGuo%26aufirst%3DJ.%2BT.%26aulast%3DGuo%26aufirst%3DH.%26atitle%3DIndoleamine%25202%252C3-dioxygenase%2520mediates%2520the%2520antiviral%2520effect%2520of%2520gamma%2520interferon%2520against%2520hepatitis%2520B%2520virus%2520in%2520human%2520hepatocyte-derived%2520cells%26jtitle%3DJ.%2520Virol.%26date%3D2011%26volume%3D85%26spage%3D1048%26epage%3D1057%26doi%3D10.1128%2FJVI.01998-10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Beno, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeung, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartberger, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pennington, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meanwell, N. A.</span><span> </span><span class="NLM_article-title">A survey of the role of noncovalent sulfur interactions in drug design</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">4383</span><span class="NLM_x">–</span> <span class="NLM_lpage">4438</span><span class="refDoi"> DOI: 10.1021/jm501853m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501853m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjs1Giu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=4383-4438&author=B.+R.+Benoauthor=K.+S.+Yeungauthor=M.+D.+Bartbergerauthor=L.+D.+Penningtonauthor=N.+A.+Meanwell&title=A+survey+of+the+role+of+noncovalent+sulfur+interactions+in+drug+design&doi=10.1021%2Fjm501853m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">A Survey of the Role of Noncovalent Sulfur Interactions in Drug Design</span></div><div class="casAuthors">Beno, Brett R.; Yeung, Kap-Sun; Bartberger, Michael D.; Pennington, Lewis D.; Meanwell, Nicholas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4383-4438</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Electron deficient, bivalent sulfur atoms have two areas of pos. electrostatic potential, a consequence of the low-lying σ* orbitals of the C-S bond that are available for interaction with electron donors including oxygen and nitrogen atoms and, possibly, π-systems.  Intramol. interactions are by far the most common manifestation of this effect, which offers a means of modulating the conformational preferences of a mol.  Although a well-documented phenomenon, a priori applications in drug design are relatively sparse and this interaction, which is often isosteric with an intramol. hydrogen-bonding interaction, appears to be underappreciated by the medicinal chem. community.  In this Perspective, we discuss the theor. basis for sulfur σ* orbital interactions and illustrate their importance in the context of drug design and org. synthesis.  The role of sulfur interactions in protein structure and function is discussed and although relatively rare, intermol. interactions between ligand C-S σ* orbitals and proteins are illustrated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYKXRsl4BQYrVg90H21EOLACvtfcHk0lidc74NEatcLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjs1Giu7g%253D&md5=d12f53eb3271c161cfc833fb9f7c02b3</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm501853m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501853m%26sid%3Dliteratum%253Aachs%26aulast%3DBeno%26aufirst%3DB.%2BR.%26aulast%3DYeung%26aufirst%3DK.%2BS.%26aulast%3DBartberger%26aufirst%3DM.%2BD.%26aulast%3DPennington%26aufirst%3DL.%2BD.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26atitle%3DA%2520survey%2520of%2520the%2520role%2520of%2520noncovalent%2520sulfur%2520interactions%2520in%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D4383%26epage%3D4438%26doi%3D10.1021%2Fjm501853m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Halgren, T. A.</span><span> </span><span class="NLM_article-title">Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94</span> <span class="citation_source-journal">J. Comput. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">490</span><span class="NLM_x">–</span> <span class="NLM_lpage">519</span><span class="refDoi"> DOI: 10.1002/(SICI)1096-987X(199604)17:5/6<490::AID-JCC1>3.0.CO;2-P</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=10.1002%2F%28SICI%291096-987X%28199604%2917%3A5%2F6%3C490%3A%3AAID-JCC1%3E3.0.CO%3B2-P" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=1%3ACAS%3A528%3ADyaK28XhvVGmsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1996&pages=490-519&author=T.+A.+Halgren&title=Merck+molecular+force+field.+I.+Basis%2C+form%2C+scope%2C+parameterization%2C+and+performance+of+MMFF94&doi=10.1002%2F%28SICI%291096-987X%28199604%2917%3A5%2F6%3C490%3A%3AAID-JCC1%3E3.0.CO%3B2-P"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94</span></div><div class="casAuthors">Halgren, Thomas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5 & 6</span>),
    <span class="NLM_cas:pages">490-519</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">Wiley</span>)
        </div><div class="casAbstract">This article introduces MMFF94, the initial published version of the Merck mol. force field (MMFF).  It describes the objectives set for MMFF, the form it takes, and the range of systems to which it applies.  This study also outlines the methodol. employed in parameterizing MMFF94 and summarizes its performance in reproducing computational and exptl. data.  Though similar to MM3 in some respects, MMFF94 differs in ways intended to facilitate application to condensed-phase processes in mol.-dynamics simulations.  Indeed, MMFF94 seeks to achieve MM3-like accuracy for small mols. in a combined "org./protein" force field that is equally applicable to proteins and other systems of biol. significance.  A second distinguishing feature is that the core protion of MMFF94 has primarily been derived from high-quality computational data-ca. 500 mol. structures optimized at the HF/6-31G* level, 475 structures optimized at the MP2/6-31G* level, 380 MP2/6-31* structures evaluated at a defined approxn. to the MP4SDQ/TZP level, and 1450 structures partly derived from MP2/6-31G* geometries and evaluated at the MP2/TZP level.  A third distinguishing feature is that MMFF94 has been parameterized for a wide variety of chem. systems of interest to org. and combinations of functional groups for which little, if any, useful exptl. data are available.  The methodol. used in parameterizing MMFF94 represents a fourth distinguishing feature.  Rather than using the common "functional group" approach, nearly all MMFF parameters have been detd. in a mutually consistent fashion from the full set of available computational data.  MMFF94 reproduces the computational data used in its parameterization very well.  In addn., MMFF94 reproduces exptl. bond lengths (0.014 Å root mean square [rms]), bond angles (1.2° rms), vibrational frequencies (61 cm-1 rms), conformational energies (0.38 kcal/mol rms), and rotational barriers (0.39 kcal/mol rms) very nearly as well as does MM3 for comparable systems.  MMFF94 also describes intermol. interactions in hydrogen-bonded systems in a way that closely parallels that given by the highly regarded OPLS force field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAzCYfKnN83rVg90H21EOLACvtfcHk0lgqxQ6I7HrM3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XhvVGmsbk%253D&md5=56fb073477b4f49d1dfbd786fc56a480</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291096-987X%28199604%2917%3A5%2F6%3C490%3A%3AAID-JCC1%3E3.0.CO%3B2-P&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291096-987X%2528199604%252917%253A5%252F6%253C490%253A%253AAID-JCC1%253E3.0.CO%253B2-P%26sid%3Dliteratum%253Aachs%26aulast%3DHalgren%26aufirst%3DT.%2BA.%26atitle%3DMerck%2520molecular%2520force%2520field.%2520I.%2520Basis%252C%2520form%252C%2520scope%252C%2520parameterization%252C%2520and%2520performance%2520of%2520MMFF94%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D1996%26volume%3D17%26spage%3D490%26epage%3D519%26doi%3D10.1002%2F%28SICI%291096-987X%28199604%2917%3A5%2F6%3C490%3A%3AAID-JCC1%3E3.0.CO%3B2-P" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Bourne, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkataiah, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korba, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finn, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zlotnick, A.</span><span> </span><span class="NLM_article-title">Small-molecule effectors of hepatitis B virus capsid assembly give insight into virus life cycle</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">10262</span><span class="NLM_x">–</span> <span class="NLM_lpage">10270</span><span class="refDoi"> DOI: 10.1128/JVI.01360-08</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=10.1128%2FJVI.01360-08" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=18684823" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1amtrjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2008&pages=10262-10270&author=C.+Bourneauthor=S.+Leeauthor=B.+Venkataiahauthor=A.+Leeauthor=B.+Korbaauthor=M.+G.+Finnauthor=A.+Zlotnick&title=Small-molecule+effectors+of+hepatitis+B+virus+capsid+assembly+give+insight+into+virus+life+cycle&doi=10.1128%2FJVI.01360-08"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule effectors of hepatitis B virus capsid assembly give insight into virus life cycle</span></div><div class="casAuthors">Bourne, Christina; Lee, Sejin; Venkataiah, Bollu; Lee, Angela; Korba, Brent; Finn, M. G.; Zlotnick, Adam</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">10262-10270</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The relationship between the phys. chem. and biol. of self-assembly is poorly understood, but it will be crit. to quant. understand infection and for the design of antivirals that target virus genesis.  Here the authors take advantage of heteroaryldihydropyrimidines (HAPs), which affect hepatitis B virus (HBV) assembly, to gain insight and correlate in vitro assembly with HBV replication in culture.  Based on a low-resoln. crystal structure of a capsid-HAP complex, a closely related series of HAPs were designed and synthesized.  These differentially strengthen the assocn. between neighboring capsid proteins, alter the kinetics of assembly, and give rise to aberrant structures incompatible with a functional capsid.  The chem. nature of the HAP variants correlated well with the structure of the HAP binding pocket.  The thermodn. and kinetics of in vitro assembly had strong and predictable effects on product morphol.  However, only the kinetics of in vitro assembly had a strong correlation with inhibition of HBV replication in HepG2.2.15 cells; there was at best a weak correlation between assembly thermodn. and replication.  The correlation between assembly kinetics and virus suppression implies a competition between successful assembly and misassembly, small mol. induced or otherwise.  This is a predictive and testable model for the mechanism of action of assembly effectors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodMfnjIqX51LVg90H21EOLACvtfcHk0lgqxQ6I7HrM3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1amtrjE&md5=78266773fa27c6f87b4c871c47cd2fe6</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1128%2FJVI.01360-08&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.01360-08%26sid%3Dliteratum%253Aachs%26aulast%3DBourne%26aufirst%3DC.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DVenkataiah%26aufirst%3DB.%26aulast%3DLee%26aufirst%3DA.%26aulast%3DKorba%26aufirst%3DB.%26aulast%3DFinn%26aufirst%3DM.%2BG.%26aulast%3DZlotnick%26aufirst%3DA.%26atitle%3DSmall-molecule%2520effectors%2520of%2520hepatitis%2520B%2520virus%2520capsid%2520assembly%2520give%2520insight%2520into%2520virus%2520life%2520cycle%26jtitle%3DJ.%2520Virol.%26date%3D2008%26volume%3D82%26spage%3D10262%26epage%3D10270%26doi%3D10.1128%2FJVI.01360-08" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blazecka, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angell, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovdahl, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curran, T. T.</span><span> </span><span class="NLM_article-title">Indium(III) mediated Markovnikov addition of malonates and beta-ketoesters to terminal alkynes and the formation of Knoevenagel condensation products</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">7807</span><span class="NLM_x">–</span> <span class="NLM_lpage">7813</span><span class="refDoi"> DOI: 10.1016/j.tet.2005.05.065</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=10.1016%2Fj.tet.2005.05.065" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2005&pages=7807-7813&author=J.+Zhangauthor=P.+G.+Blazeckaauthor=P.+Angellauthor=M.+Lovdahlauthor=T.+T.+Curran&title=Indium%28III%29+mediated+Markovnikov+addition+of+malonates+and+beta-ketoesters+to+terminal+alkynes+and+the+formation+of+Knoevenagel+condensation+products&doi=10.1016%2Fj.tet.2005.05.065"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.tet.2005.05.065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tet.2005.05.065%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DBlazecka%26aufirst%3DP.%2BG.%26aulast%3DAngell%26aufirst%3DP.%26aulast%3DLovdahl%26aufirst%3DM.%26aulast%3DCurran%26aufirst%3DT.%2BT.%26atitle%3DIndium%2528III%2529%2520mediated%2520Markovnikov%2520addition%2520of%2520malonates%2520and%2520beta-ketoesters%2520to%2520terminal%2520alkynes%2520and%2520the%2520formation%2520of%2520Knoevenagel%2520condensation%2520products%26jtitle%3DTetrahedron%26date%3D2005%26volume%3D61%26spage%3D7807%26epage%3D7813%26doi%3D10.1016%2Fj.tet.2005.05.065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Huang, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabel, Y. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graf, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arzberger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurts, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heikenwalder, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knolle, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Protzer, U.</span><span> </span><span class="NLM_article-title">Transfer of HBV genomes using low doses of adenovirus vectors leads to persistent infection in immune competent mice</span> <span class="citation_source-journal">Gastroenterology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">142</span><span class="NLM_x">, </span> <span class="NLM_fpage">1447</span><span class="NLM_x">–</span> <span class="NLM_lpage">1450</span><span class="refDoi"> DOI: 10.1053/j.gastro.2012.03.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=10.1053%2Fj.gastro.2012.03.006" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=142&publication_year=2012&pages=1447-1450&author=L.+R.+Huangauthor=Y.+A.+Gabelauthor=S.+Grafauthor=S.+Arzbergerauthor=C.+Kurtsauthor=M.+Heikenwalderauthor=P.+A.+Knolleauthor=U.+Protzer&title=Transfer+of+HBV+genomes+using+low+doses+of+adenovirus+vectors+leads+to+persistent+infection+in+immune+competent+mice&doi=10.1053%2Fj.gastro.2012.03.006"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1053%2Fj.gastro.2012.03.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1053%252Fj.gastro.2012.03.006%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DL.%2BR.%26aulast%3DGabel%26aufirst%3DY.%2BA.%26aulast%3DGraf%26aufirst%3DS.%26aulast%3DArzberger%26aufirst%3DS.%26aulast%3DKurts%26aufirst%3DC.%26aulast%3DHeikenwalder%26aufirst%3DM.%26aulast%3DKnolle%26aufirst%3DP.%2BA.%26aulast%3DProtzer%26aufirst%3DU.%26atitle%3DTransfer%2520of%2520HBV%2520genomes%2520using%2520low%2520doses%2520of%2520adenovirus%2520vectors%2520leads%2520to%2520persistent%2520infection%2520in%2520immune%2520competent%2520mice%26jtitle%3DGastroenterology%26date%3D2012%26volume%3D142%26spage%3D1447%26epage%3D1450%26doi%3D10.1053%2Fj.gastro.2012.03.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Guo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuconati, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Block, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, J.</span><span> </span><span class="NLM_article-title">Characterization of the intracellular deproteinized relaxed circular DNA of hepatitis B virus: an intermediate of covalently closed circular DNA formation</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">12472</span><span class="NLM_x">–</span> <span class="NLM_lpage">12484</span><span class="refDoi"> DOI: 10.1128/JVI.01123-07</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=10.1128%2FJVI.01123-07" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=17804499" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlKku7zJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2007&pages=12472-12484&author=H.+Guoauthor=D.+Jiangauthor=T.+Zhouauthor=A.+Cuconatiauthor=T.+Blockauthor=J.+Guo&title=Characterization+of+the+intracellular+deproteinized+relaxed+circular+DNA+of+hepatitis+B+virus%3A+an+intermediate+of+covalently+closed+circular+DNA+formation&doi=10.1128%2FJVI.01123-07"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of the intracellular deproteinized relaxed circular DNA of hepatitis B virus: an intermediate of covalently closed circular DNA formation</span></div><div class="casAuthors">Guo, Haitao; Jiang, Dong; Zhou, Tianlun; Cuconati, Andrea; Block, Timothy M.; Guo, Ju-Tao</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">12472-12484</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Covalently closed circular DNA (cccDNA) of hepatitis B virus (HBV) is formed by conversion of capsid-assocd. relaxed circular DNA (rcDNA) via unknown mechanisms and exists in the nucleus of the infected hepatocyte as a minichromosome that serves as the transcription template for viral RNAs.  To study the mol. pathway of cccDNA formation and its regulation by viral and cellular factors, we have established a cell line that supports the replication of an envelope protein-deficient HBV genome in a tetracycline-inducible manner.  Following induction of HBV replication, the cells accumulate higher levels of cccDNA as well as larger amts. of deproteinized rcDNA (DP-rcDNA) than cells that replicate wild-type HBV genomes.  These results indicate that HBV envelope proteins neg. regulate cccDNA formation, and conversion of DP-rcDNA into cccDNA is a rate-limiting step of cccDNA formation in HepG2 cells.  Detailed analyses reveal the following: (i) DP-rcDNA exists in both cytoplasm and nucleus; (ii) while nuclear DP-rcDNA is sensitive to DNase I digestion, a small fraction of cytoplasmic DP-rcDNA is DNase I resistant; (iii) both DNase I-sensitive and -resistant cytoplasmic DP-rcDNAs cosediment with capsids and can be immunopptd. with HBV core antibody; and (iv) a primer extension assay maps the 5' end of the minus strand of DP-rcDNA at the authentic end of virion rcDNA.  Hence, our results favor a hypothesis that the removal of viral polymerase protein covalently linked to the 5' end of the minus-strand DNA occurs inside the capsid in the cytoplasm and most possibly via a reaction that cleaves the phosphodiester bond between the tyrosine of the polymerase and the 5' phosphoryl group of minus-strand DNA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGot_WiB1hJ4zbVg90H21EOLACvtfcHk0ljeTzLBRB3anA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlKku7zJ&md5=91d6a9284b406680c85be2e35048d4ae</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1128%2FJVI.01123-07&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.01123-07%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DH.%26aulast%3DJiang%26aufirst%3DD.%26aulast%3DZhou%26aufirst%3DT.%26aulast%3DCuconati%26aufirst%3DA.%26aulast%3DBlock%26aufirst%3DT.%26aulast%3DGuo%26aufirst%3DJ.%26atitle%3DCharacterization%2520of%2520the%2520intracellular%2520deproteinized%2520relaxed%2520circular%2520DNA%2520of%2520hepatitis%2520B%2520virus%253A%2520an%2520intermediate%2520of%2520covalently%2520closed%2520circular%2520DNA%2520formation%26jtitle%3DJ.%2520Virol.%26date%3D2007%26volume%3D81%26spage%3D12472%26epage%3D12484%26doi%3D10.1128%2FJVI.01123-07" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Alexander, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jürgens, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shepherd, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freund, S. M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashcroft, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferguson, N.</span><span> </span><span class="NLM_article-title">Thermodynamic origins of protein folding, allostery, and capsid formation in the human hepatitis B virus core protein</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">110</span><span class="NLM_x">, </span> <span class="NLM_fpage">E2782</span><span class="NLM_x">–</span> <span class="NLM_lpage">E2791</span><span class="refDoi"> DOI: 10.1073/pnas.1308846110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=10.1073%2Fpnas.1308846110" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=E2782-E2791&author=C.+G.+Alexanderauthor=M.+C.+J%C3%BCrgensauthor=D.+A.+Shepherdauthor=S.+M.+V.+Freundauthor=A.+E.+Ashcroftauthor=N.+Ferguson&title=Thermodynamic+origins+of+protein+folding%2C+allostery%2C+and+capsid+formation+in+the+human+hepatitis+B+virus+core+protein&doi=10.1073%2Fpnas.1308846110"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1308846110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1308846110%26sid%3Dliteratum%253Aachs%26aulast%3DAlexander%26aufirst%3DC.%2BG.%26aulast%3DJ%25C3%25BCrgens%26aufirst%3DM.%2BC.%26aulast%3DShepherd%26aufirst%3DD.%2BA.%26aulast%3DFreund%26aufirst%3DS.%2BM.%2BV.%26aulast%3DAshcroft%26aufirst%3DA.%2BE.%26aulast%3DFerguson%26aufirst%3DN.%26atitle%3DThermodynamic%2520origins%2520of%2520protein%2520folding%252C%2520allostery%252C%2520and%2520capsid%2520formation%2520in%2520the%2520human%2520hepatitis%2520B%2520virus%2520core%2520protein%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2013%26volume%3D110%26spage%3DE2782%26epage%3DE2791%26doi%3D10.1073%2Fpnas.1308846110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Otwinowski, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minor, W.</span><span> </span><span class="NLM_article-title">Processing of X-ray diffraction data collected in oscillation mode</span> <span class="citation_source-journal">Methods Enzymol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">307</span><span class="NLM_x">–</span> <span class="NLM_lpage">326</span><span class="refDoi"> DOI: 10.1016/S0076-6879(97)76066-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=10.1016%2FS0076-6879%2897%2976066-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=27754618" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=1%3ACAS%3A528%3ADyaK2sXivFehsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=1997&pages=307-326&author=Z.+Otwinowskiauthor=W.+Minor&title=Processing+of+X-ray+diffraction+data+collected+in+oscillation+mode&doi=10.1016%2FS0076-6879%2897%2976066-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Processing of x-ray diffraction data collected in oscillation mode</span></div><div class="casAuthors">Otwinowski, Zbyszek; Minor, Wladek</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Enzymology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">276</span>
        (<span class="NLM_cas:issue">Macromolecular Crystallography, Part A</span>),
    <span class="NLM_cas:pages">307-326</span>CODEN:
                <span class="NLM_cas:coden">MENZAU</span>;
        ISSN:<span class="NLM_cas:issn">0076-6879</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">Macromol. crystallog. is an iterative process.  Rarely do the first crystals provide all the necessary data to solve the biol. problem being studied.  Each step benefits from experience learned in previous steps.  To monitor the progress, the HKL package provides 2 tools: (1) statistics, both weighted (χ2) and unweighted (R-merge), are provided, and the Bayesian reasoning and multicomponent error model facilitates obtaining the proper error ests. and (2) visualization of the process plays a double role by helping the operator to confirm that the process of data redn., including the resulting statistics, is correct, and allowing one to evaluate problems for which there are no good statistical criteria.  Visualization also provides confidence that the point of diminishing returns in data collection and redn. has been reached.  At that point, the effort should be directed to solving the structure.  The methods presented here have been applied to solve a large variety of problems, from inorg. mols. with 5 Å unit cell to rotavirus of 700 Å diam. crystd. in 700 × 1000 × 1400 Å cell.  Overall quality of the method was tested by many researchers by successful application of the programs to MAD structure detns.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrA3fvBOHqhhrVg90H21EOLACvtfcHk0lgP7-WYCeYn9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXivFehsbw%253D&md5=c9536971d4e32cc35352c40fb9368131</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2FS0076-6879%2897%2976066-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0076-6879%252897%252976066-X%26sid%3Dliteratum%253Aachs%26aulast%3DOtwinowski%26aufirst%3DZ.%26aulast%3DMinor%26aufirst%3DW.%26atitle%3DProcessing%2520of%2520X-ray%2520diffraction%2520data%2520collected%2520in%2520oscillation%2520mode%26jtitle%3DMethods%2520Enzymol.%26date%3D1997%26volume%3D276%26spage%3D307%26epage%3D326%26doi%3D10.1016%2FS0076-6879%2897%2976066-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">McCoy, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosse-Kunstleve, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winn, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storoni, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, R. J.</span><span> </span><span class="NLM_article-title">Phaser crystallographic software</span> <span class="citation_source-journal">J. Appl. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">658</span><span class="NLM_x">–</span> <span class="NLM_lpage">674</span><span class="refDoi"> DOI: 10.1107/S0021889807021206</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=10.1107%2FS0021889807021206" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=19461840" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnslWqsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2007&pages=658-674&author=A.+J.+McCoyauthor=R.+W.+Grosse-Kunstleveauthor=P.+D.+Adamsauthor=M.+D.+Winnauthor=L.+C.+Storoniauthor=R.+J.+Read&title=Phaser+crystallographic+software&doi=10.1107%2FS0021889807021206"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Phaser crystallographic software</span></div><div class="casAuthors">McCoy, Airlie J.; Grosse-Kunstleve, Ralf W.; Adams, Paul D.; Winn, Martyn D.; Storoni, Laurent C.; Read, Randy J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Crystallography</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">658-674</span>CODEN:
                <span class="NLM_cas:coden">JACGAR</span>;
        ISSN:<span class="NLM_cas:issn">0021-8898</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Phaser is a program for phasing macromol. crystal structures by both mol. replacement and exptl. phasing methods.  The novel phasing algorithms implemented in Phaser have been developed using max. likelihood and multivariate statistics.  For mol. replacement, the new algorithms have proved to be significantly better than traditional methods in discriminating correct solns. from noise, and for single-wavelength anomalous dispersion exptl. phasing, the new algorithms, which account for correlations between F+ and F-, give better phases (lower mean phase error with respect to the phases given by the refined structure) than those that use mean F and anomalous differences ΔF.  One of the design concepts of Phaser was that it be capable of a high degree of automation.  To this end, Phaser (written in C++) can be called directly from Python, although it can also be called using traditional CCP4 keyword-style input.  Phaser is a platform for future development of improved phasing methods and their release, including source code, to the crystallog. community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPeVyjN_FMGbVg90H21EOLACvtfcHk0lgP7-WYCeYn9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnslWqsLk%253D&md5=c63b722ae97e0a74e6a5a079d388f09f</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1107%2FS0021889807021206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0021889807021206%26sid%3Dliteratum%253Aachs%26aulast%3DMcCoy%26aufirst%3DA.%2BJ.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DStoroni%26aufirst%3DL.%2BC.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26atitle%3DPhaser%2520crystallographic%2520software%26jtitle%3DJ.%2520Appl.%2520Crystallogr.%26date%3D2007%26volume%3D40%26spage%3D658%26epage%3D674%26doi%3D10.1107%2FS0021889807021206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Adams, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Afonine, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunkoczi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, V. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, I. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Echols, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Headd, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hung, L.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapral, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosse-Kunstleve, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCoy, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moriarty, N. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oeffner, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terwilliger, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zwart, P. H.</span><span> </span><span class="NLM_article-title">PHENIX: a comprehensive Python-based system for macromolecular structure solution</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">213</span><span class="NLM_x">–</span> <span class="NLM_lpage">221</span><span class="refDoi"> DOI: 10.1107/S0907444909052925</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=10.1107%2FS0907444909052925" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=20124702" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1Sisbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=213-221&author=P.+D.+Adamsauthor=P.+V.+Afonineauthor=G.+Bunkocziauthor=V.+B.+Chenauthor=I.+W.+Davisauthor=N.+Echolsauthor=J.+J.+Headdauthor=L.-W.+Hungauthor=G.+J.+Kapralauthor=R.+W.+Grosse-Kunstleveauthor=A.+J.+McCoyauthor=N.+W.+Moriartyauthor=R.+Oeffnerauthor=R.+J.+Readauthor=D.+C.+Richardsonauthor=J.+S.+Richardsonauthor=T.+C.+Terwilligerauthor=P.+H.+Zwart&title=PHENIX%3A+a+comprehensive+Python-based+system+for+macromolecular+structure+solution&doi=10.1107%2FS0907444909052925"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">PHENIX: a comprehensive Python-based system for macromolecular structure solution</span></div><div class="casAuthors">Adams, Paul D.; Afonine, Pavel V.; Bunkoczi, Gabor; Chen, Vincent B.; Davis, Ian W.; Echols, Nathaniel; Headd, Jeffrey J.; Hung, Li Wei; Kapral, Gary J.; Grosse-Kunstleve, Ralf W.; McCoy, Airlie J.; Moriarty, Nigel W.; Oeffner, Robert; Read, Randy J.; Richardson, David C.; Richardson, Jane S.; Terwilliger, Thomas C.; Zwart, Peter H.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">213-221</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">A review.  Macromol. X-ray crystallog. is routinely applied to understand biol. processes at a mol. level.  However, significant time and effort are still required to solve and complete many of these structures because of the need for manual interpretation of complex numerical data using many software packages and the repeated use of interactive three-dimensional graphics.  PHENIX has been developed to provide a comprehensive system for macromol. crystallog. structure soln. with an emphasis on the automation of all procedures.  This has relied on the development of algorithms that minimize or eliminate subjective input, the development of algorithms that automate procedures that are traditionally performed by hand and, finally, the development of a framework that allows a tight integration between the algorithms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpm_HgKRpa-ObVg90H21EOLACvtfcHk0lh7_Uy249Or1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1Sisbc%253D&md5=67b439ff4bd61c659cae37ca4209b7bc</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1107%2FS0907444909052925&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909052925%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DAfonine%26aufirst%3DP.%2BV.%26aulast%3DBunkoczi%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DV.%2BB.%26aulast%3DDavis%26aufirst%3DI.%2BW.%26aulast%3DEchols%26aufirst%3DN.%26aulast%3DHeadd%26aufirst%3DJ.%2BJ.%26aulast%3DHung%26aufirst%3DL.-W.%26aulast%3DKapral%26aufirst%3DG.%2BJ.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DMcCoy%26aufirst%3DA.%2BJ.%26aulast%3DMoriarty%26aufirst%3DN.%2BW.%26aulast%3DOeffner%26aufirst%3DR.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26aulast%3DRichardson%26aufirst%3DD.%2BC.%26aulast%3DRichardson%26aufirst%3DJ.%2BS.%26aulast%3DTerwilliger%26aufirst%3DT.%2BC.%26aulast%3DZwart%26aufirst%3DP.%2BH.%26atitle%3DPHENIX%253A%2520a%2520comprehensive%2520Python-based%2520system%2520for%2520macromolecular%2520structure%2520solution%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D213%26epage%3D221%26doi%3D10.1107%2FS0907444909052925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Emsley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowtan, K.</span><span> </span><span class="NLM_article-title">Coot: model-building tools for molecular graphics</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">2126</span><span class="NLM_x">–</span> <span class="NLM_lpage">2132</span><span class="refDoi"> DOI: 10.1107/S0907444904019158</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=10.1107%2FS0907444904019158" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=15572765" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVars73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2004&pages=2126-2132&author=P.+Emsleyauthor=K.+Cowtan&title=Coot%3A+model-building+tools+for+molecular+graphics&doi=10.1107%2FS0907444904019158"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Coot: model-building tools for molecular graphics</span></div><div class="casAuthors">Emsley, Paul; Cowtan, Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">D60</span>
        (<span class="NLM_cas:issue">12, Pt. 1</span>),
    <span class="NLM_cas:pages">2126-2132</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">CCP4mg is a project that aims to provide a general-purpose tool for structural biologists, providing tools for x-ray structure soln., structure comparison and anal., and publication-quality graphics.  The map-fitting tools are available as a stand-alone package, distributed as 'Coot'.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMisM42468k7Vg90H21EOLACvtfcHk0lh7_Uy249Or1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVars73P&md5=1be390f3bb6fd584468499ad0921161e</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1107%2FS0907444904019158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444904019158%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DCoot%253A%2520model-building%2520tools%2520for%2520molecular%2520graphics%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2004%26volume%3D60%26spage%3D2126%26epage%3D2132%26doi%3D10.1107%2FS0907444904019158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Chen, V. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arendall, W. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Headd, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keedy, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Immormino, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapral, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, D. C.</span><span> </span><span class="NLM_article-title">MolProbity: all-atom structure validation for macromolecular crystallography</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">12</span><span class="NLM_x">–</span> <span class="NLM_lpage">21</span><span class="refDoi"> DOI: 10.1107/S0907444909042073</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=10.1107%2FS0907444909042073" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=20057044" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=1%3ACAS%3A528%3ADC%252BC3cXit1Kktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=12-21&author=V.+B.+Chenauthor=W.+B.+Arendallauthor=J.+J.+Headdauthor=D.+A.+Keedyauthor=R.+M.+Immorminoauthor=G.+J.+Kapralauthor=L.+W.+Murrayauthor=J.+S.+Richardsonauthor=D.+C.+Richardson&title=MolProbity%3A+all-atom+structure+validation+for+macromolecular+crystallography&doi=10.1107%2FS0907444909042073"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">MolProbity: all-atom structure validation for macromolecular crystallography</span></div><div class="casAuthors">Chen, Vincent B.; Arendall, W. Bryan, III; Headd, Jeffrey J.; Keedy, Daniel A.; Immormino, Robert M.; Kapral, Gary J.; Murray, Laura W.; Richardson, Jane S.; Richardson, David C.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">12-21</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">MolProbity is a structure-validation web service that provides broad-spectrum solidly based evaluation of model quality at both the global and local levels for both proteins and nucleic acids.  It relies heavily on the power and sensitivity provided by optimized hydrogen placement and all-atom contact anal., complemented by updated versions of covalent-geometry and torsion-angle criteria.  Some of the local corrections can be performed automatically in MolProbity and all of the diagnostics are presented in chart and graphical forms that help guide manual rebuilding.  X-ray crystallog. provides a wealth of biol. important mol. data in the form of at. three-dimensional structures of proteins, nucleic acids and increasingly large complexes in multiple forms and states.  Advances in automation, in everything from crystn. to data collection to phasing to model building to refinement, have made solving a structure using crystallog. easier than ever.  However, despite these improvements, local errors that can affect biol. interpretation are widespread at low resoln. and even high-resoln. structures nearly all contain at least a few local errors such as Ramachandran outliers, flipped branched protein side chains and incorrect sugar puckers.  It is crit. both for the crystallographer and for the end user that there are easy and reliable methods to diagnose and correct these sorts of errors in structures.  MolProbity is the authors' contribution to helping solve this problem and this article reviews its general capabilities, reports on recent enhancements and usage, and presents evidence that the resulting improvements are now beneficially affecting the global database.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIjgsh59dO-7Vg90H21EOLACvtfcHk0lj5mj-WGY8qHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXit1Kktg%253D%253D&md5=b5fc7574f43f01dd6e43c3663ca4f779</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1107%2FS0907444909042073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909042073%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DV.%2BB.%26aulast%3DArendall%26aufirst%3DW.%2BB.%26aulast%3DHeadd%26aufirst%3DJ.%2BJ.%26aulast%3DKeedy%26aufirst%3DD.%2BA.%26aulast%3DImmormino%26aufirst%3DR.%2BM.%26aulast%3DKapral%26aufirst%3DG.%2BJ.%26aulast%3DMurray%26aufirst%3DL.%2BW.%26aulast%3DRichardson%26aufirst%3DJ.%2BS.%26aulast%3DRichardson%26aufirst%3DD.%2BC.%26atitle%3DMolProbity%253A%2520all-atom%2520structure%2520validation%2520for%2520macromolecular%2520crystallography%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D12%26epage%3D21%26doi%3D10.1107%2FS0907444909042073" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 42 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Wuhong Chen, Feifei Liu, Qiliang Zhao, Xinna Ma, Dong Lu, Heng Li, Yanping Zeng, Xiankun Tong, Limin Zeng, Jia Liu, Li Yang, Jianping Zuo, <span class="NLM_string-name hlFld-ContribAuthor">Youhong Hu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Phthalazinone Derivatives as Novel Hepatitis B Virus Capsid Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (15)
                                     , 8134-8145. <a href="https://doi.org/10.1021/acs.jmedchem.0c00346" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00346</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00346&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00346%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BPhthalazinone%252BDerivatives%252Bas%252BNovel%252BHepatitis%252BB%252BVirus%252BCapsid%252BInhibitors%26aulast%3DChen%26aufirst%3DWuhong%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D26022020%26date%3D21072020%26volume%3D63%26issue%3D15%26spage%3D8134%26epage%3D8145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Andrew
D. Huber, Dallas L. Pineda, Dandan Liu, Kelsey N. Boschert, Anna T. Gres, Jennifer J. Wolf, Emily M. Coonrod, Jing Tang, Thomas G. Laughlin, Qiongying Yang, Maritza N. Puray-Chavez, Juan Ji, Kamalendra Singh, Karen A. Kirby, Zhengqiang Wang, <span class="NLM_string-name hlFld-ContribAuthor">Stefan G. Sarafianos</span>. </span><span class="cited-content_cbyCitation_article-title">Novel Hepatitis B Virus Capsid-Targeting Antiviral That Aggregates Core Particles and Inhibits Nuclear Entry of Viral Cores. </span><span class="cited-content_cbyCitation_journal-name">ACS Infectious Diseases</span><span> <strong>2019,</strong> <em>5 </em>
                                    (5)
                                     , 750-758. <a href="https://doi.org/10.1021/acsinfecdis.8b00235" title="DOI URL">https://doi.org/10.1021/acsinfecdis.8b00235</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsinfecdis.8b00235&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsinfecdis.8b00235%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Infectious%2520Diseases%26atitle%3DNovel%252BHepatitis%252BB%252BVirus%252BCapsid-Targeting%252BAntiviral%252BThat%252BAggregates%252BCore%252BParticles%252Band%252BInhibits%252BNuclear%252BEntry%252Bof%252BViral%252BCores%26aulast%3DHuber%26aufirst%3DAndrew%2BD.%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D09092018%26date%3D14012019%26date%3D24122018%26volume%3D5%26issue%3D5%26spage%3D750%26epage%3D758" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Xuexiang Zhang, Junjun Cheng, Julia Ma, Zhanying Hu, Shuo Wu, Nicky Hwang, John Kulp, Yanming Du, Ju-Tao Guo, <span class="NLM_string-name hlFld-ContribAuthor">Jinhong Chang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Novel Hepatitis B Virus Nucleocapsid Assembly Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ACS Infectious Diseases</span><span> <strong>2019,</strong> <em>5 </em>
                                    (5)
                                     , 759-768. <a href="https://doi.org/10.1021/acsinfecdis.8b00269" title="DOI URL">https://doi.org/10.1021/acsinfecdis.8b00269</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsinfecdis.8b00269&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsinfecdis.8b00269%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Infectious%2520Diseases%26atitle%3DDiscovery%252Bof%252BNovel%252BHepatitis%252BB%252BVirus%252BNucleocapsid%252BAssembly%252BInhibitors%26aulast%3DZhang%26aufirst%3DXuexiang%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D12102018%26date%3D19122018%26date%3D10122018%26volume%3D5%26issue%3D5%26spage%3D759%26epage%3D768" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Li Yang, Feifei Liu, Xiankun Tong, Daniel Hoffmann, Jianping Zuo, <span class="NLM_string-name hlFld-ContribAuthor">Mengji Lu</span>. </span><span class="cited-content_cbyCitation_article-title">Treatment of Chronic Hepatitis B Virus Infection Using Small Molecule Modulators of Nucleocapsid Assembly: Recent Advances and Perspectives. </span><span class="cited-content_cbyCitation_journal-name">ACS Infectious Diseases</span><span> <strong>2019,</strong> <em>5 </em>
                                    (5)
                                     , 713-724. <a href="https://doi.org/10.1021/acsinfecdis.8b00337" title="DOI URL">https://doi.org/10.1021/acsinfecdis.8b00337</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsinfecdis.8b00337&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsinfecdis.8b00337%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Infectious%2520Diseases%26atitle%3DTreatment%252Bof%252BChronic%252BHepatitis%252BB%252BVirus%252BInfection%252BUsing%252BSmall%252BMolecule%252BModulators%252Bof%252BNucleocapsid%252BAssembly%25253A%252BRecent%252BAdvances%252Band%252BPerspectives%26aulast%3DYang%26aufirst%3DLi%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D29112018%26date%3D29032019%26date%3D21032019%26volume%3D5%26issue%3D5%26spage%3D713%26epage%3D724" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Sébastien L. Degorce, Michael S. Bodnarchuk, Iain A. Cumming, <span class="NLM_string-name hlFld-ContribAuthor">James S. Scott</span>. </span><span class="cited-content_cbyCitation_article-title">Lowering Lipophilicity by Adding Carbon: One-Carbon Bridges of Morpholines and Piperazines. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (19)
                                     , 8934-8943. <a href="https://doi.org/10.1021/acs.jmedchem.8b01148" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01148</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01148&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01148%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DLowering%252BLipophilicity%252Bby%252BAdding%252BCarbon%25253A%252BOne-Carbon%252BBridges%252Bof%252BMorpholines%252Band%252BPiperazines%26aulast%3DDegorce%26aufirst%3DS%25C3%25A9bastien%2BL.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D23072018%26date%3D20092018%26date%3D06092018%26volume%3D61%26issue%3D19%26spage%3D8934%26epage%3D8943" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Song Feng, Lu Gao, Xingchun Han, Taishan Hu, Yimin Hu, Haixia Liu, Andrew W. Thomas, Zhipeng Yan, Song Yang, John A. T. Young, Hongying Yun, Wei Zhu, <span class="NLM_string-name hlFld-ContribAuthor">Hong C. Shen</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Small Molecule Therapeutics for Treatment of Chronic HBV Infection. </span><span class="cited-content_cbyCitation_journal-name">ACS Infectious Diseases</span><span> <strong>2018,</strong> <em>4 </em>
                                    (3)
                                     , 257-277. <a href="https://doi.org/10.1021/acsinfecdis.7b00144" title="DOI URL">https://doi.org/10.1021/acsinfecdis.7b00144</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsinfecdis.7b00144&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsinfecdis.7b00144%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Infectious%2520Diseases%26atitle%3DDiscovery%252Bof%252BSmall%252BMolecule%252BTherapeutics%252Bfor%252BTreatment%252Bof%252BChronic%252BHBV%252BInfection%26aulast%3DFeng%26aufirst%3DSong%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D04092017%26date%3D12022018%26date%3D25012018%26volume%3D4%26issue%3D3%26spage%3D257%26epage%3D277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qingyun  Ren</span>, <span class="hlFld-ContribAuthor ">Xinchang  Liu</span>, <span class="hlFld-ContribAuthor ">Guanghua  Yan</span>, <span class="hlFld-ContribAuthor ">Biao  Nie</span>, <span class="hlFld-ContribAuthor ">Zhifu  Zou</span>, <span class="hlFld-ContribAuthor ">Jing  Li</span>, <span class="hlFld-ContribAuthor ">Yunfu  Chen</span>, <span class="hlFld-ContribAuthor ">Yu  Wei</span>, <span class="hlFld-ContribAuthor ">Jianzhou  Huang</span>, <span class="hlFld-ContribAuthor ">Zhonghua  Luo</span>, <span class="hlFld-ContribAuthor ">Baohua  Gu</span>, <span class="hlFld-ContribAuthor ">Siegfried  Goldmann</span>, <span class="hlFld-ContribAuthor ">Jiancun  Zhang</span>, and <span class="hlFld-ContribAuthor ">Yingjun  Zhang</span>  . </span><span class="cited-content_cbyCitation_article-title">3-((R)-4-(((R)-6-(2-Bromo-4-fluorophenyl)-5-(ethoxycarbonyl)-2-(thiazol-2-yl)-3,6-dihydropyrimidin-4-yl)methyl)morpholin-2-yl)propanoic Acid (HEC72702), a Novel Hepatitis B Virus Capsid Inhibitor Based on Clinical Candidate GLS4. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (3)
                                     , 1355-1374. <a href="https://doi.org/10.1021/acs.jmedchem.7b01914" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01914</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01914&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01914%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3D3-%252528%252528R%252529-4-%252528%252528%252528R%252529-6-%2525282-Bromo-4-fluorophenyl%252529-5-%252528ethoxycarbonyl%252529-2-%252528thiazol-2-yl%252529-3%25252C6-dihydropyrimidin-4-yl%252529methyl%252529morpholin-2-yl%252529propanoic%252BAcid%252B%252528HEC72702%252529%25252C%252Ba%252BNovel%252BHepatitis%252BB%252BVirus%252BCapsid%252BInhibitor%252BBased%252Bon%252BClinical%252BCandidate%252BGLS4%26aulast%3DRen%26aufirst%3DQingyun%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D28122017%26date%3D30012018%26date%3D08022018%26volume%3D61%26issue%3D3%26spage%3D1355%26epage%3D1374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaolin  Li</span>, <span class="hlFld-ContribAuthor ">Kai  Zhou</span>, <span class="hlFld-ContribAuthor ">Haiying  He</span>, <span class="hlFld-ContribAuthor ">Qiong  Zhou</span>, <span class="hlFld-ContribAuthor ">Ya  Sun</span>, <span class="hlFld-ContribAuthor ">Lijuan  Hou</span>, <span class="hlFld-ContribAuthor ">Liang  Shen</span>, <span class="hlFld-ContribAuthor ">Xiaofei  Wang</span>, <span class="hlFld-ContribAuthor ">Yuedong  Zhou</span>, <span class="hlFld-ContribAuthor ">Zhen  Gong</span>, <span class="hlFld-ContribAuthor ">Shibo  He</span>, <span class="hlFld-ContribAuthor ">Huangtao  Jin</span>, <span class="hlFld-ContribAuthor ">Zhengxian  Gu</span>, <span class="hlFld-ContribAuthor ">Shuyong  Zhao</span>, <span class="hlFld-ContribAuthor ">Long  Zhang</span>, <span class="hlFld-ContribAuthor ">Chunyan  Sun</span>, <span class="hlFld-ContribAuthor ">Shansong  Zheng</span>, <span class="hlFld-ContribAuthor ">Zhe  Cheng</span>, <span class="hlFld-ContribAuthor ">Yidong  Zhu</span>, <span class="hlFld-ContribAuthor ">Minghui  Zhang</span>, <span class="hlFld-ContribAuthor ">Jian  Li</span>, and <span class="hlFld-ContribAuthor ">Shuhui  Chen</span>  . </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Evaluation of Tetrahydropyrrolo[1,2-c]pyrimidines as Capsid Assembly Inhibitors for HBV Treatment. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>8 </em>
                                    (9)
                                     , 969-974. <a href="https://doi.org/10.1021/acsmedchemlett.7b00288" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.7b00288</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.7b00288&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.7b00288%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BEvaluation%252Bof%252BTetrahydropyrrolo%25255B1%25252C2-c%25255Dpyrimidines%252Bas%252BCapsid%252BAssembly%252BInhibitors%252Bfor%252BHBV%252BTreatment%26aulast%3DLi%26aufirst%3DXiaolin%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D18072017%26date%3D24082017%26date%3D30082017%26date%3D14092017%26date%3D24082017%26volume%3D8%26issue%3D9%26spage%3D969%26epage%3D974" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yameng  Pei</span>, <span class="hlFld-ContribAuthor ">Chunting  Wang</span>, <span class="hlFld-ContribAuthor ">S. Frank  Yan</span>, and <span class="hlFld-ContribAuthor ">Gang  Liu</span>  . </span><span class="cited-content_cbyCitation_article-title">Past, Current, and Future Developments of Therapeutic Agents for Treatment of Chronic Hepatitis B Virus Infection. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (15)
                                     , 6461-6479. <a href="https://doi.org/10.1021/acs.jmedchem.6b01442" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01442</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01442&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01442%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPast%25252C%252BCurrent%25252C%252Band%252BFuture%252BDevelopments%252Bof%252BTherapeutic%252BAgents%252Bfor%252BTreatment%252Bof%252BChronic%252BHepatitis%252BB%252BVirus%252BInfection%26aulast%3DPei%26aufirst%3DYameng%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D28092016%26date%3D21042017%26date%3D10082017%26date%3D06042017%26volume%3D60%26issue%3D15%26spage%3D6461%26epage%3D6479" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zongxing  Qiu</span>, <span class="hlFld-ContribAuthor ">Xianfeng  Lin</span>, <span class="hlFld-ContribAuthor ">Weixing  Zhang</span>, <span class="hlFld-ContribAuthor ">Mingwei  Zhou</span>, <span class="hlFld-ContribAuthor ">Lei  Guo</span>, <span class="hlFld-ContribAuthor ">Buelent  Kocer</span>, <span class="hlFld-ContribAuthor ">Guolong  Wu</span>, <span class="hlFld-ContribAuthor ">Zhisen  Zhang</span>, <span class="hlFld-ContribAuthor ">Haixia  Liu</span>, <span class="hlFld-ContribAuthor ">Houguang  Shi</span>, <span class="hlFld-ContribAuthor ">Buyu  Kou</span>, <span class="hlFld-ContribAuthor ">Taishan  Hu</span>, <span class="hlFld-ContribAuthor ">Yimin  Hu</span>, <span class="hlFld-ContribAuthor ">Mengwei  Huang</span>, <span class="hlFld-ContribAuthor ">S. Frank  Yan</span>, <span class="hlFld-ContribAuthor ">Zhiheng  Xu</span>, <span class="hlFld-ContribAuthor ">Zheng  Zhou</span>, <span class="hlFld-ContribAuthor ">Ning  Qin</span>, <span class="hlFld-ContribAuthor ">Yue Fen  Wang</span>, <span class="hlFld-ContribAuthor ">Shuang  Ren</span>, <span class="hlFld-ContribAuthor ">Hongxia  Qiu</span>, <span class="hlFld-ContribAuthor ">Yuxia  Zhang</span>, <span class="hlFld-ContribAuthor ">Yi  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiaoyue  Wu</span>, <span class="hlFld-ContribAuthor ">Kai  Sun</span>, <span class="hlFld-ContribAuthor ">Sheng  Zhong</span>, <span class="hlFld-ContribAuthor ">Jianxun  Xie</span>, <span class="hlFld-ContribAuthor ">Giorgio  Ottaviani</span>, <span class="hlFld-ContribAuthor ">Yuan  Zhou</span>, <span class="hlFld-ContribAuthor ">Lina  Zhu</span>, <span class="hlFld-ContribAuthor ">Xiaojun  Tian</span>, <span class="hlFld-ContribAuthor ">Liping  Shi</span>, <span class="hlFld-ContribAuthor ">Fang  Shen</span>, <span class="hlFld-ContribAuthor ">Yi  Mao</span>, <span class="hlFld-ContribAuthor ">Xue  Zhou</span>, <span class="hlFld-ContribAuthor ">Lu  Gao</span>, <span class="hlFld-ContribAuthor ">John A. T.  Young</span>, <span class="hlFld-ContribAuthor ">Jim Zhen  Wu</span>, <span class="hlFld-ContribAuthor ">Guang  Yang</span>, <span class="hlFld-ContribAuthor ">Alexander V.  Mayweg</span>, <span class="hlFld-ContribAuthor ">Hong C.  Shen</span>, <span class="hlFld-ContribAuthor ">Guozhi  Tang</span>, and <span class="hlFld-ContribAuthor ">Wei  Zhu</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery and Pre-Clinical Characterization of Third-Generation 4-H Heteroaryldihydropyrimidine (HAP) Analogues as Hepatitis B Virus (HBV) Capsid Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (8)
                                     , 3352-3371. <a href="https://doi.org/10.1021/acs.jmedchem.7b00083" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00083</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00083%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252BPre-Clinical%252BCharacterization%252Bof%252BThird-Generation%252B4-H%252BHeteroaryldihydropyrimidine%252B%252528HAP%252529%252BAnalogues%252Bas%252BHepatitis%252BB%252BVirus%252B%252528HBV%252529%252BCapsid%252BInhibitors%26aulast%3DQiu%26aufirst%3DZongxing%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D18012017%26date%3D05042017%26date%3D27042017%26date%3D24032017%26volume%3D60%26issue%3D8%26spage%3D3352%26epage%3D3371" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Piet  Herdewijn</span>, <span class="hlFld-ContribAuthor ">Weijie  Gu</span>, <span class="hlFld-ContribAuthor ">Erik  Clercq</span>. </span><span class="cited-content_cbyCitation_article-title">Anti‐DNA Virus Agents. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 1-41. <a href="https://doi.org/10.1002/0471266949.bmc237.pub2" title="DOI URL">https://doi.org/10.1002/0471266949.bmc237.pub2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/0471266949.bmc237.pub2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F0471266949.bmc237.pub2%26sid%3Dliteratum%253Aachs%26atitle%3DAnti%2525E2%252580%252590DNA%252BVirus%252BAgents%26aulast%3DHerdewijn%26aufirst%3DPiet%26date%3D2021%26date%3D2021%26spage%3D1%26epage%3D41%26pub%3DWiley%26atitle%3DBurger%252527s%252BMedicinal%252BChemistry%252Band%252BDrug%252BDiscovery%26aulast%3DAbraham%26aufirst%3DDonald%2BJ.%26date%3D2003%26date%3D2003%26volume%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuan  Wang</span>, <span class="hlFld-ContribAuthor ">Zhe  Wang</span>, <span class="hlFld-ContribAuthor ">Jiacheng  Liu</span>, <span class="hlFld-ContribAuthor ">Yunwen  Wang</span>, <span class="hlFld-ContribAuthor ">Rui  Wu</span>, <span class="hlFld-ContribAuthor ">Rong  Sheng</span>, <span class="hlFld-ContribAuthor ">Tingjun  Hou</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of novel HBV capsid assembly modulators by structure-based virtual screening and bioassays. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2021,</strong> <em>36 </em>, 116096. <a href="https://doi.org/10.1016/j.bmc.2021.116096" title="DOI URL">https://doi.org/10.1016/j.bmc.2021.116096</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2021.116096&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2021.116096%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bnovel%252BHBV%252Bcapsid%252Bassembly%252Bmodulators%252Bby%252Bstructure-based%252Bvirtual%252Bscreening%252Band%252Bbioassays%26aulast%3DWang%26aufirst%3DYuan%26date%3D2021%26volume%3D36%26spage%3D116096" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bettina  Böttcher</span>. </span><span class="cited-content_cbyCitation_article-title">Hepatitis B Core Protein Capsids. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 451-470. <a href="https://doi.org/10.1007/978-3-030-58971-4_14" title="DOI URL">https://doi.org/10.1007/978-3-030-58971-4_14</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-030-58971-4_14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-030-58971-4_14%26sid%3Dliteratum%253Aachs%26atitle%3DHepatitis%252BB%252BCore%252BProtein%252BCapsids%26aulast%3DB%25C3%25B6ttcher%26aufirst%3DBettina%26date%3D2021%26date%3D2020%26spage%3D451%26epage%3D470%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DMacromolecular%252BProtein%252BComplexes%252BIII%25253A%252BStructure%252Band%252BFunction%26aulast%3DHarris%26aufirst%3DJ.%2BRobin%26date%3D2021%26volume%3D96" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaoke  Gu</span>, <span class="hlFld-ContribAuthor ">Yinpeng  Zhang</span>, <span class="hlFld-ContribAuthor ">Yueting  Zou</span>, <span class="hlFld-ContribAuthor ">Xin  Li</span>, <span class="hlFld-ContribAuthor ">Mingyu  Guan</span>, <span class="hlFld-ContribAuthor ">Qingqing  Zhou</span>, <span class="hlFld-ContribAuthor ">Jingying  Qiu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and evaluation of new phenyl acrylamide derivatives as potent non-nucleoside anti-HBV agents. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2021,</strong> <em>29 </em>, 115892. <a href="https://doi.org/10.1016/j.bmc.2020.115892" title="DOI URL">https://doi.org/10.1016/j.bmc.2020.115892</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2020.115892&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2020.115892%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bevaluation%252Bof%252Bnew%252Bphenyl%252Bacrylamide%252Bderivatives%252Bas%252Bpotent%252Bnon-nucleoside%252Banti-HBV%252Bagents%26aulast%3DGu%26aufirst%3DXiaoke%26date%3D2021%26volume%3D29%26spage%3D115892" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christopher John  Schlicksup</span>, <span class="hlFld-ContribAuthor ">Adam  Zlotnick</span>. </span><span class="cited-content_cbyCitation_article-title">Viral structural proteins as targets for antivirals. </span><span class="cited-content_cbyCitation_journal-name">Current Opinion in Virology</span><span> <strong>2020,</strong> <em>45 </em>, 43-50. <a href="https://doi.org/10.1016/j.coviro.2020.07.001" title="DOI URL">https://doi.org/10.1016/j.coviro.2020.07.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.coviro.2020.07.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.coviro.2020.07.001%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Opinion%2520in%2520Virology%26atitle%3DViral%252Bstructural%252Bproteins%252Bas%252Btargets%252Bfor%252Bantivirals%26aulast%3DSchlicksup%26aufirst%3DChristopher%2BJohn%26date%3D2020%26volume%3D45%26spage%3D43%26epage%3D50" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thierry  Verbinnen</span>, <span class="hlFld-ContribAuthor ">Moana  Hodari</span>, <span class="hlFld-ContribAuthor ">Willem  Talloen</span>, <span class="hlFld-ContribAuthor ">Jan Martin  Berke</span>, <span class="hlFld-ContribAuthor ">David  Blue</span>, <span class="hlFld-ContribAuthor ">Jeysen  Yogaratnam</span>, <span class="hlFld-ContribAuthor ">Joris  Vandenbossche</span>, <span class="hlFld-ContribAuthor ">Umesh  Shukla</span>, <span class="hlFld-ContribAuthor ">Sandra  De Meyer</span>, <span class="hlFld-ContribAuthor ">Oliver  Lenz</span>. </span><span class="cited-content_cbyCitation_article-title">Virology analysis of chronic hepatitis B virus–infected patients treated for 28 days with JNJ‐56136379 monotherapy. </span><span class="cited-content_cbyCitation_journal-name">Journal of Viral Hepatitis</span><span> <strong>2020,</strong> <em>27 </em>
                                    (11)
                                     , 1127-1137. <a href="https://doi.org/10.1111/jvh.13351" title="DOI URL">https://doi.org/10.1111/jvh.13351</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/jvh.13351&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fjvh.13351%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Viral%2520Hepatitis%26atitle%3DVirology%252Banalysis%252Bof%252Bchronic%252Bhepatitis%252BB%252Bvirus%2525E2%252580%252593infected%252Bpatients%252Btreated%252Bfor%252B28%252Bdays%252Bwith%252BJNJ%2525E2%252580%25259056136379%252Bmonotherapy%26aulast%3DVerbinnen%26aufirst%3DThierry%26date%3D2020%26date%3D2020%26volume%3D27%26issue%3D11%26spage%3D1127%26epage%3D1137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Usha  Viswanathan</span>, <span class="hlFld-ContribAuthor ">Nagraj  Mani</span>, <span class="hlFld-ContribAuthor ">Zhanying  Hu</span>, <span class="hlFld-ContribAuthor ">Haiqun  Ban</span>, <span class="hlFld-ContribAuthor ">Yanming  Du</span>, <span class="hlFld-ContribAuthor ">Jin  Hu</span>, <span class="hlFld-ContribAuthor ">Jinhong  Chang</span>, <span class="hlFld-ContribAuthor ">Ju-Tao  Guo</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting the multifunctional HBV core protein as a potential cure for chronic hepatitis B. </span><span class="cited-content_cbyCitation_journal-name">Antiviral Research</span><span> <strong>2020,</strong> <em>182 </em>, 104917. <a href="https://doi.org/10.1016/j.antiviral.2020.104917" title="DOI URL">https://doi.org/10.1016/j.antiviral.2020.104917</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.antiviral.2020.104917&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.antiviral.2020.104917%26sid%3Dliteratum%253Aachs%26jtitle%3DAntiviral%2520Research%26atitle%3DTargeting%252Bthe%252Bmultifunctional%252BHBV%252Bcore%252Bprotein%252Bas%252Ba%252Bpotential%252Bcure%252Bfor%252Bchronic%252Bhepatitis%252BB%26aulast%3DViswanathan%26aufirst%3DUsha%26date%3D2020%26volume%3D182%26spage%3D104917" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thierry  Verbinnen</span>, <span class="hlFld-ContribAuthor ">Ying  Tan</span>, <span class="hlFld-ContribAuthor ">Gengyan  Wang</span>, <span class="hlFld-ContribAuthor ">Pascale  Dehertogh</span>, <span class="hlFld-ContribAuthor ">Karen  Vergauwen</span>, <span class="hlFld-ContribAuthor ">Jean-Marc  Neefs</span>, <span class="hlFld-ContribAuthor ">Edgar  Jacoby</span>, <span class="hlFld-ContribAuthor ">Oliver  Lenz</span>, <span class="hlFld-ContribAuthor ">Jan Martin  Berke</span>. </span><span class="cited-content_cbyCitation_article-title">Anti-HBV activity of the HBV capsid assembly modulator JNJ-56136379 across full-length genotype A–H clinical isolates and core site-directed mutants in vitro. </span><span class="cited-content_cbyCitation_journal-name">Journal of Antimicrobial Chemotherapy</span><span> <strong>2020,</strong> <em>75 </em>
                                    (9)
                                     , 2526-2534. <a href="https://doi.org/10.1093/jac/dkaa179" title="DOI URL">https://doi.org/10.1093/jac/dkaa179</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/jac/dkaa179&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fjac%2Fdkaa179%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Antimicrobial%2520Chemotherapy%26atitle%3DAnti-HBV%252Bactivity%252Bof%252Bthe%252BHBV%252Bcapsid%252Bassembly%252Bmodulator%252BJNJ-56136379%252Bacross%252Bfull-length%252Bgenotype%252BA%2525E2%252580%252593H%252Bclinical%252Bisolates%252Band%252Bcore%252Bsite-directed%252Bmutants%252Bin%252Bvitro%26aulast%3DVerbinnen%26aufirst%3DThierry%26date%3D2020%26date%3D2020%26volume%3D75%26issue%3D9%26spage%3D2526%26epage%3D2534" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fabien  Zoulim</span>, <span class="hlFld-ContribAuthor ">Oliver  Lenz</span>, <span class="hlFld-ContribAuthor ">Joris J.  Vandenbossche</span>, <span class="hlFld-ContribAuthor ">Willem  Talloen</span>, <span class="hlFld-ContribAuthor ">Thierry  Verbinnen</span>, <span class="hlFld-ContribAuthor ">Iurie  Moscalu</span>, <span class="hlFld-ContribAuthor ">Adrian  Streinu-Cercel</span>, <span class="hlFld-ContribAuthor ">Stefan  Bourgeois</span>, <span class="hlFld-ContribAuthor ">Maria  Buti</span>, <span class="hlFld-ContribAuthor ">Javier  Crespo</span>, <span class="hlFld-ContribAuthor ">Juan  Manuel Pascasio</span>, <span class="hlFld-ContribAuthor ">Christoph  Sarrazin</span>, <span class="hlFld-ContribAuthor ">Thomas  Vanwolleghem</span>, <span class="hlFld-ContribAuthor ">Umesh  Shukla</span>, <span class="hlFld-ContribAuthor ">John  Fry</span>, <span class="hlFld-ContribAuthor ">Jeysen Z.  Yogaratnam</span>. </span><span class="cited-content_cbyCitation_article-title">JNJ-56136379, an HBV Capsid Assembly Modulator, Is Well-Tolerated and Has Antiviral Activity in a Phase 1 Study of Patients With Chronic Infection. </span><span class="cited-content_cbyCitation_journal-name">Gastroenterology</span><span> <strong>2020,</strong> <em>159 </em>
                                    (2)
                                     , 521-533.e9. <a href="https://doi.org/10.1053/j.gastro.2020.04.036" title="DOI URL">https://doi.org/10.1053/j.gastro.2020.04.036</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1053/j.gastro.2020.04.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1053%2Fj.gastro.2020.04.036%26sid%3Dliteratum%253Aachs%26jtitle%3DGastroenterology%26atitle%3DJNJ-56136379%25252C%252Ban%252BHBV%252BCapsid%252BAssembly%252BModulator%25252C%252BIs%252BWell-Tolerated%252Band%252BHas%252BAntiviral%252BActivity%252Bin%252Ba%252BPhase%252B1%252BStudy%252Bof%252BPatients%252BWith%252BChronic%252BInfection%26aulast%3DZoulim%26aufirst%3DFabien%26date%3D2020%26volume%3D159%26issue%3D2%26spage%3D521%26epage%3D533.e9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ji  Yu</span>, <span class="hlFld-ContribAuthor ">Haiyong  Jia</span>, <span class="hlFld-ContribAuthor ">Xiaowei  Guo</span>, <span class="hlFld-ContribAuthor ">Samuel  Desta</span>, <span class="hlFld-ContribAuthor ">Shuo  Zhang</span>, <span class="hlFld-ContribAuthor ">Jian  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiao  Ding</span>, <span class="hlFld-ContribAuthor ">Xiaohong  Liang</span>, <span class="hlFld-ContribAuthor ">Xinyong  Liu</span>, <span class="hlFld-ContribAuthor ">Peng  Zhan</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and evaluation of novel heteroaryldihydropyrimidine derivatives as non‐nucleoside hepatitis B virus inhibitors by exploring the solvent‐exposed region. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2020,</strong> <em>95 </em>
                                    (6)
                                     , 567-583. <a href="https://doi.org/10.1111/cbdd.13512" title="DOI URL">https://doi.org/10.1111/cbdd.13512</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cbdd.13512&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcbdd.13512%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bevaluation%252Bof%252Bnovel%252Bheteroaryldihydropyrimidine%252Bderivatives%252Bas%252Bnon%2525E2%252580%252590nucleoside%252Bhepatitis%252BB%252Bvirus%252Binhibitors%252Bby%252Bexploring%252Bthe%252Bsolvent%2525E2%252580%252590exposed%252Bregion%26aulast%3DYu%26aufirst%3DJi%26date%3D2020%26date%3D2020%26volume%3D95%26issue%3D6%26spage%3D567%26epage%3D583" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kai  Lv</span>, <span class="hlFld-ContribAuthor ">Shuo  Wu</span>, <span class="hlFld-ContribAuthor ">Wenyan  Li</span>, <span class="hlFld-ContribAuthor ">Yunhe  Geng</span>, <span class="hlFld-ContribAuthor ">Meng  Wu</span>, <span class="hlFld-ContribAuthor ">Jinming  Zhou</span>, <span class="hlFld-ContribAuthor ">Yuhuan  Li</span>, <span class="hlFld-ContribAuthor ">Qiang  Gao</span>, <span class="hlFld-ContribAuthor ">Mingliang  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and anti-HBV activity of NVR3-778 derivatives. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>94 </em>, 103363. <a href="https://doi.org/10.1016/j.bioorg.2019.103363" title="DOI URL">https://doi.org/10.1016/j.bioorg.2019.103363</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2019.103363&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2019.103363%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Banti-HBV%252Bactivity%252Bof%252BNVR3-778%252Bderivatives%26aulast%3DLv%26aufirst%3DKai%26date%3D2020%26volume%3D94%26spage%3D103363" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jung-Ah  Kang</span>, <span class="hlFld-ContribAuthor ">Songwon  Kim</span>, <span class="hlFld-ContribAuthor ">Minji  Park</span>, <span class="hlFld-ContribAuthor ">Hyun-Jin  Park</span>, <span class="hlFld-ContribAuthor ">Jeong-Hyun  Kim</span>, <span class="hlFld-ContribAuthor ">Sanghyeok  Park</span>, <span class="hlFld-ContribAuthor ">Jeong-Ryul  Hwang</span>, <span class="hlFld-ContribAuthor ">Yong-Chul  Kim</span>, <span class="hlFld-ContribAuthor ">Yoon  Jun Kim</span>, <span class="hlFld-ContribAuthor ">Yuri  Cho</span>, <span class="hlFld-ContribAuthor ">Mi  Sun Jin</span>, <span class="hlFld-ContribAuthor ">Sung-Gyoo  Park</span>. </span><span class="cited-content_cbyCitation_article-title">Ciclopirox inhibits Hepatitis B Virus secretion by blocking capsid assembly. </span><span class="cited-content_cbyCitation_journal-name">Nature Communications</span><span> <strong>2019,</strong> <em>10 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41467-019-10200-5" title="DOI URL">https://doi.org/10.1038/s41467-019-10200-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41467-019-10200-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41467-019-10200-5%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Communications%26atitle%3DCiclopirox%252Binhibits%252BHepatitis%252BB%252BVirus%252Bsecretion%252Bby%252Bblocking%252Bcapsid%252Bassembly%26aulast%3DKang%26aufirst%3DJung-Ah%26date%3D2019%26date%3D2019%26volume%3D10%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shishan  Wang</span>, <span class="hlFld-ContribAuthor ">Marie-Laure  Fogeron</span>, <span class="hlFld-ContribAuthor ">Maarten  Schledorn</span>, <span class="hlFld-ContribAuthor ">Marie  Dujardin</span>, <span class="hlFld-ContribAuthor ">Susanne  Penzel</span>, <span class="hlFld-ContribAuthor ">Dara  Burdette</span>, <span class="hlFld-ContribAuthor ">Jan Martin  Berke</span>, <span class="hlFld-ContribAuthor ">Michael  Nassal</span>, <span class="hlFld-ContribAuthor ">Lauriane  Lecoq</span>, <span class="hlFld-ContribAuthor ">Beat H.  Meier</span>, <span class="hlFld-ContribAuthor ">Anja  Böckmann</span>. </span><span class="cited-content_cbyCitation_article-title">Combining Cell-Free Protein Synthesis and NMR Into a Tool to Study Capsid Assembly Modulation. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Molecular Biosciences</span><span> <strong>2019,</strong> <em>6 </em><a href="https://doi.org/10.3389/fmolb.2019.00067" title="DOI URL">https://doi.org/10.3389/fmolb.2019.00067</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fmolb.2019.00067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffmolb.2019.00067%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Molecular%2520Biosciences%26atitle%3DCombining%252BCell-Free%252BProtein%252BSynthesis%252Band%252BNMR%252BInto%252Ba%252BTool%252Bto%252BStudy%252BCapsid%252BAssembly%252BModulation%26aulast%3DWang%26aufirst%3DShishan%26date%3D2019%26date%3D2019%26volume%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jingying  Qiu</span>, <span class="hlFld-ContribAuthor ">Wang  Chen</span>, <span class="hlFld-ContribAuthor ">Yinpeng  Zhang</span>, <span class="hlFld-ContribAuthor ">Qingqing  Zhou</span>, <span class="hlFld-ContribAuthor ">Jing  Chen</span>, <span class="hlFld-ContribAuthor ">Lihua  Yang</span>, <span class="hlFld-ContribAuthor ">Jian  Gao</span>, <span class="hlFld-ContribAuthor ">Xiaoke  Gu</span>, <span class="hlFld-ContribAuthor ">Daoquan  Tang</span>. </span><span class="cited-content_cbyCitation_article-title">Assessment of quinazolinone derivatives as novel non-nucleoside hepatitis B virus inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>176 </em>, 41-49. <a href="https://doi.org/10.1016/j.ejmech.2019.05.014" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.05.014</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.05.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.05.014%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAssessment%252Bof%252Bquinazolinone%252Bderivatives%252Bas%252Bnovel%252Bnon-nucleoside%252Bhepatitis%252BB%252Bvirus%252Binhibitors%26aulast%3DQiu%26aufirst%3DJingying%26date%3D2019%26volume%3D176%26spage%3D41%26epage%3D49" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Li Ting  Song</span>, <span class="hlFld-ContribAuthor ">Rui Rui  Liu</span>, <span class="hlFld-ContribAuthor ">Hong Lin  Zhai</span>, <span class="hlFld-ContribAuthor ">Ya Jie  Meng</span>, <span class="hlFld-ContribAuthor ">Min  Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular mechanisms of tetrahydropyrrolo[1,2-c]pyrimidines as HBV capsid assembly inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Archives of Biochemistry and Biophysics</span><span> <strong>2019,</strong> <em>663 </em>, 1-10. <a href="https://doi.org/10.1016/j.abb.2018.12.029" title="DOI URL">https://doi.org/10.1016/j.abb.2018.12.029</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.abb.2018.12.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.abb.2018.12.029%26sid%3Dliteratum%253Aachs%26jtitle%3DArchives%2520of%2520Biochemistry%2520and%2520Biophysics%26atitle%3DMolecular%252Bmechanisms%252Bof%252Btetrahydropyrrolo%25255B1%25252C2-c%25255Dpyrimidines%252Bas%252BHBV%252Bcapsid%252Bassembly%252Binhibitors%26aulast%3DSong%26aufirst%3DLi%2BTing%26date%3D2019%26volume%3D663%26spage%3D1%26epage%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ting  Pan</span>, <span class="hlFld-ContribAuthor ">Yanchao  Ding</span>, <span class="hlFld-ContribAuthor ">Liyang  Wu</span>, <span class="hlFld-ContribAuthor ">Liting  Liang</span>, <span class="hlFld-ContribAuthor ">Xin  He</span>, <span class="hlFld-ContribAuthor ">Qianwen  Li</span>, <span class="hlFld-ContribAuthor ">Chuan  Bai</span>, <span class="hlFld-ContribAuthor ">Hui  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of aminothiazole based Hepatitis B Virus (HBV) capsid inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>166 </em>, 480-501. <a href="https://doi.org/10.1016/j.ejmech.2019.01.059" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.01.059</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.01.059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.01.059%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252Baminothiazole%252Bbased%252BHepatitis%252BB%252BVirus%252B%252528HBV%252529%252Bcapsid%252Binhibitors%26aulast%3DPan%26aufirst%3DTing%26date%3D2019%26volume%3D166%26spage%3D480%26epage%3D501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jing  Tang</span>, <span class="hlFld-ContribAuthor ">Andrew D.  Huber</span>, <span class="hlFld-ContribAuthor ">Dallas L.  Pineda</span>, <span class="hlFld-ContribAuthor ">Kelsey N.  Boschert</span>, <span class="hlFld-ContribAuthor ">Jennifer J.  Wolf</span>, <span class="hlFld-ContribAuthor ">Jayakanth  Kankanala</span>, <span class="hlFld-ContribAuthor ">Jiashu  Xie</span>, <span class="hlFld-ContribAuthor ">Stefan G.  Sarafianos</span>, <span class="hlFld-ContribAuthor ">Zhengqiang  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">5-Aminothiophene-2,4-dicarboxamide analogues as hepatitis B virus capsid assembly effectors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>164 </em>, 179-192. <a href="https://doi.org/10.1016/j.ejmech.2018.12.047" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.12.047</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.12.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.12.047%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3D5-Aminothiophene-2%25252C4-dicarboxamide%252Banalogues%252Bas%252Bhepatitis%252BB%252Bvirus%252Bcapsid%252Bassembly%252Beffectors%26aulast%3DTang%26aufirst%3DJing%26date%3D2019%26volume%3D164%26spage%3D179%26epage%3D192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Angela M.  Lam</span>, <span class="hlFld-ContribAuthor ">Christine  Espiritu</span>, <span class="hlFld-ContribAuthor ">Robert  Vogel</span>, <span class="hlFld-ContribAuthor ">Suping  Ren</span>, <span class="hlFld-ContribAuthor ">Vincent  Lau</span>, <span class="hlFld-ContribAuthor ">Mollie  Kelly</span>, <span class="hlFld-ContribAuthor ">Scott D.  Kuduk</span>, <span class="hlFld-ContribAuthor ">George D.  Hartman</span>, <span class="hlFld-ContribAuthor ">Osvaldo A.  Flores</span>, <span class="hlFld-ContribAuthor ">Klaus  Klumpp</span>. </span><span class="cited-content_cbyCitation_article-title">Preclinical Characterization of NVR 3-778, a First-in-Class Capsid Assembly Modulator against Hepatitis B Virus. </span><span class="cited-content_cbyCitation_journal-name">Antimicrobial Agents and Chemotherapy</span><span> <strong>2019,</strong> <em>63 </em>
                                    (1)
                                     <a href="https://doi.org/10.1128/AAC.01734-18" title="DOI URL">https://doi.org/10.1128/AAC.01734-18</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1128/AAC.01734-18&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1128%2FAAC.01734-18%26sid%3Dliteratum%253Aachs%26jtitle%3DAntimicrobial%2520Agents%2520and%2520Chemotherapy%26atitle%3DPreclinical%252BCharacterization%252Bof%252BNVR%252B3-778%25252C%252Ba%252BFirst-in-Class%252BCapsid%252BAssembly%252BModulator%252Bagainst%252BHepatitis%252BB%252BVirus%26aulast%3DLam%26aufirst%3DAngela%2BM.%26date%3D2019%26volume%3D63%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elif  Eren</span>, <span class="hlFld-ContribAuthor ">Norman R.  Watts</span>, <span class="hlFld-ContribAuthor ">Altaira D.  Dearborn</span>, <span class="hlFld-ContribAuthor ">Ira W.  Palmer</span>, <span class="hlFld-ContribAuthor ">Joshua D.  Kaufman</span>, <span class="hlFld-ContribAuthor ">Alasdair C.  Steven</span>, <span class="hlFld-ContribAuthor ">Paul T.  Wingfield</span>. </span><span class="cited-content_cbyCitation_article-title">Structures of Hepatitis B Virus Core- and e-Antigen Immune Complexes Suggest Multi-point Inhibition. </span><span class="cited-content_cbyCitation_journal-name">Structure</span><span> <strong>2018,</strong> <em>26 </em>
                                    (10)
                                     , 1314-1326.e4. <a href="https://doi.org/10.1016/j.str.2018.06.012" title="DOI URL">https://doi.org/10.1016/j.str.2018.06.012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.str.2018.06.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.str.2018.06.012%26sid%3Dliteratum%253Aachs%26jtitle%3DStructure%26atitle%3DStructures%252Bof%252BHepatitis%252BB%252BVirus%252BCore-%252Band%252Be-Antigen%252BImmune%252BComplexes%252BSuggest%252BMulti-point%252BInhibition%26aulast%3DEren%26aufirst%3DElif%26date%3D2018%26volume%3D26%26issue%3D10%26spage%3D1314%26epage%3D1326.e4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nagraj  Mani</span>, <span class="hlFld-ContribAuthor ">Andrew G.  Cole</span>, <span class="hlFld-ContribAuthor ">Janet R.  Phelps</span>, <span class="hlFld-ContribAuthor ">Andrzej  Ardzinski</span>, <span class="hlFld-ContribAuthor ">Kyle D.  Cobarrubias</span>, <span class="hlFld-ContribAuthor ">Andrea  Cuconati</span>, <span class="hlFld-ContribAuthor ">Bruce D.  Dorsey</span>, <span class="hlFld-ContribAuthor ">Ellen  Evangelista</span>, <span class="hlFld-ContribAuthor ">Kristi  Fan</span>, <span class="hlFld-ContribAuthor ">Fang  Guo</span>, <span class="hlFld-ContribAuthor ">Haitao  Guo</span>, <span class="hlFld-ContribAuthor ">Ju-Tao  Guo</span>, <span class="hlFld-ContribAuthor ">Troy O.  Harasym</span>, <span class="hlFld-ContribAuthor ">Salam  Kadhim</span>, <span class="hlFld-ContribAuthor ">Steven G.  Kultgen</span>, <span class="hlFld-ContribAuthor ">Amy C. H.  Lee</span>, <span class="hlFld-ContribAuthor ">Alice H. L.  Li</span>, <span class="hlFld-ContribAuthor ">Quanxin  Long</span>, <span class="hlFld-ContribAuthor ">Sara A.  Majeski</span>, <span class="hlFld-ContribAuthor ">Richeng  Mao</span>, <span class="hlFld-ContribAuthor ">Kevin D.  McClintock</span>, <span class="hlFld-ContribAuthor ">Stephen P.  Reid</span>, <span class="hlFld-ContribAuthor ">Rene  Rijnbrand</span>, <span class="hlFld-ContribAuthor ">Nicholas M.  Snead</span>, <span class="hlFld-ContribAuthor ">Holly M.  Micolochick Steuer</span>, <span class="hlFld-ContribAuthor ">Kim  Stever</span>, <span class="hlFld-ContribAuthor ">Sunny  Tang</span>, <span class="hlFld-ContribAuthor ">Xiaohe  Wang</span>, <span class="hlFld-ContribAuthor ">Qiong  Zhao</span>, <span class="hlFld-ContribAuthor ">Michael J.  Sofia</span>. </span><span class="cited-content_cbyCitation_article-title">Preclinical Profile of AB-423, an Inhibitor of Hepatitis B Virus Pregenomic RNA Encapsidation. </span><span class="cited-content_cbyCitation_journal-name">Antimicrobial Agents and Chemotherapy</span><span> <strong>2018,</strong> <em>62 </em>
                                    (6)
                                     <a href="https://doi.org/10.1128/AAC.00082-18" title="DOI URL">https://doi.org/10.1128/AAC.00082-18</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1128/AAC.00082-18&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1128%2FAAC.00082-18%26sid%3Dliteratum%253Aachs%26jtitle%3DAntimicrobial%2520Agents%2520and%2520Chemotherapy%26atitle%3DPreclinical%252BProfile%252Bof%252BAB-423%25252C%252Ban%252BInhibitor%252Bof%252BHepatitis%252BB%252BVirus%252BPregenomic%252BRNA%252BEncapsidation%26aulast%3DMani%26aufirst%3DNagraj%26date%3D2018%26volume%3D62%26issue%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrew D.  Huber</span>, <span class="hlFld-ContribAuthor ">Jennifer J.  Wolf</span>, <span class="hlFld-ContribAuthor ">Dandan  Liu</span>, <span class="hlFld-ContribAuthor ">Anna T.  Gres</span>, <span class="hlFld-ContribAuthor ">Jing  Tang</span>, <span class="hlFld-ContribAuthor ">Kelsey N.  Boschert</span>, <span class="hlFld-ContribAuthor ">Maritza N.  Puray-Chavez</span>, <span class="hlFld-ContribAuthor ">Dallas L.  Pineda</span>, <span class="hlFld-ContribAuthor ">Thomas G.  Laughlin</span>, <span class="hlFld-ContribAuthor ">Emily M.  Coonrod</span>, <span class="hlFld-ContribAuthor ">Qiongying  Yang</span>, <span class="hlFld-ContribAuthor ">Juan  Ji</span>, <span class="hlFld-ContribAuthor ">Karen A.  Kirby</span>, <span class="hlFld-ContribAuthor ">Zhengqiang  Wang</span>, <span class="hlFld-ContribAuthor ">Stefan G.  Sarafianos</span>, , <span class="hlFld-ContribAuthor ">Nathan  Sherer</span>, <span class="hlFld-ContribAuthor ">Priscilla L.  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">The Heteroaryldihydropyrimidine Bay 38-7690 Induces Hepatitis B Virus Core Protein Aggregates Associated with Promyelocytic Leukemia Nuclear Bodies in Infected Cells. </span><span class="cited-content_cbyCitation_journal-name">mSphere</span><span> <strong>2018,</strong> <em>3 </em>
                                    (2)
                                     <a href="https://doi.org/10.1128/mSphereDirect.00131-18" title="DOI URL">https://doi.org/10.1128/mSphereDirect.00131-18</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1128/mSphereDirect.00131-18&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1128%2FmSphereDirect.00131-18%26sid%3Dliteratum%253Aachs%26jtitle%3DmSphere%26atitle%3DThe%252BHeteroaryldihydropyrimidine%252BBay%252B38-7690%252BInduces%252BHepatitis%252BB%252BVirus%252BCore%252BProtein%252BAggregates%252BAssociated%252Bwith%252BPromyelocytic%252BLeukemia%252BNuclear%252BBodies%252Bin%252BInfected%252BCells%26aulast%3DHuber%26aufirst%3DAndrew%2BD.%26date%3D2018%26volume%3D3%26issue%3D2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dejuan  Sun</span>, <span class="hlFld-ContribAuthor ">Lingjuan  Zhu</span>, <span class="hlFld-ContribAuthor ">Dahong  Yao</span>, <span class="hlFld-ContribAuthor ">Lixia  Chen</span>, <span class="hlFld-ContribAuthor ">Leilei  Fu</span>, <span class="hlFld-ContribAuthor ">Liang  Ouyang</span>. </span><span class="cited-content_cbyCitation_article-title">Recent progress in potential anti-hepatitis B virus agents: Structural and pharmacological perspectives. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>147 </em>, 205-217. <a href="https://doi.org/10.1016/j.ejmech.2018.02.001" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.02.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.02.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.02.001%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRecent%252Bprogress%252Bin%252Bpotential%252Banti-hepatitis%252BB%252Bvirus%252Bagents%25253A%252BStructural%252Band%252Bpharmacological%252Bperspectives%26aulast%3DSun%26aufirst%3DDejuan%26date%3D2018%26volume%3D147%26spage%3D205%26epage%3D217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shugo  Tsuda</span>, <span class="hlFld-ContribAuthor ">Masayoshi  Mochizuki</span>, <span class="hlFld-ContribAuthor ">Hiroyuki  Ishiba</span>, <span class="hlFld-ContribAuthor ">Kumiko  Yoshizawa-Kumagaye</span>, <span class="hlFld-ContribAuthor ">Hideki  Nishio</span>, <span class="hlFld-ContribAuthor ">Shinya  Oishi</span>, <span class="hlFld-ContribAuthor ">Taku  Yoshiya</span>. </span><span class="cited-content_cbyCitation_article-title">Easy-to-Attach/Detach Solubilizing-Tag-Aided Chemical Synthesis of an Aggregative Capsid Protein. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2018,</strong> <em>130 </em>
                                    (8)
                                     , 2127-2131. <a href="https://doi.org/10.1002/ange.201711546" title="DOI URL">https://doi.org/10.1002/ange.201711546</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.201711546&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.201711546%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DEasy-to-Attach%25252FDetach%252BSolubilizing-Tag-Aided%252BChemical%252BSynthesis%252Bof%252Ban%252BAggregative%252BCapsid%252BProtein%26aulast%3DTsuda%26aufirst%3DShugo%26date%3D2018%26date%3D2018%26volume%3D130%26issue%3D8%26spage%3D2127%26epage%3D2131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shugo  Tsuda</span>, <span class="hlFld-ContribAuthor ">Masayoshi  Mochizuki</span>, <span class="hlFld-ContribAuthor ">Hiroyuki  Ishiba</span>, <span class="hlFld-ContribAuthor ">Kumiko  Yoshizawa-Kumagaye</span>, <span class="hlFld-ContribAuthor ">Hideki  Nishio</span>, <span class="hlFld-ContribAuthor ">Shinya  Oishi</span>, <span class="hlFld-ContribAuthor ">Taku  Yoshiya</span>. </span><span class="cited-content_cbyCitation_article-title">Easy-to-Attach/Detach Solubilizing-Tag-Aided Chemical Synthesis of an Aggregative Capsid Protein. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2018,</strong> <em>57 </em>
                                    (8)
                                     , 2105-2109. <a href="https://doi.org/10.1002/anie.201711546" title="DOI URL">https://doi.org/10.1002/anie.201711546</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.201711546&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.201711546%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DEasy-to-Attach%25252FDetach%252BSolubilizing-Tag-Aided%252BChemical%252BSynthesis%252Bof%252Ban%252BAggregative%252BCapsid%252BProtein%26aulast%3DTsuda%26aufirst%3DShugo%26date%3D2018%26date%3D2018%26volume%3D57%26issue%3D8%26spage%3D2105%26epage%3D2109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Katrin  Schöneweis</span>, <span class="hlFld-ContribAuthor ">Neil  Motter</span>, <span class="hlFld-ContribAuthor ">Pia L.  Roppert</span>, <span class="hlFld-ContribAuthor ">Mengji  Lu</span>, <span class="hlFld-ContribAuthor ">Baoju  Wang</span>, <span class="hlFld-ContribAuthor ">Ingo  Roehl</span>, <span class="hlFld-ContribAuthor ">Dieter  Glebe</span>, <span class="hlFld-ContribAuthor ">Dongliang  Yang</span>, <span class="hlFld-ContribAuthor ">John D.  Morrey</span>, <span class="hlFld-ContribAuthor ">Michael  Roggendorf</span>, <span class="hlFld-ContribAuthor ">Andrew  Vaillant</span>. </span><span class="cited-content_cbyCitation_article-title">Activity of nucleic acid polymers in rodent models of HBV infection. </span><span class="cited-content_cbyCitation_journal-name">Antiviral Research</span><span> <strong>2018,</strong> <em>149 </em>, 26-33. <a href="https://doi.org/10.1016/j.antiviral.2017.10.022" title="DOI URL">https://doi.org/10.1016/j.antiviral.2017.10.022</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.antiviral.2017.10.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.antiviral.2017.10.022%26sid%3Dliteratum%253Aachs%26jtitle%3DAntiviral%2520Research%26atitle%3DActivity%252Bof%252Bnucleic%252Bacid%252Bpolymers%252Bin%252Brodent%252Bmodels%252Bof%252BHBV%252Binfection%26aulast%3DSch%25C3%25B6neweis%26aufirst%3DKatrin%26date%3D2018%26volume%3D149%26spage%3D26%26epage%3D33" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shuye  Zhang</span>, <span class="hlFld-ContribAuthor ">Fusheng  Wang</span>, <span class="hlFld-ContribAuthor ">Zheng  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Current advances in the elimination of hepatitis B in China by 2030. </span><span class="cited-content_cbyCitation_journal-name">Frontiers of Medicine</span><span> <strong>2017,</strong> <em>11 </em>
                                    (4)
                                     , 490-501. <a href="https://doi.org/10.1007/s11684-017-0598-4" title="DOI URL">https://doi.org/10.1007/s11684-017-0598-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11684-017-0598-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11684-017-0598-4%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520of%2520Medicine%26atitle%3DCurrent%252Badvances%252Bin%252Bthe%252Belimination%252Bof%252Bhepatitis%252BB%252Bin%252BChina%252Bby%252B2030%26aulast%3DZhang%26aufirst%3DShuye%26date%3D2017%26date%3D2017%26volume%3D11%26issue%3D4%26spage%3D490%26epage%3D501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shuo  Wu</span>, <span class="hlFld-ContribAuthor ">Qiong  Zhao</span>, <span class="hlFld-ContribAuthor ">Pinghu  Zhang</span>, <span class="hlFld-ContribAuthor ">John  Kulp</span>, <span class="hlFld-ContribAuthor ">Lydia  Hu</span>, <span class="hlFld-ContribAuthor ">Nicky  Hwang</span>, <span class="hlFld-ContribAuthor ">Jiming  Zhang</span>, <span class="hlFld-ContribAuthor ">Timothy M.  Block</span>, <span class="hlFld-ContribAuthor ">Xiaodong  Xu</span>, <span class="hlFld-ContribAuthor ">Yanming  Du</span>, <span class="hlFld-ContribAuthor ">Jinhong  Chang</span>, <span class="hlFld-ContribAuthor ">Ju-Tao  Guo</span>, . </span><span class="cited-content_cbyCitation_article-title">Discovery and Mechanistic Study of Benzamide Derivatives That Modulate Hepatitis B Virus Capsid Assembly. </span><span class="cited-content_cbyCitation_journal-name">Journal of Virology</span><span> <strong>2017,</strong> <em>91 </em>
                                    (16)
                                     <a href="https://doi.org/10.1128/JVI.00519-17" title="DOI URL">https://doi.org/10.1128/JVI.00519-17</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1128/JVI.00519-17&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1128%2FJVI.00519-17%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Virology%26atitle%3DDiscovery%252Band%252BMechanistic%252BStudy%252Bof%252BBenzamide%252BDerivatives%252BThat%252BModulate%252BHepatitis%252BB%252BVirus%252BCapsid%252BAssembly%26aulast%3DWu%26aufirst%3DShuo%26date%3D2017%26volume%3D91%26issue%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jan Martin  Berke</span>, <span class="hlFld-ContribAuthor ">Ying  Tan</span>, <span class="hlFld-ContribAuthor ">Thierry  Verbinnen</span>, <span class="hlFld-ContribAuthor ">Pascale  Dehertogh</span>, <span class="hlFld-ContribAuthor ">Karen  Vergauwen</span>, <span class="hlFld-ContribAuthor ">Ann  Vos</span>, <span class="hlFld-ContribAuthor ">Oliver  Lenz</span>, <span class="hlFld-ContribAuthor ">Frederik  Pauwels</span>. </span><span class="cited-content_cbyCitation_article-title">Antiviral profiling of the capsid assembly modulator BAY41-4109 on full-length HBV genotype A-H clinical isolates and core site-directed mutants  in vitro. </span><span class="cited-content_cbyCitation_journal-name">Antiviral Research</span><span> <strong>2017,</strong> <em>144 </em>, 205-215. <a href="https://doi.org/10.1016/j.antiviral.2017.06.016" title="DOI URL">https://doi.org/10.1016/j.antiviral.2017.06.016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.antiviral.2017.06.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.antiviral.2017.06.016%26sid%3Dliteratum%253Aachs%26jtitle%3DAntiviral%2520Research%26atitle%3DAntiviral%252Bprofiling%252Bof%252Bthe%252Bcapsid%252Bassembly%252Bmodulator%252BBAY41-4109%252Bon%252Bfull-length%252BHBV%252Bgenotype%252BA-H%252Bclinical%252Bisolates%252Band%252Bcore%252Bsite-directed%252Bmutants%252Bin%2525C2%2525A0vitro%26aulast%3DBerke%26aufirst%3DJan%2BMartin%26date%3D2017%26volume%3D144%26spage%3D205%26epage%3D215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Angela M.  Lam</span>, <span class="hlFld-ContribAuthor ">Suping  Ren</span>, <span class="hlFld-ContribAuthor ">Christine  Espiritu</span>, <span class="hlFld-ContribAuthor ">Mollie  Kelly</span>, <span class="hlFld-ContribAuthor ">Vincent  Lau</span>, <span class="hlFld-ContribAuthor ">Lingjie  Zheng</span>, <span class="hlFld-ContribAuthor ">George D.  Hartman</span>, <span class="hlFld-ContribAuthor ">Osvaldo A.  Flores</span>, <span class="hlFld-ContribAuthor ">Klaus  Klumpp</span>. </span><span class="cited-content_cbyCitation_article-title">Hepatitis B Virus Capsid Assembly Modulators, but Not Nucleoside Analogs, Inhibit the Production of Extracellular Pregenomic RNA and Spliced RNA Variants. </span><span class="cited-content_cbyCitation_journal-name">Antimicrobial Agents and Chemotherapy</span><span> <strong>2017,</strong> <em>61 </em>
                                    (8)
                                     <a href="https://doi.org/10.1128/AAC.00680-17" title="DOI URL">https://doi.org/10.1128/AAC.00680-17</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1128/AAC.00680-17&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1128%2FAAC.00680-17%26sid%3Dliteratum%253Aachs%26jtitle%3DAntimicrobial%2520Agents%2520and%2520Chemotherapy%26atitle%3DHepatitis%252BB%252BVirus%252BCapsid%252BAssembly%252BModulators%25252C%252Bbut%252BNot%252BNucleoside%252BAnalogs%25252C%252BInhibit%252Bthe%252BProduction%252Bof%252BExtracellular%252BPregenomic%252BRNA%252Band%252BSpliced%252BRNA%252BVariants%26aulast%3DLam%26aufirst%3DAngela%2BM.%26date%3D2017%26volume%3D61%26issue%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zheng  Zhou</span>, <span class="hlFld-ContribAuthor ">Taishan  Hu</span>, <span class="hlFld-ContribAuthor ">Xue  Zhou</span>, <span class="hlFld-ContribAuthor ">Steffen  Wildum</span>, <span class="hlFld-ContribAuthor ">Fernando  Garcia-Alcalde</span>, <span class="hlFld-ContribAuthor ">Zhiheng  Xu</span>, <span class="hlFld-ContribAuthor ">Daitze  Wu</span>, <span class="hlFld-ContribAuthor ">Yi  Mao</span>, <span class="hlFld-ContribAuthor ">Xiaojun  Tian</span>, <span class="hlFld-ContribAuthor ">Yuan  Zhou</span>, <span class="hlFld-ContribAuthor ">Fang  Shen</span>, <span class="hlFld-ContribAuthor ">Zhisen  Zhang</span>, <span class="hlFld-ContribAuthor ">Guozhi  Tang</span>, <span class="hlFld-ContribAuthor ">Isabel  Najera</span>, <span class="hlFld-ContribAuthor ">Guang  Yang</span>, <span class="hlFld-ContribAuthor ">Hong C.  Shen</span>, <span class="hlFld-ContribAuthor ">John A. T.  Young</span>, <span class="hlFld-ContribAuthor ">Ning  Qin</span>. </span><span class="cited-content_cbyCitation_article-title">Heteroaryldihydropyrimidine (HAP) and Sulfamoylbenzamide (SBA) Inhibit Hepatitis B Virus Replication by Different Molecular Mechanisms. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2017,</strong> <em>7 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/srep42374" title="DOI URL">https://doi.org/10.1038/srep42374</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/srep42374&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fsrep42374%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DHeteroaryldihydropyrimidine%252B%252528HAP%252529%252Band%252BSulfamoylbenzamide%252B%252528SBA%252529%252BInhibit%252BHepatitis%252BB%252BVirus%252BReplication%252Bby%252BDifferent%252BMolecular%252BMechanisms%26aulast%3DZhou%26aufirst%3DZheng%26date%3D2017%26date%3D2017%26volume%3D7%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Liudi  Tang</span>, <span class="hlFld-ContribAuthor ">Qiong  Zhao</span>, <span class="hlFld-ContribAuthor ">Shuo  Wu</span>, <span class="hlFld-ContribAuthor ">Junjun  Cheng</span>, <span class="hlFld-ContribAuthor ">Jinhong  Chang</span>, <span class="hlFld-ContribAuthor ">Ju-Tao  Guo</span>. </span><span class="cited-content_cbyCitation_article-title">The current status and future directions of hepatitis B antiviral drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2017,</strong> <em>12 </em>
                                    (1)
                                     , 5-15. <a href="https://doi.org/10.1080/17460441.2017.1255195" title="DOI URL">https://doi.org/10.1080/17460441.2017.1255195</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/17460441.2017.1255195&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F17460441.2017.1255195%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DThe%252Bcurrent%252Bstatus%252Band%252Bfuture%252Bdirections%252Bof%252Bhepatitis%252BB%252Bantiviral%252Bdrug%252Bdiscovery%26aulast%3DTang%26aufirst%3DLiudi%26date%3D2017%26date%3D2016%26volume%3D12%26issue%3D1%26spage%3D5%26epage%3D15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christelle  Doebelin</span>, <span class="hlFld-ContribAuthor ">Yuanjun  He</span>, <span class="hlFld-ContribAuthor ">Theodore M.  Kamenecka</span>. </span><span class="cited-content_cbyCitation_article-title">Multigram-scale synthesis of enantiopure 3,3-difluoroproline. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2016,</strong> <em>57 </em>
                                    (50)
                                     , 5658-5660. <a href="https://doi.org/10.1016/j.tetlet.2016.11.012" title="DOI URL">https://doi.org/10.1016/j.tetlet.2016.11.012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2016.11.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2016.11.012%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DMultigram-scale%252Bsynthesis%252Bof%252Benantiopure%252B3%25252C3-difluoroproline%26aulast%3DDoebelin%26aufirst%3DChristelle%26date%3D2016%26volume%3D57%26issue%3D50%26spage%3D5658%26epage%3D5660" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00879/20160819/images/medium/jm-2016-008799_0021.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00879/20160819/images/large/jm-2016-008799_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00879&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00879/20160819/images/medium/jm-2016-008799_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00879/20160819/images/large/jm-2016-008799_0002.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Chemical structures of reported HBV capsid inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00879/20160819/images/large/jm-2016-008799_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00879&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00879/20160819/images/medium/jm-2016-008799_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00879/20160819/images/large/jm-2016-008799_0003.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Predicted lowest energy conformations of <b>1</b> (A) and (<i>S</i>)-enantiomer of <b>7a</b> (B) in vacuum. Force field MMFF94x<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> was applied in Molecular Operating Environment (MOE), CCG. An intramolecular hydrogen-bonding (HB) interaction between 1-NH and 2-heteroaryl group is indicated. Molecules are presented as ball and stick with electrostatic surface included. Carbon, oxygen, nitrogen, fluorine, and chlorine atoms are shown in gray, red, blue, green, and dark green colors, respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00879/20160819/images/large/jm-2016-008799_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00879&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00879/20160819/images/medium/jm-2016-008799_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00879/20160819/images/large/jm-2016-008799_0006.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of 4-Alkyl-Substituted HAP Analogues <b>7a</b>–<b>j</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00879/20160819/images/large/jm-2016-008799_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00879&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) piperidine, HOAc, EtOH; (b) CH<sub>3</sub>CuLi, THF, – 78 °C; (c) PhSeCl, NaH, THF; (d) H<sub>2</sub>O<sub>2</sub>/H<sub>2</sub>O, DCM; (e) NaHCO<sub>3</sub>, NMP, 120 °C, 2 h, 30–70%; (f) NaBH<sub>4</sub>, EtOH; (g) SOCl<sub>2</sub>, DCM, 90% for 2 steps; (h) <b>8</b>, NaH, THF, 60%; (i) thiazole-2-carboxamidine, AcOK, <i>i</i>-PrOH, 120 °C, 15%.</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00879/20160819/images/medium/jm-2016-008799_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00879/20160819/images/large/jm-2016-008799_0007.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of 4-Methyl HAP Analogues <b>18a</b>–<b>k</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00879/20160819/images/large/jm-2016-008799_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00879&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (Boc)<sub>2</sub>O, DMAP, DCM, rt, overnight; (b) NBS, AIBN, CCl<sub>4</sub>, 50 °C, 2 h; (c) morpholine, DCM, 50 °C, 1 h; (d) TFA, DCM, rt.</p></p></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00879/20160819/images/medium/jm-2016-008799_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00879/20160819/images/large/jm-2016-008799_0008.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of HAP Analogue <b>27a</b>–<b>e</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00879/20160819/images/large/jm-2016-008799_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00879&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) TFA, DCM, 3 h, 100%; (b) HATU, NH<sub>3</sub>, NEt<sub>3</sub>, DCM, 40%; (c) TFAA, DCM, 3 h, 87%; (d) CDI, THF; (e) CH<sub>3</sub>NH<sub>2</sub>·HCl, NEt<sub>3</sub>, CH<sub>3</sub>CN, 90 °C, 80%; (f) 2,2-dimethoxyethanamine, CH<sub>3</sub>CN, 0.5 h, 120 °C, microwave, 90%; (g) PPA, 2 h, 120 °C, 30%; (h) NBS, AIBN, CCl<sub>4</sub>, 50 °C, 2 h, then morpholine, DCM, 50 °C, 1 h, >20% over 2 steps.</p></p></figure><figure data-id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00879/20160819/images/medium/jm-2016-008799_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00879/20160819/images/large/jm-2016-008799_0009.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of N-Linked and O-Linked Analogues <b>31a</b>–<b>w</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00879/20160819/images/large/jm-2016-008799_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00879&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) In(OTf)<sub>3</sub>, <i>o</i>-xylene, 120 °C, 1 h, 40%; (b) thiazole-2-carboxamidine, NaHCO<sub>3</sub>, NMP, 120 °C, 2 h, 60%; (c) (Boc)<sub>2</sub>O, DMAP, DCM, rt, overnight; (d) NBS, CCl<sub>4</sub>, 50 °C, 2 h, 82% for 2 steps; (e) amine <b>32</b>, K<sub>2</sub>CO<sub>3</sub> or <i>t</i>-BuOK [for (sulfon)amides], DMF, 40 °C, 3 h; (f) LiOH, MeOH/H<sub>2</sub>O, rt, 2 h for hydrolysis of the amino ester group; (g) TFA, DCM, rt, 2 h; (h) alcohol <b>33</b>, NaH, THF, rt, overnight.</p></p></figure><figure data-id="sch5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00879/20160819/images/medium/jm-2016-008799_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00879/20160819/images/large/jm-2016-008799_0010.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Design and Synthesis of Amino Acid Substituted HAPs <b>34a</b>–<b>f</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00879/20160819/images/large/jm-2016-008799_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00879&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (Boc)<sub>2</sub>O, DMAP, DCM, rt, overnight; (b) NBS, CCl<sub>4</sub>, 50 °C, 2 h, 82% for 2 steps; (c) amino ester, K<sub>2</sub>CO<sub>3</sub>, DMF, 40 °C, 3 h; (d) LiOH, MeOH, rt, 2 h; (e) TFA, DCM, rt, 2 h.</p></p></figure><figure data-id="fig3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00879/20160819/images/medium/jm-2016-008799_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00879/20160819/images/large/jm-2016-008799_0004.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Binding site of <b>34a</b> with HBV capsid protein Y132A. The compound binding pocket at B–C interface is shown as an exemplary site. Chain B and chain C of Y132A-<b>34a</b> structure are colored in cyan and magenta, respectively. Compound <b>34a</b> is highlighted in green stick. Residues within 4 Å radius are shown as lines. Red spheres represent water molecules in the pocket. Black dash lines indicate hydrogen bonds between <b>34a</b> and core protein.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00879/20160819/images/large/jm-2016-008799_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00879&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00879/20160819/images/medium/jm-2016-008799_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00879/20160819/images/large/jm-2016-008799_0005.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Levels of HBV DNA in the plasma (A) and liver (B) of infected mice. Treatments with the vehicle control, <b>34a</b>, and ETV are included. The HBV DNA was quantified by real-time PCR. Error bars represent standard error. Statistical analysis was done by Student’s <i>t</i> test: (∗) <i>P</i> < 0.001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-16/acs.jmedchem.6b00879/20160819/images/large/jm-2016-008799_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00879&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i106">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27886" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27886" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 31 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">You, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jang, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoon, S. K.</span><span> </span><span class="NLM_article-title">Update on hepatitis B virus infection</span> <span class="citation_source-journal">World J. of Gastroenterol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">13293</span><span class="NLM_x">–</span> <span class="NLM_lpage">13305</span><span class="refDoi"> DOI: 10.3748/wjg.v20.i37.13293</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=10.3748%2Fwjg.v20.i37.13293" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=25309066" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFKntrbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2014&pages=13293-13305&author=C.+R.+Youauthor=S.+W.+Leeauthor=J.+W.+Jangauthor=S.+K.+Yoon&title=Update+on+hepatitis+B+virus+infection&doi=10.3748%2Fwjg.v20.i37.13293"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Update on hepatitis B virus infection</span></div><div class="casAuthors">You, Chan Ran; Lee, Sung Won; Jang, Jeong Won; Yoon, Seung Kew</div><div class="citationInfo"><span class="NLM_cas:title">World Journal of Gastroenterology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">13293-13305</span>CODEN:
                <span class="NLM_cas:coden">WJGAF2</span>;
        ISSN:<span class="NLM_cas:issn">1007-9327</span>.
    
            (<span class="NLM_cas:orgname">Baishideng Publishing Group Inc.</span>)
        </div><div class="casAbstract">A review.  Chronic infection with hepatitis B virus (HBV) leads to the development of hepatocellular carcinoma and/or chronic liver failure.  Despite extensive research, the immunopathogenesis is not completely understood.  Viral persistence and clin. outcomes following HBV infection depend on viral factors and host factors; including genetic factors that det. a host's immune mechanisms.  The primary goal of chronic hepatitis B (CHB) treatment is to eradicate HBV or to at least maintain suppression of HBV replication.  Despite recent advances in anti-viral agents for chronic HBV infection, complete eradication of the virus has been difficult to achieve.  Agents for the treatment of CHB are divided mainly into two groups: immunomodulating agents and antiviral nucleos(t)ide analogs (NAs).  Although NAs are safe, effective and easily administered orally, their long-term use poses the risk of drug resistance.  Currently, international evidence-based guidelines have been developed to support physicians in managing CHB patients.  However, treatment of patients with drug resistance is still challenging, as only a few classes of anti-HBV drugs are available and cross-resistance between drugs can occur.  In addn., as the currently available genotypic test for detection of drug resistance still has limitations in identifying the different substitutions present in the same viral genome, the development of a new virol. test to overcome this limitation is necessary.  Among the predictive factors assocd. with response to pegylated interferon (PEG-IFN) therapy, hepatitis B surface antigen quantification is considered to be a surrogate marker for monitoring response to PEG-IFN.  Current practice guidelines stress the importance of profound and durable HBV viral suppression in the treatment of CHB patients.  To this end, it is essential to choose a potent antiviral drug with a low risk of resistance for initial treatment of CHB to achieve sustained virol. response.  This review highlights recent advances in the understanding of the immunopathogenesis of HBV and currently available and developing treatment strategies against HBV infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrb4R2NC4R1obVg90H21EOLACvtfcHk0lhvQ0un0tuXvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFKntrbE&md5=bae4ee7caaed772318f0389455a409b2</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.3748%2Fwjg.v20.i37.13293&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3748%252Fwjg.v20.i37.13293%26sid%3Dliteratum%253Aachs%26aulast%3DYou%26aufirst%3DC.%2BR.%26aulast%3DLee%26aufirst%3DS.%2BW.%26aulast%3DJang%26aufirst%3DJ.%2BW.%26aulast%3DYoon%26aufirst%3DS.%2BK.%26atitle%3DUpdate%2520on%2520hepatitis%2520B%2520virus%2520infection%26jtitle%3DWorld%2520J.%2520of%2520Gastroenterol.%26date%3D2014%26volume%3D20%26spage%3D13293%26epage%3D13305%26doi%3D10.3748%2Fwjg.v20.i37.13293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Hadziyannis, S. J.</span><span> </span><span class="NLM_article-title">Update on hepatitis B virus infection: focus on treatment</span> <span class="citation_source-journal">J. Clin. Transl. Hepatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">285</span><span class="NLM_x">–</span> <span class="NLM_lpage">291</span><span class="refDoi"> DOI: 10.14218/JCTH.2014.00026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=10.14218%2FJCTH.2014.00026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=26355326" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=1%3ACAS%3A280%3ADC%252BC283ht1Cktw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2014&pages=285-291&author=S.+J.+Hadziyannis&title=Update+on+hepatitis+B+virus+infection%3A+focus+on+treatment&doi=10.14218%2FJCTH.2014.00026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Update on Hepatitis B Virus Infection: Focus on Treatment</span></div><div class="casAuthors">Hadziyannis Stephanos J</div><div class="citationInfo"><span class="NLM_cas:title">Journal of clinical and translational hepatology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">285-91</span>
        ISSN:<span class="NLM_cas:issn">2225-0719</span>.
    </div><div class="casAbstract">This review article is an update of the current treatment strategies available for chronic hepatitis B.  In addition to achieving on-therapy clinical remission and suppression of HBV replication without resistance, the ultimate goal of therapy is the development of sustained remission and HBsAg loss after discontinuation of treatment.  This is the closest possible to cure outcome for hepatitis B virus (HBV) infection.  These goals can be achieved by response-guided courses of pegylated interferon (peg-IFN)-alpha at rates higher than 30%, both in hepatitis B e antigen (HBeAg)-positive and HBeAg-negative patients.  Review of the data regarding discontinuation of long term NA treatment in HBeAg-negative patients revealed that stopping such therapy is safe with high rates of sustained off treatment responses that appear to be immunologically induced.  Decreasing hepatitis B surface antigen (HBsAg) titers under therapy to <500, particularly <100 IU/mL, and adding a course of peg-IFN to ongoing long term nucleos(t)ide analogue (NA) therapy increase the percentage of sustained responses following discontinuation of NA treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQWNwPk-7Mg3vSAs_PE1QvifW6udTcc2ebSGzo7VWm8xLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC283ht1Cktw%253D%253D&md5=48e53aa28d6c1f6b80f24caac84d5e0d</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.14218%2FJCTH.2014.00026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.14218%252FJCTH.2014.00026%26sid%3Dliteratum%253Aachs%26aulast%3DHadziyannis%26aufirst%3DS.%2BJ.%26atitle%3DUpdate%2520on%2520hepatitis%2520B%2520virus%2520infection%253A%2520focus%2520on%2520treatment%26jtitle%3DJ.%2520Clin.%2520Transl.%2520Hepatol.%26date%3D2014%26volume%3D2%26spage%3D285%26epage%3D291%26doi%3D10.14218%2FJCTH.2014.00026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Baltayiannis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karayiannis, P.</span><span> </span><span class="NLM_article-title">Treatment options beyond IFNalpha and NUCs for chronic HBV infection: expectations for tomorrow</span> <span class="citation_source-journal">J. Viral Hepat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">753</span><span class="NLM_x">–</span> <span class="NLM_lpage">761</span><span class="refDoi"> DOI: 10.1111/jvh.12307</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=10.1111%2Fjvh.12307" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=25271858" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVegsrvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2014&pages=753-761&author=G.+Baltayiannisauthor=P.+Karayiannis&title=Treatment+options+beyond+IFNalpha+and+NUCs+for+chronic+HBV+infection%3A+expectations+for+tomorrow&doi=10.1111%2Fjvh.12307"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment options beyond IFNα and NUCs for chronic HBV infection: expectations for tomorrow</span></div><div class="casAuthors">Baltayiannis, G.; Karayiannis, P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Viral Hepatitis</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">753-761</span>CODEN:
                <span class="NLM_cas:coden">JVHEER</span>;
        ISSN:<span class="NLM_cas:issn">1365-2893</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A review.  Summary : Chronic hepatitis B virus (HBV) infection may progress to cirrhosis, hepatocellular carcinoma (HCC) and end-stage liver failure with time.  Interruption of this process can only be achieved through effective antiviral treatment.  This approach has so far involved the use of immunomodulators such as pegylated interferon alpha (Peg-IFNα) for a finite period of up to a year and nucleos-(t)ide analogs (NUCs) for treatment over much longer periods of time.  The latter act by suppressing HBV replication at the level of DNA synthesis by inhibiting the viral reverse transcriptase/DNA polymerase and causing premature termination of DNA synthesis.  The ideal treatment end point is loss of HBsAg in both HBeAg+ve and HBeAg-ve patients following monotherapy.  This, however, is only achievable in a minority of patients.  Secondary outcomes are durable HBeAg loss and seroconversion to anti-HBe, which occur in about 18-30% of HBeAg+ve patients depending on the antiviral used, and sustained suppression of HBV-DNA accompanied by biochem. normalization and histol. improvement in non-HBeAg+ve seroconverting and HBeAg-ve patients.  There is therefore a need for addnl. direct-acting antivirals (DAAs) targeting different stages of the life cycle of the virus, as well as immunotherapeutic approaches.  Such developments may pave the way for their use either alone or more likely in combination in the fight against chronic HBV infection.  Such drugs or approaches, which are currently undergoing preclin. or clin. testing, are the subject of this review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrR0tPQan3UuLVg90H21EOLACvtfcHk0lj63w41Njw99w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVegsrvK&md5=b786ee6b16533d778883cadc3bf543a4</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1111%2Fjvh.12307&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjvh.12307%26sid%3Dliteratum%253Aachs%26aulast%3DBaltayiannis%26aufirst%3DG.%26aulast%3DKarayiannis%26aufirst%3DP.%26atitle%3DTreatment%2520options%2520beyond%2520IFNalpha%2520and%2520NUCs%2520for%2520chronic%2520HBV%2520infection%253A%2520expectations%2520for%2520tomorrow%26jtitle%3DJ.%2520Viral%2520Hepat.%26date%3D2014%26volume%3D21%26spage%3D753%26epage%3D761%26doi%3D10.1111%2Fjvh.12307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Orlando, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foggia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maraolo, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mascolo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmiero, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tambaro, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tosone, G.</span><span> </span><span class="NLM_article-title">Prevention of hepatitis B virus infection: from the past to the future</span> <span class="citation_source-journal">Eur. J. Clin. Microbiol. Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">1059</span><span class="NLM_x">–</span> <span class="NLM_lpage">1070</span><span class="refDoi"> DOI: 10.1007/s10096-015-2341-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=10.1007%2Fs10096-015-2341-x" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2015&pages=1059-1070&author=R.+Orlandoauthor=M.+Foggiaauthor=A.+E.+Maraoloauthor=S.+Mascoloauthor=G.+Palmieroauthor=O.+Tambaroauthor=G.+Tosone&title=Prevention+of+hepatitis+B+virus+infection%3A+from+the+past+to+the+future&doi=10.1007%2Fs10096-015-2341-x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1007%2Fs10096-015-2341-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10096-015-2341-x%26sid%3Dliteratum%253Aachs%26aulast%3DOrlando%26aufirst%3DR.%26aulast%3DFoggia%26aufirst%3DM.%26aulast%3DMaraolo%26aufirst%3DA.%2BE.%26aulast%3DMascolo%26aufirst%3DS.%26aulast%3DPalmiero%26aufirst%3DG.%26aulast%3DTambaro%26aufirst%3DO.%26aulast%3DTosone%26aufirst%3DG.%26atitle%3DPrevention%2520of%2520hepatitis%2520B%2520virus%2520infection%253A%2520from%2520the%2520past%2520to%2520the%2520future%26jtitle%3DEur.%2520J.%2520Clin.%2520Microbiol.%2520Infect.%2520Dis.%26date%3D2015%26volume%3D34%26spage%3D1059%26epage%3D1070%26doi%3D10.1007%2Fs10096-015-2341-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Packianathan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katen, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dann, C. E.,  3rd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zlotnick, A.</span><span> </span><span class="NLM_article-title">Conformational changes in the hepatitis B virus core protein are consistent with a role for allostery in virus assembly</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">1607</span><span class="NLM_x">–</span> <span class="NLM_lpage">1615</span><span class="refDoi"> DOI: 10.1128/JVI.02033-09</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=10.1128%2FJVI.02033-09" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=19939922" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=1%3ACAS%3A280%3ADC%252BC3c%252Fhslemtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2010&pages=1607-1615&author=C.+Packianathanauthor=S.+P.+Katenauthor=C.+E.+Dannauthor=A.+Zlotnick&title=Conformational+changes+in+the+hepatitis+B+virus+core+protein+are+consistent+with+a+role+for+allostery+in+virus+assembly&doi=10.1128%2FJVI.02033-09"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Conformational changes in the hepatitis B virus core protein are consistent with a role for allostery in virus assembly</span></div><div class="casAuthors">Packianathan Charles; Katen Sarah P; Dann Charles E 3rd; Zlotnick Adam</div><div class="citationInfo"><span class="NLM_cas:title">Journal of virology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1607-15</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">In infected cells, virus components must be organized at the right place and time to ensure assembly of infectious virions.  From a different perspective, assembly must be prevented until all components are available.  Hypothetically, this can be achieved by allosterically controlling assembly.  Consistent with this hypothesis, here we show that the structure of the hepatitis B virus (HBV) core protein dimer, which can spontaneously self-assemble, is incompatible with capsid assembly.  Systematic differences between core protein dimer and capsid conformations demonstrate linkage between the intradimer interface and interdimer contact surface.  These structures also provide explanations for the capsid-dimer selectivity of some antibodies and the activities of assembly effectors.  Solution studies suggest that the assembly-inactive state is more accurately an ensemble of conformations.  Simulations show that allostery supports controlled assembly and results in capsids that are resistant to dissociation.  We propose that allostery, as demonstrated in HBV, is common to most self-assembling viruses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQzWid3-Vdf7nwOGIfWJ7-GfW6udTcc2eZX3mYzooF5Obntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3c%252Fhslemtw%253D%253D&md5=4ce07c34c733c1cb72c9c521ce0b8302</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1128%2FJVI.02033-09&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.02033-09%26sid%3Dliteratum%253Aachs%26aulast%3DPackianathan%26aufirst%3DC.%26aulast%3DKaten%26aufirst%3DS.%2BP.%26aulast%3DDann%26aufirst%3DC.%2BE.%26aulast%3DZlotnick%26aufirst%3DA.%26atitle%3DConformational%2520changes%2520in%2520the%2520hepatitis%2520B%2520virus%2520core%2520protein%2520are%2520consistent%2520with%2520a%2520role%2520for%2520allostery%2520in%2520virus%2520assembly%26jtitle%3DJ.%2520Virol.%26date%3D2010%26volume%3D84%26spage%3D1607%26epage%3D1615%26doi%3D10.1128%2FJVI.02033-09" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Zlotnick, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkatakrishnan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewellyn, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francis, S.</span><span> </span><span class="NLM_article-title">Core protein: A pleiotropic keystone in the HBV lifecycle</span> <span class="citation_source-journal">Antiviral Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">121</span><span class="NLM_x">, </span> <span class="NLM_fpage">82</span><span class="NLM_x">–</span> <span class="NLM_lpage">93</span><span class="refDoi"> DOI: 10.1016/j.antiviral.2015.06.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=10.1016%2Fj.antiviral.2015.06.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=26129969" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtV2ltLvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=2015&pages=82-93&author=A.+Zlotnickauthor=B.+Venkatakrishnanauthor=Z.+Tanauthor=E.+Lewellynauthor=W.+Turnerauthor=S.+Francis&title=Core+protein%3A+A+pleiotropic+keystone+in+the+HBV+lifecycle&doi=10.1016%2Fj.antiviral.2015.06.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Core protein: A pleiotropic keystone in the HBV lifecycle</span></div><div class="casAuthors">Zlotnick, Adam; Venkatakrishnan, Balasubramanian; Tan, Zhenning; Lewellyn, Eric; Turner, William; Francis, Samson</div><div class="citationInfo"><span class="NLM_cas:title">Antiviral Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">121</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">82-93</span>CODEN:
                <span class="NLM_cas:coden">ARSRDR</span>;
        ISSN:<span class="NLM_cas:issn">0166-3542</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Hepatitis B Virus (HBV) is a small virus whose genome has only four open reading frames.  We argue that the simplicity of the virion correlates with a complexity of functions for viral proteins.  We focus on the HBV core protein (Cp), a small (183 residue) protein that self-assembles to form the viral capsid.  However, its functions are a little more complicated than that.  In an infected cell Cp modulates almost every step of the viral lifecycle.  Cp is bound to nuclear viral DNA and affects its epigenetics.  Cp correlates with RNA specificity.  Cp assembles specifically on a reverse transcriptase-viral RNA complex or, apparently, nothing at all.  Indeed Cp has been one of the model systems for investigation of virus self-assembly.  Cp participates in regulation of reverse transcription.  Cp signals completion of reverse transcription to support virus secretion.  Cp carries both nuclear localization signals and HBV surface antigen (HBsAg) binding sites; both of these functions appear to be regulated by contents of the capsid.  Cp can be targeted by antivirals - while self-assembly is the most accessible of Cp activities, we argue that it makes sense to engage the broader spectrum of Cp function.  This article forms part of a symposium in Antiviral Research on "From the discovery of the Australia antigen to the development of new curative therapies for hepatitis B: an unfinished story.".</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyafN5HJZSQLVg90H21EOLACvtfcHk0lhs3tcUpAn5Vg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtV2ltLvM&md5=e1bd58b97219cb54136dbb2db2fadb70</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.antiviral.2015.06.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.antiviral.2015.06.020%26sid%3Dliteratum%253Aachs%26aulast%3DZlotnick%26aufirst%3DA.%26aulast%3DVenkatakrishnan%26aufirst%3DB.%26aulast%3DTan%26aufirst%3DZ.%26aulast%3DLewellyn%26aufirst%3DE.%26aulast%3DTurner%26aufirst%3DW.%26aulast%3DFrancis%26aufirst%3DS.%26atitle%3DCore%2520protein%253A%2520A%2520pleiotropic%2520keystone%2520in%2520the%2520HBV%2520lifecycle%26jtitle%3DAntiviral%2520Res.%26date%3D2015%26volume%3D121%26spage%3D82%26epage%3D93%26doi%3D10.1016%2Fj.antiviral.2015.06.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Deres, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schroder, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paessens, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldmann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hacker, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kramer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niewohner, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pleiss, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoltefuss, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graef, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koletzki, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masantschek, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reimann, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaeger, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beckermann, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlemmer, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haebich, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubsamen-Waigmann, H.</span><span> </span><span class="NLM_article-title">Inhibition of hepatitis B virus replication by drug-induced depletion of nucleocapsids</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">299</span><span class="NLM_x">, </span> <span class="NLM_fpage">893</span><span class="NLM_x">–</span> <span class="NLM_lpage">896</span><span class="refDoi"> DOI: 10.1126/science.1077215</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=10.1126%2Fscience.1077215" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=12574631" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpt1Sgsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=299&publication_year=2003&pages=893-896&author=K.+Deresauthor=C.+H.+Schroderauthor=A.+Paessensauthor=S.+Goldmannauthor=H.+J.+Hackerauthor=O.+Weberauthor=T.+Kramerauthor=U.+Niewohnerauthor=U.+Pleissauthor=J.+Stoltefussauthor=E.+Graefauthor=D.+Koletzkiauthor=R.+N.+Masantschekauthor=A.+Reimannauthor=R.+Jaegerauthor=R.+Grossauthor=B.+Beckermannauthor=K.+H.+Schlemmerauthor=D.+Haebichauthor=H.+Rubsamen-Waigmann&title=Inhibition+of+hepatitis+B+virus+replication+by+drug-induced+depletion+of+nucleocapsids&doi=10.1126%2Fscience.1077215"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of Hepatitis B Virus Replication by Drug-Induced Depletion of Nucleocapsids</span></div><div class="casAuthors">Deres, Karl; Schroeder, Claus H.; Paessens, Arnold; Goldmann, Siegfried; Hacker, Hans Joerg; Weber, Olaf; Kraemer, Thomas; Niewoehner, Ulrich; Pleiss, Ulrich; Stoltefuss, Juergen; Graef, Erwin; Koletzki, Diana; Masantschek, Ralf N. A.; Reimann, Anja; Jaeger, Rainer; Gro, Rainer; Beckermann, Bernhard; Schlemmer, Karl-Heinz; Haebich, Dieter; Ruebsamen-Waigmann, Helga</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">299</span>
        (<span class="NLM_cas:issue">5608</span>),
    <span class="NLM_cas:pages">893-896</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Chronic hepatitis B virus (HBV) infection is a major cause of liver disease.  Only interferon-α and the nucleosidic inhibitors of the viral polymerase, 3TC and adefovir, are approved for therapy.  However, these therapies are limited by the side effects of interferon and the substantial resistance of the virus to nucleosidic inhibitors.  Potent new antiviral compds. suitable for monotherapy or combination therapy are highly desired.  We describe non-nucleosidic inhibitors of HBV nucleocapsid maturation that possess in vitro and in vivo antiviral activity.  These inhibitors have potential for future therapeutic regimens to combat chronic HBV infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAlJUFASSEhLVg90H21EOLACvtfcHk0lier4j7R5E17g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpt1Sgsg%253D%253D&md5=a5e74b45d335f74ba17ec9fe4d31e24b</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1126%2Fscience.1077215&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1077215%26sid%3Dliteratum%253Aachs%26aulast%3DDeres%26aufirst%3DK.%26aulast%3DSchroder%26aufirst%3DC.%2BH.%26aulast%3DPaessens%26aufirst%3DA.%26aulast%3DGoldmann%26aufirst%3DS.%26aulast%3DHacker%26aufirst%3DH.%2BJ.%26aulast%3DWeber%26aufirst%3DO.%26aulast%3DKramer%26aufirst%3DT.%26aulast%3DNiewohner%26aufirst%3DU.%26aulast%3DPleiss%26aufirst%3DU.%26aulast%3DStoltefuss%26aufirst%3DJ.%26aulast%3DGraef%26aufirst%3DE.%26aulast%3DKoletzki%26aufirst%3DD.%26aulast%3DMasantschek%26aufirst%3DR.%2BN.%26aulast%3DReimann%26aufirst%3DA.%26aulast%3DJaeger%26aufirst%3DR.%26aulast%3DGross%26aufirst%3DR.%26aulast%3DBeckermann%26aufirst%3DB.%26aulast%3DSchlemmer%26aufirst%3DK.%2BH.%26aulast%3DHaebich%26aufirst%3DD.%26aulast%3DRubsamen-Waigmann%26aufirst%3DH.%26atitle%3DInhibition%2520of%2520hepatitis%2520B%2520virus%2520replication%2520by%2520drug-induced%2520depletion%2520of%2520nucleocapsids%26jtitle%3DScience%26date%3D2003%26volume%3D299%26spage%3D893%26epage%3D896%26doi%3D10.1126%2Fscience.1077215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Bourne, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finn, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zlotnick, A.</span><span> </span><span class="NLM_article-title">Global structural changes in hepatitis B virus capsids induced by the assembly effector HAP1</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">80</span><span class="NLM_x">, </span> <span class="NLM_fpage">11055</span><span class="NLM_x">–</span> <span class="NLM_lpage">11061</span><span class="refDoi"> DOI: 10.1128/JVI.00933-06</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=10.1128%2FJVI.00933-06" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=16943288" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1KhurrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2006&pages=11055-11061&author=C.+R.+Bourneauthor=M.+G.+Finnauthor=A.+Zlotnick&title=Global+structural+changes+in+hepatitis+B+virus+capsids+induced+by+the+assembly+effector+HAP1&doi=10.1128%2FJVI.00933-06"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Global structural changes in hepatitis B virus capsids induced by the assembly effector HAP1</span></div><div class="casAuthors">Bourne, Christina R.; Finn, M. G.; Zlotnick, Adam</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">11055-11061</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Hepatitis B virus (HBV) is a leading cause of liver disease and hepatocellular carcinoma; over 400 million people are chronically infected with HBV.  Specific anti-HBV treatments, like most antivirals, target enzymes that are similar to host proteins.  Virus capsid protein has no human homolog, making its assembly a promising but undeveloped therapeutic target.  HAP1 [methyl 4-(2-chloro-4-fluorophenyl)-6-methyl-2-(pyridin-2-yl)-1,4-dihydropyrimidine-5-carboxylate], a heteroaryldihydropyrimidine, is a potent HBV capsid assembly activator and misdirector.  Knowledge of the structural basis for this activity would directly benefit the development of capsid-targeting therapeutic strategies.  This report details the crystal structures of icosahedral HBV capsids with and without HAP1.  We show that HAP1 leads to global structural changes by movements of subunits as connected rigid bodies.  The obsd. movements cause the fivefold vertices to protrude from the liganded capsid, the threefold vertices to open, and the quasi-sixfold vertices to flatten, explaining the effects of HAP1 on assembled capsids and on the assembly process.  We have identified a likely HAP1-binding site that bridges elements of secondary structure within a capsid-bound monomer, offering explanation for assembly activation.  This site also interferes with interactions between capsid proteins, leading to quaternary changes and presumably assembly misdirection.  These results demonstrate the plasticity of HBV capsids and the mol. basis for a tenable antiviral strategy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpdf0rkzY6lbVg90H21EOLACvtfcHk0lier4j7R5E17g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1KhurrJ&md5=9d176d66a1d3c2e323203877c225be6e</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1128%2FJVI.00933-06&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.00933-06%26sid%3Dliteratum%253Aachs%26aulast%3DBourne%26aufirst%3DC.%2BR.%26aulast%3DFinn%26aufirst%3DM.%2BG.%26aulast%3DZlotnick%26aufirst%3DA.%26atitle%3DGlobal%2520structural%2520changes%2520in%2520hepatitis%2520B%2520virus%2520capsids%2520induced%2520by%2520the%2520assembly%2520effector%2520HAP1%26jtitle%3DJ.%2520Virol.%26date%3D2006%26volume%3D80%26spage%3D11055%26epage%3D11061%26doi%3D10.1128%2FJVI.00933-06" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Brezillon, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brunelle, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massinet, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giang, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamant, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DaSilva, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berissi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belghiti, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hannoun, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puerstinger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wimmer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neyts, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hantz, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soussan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morosan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kremsdorf, D.</span><span> </span><span class="NLM_article-title">Antiviral activity of Bay 41-4109 on hepatitis B virus in humanized Alb-uPA/SCID mice</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">e25096</span><span class="refDoi"> DOI: 10.1371/journal.pone.0025096</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=10.1371%2Fjournal.pone.0025096" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=e25096&author=N.+Brezillonauthor=M.+N.+Brunelleauthor=H.+Massinetauthor=E.+Giangauthor=C.+Lamantauthor=L.+DaSilvaauthor=S.+Berissiauthor=J.+Belghitiauthor=L.+Hannounauthor=G.+Puerstingerauthor=E.+Wimmerauthor=J.+Neytsauthor=O.+Hantzauthor=P.+Soussanauthor=S.+Morosanauthor=D.+Kremsdorf&title=Antiviral+activity+of+Bay+41-4109+on+hepatitis+B+virus+in+humanized+Alb-uPA%2FSCID+mice&doi=10.1371%2Fjournal.pone.0025096"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0025096&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0025096%26sid%3Dliteratum%253Aachs%26aulast%3DBrezillon%26aufirst%3DN.%26aulast%3DBrunelle%26aufirst%3DM.%2BN.%26aulast%3DMassinet%26aufirst%3DH.%26aulast%3DGiang%26aufirst%3DE.%26aulast%3DLamant%26aufirst%3DC.%26aulast%3DDaSilva%26aufirst%3DL.%26aulast%3DBerissi%26aufirst%3DS.%26aulast%3DBelghiti%26aufirst%3DJ.%26aulast%3DHannoun%26aufirst%3DL.%26aulast%3DPuerstinger%26aufirst%3DG.%26aulast%3DWimmer%26aufirst%3DE.%26aulast%3DNeyts%26aufirst%3DJ.%26aulast%3DHantz%26aufirst%3DO.%26aulast%3DSoussan%26aufirst%3DP.%26aulast%3DMorosan%26aufirst%3DS.%26aulast%3DKremsdorf%26aufirst%3DD.%26atitle%3DAntiviral%2520activity%2520of%2520Bay%252041-4109%2520on%2520hepatitis%2520B%2520virus%2520in%2520humanized%2520Alb-uPA%252FSCID%2520mice%26jtitle%3DPLoS%2520One%26date%3D2011%26volume%3D6%26spage%3De25096%26doi%3D10.1371%2Fjournal.pone.0025096" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Shi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, C. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheng, H. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, X. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, M. Y.</span><span> </span><span class="NLM_article-title">NMR-spectroscopy-based metabonomic approach to the analysis of Bay41-4109, a novel anti-HBV compound, induced hepatotoxicity in rats</span> <span class="citation_source-journal">Toxicol. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">173</span><span class="NLM_x">, </span> <span class="NLM_fpage">161</span><span class="NLM_x">–</span> <span class="NLM_lpage">167</span><span class="refDoi"> DOI: 10.1016/j.toxlet.2007.07.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=10.1016%2Fj.toxlet.2007.07.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=17826925" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVeqsrrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=173&publication_year=2007&pages=161-167&author=C.+Shiauthor=C.+Q.+Wuauthor=A.+M.+Caoauthor=H.+Z.+Shengauthor=X.+Z.+Yanauthor=M.+Y.+Liao&title=NMR-spectroscopy-based+metabonomic+approach+to+the+analysis+of+Bay41-4109%2C+a+novel+anti-HBV+compound%2C+induced+hepatotoxicity+in+rats&doi=10.1016%2Fj.toxlet.2007.07.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">NMR-spectroscopy-based metabonomic approach to the analysis of Bay41-4109, a novel anti-HBV compound, induced hepatotoxicity in rats</span></div><div class="casAuthors">Shi, Chang; Wu, Chun-qi; Cao, An-min; Sheng, He-Zhang; Yan, Xian-zhong; Liao, Ming-yang</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">173</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">161-167</span>CODEN:
                <span class="NLM_cas:coden">TOLED5</span>;
        ISSN:<span class="NLM_cas:issn">0378-4274</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">An integrated metabonomics study using high-resoln. 1H NMR spectroscopy has been applied to investigate the biochem. compn. of urine, serum, liver tissue aq. exts. (acetonitrile/water) and liver tissue lipidic exts. (chloroform/methanol) obtained from control and Bay41-4109 treated rats (10, 50, 400 mg kg-1 d-1 for 5 days, i.g.).  Principal components anal. was used to visualize similarities and differences in biochem. profiles.  The results showed the effects induced by Bay41-4109 at 400 mg kg-1 d-1 are different from those induced at 10, 50 mg kg-1 d-1.  The biochem. profiles of 400 mg kg-1 d-1 group might reflect the hepatotoxicity of Bay41-4109 more exactly.  The elevation in the level of 3-HB, lactate, 2-hydroxy-acetol and D-glucose was found in the urine, and the levels of VLDL/LDL(CH2)n, VLDL/LDL-CH3, 2-oxo-3-methyl-n-valerate, 3-HB, lactate, acetate, taurine, 2-hydroxy-isovalerate in serum were increased significantly in 400 mg kg-1 d-1 group.  The predominant changes identified in liver tissue aq. exts. included an increase in the signal intensities of lactate, 3-amino-isovalerate, pyruvate, choline, trimethylamine-N-oxide (TMAO) and a redn. in the intensities of taurine, hippurate and D-glucose.  In liver tissue chloroform/methanol exts., there was a remarkably increase in many of the lipid signals including the triglyceride terminal Me, methylene groups, and CH2CO, N+(CH3)3, CH2OPO2, CH2OCOR.  These observations all provide evidence that fatty acid metab. disorder and mitochondrial inability might contribute to the hepatotoxicity of Bay41-4109.  The application of 1H NMR spectroscopy to an array of biol. samples comprising urine, serum and liver tissue exts. yields new insight into the hepatotoxicity of xenobiotics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEdIWT-FpgZLVg90H21EOLACvtfcHk0lgFdl79OokCmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVeqsrrP&md5=89bd5589fb93920c51723e5b75c99673</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.toxlet.2007.07.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.toxlet.2007.07.010%26sid%3Dliteratum%253Aachs%26aulast%3DShi%26aufirst%3DC.%26aulast%3DWu%26aufirst%3DC.%2BQ.%26aulast%3DCao%26aufirst%3DA.%2BM.%26aulast%3DSheng%26aufirst%3DH.%2BZ.%26aulast%3DYan%26aufirst%3DX.%2BZ.%26aulast%3DLiao%26aufirst%3DM.%2BY.%26atitle%3DNMR-spectroscopy-based%2520metabonomic%2520approach%2520to%2520the%2520analysis%2520of%2520Bay41-4109%252C%2520a%2520novel%2520anti-HBV%2520compound%252C%2520induced%2520hepatotoxicity%2520in%2520rats%26jtitle%3DToxicol.%2520Lett.%26date%3D2007%26volume%3D173%26spage%3D161%26epage%3D167%26doi%3D10.1016%2Fj.toxlet.2007.07.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Wu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arzumanyan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clayton, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schinazi, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldmann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feitelson, M. A.</span><span> </span><span class="NLM_article-title">Preclinical characterization of GLS4, an inhibitor of hepatitis B virus core particle assembly</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">5344</span><span class="NLM_x">–</span> <span class="NLM_lpage">5354</span><span class="refDoi"> DOI: 10.1128/AAC.01091-13</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=10.1128%2FAAC.01091-13" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2013&pages=5344-5354&author=G.+Wuauthor=B.+Liuauthor=Y.+Zhangauthor=J.+Liauthor=A.+Arzumanyanauthor=M.+M.+Claytonauthor=R.+F.+Schinaziauthor=Z.+Wangauthor=S.+Goldmannauthor=Q.+Renauthor=F.+Zhangauthor=M.+A.+Feitelson&title=Preclinical+characterization+of+GLS4%2C+an+inhibitor+of+hepatitis+B+virus+core+particle+assembly&doi=10.1128%2FAAC.01091-13"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1128%2FAAC.01091-13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.01091-13%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DG.%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DArzumanyan%26aufirst%3DA.%26aulast%3DClayton%26aufirst%3DM.%2BM.%26aulast%3DSchinazi%26aufirst%3DR.%2BF.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DGoldmann%26aufirst%3DS.%26aulast%3DRen%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DF.%26aulast%3DFeitelson%26aufirst%3DM.%2BA.%26atitle%3DPreclinical%2520characterization%2520of%2520GLS4%252C%2520an%2520inhibitor%2520of%2520hepatitis%2520B%2520virus%2520core%2520particle%2520assembly%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2013%26volume%3D57%26spage%3D5344%26epage%3D5354%26doi%3D10.1128%2FAAC.01091-13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Klumpp, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukacs, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Espiritu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baydo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atkins, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abendroth, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Efimov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flores, O. A.</span><span> </span><span class="NLM_article-title">High-resolution crystal structure of a hepatitis B virus replication inhibitor bound to the viral core protein</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x">, </span> <span class="NLM_fpage">15196</span><span class="NLM_x">–</span> <span class="NLM_lpage">15201</span><span class="refDoi"> DOI: 10.1073/pnas.1513803112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=10.1073%2Fpnas.1513803112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=26598693" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFWqsrbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2015&pages=15196-15201&author=K.+Klumppauthor=A.+M.+Lamauthor=C.+Lukacsauthor=R.+Vogelauthor=S.+Renauthor=C.+Espirituauthor=R.+Baydoauthor=K.+Atkinsauthor=J.+Abendrothauthor=G.+Liaoauthor=A.+Efimovauthor=G.+Hartmanauthor=O.+A.+Flores&title=High-resolution+crystal+structure+of+a+hepatitis+B+virus+replication+inhibitor+bound+to+the+viral+core+protein&doi=10.1073%2Fpnas.1513803112"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">High-resolution crystal structure of a hepatitis B virus replication inhibitor bound to the viral core protein</span></div><div class="casAuthors">Klumpp, Klaus; Lam, Angela M.; Lukacs, Christine; Vogel, Robert; Ren, Suping; Espiritu, Christine; Baydo, Ruth; Atkins, Kateri; Abendroth, Jan; Liao, Guochun; Efimov, Andrey; Hartman, George; Flores, Osvaldo A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">49</span>),
    <span class="NLM_cas:pages">15196-15201</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The hepatitis B virus (HBV) core protein is essential for HBV replication and an important target for antiviral drug discovery.  We report the first, to our knowledge, high-resoln. crystal structure of an antiviral compd. bound to the HBV core protein.  The compd. NVR-010-001-E2 can induce assembly of the HBV core wild-type and Y132A mutant proteins and thermostabilize the proteins with a Tm increase of more than 10 °C.  NVR-010-001-E2 binds at the dimer-dimer interface of the core proteins, forms a new interaction surface promoting protein-protein interaction, induces protein assembly, and increases stability.  The impact of naturally occurring core protein mutations on antiviral activity correlates with NVR-010-001-E2 binding interactions detd. by crystallog.  The crystal structure provides understanding of a drug efficacy mechanism related to the induction and stabilization of protein-protein interactions and enables structure-guided design to improve antiviral potency and drug-like properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYxV-odPonGbVg90H21EOLACvtfcHk0lhTMxjuwUNygA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFWqsrbK&md5=bf487dda7165d1637fad0ebab8f46142</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1513803112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1513803112%26sid%3Dliteratum%253Aachs%26aulast%3DKlumpp%26aufirst%3DK.%26aulast%3DLam%26aufirst%3DA.%2BM.%26aulast%3DLukacs%26aufirst%3DC.%26aulast%3DVogel%26aufirst%3DR.%26aulast%3DRen%26aufirst%3DS.%26aulast%3DEspiritu%26aufirst%3DC.%26aulast%3DBaydo%26aufirst%3DR.%26aulast%3DAtkins%26aufirst%3DK.%26aulast%3DAbendroth%26aufirst%3DJ.%26aulast%3DLiao%26aufirst%3DG.%26aulast%3DEfimov%26aufirst%3DA.%26aulast%3DHartman%26aufirst%3DG.%26aulast%3DFlores%26aufirst%3DO.%2BA.%26atitle%3DHigh-resolution%2520crystal%2520structure%2520of%2520a%2520hepatitis%2520B%2520virus%2520replication%2520inhibitor%2520bound%2520to%2520the%2520viral%2520core%2520protein%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2015%26volume%3D112%26spage%3D15196%26epage%3D15201%26doi%3D10.1073%2Fpnas.1513803112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Wang, X. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, Z. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, G. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, X. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H. S.</span><span> </span><span class="NLM_article-title">In vitro inhibition of HBV replication by a novel compound, GLS4, and its efficacy against adefovir-dipivoxil-resistant HBV mutations</span> <span class="citation_source-journal">Antiviral Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">793</span><span class="NLM_x">–</span> <span class="NLM_lpage">803</span><span class="refDoi"> DOI: 10.3851/IMP2152</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=10.3851%2FIMP2152" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2012&pages=793-803&author=X.+Y.+Wangauthor=Z.+M.+Weiauthor=G.+Y.+Wuauthor=J.+H.+Wangauthor=Y.+J.+Zhangauthor=J.+Liauthor=H.+H.+Zhangauthor=X.+W.+Xieauthor=X.+Wangauthor=Z.+H.+Wangauthor=L.+Weiauthor=Y.+Wangauthor=H.+S.+Chen&title=In+vitro+inhibition+of+HBV+replication+by+a+novel+compound%2C+GLS4%2C+and+its+efficacy+against+adefovir-dipivoxil-resistant+HBV+mutations&doi=10.3851%2FIMP2152"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.3851%2FIMP2152&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3851%252FIMP2152%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%2BY.%26aulast%3DWei%26aufirst%3DZ.%2BM.%26aulast%3DWu%26aufirst%3DG.%2BY.%26aulast%3DWang%26aufirst%3DJ.%2BH.%26aulast%3DZhang%26aufirst%3DY.%2BJ.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DH.%2BH.%26aulast%3DXie%26aufirst%3DX.%2BW.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DZ.%2BH.%26aulast%3DWei%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DH.%2BS.%26atitle%3DIn%2520vitro%2520inhibition%2520of%2520HBV%2520replication%2520by%2520a%2520novel%2520compound%252C%2520GLS4%252C%2520and%2520its%2520efficacy%2520against%2520adefovir-dipivoxil-resistant%2520HBV%2520mutations%26jtitle%3DAntiviral%2520Ther.%26date%3D2012%26volume%3D17%26spage%3D793%26epage%3D803%26doi%3D10.3851%2FIMP2152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Delaney, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colledge, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Painter, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Locarnini, S.</span><span> </span><span class="NLM_article-title">Phenylpropenamide derivatives AT-61 and AT-130 inhibit replication of wild-type and lamivudine-resistant strains of hepatitis B virus in vitro</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">3057</span><span class="NLM_x">–</span> <span class="NLM_lpage">3060</span><span class="refDoi"> DOI: 10.1128/AAC.46.9.3057-3060.2002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=10.1128%2FAAC.46.9.3057-3060.2002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=12183271" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=1%3ACAS%3A528%3ADC%252BD38Xmtl2kurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2002&pages=3057-3060&author=W.+E.+Delaneyauthor=R.+Edwardsauthor=D.+Colledgeauthor=T.+Shawauthor=P.+Furmanauthor=G.+Painterauthor=S.+Locarnini&title=Phenylpropenamide+derivatives+AT-61+and+AT-130+inhibit+replication+of+wild-type+and+lamivudine-resistant+strains+of+hepatitis+B+virus+in+vitro&doi=10.1128%2FAAC.46.9.3057-3060.2002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Phenylpropenamide derivatives AT-61 and AT-130 inhibit replication of wild-type and lamivudine-resistant strains of hepatitis B virus in vitro</span></div><div class="casAuthors">Delaney, William E., IV; Edwards, Ros; Colledge, Danni; Shaw, Tim; Furman, Phil; Painter, George; Locarnini, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3057-3060</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The phenylpropenamide derivs. AT-61 and AT-130 are nonnucleoside analog inhibitors of hepatitis B virus (HBV) replication.  They inhibited the replication of wild-type HBV with 50% inhibitory concns. of 21.2±9.5 and 2.40±0.92 μM, resp., compared to 0.064±0.020 μM lamivudine.  There were no significant differences in sensitivity between wild-type and nucleoside analog-resistant (rtL180M, rtM204I, and rtL180M + rtM204V) HBV.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4UNW_6bFxUrVg90H21EOLACvtfcHk0lhLxzt2MbhLfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xmtl2kurw%253D&md5=ffb8ff070fda879480d93597468cbd9b</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1128%2FAAC.46.9.3057-3060.2002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.46.9.3057-3060.2002%26sid%3Dliteratum%253Aachs%26aulast%3DDelaney%26aufirst%3DW.%2BE.%26aulast%3DEdwards%26aufirst%3DR.%26aulast%3DColledge%26aufirst%3DD.%26aulast%3DShaw%26aufirst%3DT.%26aulast%3DFurman%26aufirst%3DP.%26aulast%3DPainter%26aufirst%3DG.%26aulast%3DLocarnini%26aufirst%3DS.%26atitle%3DPhenylpropenamide%2520derivatives%2520AT-61%2520and%2520AT-130%2520inhibit%2520replication%2520of%2520wild-type%2520and%2520lamivudine-resistant%2520strains%2520of%2520hepatitis%2520B%2520virus%2520in%2520vitro%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2002%26volume%3D46%26spage%3D3057%26epage%3D3060%26doi%3D10.1128%2FAAC.46.9.3057-3060.2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Wang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naduthambi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosley, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furman, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otto, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sofia, M. J.</span><span> </span><span class="NLM_article-title">Phenylpropenamide derivatives: anti-hepatitis B virus activity of the Z isomer, SAR and the search for novel analogs</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">4642</span><span class="NLM_x">–</span> <span class="NLM_lpage">4647</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2011.05.077</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=10.1016%2Fj.bmcl.2011.05.077" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=4642-4647&author=P.+Wangauthor=D.+Naduthambiauthor=R.+T.+Mosleyauthor=C.+Niuauthor=P.+A.+Furmanauthor=M.+J.+Ottoauthor=M.+J.+Sofia&title=Phenylpropenamide+derivatives%3A+anti-hepatitis+B+virus+activity+of+the+Z+isomer%2C+SAR+and+the+search+for+novel+analogs&doi=10.1016%2Fj.bmcl.2011.05.077"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.05.077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.05.077%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DP.%26aulast%3DNaduthambi%26aufirst%3DD.%26aulast%3DMosley%26aufirst%3DR.%2BT.%26aulast%3DNiu%26aufirst%3DC.%26aulast%3DFurman%26aufirst%3DP.%2BA.%26aulast%3DOtto%26aufirst%3DM.%2BJ.%26aulast%3DSofia%26aufirst%3DM.%2BJ.%26atitle%3DPhenylpropenamide%2520derivatives%253A%2520anti-hepatitis%2520B%2520virus%2520activity%2520of%2520the%2520Z%2520isomer%252C%2520SAR%2520and%2520the%2520search%2520for%2520novel%2520analogs%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D4642%26epage%3D4647%26doi%3D10.1016%2Fj.bmcl.2011.05.077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Campagna, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuconati, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Block, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, J. T.</span><span> </span><span class="NLM_article-title">Sulfamoylbenzamide derivatives inhibit the assembly of hepatitis B virus nucleocapsids</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">87</span><span class="NLM_x">, </span> <span class="NLM_fpage">6931</span><span class="NLM_x">–</span> <span class="NLM_lpage">6942</span><span class="refDoi"> DOI: 10.1128/JVI.00582-13</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=10.1128%2FJVI.00582-13" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=23576513" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=1%3ACAS%3A528%3ADC%252BC3sXptlKrsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2013&pages=6931-6942&author=M.+R.+Campagnaauthor=F.+Liuauthor=R.+Maoauthor=C.+Millsauthor=D.+Caiauthor=F.+Guoauthor=X.+Zhaoauthor=H.+Yeauthor=A.+Cuconatiauthor=H.+Guoauthor=J.+Changauthor=X.+Xuauthor=T.+M.+Blockauthor=J.+T.+Guo&title=Sulfamoylbenzamide+derivatives+inhibit+the+assembly+of+hepatitis+B+virus+nucleocapsids&doi=10.1128%2FJVI.00582-13"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Sulfamoylbenzamide derivatives inhibit the assembly of hepatitis B virus nucleocapsids</span></div><div class="casAuthors">Campagna, Matthew R.; Liu, Fei; Mao, Richeng; Mills, Courtney; Cai, Dawei; Guo, Fang; Zhao, Xuesen; Ye, Hong; Cuconati, Andrea; Guo, Haitao; Chang, Jinhong; Xu, Xiaodong; Block, Timothy M.; Guo, Ju-Tao</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">6931-6942</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Chronic hepatitis B virus (HBV) infection, a serious public health problem leading to cirrhosis and hepatocellular carcinoma, is currently treated with either pegylated alpha interferon (pegIFN-α) or one of the five nucleos(t)ide analog viral DNA polymerase inhibitors.  However, neither pegIFN-α nor nucleos(t)ide analogs are capable of reliably curing the viral infection.  In order to develop novel antiviral drugs against HBV, we established a cell-based screening assay by using an immortalized mouse hepatocyte-derived stable cell line supporting a high level of HBV replication in a tetracycline-inducible manner.  Screening of a library consisting of 26,900 small mols. led to the discovery of a series of sulfamoylbenzamide (SBA) derivs. that significantly reduced the amt. of cytoplasmic HBV DNA.  Structure-activity relationship studies have thus far identified a group of fluorine-substituted SBAs with submicromolar antiviral activity against HBV in human hepatoma cells.  Mechanistic analyses reveal that the compds. dose dependently inhibit the formation of pregenomic RNA (pgRNA)-contg. nucleocapsids of HBV but not other animal hepadnaviruses, such as woodchuck hepatitis virus (WHV) and duck hepatitis B virus (DHBV).  Moreover, heterologous genetic complementation studies of capsid protein, DNA polymerase, and pgRNA between HBV and WHV suggest that HBV capsid protein confers sensitivity to the SBAs.  In summary, SBAs represent a novel chem. entity with superior activity and a unique antiviral mechanism and are thus warranted for further development as novel antiviral therapeutics for the treatment of chronic hepatitis B.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNUsTkQKVBQbVg90H21EOLACvtfcHk0lhLxzt2MbhLfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXptlKrsr0%253D&md5=80cd9d05d889ecf1bd2f6c28f7946bcf</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1128%2FJVI.00582-13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.00582-13%26sid%3Dliteratum%253Aachs%26aulast%3DCampagna%26aufirst%3DM.%2BR.%26aulast%3DLiu%26aufirst%3DF.%26aulast%3DMao%26aufirst%3DR.%26aulast%3DMills%26aufirst%3DC.%26aulast%3DCai%26aufirst%3DD.%26aulast%3DGuo%26aufirst%3DF.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DYe%26aufirst%3DH.%26aulast%3DCuconati%26aufirst%3DA.%26aulast%3DGuo%26aufirst%3DH.%26aulast%3DChang%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DBlock%26aufirst%3DT.%2BM.%26aulast%3DGuo%26aufirst%3DJ.%2BT.%26atitle%3DSulfamoylbenzamide%2520derivatives%2520inhibit%2520the%2520assembly%2520of%2520hepatitis%2520B%2520virus%2520nucleocapsids%26jtitle%3DJ.%2520Virol.%26date%3D2013%26volume%3D87%26spage%3D6931%26epage%3D6942%26doi%3D10.1128%2FJVI.00582-13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Yang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, X. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, F. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hao, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nan, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuo, J. P.</span><span> </span><span class="NLM_article-title">Isothiafludine, a novel non-nucleoside compound, inhibits hepatitis B virus replication through blocking pregenomic RNA encapsidation</span> <span class="citation_source-journal">Acta Pharmacol. Sin.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">410</span><span class="NLM_x">–</span> <span class="NLM_lpage">418</span><span class="refDoi"> DOI: 10.1038/aps.2013.175</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=10.1038%2Faps.2013.175" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=24487969" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjtl2itrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2014&pages=410-418&author=L.+Yangauthor=L.+P.+Shiauthor=H.+J.+Chenauthor=X.+K.+Tongauthor=G.+F.+Wangauthor=Y.+M.+Zhangauthor=W.+L.+Wangauthor=C.+L.+Fengauthor=P.+L.+Heauthor=F.+H.+Zhuauthor=Y.+H.+Haoauthor=B.+J.+Wangauthor=D.+L.+Yangauthor=W.+Tangauthor=F.+J.+Nanauthor=J.+P.+Zuo&title=Isothiafludine%2C+a+novel+non-nucleoside+compound%2C+inhibits+hepatitis+B+virus+replication+through+blocking+pregenomic+RNA+encapsidation&doi=10.1038%2Faps.2013.175"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Isothiafludine, a novel non-nucleoside compound, inhibits hepatitis B virus replication through blocking pregenomic RNA encapsidation</span></div><div class="casAuthors">Yang, Li; Shi, Li-ping; Chen, Hai-jun; Tong, Xian-Kun; Wang, Gui-feng; Zhang, Yang-ming; Wang, Wen-long; Feng, Chun-lan; He, Pei-lan; Zhu, Feng-hua; Hao, You-hua; Wang, Bao-ju; Yang, Dong-liang; Tang, Wei; Nan, Fa-jun; Zuo, Jian-ping</div><div class="citationInfo"><span class="NLM_cas:title">Acta Pharmacologica Sinica</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">410-418</span>CODEN:
                <span class="NLM_cas:coden">APSCG5</span>;
        ISSN:<span class="NLM_cas:issn">1671-4083</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Aim: To investigate the action of isothiafludine (NZ-4), a deriv. of bis-heterocycle tandem pairs from the natural product leucamide A, on the replication cycle of hepatitis B virus (HBV) in vitro and in vivo.  Methods: HBV replication cycle was monitored in HepG2.2.15 cells using qPCR, qRT-PCR, and Southern and Northern blotting.  HBV protein expression and capsid assembly were detected using Western blotting and native agarose gel electrophoresis anal.  The interaction of pregenomic RNA (pgRNA) and the core protein was investigated by RNA immunopptn.  To evaluate the anti-HBV effect of NZ-4 in vivo, DHBV-infected ducks were orally administered NZ-4 (25, 50 or 100 mg·kg-1·d-1) for 15 d.  Results: NZ-4 suppressed intracellular HBV replication in HepG2.2.15 cells with an IC50 value of 1.33 μmol/L, whereas the compd. inhibited the cell viability with an IC50 value of 50.4 μmol/L.  Furthermore, NZ-4 was active against the replication of various drug-resistant HBV mutants, including 3TC/ETV-dual-resistant and ADV-resistant HBV mutants.  NZ-4 (5, 10, 20 μmol/L) concn.-dependently reduced the encapsidated HBV pgRNA, resulting in the assembly of replication-deficient capsids in HepG2.2.15 cells.  Oral administration of NZ-4 dose-dependently inhibited DHBV DNA replication in the DHBV-infected ducks.  Conclusion: NZ-4 inhibits HBV replication by interfering with the interaction between pgRNA and HBcAg in the capsid assembly process, thus increasing the replication-deficient HBV capsids.  Such mechanism of action might provide a new therapeutic strategy to combat HBV infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfXI1ksk5-erVg90H21EOLACvtfcHk0lgHnQXNT2_R0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjtl2itrs%253D&md5=7a046b35ab2f26aa43cf52fa76f85dea</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Faps.2013.175&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Faps.2013.175%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DL.%26aulast%3DShi%26aufirst%3DL.%2BP.%26aulast%3DChen%26aufirst%3DH.%2BJ.%26aulast%3DTong%26aufirst%3DX.%2BK.%26aulast%3DWang%26aufirst%3DG.%2BF.%26aulast%3DZhang%26aufirst%3DY.%2BM.%26aulast%3DWang%26aufirst%3DW.%2BL.%26aulast%3DFeng%26aufirst%3DC.%2BL.%26aulast%3DHe%26aufirst%3DP.%2BL.%26aulast%3DZhu%26aufirst%3DF.%2BH.%26aulast%3DHao%26aufirst%3DY.%2BH.%26aulast%3DWang%26aufirst%3DB.%2BJ.%26aulast%3DYang%26aufirst%3DD.%2BL.%26aulast%3DTang%26aufirst%3DW.%26aulast%3DNan%26aufirst%3DF.%2BJ.%26aulast%3DZuo%26aufirst%3DJ.%2BP.%26atitle%3DIsothiafludine%252C%2520a%2520novel%2520non-nucleoside%2520compound%252C%2520inhibits%2520hepatitis%2520B%2520virus%2520replication%2520through%2520blocking%2520pregenomic%2520RNA%2520encapsidation%26jtitle%3DActa%2520Pharmacol.%2520Sin.%26date%3D2014%26volume%3D35%26spage%3D410%26epage%3D418%26doi%3D10.1038%2Faps.2013.175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Katen, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chirapu, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finn, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zlotnick, A.</span><span> </span><span class="NLM_article-title">Trapping of hepatitis B virus capsid assembly intermediates by phenylpropenamide assembly accelerators</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1125</span><span class="NLM_x">–</span> <span class="NLM_lpage">1136</span><span class="refDoi"> DOI: 10.1021/cb100275b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb100275b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1eku7jL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=1125-1136&author=S.+P.+Katenauthor=S.+R.+Chirapuauthor=M.+G.+Finnauthor=A.+Zlotnick&title=Trapping+of+hepatitis+B+virus+capsid+assembly+intermediates+by+phenylpropenamide+assembly+accelerators&doi=10.1021%2Fcb100275b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Trapping of Hepatitis B Virus Capsid Assembly Intermediates by Phenylpropenamide Assembly Accelerators</span></div><div class="casAuthors">Katen, Sarah P.; Chirapu, Srinivas Reddy; Finn, M. G.; Zlotnick, Adam</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1125-1136</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Understanding the biol. self-assembly process of virus capsids is key to understanding the viral life cycle, as well as serving as a platform for the design of assembly-based antiviral drugs.  Here we identify and characterize the phenylpropenamide family of small mols., known to have antiviral activity in vivo, as assembly effectors of the hepatitis B virus (HBV) capsid.  We have found two representative phenylpropenamides to be assembly accelerators, increasing the rate of assembly with only modest increases in the stability of the HBV capsids; these data provide a phys.-chem. basis for their antiviral activity.  Unlike previously described HBV assembly effectors, the phenylpropenamides do not misdirect assembly; rather, the accelerated reactions proceed on-path to produce morphol. normal capsids.  However, capsid assembly in the presence of phenylpropenamides is characterized by kinetic trapping of assembly intermediates.  These traps resolve under conditions close to physiol., but we found that trapped intermediates persist under conditions that favor phenylpropenamide binding and strong core protein-protein interactions.  The phenylpropenamides serve as chem. probes of the HBV capsid assembly pathway by trapping on-path assembly intermediates, illustrating the governing influence of reaction kinetics on capsid assembly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0sU96uRbhi7Vg90H21EOLACvtfcHk0lgHnQXNT2_R0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1eku7jL&md5=90a8728ca9cc6bb2ff3acf47694e0d50</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fcb100275b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb100275b%26sid%3Dliteratum%253Aachs%26aulast%3DKaten%26aufirst%3DS.%2BP.%26aulast%3DChirapu%26aufirst%3DS.%2BR.%26aulast%3DFinn%26aufirst%3DM.%2BG.%26aulast%3DZlotnick%26aufirst%3DA.%26atitle%3DTrapping%2520of%2520hepatitis%2520B%2520virus%2520capsid%2520assembly%2520intermediates%2520by%2520phenylpropenamide%2520assembly%2520accelerators%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2010%26volume%3D5%26spage%3D1125%26epage%3D1136%26doi%3D10.1021%2Fcb100275b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Mao, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levy, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuconati, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Block, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, H.</span><span> </span><span class="NLM_article-title">Indoleamine 2,3-dioxygenase mediates the antiviral effect of gamma interferon against hepatitis B virus in human hepatocyte-derived cells</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">1048</span><span class="NLM_x">–</span> <span class="NLM_lpage">1057</span><span class="refDoi"> DOI: 10.1128/JVI.01998-10</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=10.1128%2FJVI.01998-10" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=21084489" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=1%3ACAS%3A528%3ADC%252BC3MXisVOkurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2011&pages=1048-1057&author=R.+Maoauthor=J.+Zhangauthor=D.+Jiangauthor=D.+Caiauthor=J.+M.+Levyauthor=A.+Cuconatiauthor=T.+M.+Blockauthor=J.+T.+Guoauthor=H.+Guo&title=Indoleamine+2%2C3-dioxygenase+mediates+the+antiviral+effect+of+gamma+interferon+against+hepatitis+B+virus+in+human+hepatocyte-derived+cells&doi=10.1128%2FJVI.01998-10"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Indoleamine 2,3-dioxygenase mediates the antiviral effect of gamma interferon against hepatitis B virus in human hepatocyte-derived cells</span></div><div class="casAuthors">Mao, Richeng; Zhang, Jiming; Jiang, Dong; Cai, Dawei; Levy, Jessica M.; Cuconati, Andrea; Block, Timothy M.; Guo, Ju-Tao; Guo, Haitao</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">1048-1057</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Alpha interferon (IFN-α) is an approved medication for chronic hepatitis B. Gamma interferon (IFN-γ) is a key mediator of host innate and adaptive antiviral immunity against hepatitis B virus (HBV) infection in vivo.  In an effort to elucidate the antiviral mechanism of these cytokines, 37 IFN-stimulated genes (ISGs), which are highly inducible in hepatocytes, were tested for their ability to inhibit HBV replication upon overexpression in human hepatoma cells.  One ISG candidate, indoleamine 2,3-dioxygenase (IDO), an IFN-γ-induced enzyme catalyzing tryptophan degrdn., efficiently reduced the level of intracellular HBV DNA without altering the steady-state level of viral RNA.  Furthermore, expression of an enzymically inactive IDO mutant did not inhibit HBV replication, and tryptophan supplementation in culture completely restored HBV replication in IDO-expressing cells, indicating that the antiviral effect elicited by IDO is mediated by tryptophan deprivation.  Interestingly, IDO-mediated tryptophan deprivation preferentially inhibited viral protein translation and genome replication but did not significantly alter global cellular protein synthesis.  Finally, trytophan supplementation was able to completely restore HBV replication in IFN-γ- but not IFN-α-treated cells, which strongly argues that IDO is the primary mediator of IFN-γ-elicited antiviral response against HBV in human hepatocyte-derived cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrm0Y8NjSSFC7Vg90H21EOLACvtfcHk0lgk6uw0Dcy7Yg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXisVOkurw%253D&md5=dc26e73ed5799bd0a41d2f34cda1f075</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1128%2FJVI.01998-10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.01998-10%26sid%3Dliteratum%253Aachs%26aulast%3DMao%26aufirst%3DR.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DJiang%26aufirst%3DD.%26aulast%3DCai%26aufirst%3DD.%26aulast%3DLevy%26aufirst%3DJ.%2BM.%26aulast%3DCuconati%26aufirst%3DA.%26aulast%3DBlock%26aufirst%3DT.%2BM.%26aulast%3DGuo%26aufirst%3DJ.%2BT.%26aulast%3DGuo%26aufirst%3DH.%26atitle%3DIndoleamine%25202%252C3-dioxygenase%2520mediates%2520the%2520antiviral%2520effect%2520of%2520gamma%2520interferon%2520against%2520hepatitis%2520B%2520virus%2520in%2520human%2520hepatocyte-derived%2520cells%26jtitle%3DJ.%2520Virol.%26date%3D2011%26volume%3D85%26spage%3D1048%26epage%3D1057%26doi%3D10.1128%2FJVI.01998-10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Beno, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeung, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartberger, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pennington, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meanwell, N. A.</span><span> </span><span class="NLM_article-title">A survey of the role of noncovalent sulfur interactions in drug design</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">4383</span><span class="NLM_x">–</span> <span class="NLM_lpage">4438</span><span class="refDoi"> DOI: 10.1021/jm501853m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501853m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjs1Giu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=4383-4438&author=B.+R.+Benoauthor=K.+S.+Yeungauthor=M.+D.+Bartbergerauthor=L.+D.+Penningtonauthor=N.+A.+Meanwell&title=A+survey+of+the+role+of+noncovalent+sulfur+interactions+in+drug+design&doi=10.1021%2Fjm501853m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">A Survey of the Role of Noncovalent Sulfur Interactions in Drug Design</span></div><div class="casAuthors">Beno, Brett R.; Yeung, Kap-Sun; Bartberger, Michael D.; Pennington, Lewis D.; Meanwell, Nicholas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4383-4438</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Electron deficient, bivalent sulfur atoms have two areas of pos. electrostatic potential, a consequence of the low-lying σ* orbitals of the C-S bond that are available for interaction with electron donors including oxygen and nitrogen atoms and, possibly, π-systems.  Intramol. interactions are by far the most common manifestation of this effect, which offers a means of modulating the conformational preferences of a mol.  Although a well-documented phenomenon, a priori applications in drug design are relatively sparse and this interaction, which is often isosteric with an intramol. hydrogen-bonding interaction, appears to be underappreciated by the medicinal chem. community.  In this Perspective, we discuss the theor. basis for sulfur σ* orbital interactions and illustrate their importance in the context of drug design and org. synthesis.  The role of sulfur interactions in protein structure and function is discussed and although relatively rare, intermol. interactions between ligand C-S σ* orbitals and proteins are illustrated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYKXRsl4BQYrVg90H21EOLACvtfcHk0lgk6uw0Dcy7Yg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjs1Giu7g%253D&md5=d12f53eb3271c161cfc833fb9f7c02b3</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm501853m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501853m%26sid%3Dliteratum%253Aachs%26aulast%3DBeno%26aufirst%3DB.%2BR.%26aulast%3DYeung%26aufirst%3DK.%2BS.%26aulast%3DBartberger%26aufirst%3DM.%2BD.%26aulast%3DPennington%26aufirst%3DL.%2BD.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26atitle%3DA%2520survey%2520of%2520the%2520role%2520of%2520noncovalent%2520sulfur%2520interactions%2520in%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D4383%26epage%3D4438%26doi%3D10.1021%2Fjm501853m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Halgren, T. A.</span><span> </span><span class="NLM_article-title">Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94</span> <span class="citation_source-journal">J. Comput. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">490</span><span class="NLM_x">–</span> <span class="NLM_lpage">519</span><span class="refDoi"> DOI: 10.1002/(SICI)1096-987X(199604)17:5/6<490::AID-JCC1>3.0.CO;2-P</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=10.1002%2F%28SICI%291096-987X%28199604%2917%3A5%2F6%3C490%3A%3AAID-JCC1%3E3.0.CO%3B2-P" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=1%3ACAS%3A528%3ADyaK28XhvVGmsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1996&pages=490-519&author=T.+A.+Halgren&title=Merck+molecular+force+field.+I.+Basis%2C+form%2C+scope%2C+parameterization%2C+and+performance+of+MMFF94&doi=10.1002%2F%28SICI%291096-987X%28199604%2917%3A5%2F6%3C490%3A%3AAID-JCC1%3E3.0.CO%3B2-P"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94</span></div><div class="casAuthors">Halgren, Thomas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5 & 6</span>),
    <span class="NLM_cas:pages">490-519</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">Wiley</span>)
        </div><div class="casAbstract">This article introduces MMFF94, the initial published version of the Merck mol. force field (MMFF).  It describes the objectives set for MMFF, the form it takes, and the range of systems to which it applies.  This study also outlines the methodol. employed in parameterizing MMFF94 and summarizes its performance in reproducing computational and exptl. data.  Though similar to MM3 in some respects, MMFF94 differs in ways intended to facilitate application to condensed-phase processes in mol.-dynamics simulations.  Indeed, MMFF94 seeks to achieve MM3-like accuracy for small mols. in a combined "org./protein" force field that is equally applicable to proteins and other systems of biol. significance.  A second distinguishing feature is that the core protion of MMFF94 has primarily been derived from high-quality computational data-ca. 500 mol. structures optimized at the HF/6-31G* level, 475 structures optimized at the MP2/6-31G* level, 380 MP2/6-31* structures evaluated at a defined approxn. to the MP4SDQ/TZP level, and 1450 structures partly derived from MP2/6-31G* geometries and evaluated at the MP2/TZP level.  A third distinguishing feature is that MMFF94 has been parameterized for a wide variety of chem. systems of interest to org. and combinations of functional groups for which little, if any, useful exptl. data are available.  The methodol. used in parameterizing MMFF94 represents a fourth distinguishing feature.  Rather than using the common "functional group" approach, nearly all MMFF parameters have been detd. in a mutually consistent fashion from the full set of available computational data.  MMFF94 reproduces the computational data used in its parameterization very well.  In addn., MMFF94 reproduces exptl. bond lengths (0.014 Å root mean square [rms]), bond angles (1.2° rms), vibrational frequencies (61 cm-1 rms), conformational energies (0.38 kcal/mol rms), and rotational barriers (0.39 kcal/mol rms) very nearly as well as does MM3 for comparable systems.  MMFF94 also describes intermol. interactions in hydrogen-bonded systems in a way that closely parallels that given by the highly regarded OPLS force field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAzCYfKnN83rVg90H21EOLACvtfcHk0li_3q-XJlSuLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XhvVGmsbk%253D&md5=56fb073477b4f49d1dfbd786fc56a480</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291096-987X%28199604%2917%3A5%2F6%3C490%3A%3AAID-JCC1%3E3.0.CO%3B2-P&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291096-987X%2528199604%252917%253A5%252F6%253C490%253A%253AAID-JCC1%253E3.0.CO%253B2-P%26sid%3Dliteratum%253Aachs%26aulast%3DHalgren%26aufirst%3DT.%2BA.%26atitle%3DMerck%2520molecular%2520force%2520field.%2520I.%2520Basis%252C%2520form%252C%2520scope%252C%2520parameterization%252C%2520and%2520performance%2520of%2520MMFF94%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D1996%26volume%3D17%26spage%3D490%26epage%3D519%26doi%3D10.1002%2F%28SICI%291096-987X%28199604%2917%3A5%2F6%3C490%3A%3AAID-JCC1%3E3.0.CO%3B2-P" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Bourne, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkataiah, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korba, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finn, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zlotnick, A.</span><span> </span><span class="NLM_article-title">Small-molecule effectors of hepatitis B virus capsid assembly give insight into virus life cycle</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">10262</span><span class="NLM_x">–</span> <span class="NLM_lpage">10270</span><span class="refDoi"> DOI: 10.1128/JVI.01360-08</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=10.1128%2FJVI.01360-08" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=18684823" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1amtrjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2008&pages=10262-10270&author=C.+Bourneauthor=S.+Leeauthor=B.+Venkataiahauthor=A.+Leeauthor=B.+Korbaauthor=M.+G.+Finnauthor=A.+Zlotnick&title=Small-molecule+effectors+of+hepatitis+B+virus+capsid+assembly+give+insight+into+virus+life+cycle&doi=10.1128%2FJVI.01360-08"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule effectors of hepatitis B virus capsid assembly give insight into virus life cycle</span></div><div class="casAuthors">Bourne, Christina; Lee, Sejin; Venkataiah, Bollu; Lee, Angela; Korba, Brent; Finn, M. G.; Zlotnick, Adam</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">10262-10270</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The relationship between the phys. chem. and biol. of self-assembly is poorly understood, but it will be crit. to quant. understand infection and for the design of antivirals that target virus genesis.  Here the authors take advantage of heteroaryldihydropyrimidines (HAPs), which affect hepatitis B virus (HBV) assembly, to gain insight and correlate in vitro assembly with HBV replication in culture.  Based on a low-resoln. crystal structure of a capsid-HAP complex, a closely related series of HAPs were designed and synthesized.  These differentially strengthen the assocn. between neighboring capsid proteins, alter the kinetics of assembly, and give rise to aberrant structures incompatible with a functional capsid.  The chem. nature of the HAP variants correlated well with the structure of the HAP binding pocket.  The thermodn. and kinetics of in vitro assembly had strong and predictable effects on product morphol.  However, only the kinetics of in vitro assembly had a strong correlation with inhibition of HBV replication in HepG2.2.15 cells; there was at best a weak correlation between assembly thermodn. and replication.  The correlation between assembly kinetics and virus suppression implies a competition between successful assembly and misassembly, small mol. induced or otherwise.  This is a predictive and testable model for the mechanism of action of assembly effectors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodMfnjIqX51LVg90H21EOLACvtfcHk0li_3q-XJlSuLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1amtrjE&md5=78266773fa27c6f87b4c871c47cd2fe6</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1128%2FJVI.01360-08&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.01360-08%26sid%3Dliteratum%253Aachs%26aulast%3DBourne%26aufirst%3DC.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DVenkataiah%26aufirst%3DB.%26aulast%3DLee%26aufirst%3DA.%26aulast%3DKorba%26aufirst%3DB.%26aulast%3DFinn%26aufirst%3DM.%2BG.%26aulast%3DZlotnick%26aufirst%3DA.%26atitle%3DSmall-molecule%2520effectors%2520of%2520hepatitis%2520B%2520virus%2520capsid%2520assembly%2520give%2520insight%2520into%2520virus%2520life%2520cycle%26jtitle%3DJ.%2520Virol.%26date%3D2008%26volume%3D82%26spage%3D10262%26epage%3D10270%26doi%3D10.1128%2FJVI.01360-08" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blazecka, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angell, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovdahl, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curran, T. T.</span><span> </span><span class="NLM_article-title">Indium(III) mediated Markovnikov addition of malonates and beta-ketoesters to terminal alkynes and the formation of Knoevenagel condensation products</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">7807</span><span class="NLM_x">–</span> <span class="NLM_lpage">7813</span><span class="refDoi"> DOI: 10.1016/j.tet.2005.05.065</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=10.1016%2Fj.tet.2005.05.065" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2005&pages=7807-7813&author=J.+Zhangauthor=P.+G.+Blazeckaauthor=P.+Angellauthor=M.+Lovdahlauthor=T.+T.+Curran&title=Indium%28III%29+mediated+Markovnikov+addition+of+malonates+and+beta-ketoesters+to+terminal+alkynes+and+the+formation+of+Knoevenagel+condensation+products&doi=10.1016%2Fj.tet.2005.05.065"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.tet.2005.05.065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tet.2005.05.065%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DBlazecka%26aufirst%3DP.%2BG.%26aulast%3DAngell%26aufirst%3DP.%26aulast%3DLovdahl%26aufirst%3DM.%26aulast%3DCurran%26aufirst%3DT.%2BT.%26atitle%3DIndium%2528III%2529%2520mediated%2520Markovnikov%2520addition%2520of%2520malonates%2520and%2520beta-ketoesters%2520to%2520terminal%2520alkynes%2520and%2520the%2520formation%2520of%2520Knoevenagel%2520condensation%2520products%26jtitle%3DTetrahedron%26date%3D2005%26volume%3D61%26spage%3D7807%26epage%3D7813%26doi%3D10.1016%2Fj.tet.2005.05.065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Huang, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabel, Y. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graf, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arzberger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurts, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heikenwalder, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knolle, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Protzer, U.</span><span> </span><span class="NLM_article-title">Transfer of HBV genomes using low doses of adenovirus vectors leads to persistent infection in immune competent mice</span> <span class="citation_source-journal">Gastroenterology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">142</span><span class="NLM_x">, </span> <span class="NLM_fpage">1447</span><span class="NLM_x">–</span> <span class="NLM_lpage">1450</span><span class="refDoi"> DOI: 10.1053/j.gastro.2012.03.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=10.1053%2Fj.gastro.2012.03.006" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=142&publication_year=2012&pages=1447-1450&author=L.+R.+Huangauthor=Y.+A.+Gabelauthor=S.+Grafauthor=S.+Arzbergerauthor=C.+Kurtsauthor=M.+Heikenwalderauthor=P.+A.+Knolleauthor=U.+Protzer&title=Transfer+of+HBV+genomes+using+low+doses+of+adenovirus+vectors+leads+to+persistent+infection+in+immune+competent+mice&doi=10.1053%2Fj.gastro.2012.03.006"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1053%2Fj.gastro.2012.03.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1053%252Fj.gastro.2012.03.006%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DL.%2BR.%26aulast%3DGabel%26aufirst%3DY.%2BA.%26aulast%3DGraf%26aufirst%3DS.%26aulast%3DArzberger%26aufirst%3DS.%26aulast%3DKurts%26aufirst%3DC.%26aulast%3DHeikenwalder%26aufirst%3DM.%26aulast%3DKnolle%26aufirst%3DP.%2BA.%26aulast%3DProtzer%26aufirst%3DU.%26atitle%3DTransfer%2520of%2520HBV%2520genomes%2520using%2520low%2520doses%2520of%2520adenovirus%2520vectors%2520leads%2520to%2520persistent%2520infection%2520in%2520immune%2520competent%2520mice%26jtitle%3DGastroenterology%26date%3D2012%26volume%3D142%26spage%3D1447%26epage%3D1450%26doi%3D10.1053%2Fj.gastro.2012.03.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Guo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuconati, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Block, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, J.</span><span> </span><span class="NLM_article-title">Characterization of the intracellular deproteinized relaxed circular DNA of hepatitis B virus: an intermediate of covalently closed circular DNA formation</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">12472</span><span class="NLM_x">–</span> <span class="NLM_lpage">12484</span><span class="refDoi"> DOI: 10.1128/JVI.01123-07</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=10.1128%2FJVI.01123-07" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=17804499" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlKku7zJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2007&pages=12472-12484&author=H.+Guoauthor=D.+Jiangauthor=T.+Zhouauthor=A.+Cuconatiauthor=T.+Blockauthor=J.+Guo&title=Characterization+of+the+intracellular+deproteinized+relaxed+circular+DNA+of+hepatitis+B+virus%3A+an+intermediate+of+covalently+closed+circular+DNA+formation&doi=10.1128%2FJVI.01123-07"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of the intracellular deproteinized relaxed circular DNA of hepatitis B virus: an intermediate of covalently closed circular DNA formation</span></div><div class="casAuthors">Guo, Haitao; Jiang, Dong; Zhou, Tianlun; Cuconati, Andrea; Block, Timothy M.; Guo, Ju-Tao</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">12472-12484</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Covalently closed circular DNA (cccDNA) of hepatitis B virus (HBV) is formed by conversion of capsid-assocd. relaxed circular DNA (rcDNA) via unknown mechanisms and exists in the nucleus of the infected hepatocyte as a minichromosome that serves as the transcription template for viral RNAs.  To study the mol. pathway of cccDNA formation and its regulation by viral and cellular factors, we have established a cell line that supports the replication of an envelope protein-deficient HBV genome in a tetracycline-inducible manner.  Following induction of HBV replication, the cells accumulate higher levels of cccDNA as well as larger amts. of deproteinized rcDNA (DP-rcDNA) than cells that replicate wild-type HBV genomes.  These results indicate that HBV envelope proteins neg. regulate cccDNA formation, and conversion of DP-rcDNA into cccDNA is a rate-limiting step of cccDNA formation in HepG2 cells.  Detailed analyses reveal the following: (i) DP-rcDNA exists in both cytoplasm and nucleus; (ii) while nuclear DP-rcDNA is sensitive to DNase I digestion, a small fraction of cytoplasmic DP-rcDNA is DNase I resistant; (iii) both DNase I-sensitive and -resistant cytoplasmic DP-rcDNAs cosediment with capsids and can be immunopptd. with HBV core antibody; and (iv) a primer extension assay maps the 5' end of the minus strand of DP-rcDNA at the authentic end of virion rcDNA.  Hence, our results favor a hypothesis that the removal of viral polymerase protein covalently linked to the 5' end of the minus-strand DNA occurs inside the capsid in the cytoplasm and most possibly via a reaction that cleaves the phosphodiester bond between the tyrosine of the polymerase and the 5' phosphoryl group of minus-strand DNA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGot_WiB1hJ4zbVg90H21EOLACvtfcHk0ljZeIAR5jrb3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlKku7zJ&md5=91d6a9284b406680c85be2e35048d4ae</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1128%2FJVI.01123-07&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.01123-07%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DH.%26aulast%3DJiang%26aufirst%3DD.%26aulast%3DZhou%26aufirst%3DT.%26aulast%3DCuconati%26aufirst%3DA.%26aulast%3DBlock%26aufirst%3DT.%26aulast%3DGuo%26aufirst%3DJ.%26atitle%3DCharacterization%2520of%2520the%2520intracellular%2520deproteinized%2520relaxed%2520circular%2520DNA%2520of%2520hepatitis%2520B%2520virus%253A%2520an%2520intermediate%2520of%2520covalently%2520closed%2520circular%2520DNA%2520formation%26jtitle%3DJ.%2520Virol.%26date%3D2007%26volume%3D81%26spage%3D12472%26epage%3D12484%26doi%3D10.1128%2FJVI.01123-07" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Alexander, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jürgens, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shepherd, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freund, S. M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashcroft, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferguson, N.</span><span> </span><span class="NLM_article-title">Thermodynamic origins of protein folding, allostery, and capsid formation in the human hepatitis B virus core protein</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">110</span><span class="NLM_x">, </span> <span class="NLM_fpage">E2782</span><span class="NLM_x">–</span> <span class="NLM_lpage">E2791</span><span class="refDoi"> DOI: 10.1073/pnas.1308846110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=10.1073%2Fpnas.1308846110" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=E2782-E2791&author=C.+G.+Alexanderauthor=M.+C.+J%C3%BCrgensauthor=D.+A.+Shepherdauthor=S.+M.+V.+Freundauthor=A.+E.+Ashcroftauthor=N.+Ferguson&title=Thermodynamic+origins+of+protein+folding%2C+allostery%2C+and+capsid+formation+in+the+human+hepatitis+B+virus+core+protein&doi=10.1073%2Fpnas.1308846110"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1308846110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1308846110%26sid%3Dliteratum%253Aachs%26aulast%3DAlexander%26aufirst%3DC.%2BG.%26aulast%3DJ%25C3%25BCrgens%26aufirst%3DM.%2BC.%26aulast%3DShepherd%26aufirst%3DD.%2BA.%26aulast%3DFreund%26aufirst%3DS.%2BM.%2BV.%26aulast%3DAshcroft%26aufirst%3DA.%2BE.%26aulast%3DFerguson%26aufirst%3DN.%26atitle%3DThermodynamic%2520origins%2520of%2520protein%2520folding%252C%2520allostery%252C%2520and%2520capsid%2520formation%2520in%2520the%2520human%2520hepatitis%2520B%2520virus%2520core%2520protein%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2013%26volume%3D110%26spage%3DE2782%26epage%3DE2791%26doi%3D10.1073%2Fpnas.1308846110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Otwinowski, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minor, W.</span><span> </span><span class="NLM_article-title">Processing of X-ray diffraction data collected in oscillation mode</span> <span class="citation_source-journal">Methods Enzymol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">307</span><span class="NLM_x">–</span> <span class="NLM_lpage">326</span><span class="refDoi"> DOI: 10.1016/S0076-6879(97)76066-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=10.1016%2FS0076-6879%2897%2976066-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=27754618" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=1%3ACAS%3A528%3ADyaK2sXivFehsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=1997&pages=307-326&author=Z.+Otwinowskiauthor=W.+Minor&title=Processing+of+X-ray+diffraction+data+collected+in+oscillation+mode&doi=10.1016%2FS0076-6879%2897%2976066-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Processing of x-ray diffraction data collected in oscillation mode</span></div><div class="casAuthors">Otwinowski, Zbyszek; Minor, Wladek</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Enzymology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">276</span>
        (<span class="NLM_cas:issue">Macromolecular Crystallography, Part A</span>),
    <span class="NLM_cas:pages">307-326</span>CODEN:
                <span class="NLM_cas:coden">MENZAU</span>;
        ISSN:<span class="NLM_cas:issn">0076-6879</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">Macromol. crystallog. is an iterative process.  Rarely do the first crystals provide all the necessary data to solve the biol. problem being studied.  Each step benefits from experience learned in previous steps.  To monitor the progress, the HKL package provides 2 tools: (1) statistics, both weighted (χ2) and unweighted (R-merge), are provided, and the Bayesian reasoning and multicomponent error model facilitates obtaining the proper error ests. and (2) visualization of the process plays a double role by helping the operator to confirm that the process of data redn., including the resulting statistics, is correct, and allowing one to evaluate problems for which there are no good statistical criteria.  Visualization also provides confidence that the point of diminishing returns in data collection and redn. has been reached.  At that point, the effort should be directed to solving the structure.  The methods presented here have been applied to solve a large variety of problems, from inorg. mols. with 5 Å unit cell to rotavirus of 700 Å diam. crystd. in 700 × 1000 × 1400 Å cell.  Overall quality of the method was tested by many researchers by successful application of the programs to MAD structure detns.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrA3fvBOHqhhrVg90H21EOLACvtfcHk0ljD6rwX3CV1cg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXivFehsbw%253D&md5=c9536971d4e32cc35352c40fb9368131</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2FS0076-6879%2897%2976066-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0076-6879%252897%252976066-X%26sid%3Dliteratum%253Aachs%26aulast%3DOtwinowski%26aufirst%3DZ.%26aulast%3DMinor%26aufirst%3DW.%26atitle%3DProcessing%2520of%2520X-ray%2520diffraction%2520data%2520collected%2520in%2520oscillation%2520mode%26jtitle%3DMethods%2520Enzymol.%26date%3D1997%26volume%3D276%26spage%3D307%26epage%3D326%26doi%3D10.1016%2FS0076-6879%2897%2976066-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">McCoy, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosse-Kunstleve, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winn, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storoni, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, R. J.</span><span> </span><span class="NLM_article-title">Phaser crystallographic software</span> <span class="citation_source-journal">J. Appl. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">658</span><span class="NLM_x">–</span> <span class="NLM_lpage">674</span><span class="refDoi"> DOI: 10.1107/S0021889807021206</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=10.1107%2FS0021889807021206" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=19461840" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnslWqsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2007&pages=658-674&author=A.+J.+McCoyauthor=R.+W.+Grosse-Kunstleveauthor=P.+D.+Adamsauthor=M.+D.+Winnauthor=L.+C.+Storoniauthor=R.+J.+Read&title=Phaser+crystallographic+software&doi=10.1107%2FS0021889807021206"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Phaser crystallographic software</span></div><div class="casAuthors">McCoy, Airlie J.; Grosse-Kunstleve, Ralf W.; Adams, Paul D.; Winn, Martyn D.; Storoni, Laurent C.; Read, Randy J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Crystallography</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">658-674</span>CODEN:
                <span class="NLM_cas:coden">JACGAR</span>;
        ISSN:<span class="NLM_cas:issn">0021-8898</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Phaser is a program for phasing macromol. crystal structures by both mol. replacement and exptl. phasing methods.  The novel phasing algorithms implemented in Phaser have been developed using max. likelihood and multivariate statistics.  For mol. replacement, the new algorithms have proved to be significantly better than traditional methods in discriminating correct solns. from noise, and for single-wavelength anomalous dispersion exptl. phasing, the new algorithms, which account for correlations between F+ and F-, give better phases (lower mean phase error with respect to the phases given by the refined structure) than those that use mean F and anomalous differences ΔF.  One of the design concepts of Phaser was that it be capable of a high degree of automation.  To this end, Phaser (written in C++) can be called directly from Python, although it can also be called using traditional CCP4 keyword-style input.  Phaser is a platform for future development of improved phasing methods and their release, including source code, to the crystallog. community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPeVyjN_FMGbVg90H21EOLACvtfcHk0ljD6rwX3CV1cg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnslWqsLk%253D&md5=c63b722ae97e0a74e6a5a079d388f09f</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1107%2FS0021889807021206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0021889807021206%26sid%3Dliteratum%253Aachs%26aulast%3DMcCoy%26aufirst%3DA.%2BJ.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DStoroni%26aufirst%3DL.%2BC.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26atitle%3DPhaser%2520crystallographic%2520software%26jtitle%3DJ.%2520Appl.%2520Crystallogr.%26date%3D2007%26volume%3D40%26spage%3D658%26epage%3D674%26doi%3D10.1107%2FS0021889807021206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Adams, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Afonine, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunkoczi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, V. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, I. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Echols, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Headd, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hung, L.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapral, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosse-Kunstleve, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCoy, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moriarty, N. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oeffner, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terwilliger, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zwart, P. H.</span><span> </span><span class="NLM_article-title">PHENIX: a comprehensive Python-based system for macromolecular structure solution</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">213</span><span class="NLM_x">–</span> <span class="NLM_lpage">221</span><span class="refDoi"> DOI: 10.1107/S0907444909052925</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=10.1107%2FS0907444909052925" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=20124702" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1Sisbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=213-221&author=P.+D.+Adamsauthor=P.+V.+Afonineauthor=G.+Bunkocziauthor=V.+B.+Chenauthor=I.+W.+Davisauthor=N.+Echolsauthor=J.+J.+Headdauthor=L.-W.+Hungauthor=G.+J.+Kapralauthor=R.+W.+Grosse-Kunstleveauthor=A.+J.+McCoyauthor=N.+W.+Moriartyauthor=R.+Oeffnerauthor=R.+J.+Readauthor=D.+C.+Richardsonauthor=J.+S.+Richardsonauthor=T.+C.+Terwilligerauthor=P.+H.+Zwart&title=PHENIX%3A+a+comprehensive+Python-based+system+for+macromolecular+structure+solution&doi=10.1107%2FS0907444909052925"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">PHENIX: a comprehensive Python-based system for macromolecular structure solution</span></div><div class="casAuthors">Adams, Paul D.; Afonine, Pavel V.; Bunkoczi, Gabor; Chen, Vincent B.; Davis, Ian W.; Echols, Nathaniel; Headd, Jeffrey J.; Hung, Li Wei; Kapral, Gary J.; Grosse-Kunstleve, Ralf W.; McCoy, Airlie J.; Moriarty, Nigel W.; Oeffner, Robert; Read, Randy J.; Richardson, David C.; Richardson, Jane S.; Terwilliger, Thomas C.; Zwart, Peter H.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">213-221</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">A review.  Macromol. X-ray crystallog. is routinely applied to understand biol. processes at a mol. level.  However, significant time and effort are still required to solve and complete many of these structures because of the need for manual interpretation of complex numerical data using many software packages and the repeated use of interactive three-dimensional graphics.  PHENIX has been developed to provide a comprehensive system for macromol. crystallog. structure soln. with an emphasis on the automation of all procedures.  This has relied on the development of algorithms that minimize or eliminate subjective input, the development of algorithms that automate procedures that are traditionally performed by hand and, finally, the development of a framework that allows a tight integration between the algorithms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpm_HgKRpa-ObVg90H21EOLACvtfcHk0ljD6rwX3CV1cg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1Sisbc%253D&md5=67b439ff4bd61c659cae37ca4209b7bc</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1107%2FS0907444909052925&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909052925%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DAfonine%26aufirst%3DP.%2BV.%26aulast%3DBunkoczi%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DV.%2BB.%26aulast%3DDavis%26aufirst%3DI.%2BW.%26aulast%3DEchols%26aufirst%3DN.%26aulast%3DHeadd%26aufirst%3DJ.%2BJ.%26aulast%3DHung%26aufirst%3DL.-W.%26aulast%3DKapral%26aufirst%3DG.%2BJ.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DMcCoy%26aufirst%3DA.%2BJ.%26aulast%3DMoriarty%26aufirst%3DN.%2BW.%26aulast%3DOeffner%26aufirst%3DR.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26aulast%3DRichardson%26aufirst%3DD.%2BC.%26aulast%3DRichardson%26aufirst%3DJ.%2BS.%26aulast%3DTerwilliger%26aufirst%3DT.%2BC.%26aulast%3DZwart%26aufirst%3DP.%2BH.%26atitle%3DPHENIX%253A%2520a%2520comprehensive%2520Python-based%2520system%2520for%2520macromolecular%2520structure%2520solution%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D213%26epage%3D221%26doi%3D10.1107%2FS0907444909052925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Emsley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowtan, K.</span><span> </span><span class="NLM_article-title">Coot: model-building tools for molecular graphics</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">2126</span><span class="NLM_x">–</span> <span class="NLM_lpage">2132</span><span class="refDoi"> DOI: 10.1107/S0907444904019158</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=10.1107%2FS0907444904019158" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=15572765" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVars73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2004&pages=2126-2132&author=P.+Emsleyauthor=K.+Cowtan&title=Coot%3A+model-building+tools+for+molecular+graphics&doi=10.1107%2FS0907444904019158"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Coot: model-building tools for molecular graphics</span></div><div class="casAuthors">Emsley, Paul; Cowtan, Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">D60</span>
        (<span class="NLM_cas:issue">12, Pt. 1</span>),
    <span class="NLM_cas:pages">2126-2132</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">CCP4mg is a project that aims to provide a general-purpose tool for structural biologists, providing tools for x-ray structure soln., structure comparison and anal., and publication-quality graphics.  The map-fitting tools are available as a stand-alone package, distributed as 'Coot'.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMisM42468k7Vg90H21EOLACvtfcHk0lgx-_a3srW6Sg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVars73P&md5=1be390f3bb6fd584468499ad0921161e</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1107%2FS0907444904019158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444904019158%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DCoot%253A%2520model-building%2520tools%2520for%2520molecular%2520graphics%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2004%26volume%3D60%26spage%3D2126%26epage%3D2132%26doi%3D10.1107%2FS0907444904019158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Chen, V. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arendall, W. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Headd, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keedy, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Immormino, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapral, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, D. C.</span><span> </span><span class="NLM_article-title">MolProbity: all-atom structure validation for macromolecular crystallography</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">12</span><span class="NLM_x">–</span> <span class="NLM_lpage">21</span><span class="refDoi"> DOI: 10.1107/S0907444909042073</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=10.1107%2FS0907444909042073" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=20057044" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;key=1%3ACAS%3A528%3ADC%252BC3cXit1Kktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=12-21&author=V.+B.+Chenauthor=W.+B.+Arendallauthor=J.+J.+Headdauthor=D.+A.+Keedyauthor=R.+M.+Immorminoauthor=G.+J.+Kapralauthor=L.+W.+Murrayauthor=J.+S.+Richardsonauthor=D.+C.+Richardson&title=MolProbity%3A+all-atom+structure+validation+for+macromolecular+crystallography&doi=10.1107%2FS0907444909042073"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">MolProbity: all-atom structure validation for macromolecular crystallography</span></div><div class="casAuthors">Chen, Vincent B.; Arendall, W. Bryan, III; Headd, Jeffrey J.; Keedy, Daniel A.; Immormino, Robert M.; Kapral, Gary J.; Murray, Laura W.; Richardson, Jane S.; Richardson, David C.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">12-21</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">MolProbity is a structure-validation web service that provides broad-spectrum solidly based evaluation of model quality at both the global and local levels for both proteins and nucleic acids.  It relies heavily on the power and sensitivity provided by optimized hydrogen placement and all-atom contact anal., complemented by updated versions of covalent-geometry and torsion-angle criteria.  Some of the local corrections can be performed automatically in MolProbity and all of the diagnostics are presented in chart and graphical forms that help guide manual rebuilding.  X-ray crystallog. provides a wealth of biol. important mol. data in the form of at. three-dimensional structures of proteins, nucleic acids and increasingly large complexes in multiple forms and states.  Advances in automation, in everything from crystn. to data collection to phasing to model building to refinement, have made solving a structure using crystallog. easier than ever.  However, despite these improvements, local errors that can affect biol. interpretation are widespread at low resoln. and even high-resoln. structures nearly all contain at least a few local errors such as Ramachandran outliers, flipped branched protein side chains and incorrect sugar puckers.  It is crit. both for the crystallographer and for the end user that there are easy and reliable methods to diagnose and correct these sorts of errors in structures.  MolProbity is the authors' contribution to helping solve this problem and this article reviews its general capabilities, reports on recent enhancements and usage, and presents evidence that the resulting improvements are now beneficially affecting the global database.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIjgsh59dO-7Vg90H21EOLACvtfcHk0lgx-_a3srW6Sg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXit1Kktg%253D%253D&md5=b5fc7574f43f01dd6e43c3663ca4f779</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1107%2FS0907444909042073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909042073%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DV.%2BB.%26aulast%3DArendall%26aufirst%3DW.%2BB.%26aulast%3DHeadd%26aufirst%3DJ.%2BJ.%26aulast%3DKeedy%26aufirst%3DD.%2BA.%26aulast%3DImmormino%26aufirst%3DR.%2BM.%26aulast%3DKapral%26aufirst%3DG.%2BJ.%26aulast%3DMurray%26aufirst%3DL.%2BW.%26aulast%3DRichardson%26aufirst%3DJ.%2BS.%26aulast%3DRichardson%26aufirst%3DD.%2BC.%26atitle%3DMolProbity%253A%2520all-atom%2520structure%2520validation%2520for%2520macromolecular%2520crystallography%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D12%26epage%3D21%26doi%3D10.1107%2FS0907444909042073" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5GMZ" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5GMZ','PDB','5GMZ'); return false;">PDB: 5GMZ</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5E0I" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5E0I','PDB','5E0I'); return false;">PDB: 5E0I</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i101"><a href="/doi/suppl/10.1021/acs.jmedchem.6b00879">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_50006"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.6b00879">10.1021/acs.jmedchem.6b00879</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Detailed experimental procedures for the synthesis of key intermediates including amidines <b>12</b>, 4,4-difluoroproline methyl ester, and <i>tert</i>-butyl ester <b>20</b>; X-ray structure of (<i>S</i>)-<b>7a</b>; data collection and refinement statistics of Y132A-<b>34a</b> cocrystal structure; CYP inhibition, plasma protein binding assay, and mechanistic studies of <b>34a</b> to the capsid assembly by size-exclusion chromatography (SEC) and transmission electron microscopy (TEM) (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b00879/suppl_file/jm6b00879_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and some data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b00879/suppl_file/jm6b00879_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00879/suppl_file/jm6b00879_si_001.pdf">jm6b00879_si_001.pdf (1.07 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00879/suppl_file/jm6b00879_si_002.csv">jm6b00879_si_002.csv (4.8 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">PDB code for <b>34a</b> is <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5GMZ">5GMZ</a>. Authors will release the atomic coordinates and experimental data upon article publication.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.6b00879&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.6b00879%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2016.59.issue-16%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.6b00879" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67996199990f3c8e","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
